UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): March 31, 2010

 

 

MDRNA, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   000-13789   11-2658569

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(I.R.S. Employer

Identification No.)

 

3830 Monte Villa Parkway, Bothell,

Washington

  98021
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: 425-908-3600

Not Applicable

Former name or former address, if changed since last report

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

x Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 1.01. Entry into a Material Definitive Agreement

On April 1, 2010, MDRNA, Inc. (the “Company”) announced that it had entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) dated as of March 31, 2010, with Cequent Pharmaceuticals, Inc. (“Cequent”), a privately-held Delaware corporation, Calais Acquisition Corp., a wholly-owned subsidiary of the Company (“Merger Sub”), and a representative of the stockholders of Cequent. The Merger Agreement provides that, upon the terms and subject to the conditions set forth in the Merger Agreement, Cequent will merge with and into Merger Sub (the “Merger”), and Cequent will be the surviving corporation. As a result of the Merger, Cequent will become a wholly-owned subsidiary of the Company.

Subject to the terms and conditions of the Merger Agreement, at the effective time of the Merger, each share of Cequent Series A-1 preferred stock and common stock outstanding immediately prior to the Merger will be exchanged for shares of the common stock, par value $0.006 per share, of the Company (“Common Stock”), at an exchange ratio that implies a purchase price for Cequent shareholders of approximately $44 million, plus an additional value of $2 million to warrant and option holders, based on the 10-day volume-weighted average price of the Common Stock on The NASDAQ Global Market ending on March 31, 2010 (the “Signing Date Stock Price”). This represents an approximate 56% equity ownership of the combined company for the stockholders of the Company and an approximate 44% equity ownership of the combined company for the stockholders of Cequent immediately following the Merger.

The transaction is expected to be tax free for U.S. federal income tax purposes for shareholders of both companies.

The Company and Cequent have made customary representations, warranties and covenants in the Merger Agreement, including, among others, covenants to conduct their businesses in the ordinary course between the execution and delivery of the Merger Agreement and the consummation of the Merger and not to engage in certain kinds of transactions or take certain actions during such period.

The Merger Agreement provides each of the Company and Cequent with specified termination rights, including the right to terminate (i) by mutual consent, (ii) by the other party if the other party fails to satisfy a closing condition, (iii) by the non-breaching party if there is a material breach of the Merger Agreement not cured within ten days of written notice by the non-breaching party, (iv) upon written notice to the other party if the Merger has not closed by August 31, 2010, (v) by the other party if there is a material adverse effect to either the Company or Cequent, (vi) by the other party if either the Company or Cequent fails to obtain stockholder approval of the transaction, (vii) by Cequent if the Company’s common stock closes below 75% of the Signing Date Stock Price (as defined in the Merger Agreement) for any ten consecutive trading days following the signing of the Merger Agreement, (viii) by the Company if the Company’s common stock closes above 125% of the Signing Date Stock Price (as defined in the Merger Agreement) for any ten consecutive trading days following the signing of the Merger Agreement and (ix) by the Company if holders representing more than 10% of Cequent’s shares outstanding exercise their appraisal rights. If Cequent terminates the Merger Agreement due to the fact that the required approval of the stockholders of the Company contemplated by the Merger Agreement is not obtained by reason of the failure to obtain the requisite vote upon a vote taken at a meeting of the Company’s stockholders convened therefor, the Company will be required to pay to Cequent an amount equal to the lesser of $500,000 or Cequent’s reasonable and actual expenses incurred in connection with the negotiation, preparation and performance of the Merger Agreement and the transactions contemplated thereby.

The Merger Agreement contains a customary “no-solicitation” covenant pursuant to which Cequent is not permitted to solicit any alternative acquisition proposals, provide any information to any person in connection with any alternative acquisition proposal, participate in any discussions or negotiations relating to any alternative acquisition proposal, approve, endorse or recommend any alternative acquisition proposal, or enter into any agreement relating to any alternative acquisition proposal.

Consummation of the Merger is subject to the satisfaction or waiver of customary closing conditions, including obtaining the requisite approvals of the stockholders of both the Company and Cequent. As of the date hereof, Cequent had obtained the approval of the requisite number of its stockholders to approve the Merger.

J. Michael French, the President, CEO and a member of the Board of Directors of the Company, will continue to serve in those roles for the combined company following the consummation of the Merger, and Peter D. Parker, Cequent’s President and CEO, will assume the Chairmanship of the combined company’s Board of Directors. The Board of Directors of the combined company will include an additional five members, two each from the existing Board of Directors of each of MDRNA and Cequent, and one additional independent director to be chosen by the new combined Board. In addition to Mr. Parker, Cequent has identified Dr. Chiang Li and Dr. Michael Taylor as its representatives on the combined company’s Board of Directors. The Company’s representatives will be chosen prior to the 2010 Annual Meeting of Stockholders.

The Merger Agreement contemplates that upon the consummation of the Merger certain principal stockholders of Cequent will enter into Lock-Up Agreements (the “Cequent Lock-Up Agreements”) pursuant to which they will agree that they shall not, without the prior approval of the Company, offer, pledge, sell, contract to sell, grant, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock received in the Merger during the period commencing on the effective date of the Merger and ending on the earlier of (A) one hundred and eighty (180) days after the effective date of the Merger or (B) thirty (30) days following the closing of an equity financing by the Company for the issuance of shares of equity or securities convertible into or exchangeable or exercisable for shares of equity of the Company (an “Equity Financing”) which, when added together to all other Equity Financings from and after the date of execution of the Merger Agreement, results in aggregate gross proceeds


to the Company of at least $10 million. Prior to the execution of the Merger Agreement, the directors and executive officers of the Company entered into Lock-Up Agreements (the “MDRNA Lock-Up Agreements”) providing for similar restrictions on sales and other dispositions of Common Stock commencing upon the signing of the Merger Agreement.

Upon the consummation of the Merger, the Company shall enter into a Registration Rights Agreement with the stockholders of Cequent pursuant to which it shall file a Registration Statement on Form S-3 with the Securities and Exchange Commission within 45 days following the consummation of the Merger to register the shares of Common Stock being issued to the stockholders of Cequent in the Merger, and provide certain other demand and piggy-back registration rights to the stockholders of Cequent.

The Board of Directors of the Company has unanimously approved the Merger Agreement and the related transactions, and has adopted a resolution recommending the requisite stockholder approval for consummation of the Merger. The Company will present the Merger at the 2010 annual stockholders’ meeting to submit these matters to its stockholders for their consideration.

The Merger Agreement has been included to provide investors and security holders with information regarding its terms. It is not intended to provide any other factual information about the Company or Cequent. The Merger Agreement contains representations, warranties and covenants that the Company and Cequent made to each other as of specific dates. The assertions embodied in those representations, warranties and covenants were made solely for purposes of the Merger Agreement between the Company and Cequent and may be subject to important qualifications and limitations agreed to by the Company and Cequent in connection with negotiating its terms, including being qualified by confidential disclosures exchanged between the parties in connection with the execution of the Merger Agreement. Moreover, the representations and warranties may be subject to a contractual standard of materiality that may be different from what may be viewed as material to investors or security holders, or may have been used for the purpose of allocating risk between the Company and Cequent rather than establishing matters as facts. Moreover, information concerning the subject matter of the representations and warranties may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in public disclosures. For the foregoing reasons, no person should rely on the representations and warranties as statements of factual information at the time they were made or otherwise.

A copy of each of the Merger Agreement, the form of Cequent Lock-Up Agreement and the form of MDRNA Lock-Up Agreement is attached hereto as Exhibit 2.1, 10.1 and 10.2, respectively, and is incorporated herein by reference. The foregoing description of the Merger, the Merger Agreement and the documents and instruments to be executed and/or issued in connection therewith, does not purport to be complete and is qualified in its entirety by reference to the definitive Merger Agreement, a copy of which is attached as an exhibit to this Current Report on Form 8-K.

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

Concurrently and in connection with the execution of the Merger Agreement described in Item 1.01 above, the Company and Cequent entered into a Loan Agreement (the “Loan Agreement”), pursuant to which, among other things, Cequent shall extend one or more loans to the Company in the aggregate principal amount of up to $3,000,000 (the “Term Loans”) to fund the Company’s operations prior to the Merger. The Term Loans are evidenced by a secured promissory note issued by the Company to Cequent (the “Term Note”), which bears interest absent an event of default, at a rate of ten percent per annum. The Company shall repay the principal and interest of the Term Loans in three equal consecutive monthly installments, commencing on August 15, 2010 and continuing on the 15 th day of each month thereafter through and including October 15, 2010. Notwithstanding the foregoing, if the Merger is consummated prior to August 15, 2010, then, on the closing date of the Merger, the Company shall not owe to any third party any obligations with respect to the Term Loans, including, without limitation the then outstanding principal balance of the Term Loans and any interest then accrued but unpaid thereon. The Company may prepay any Term Loan in whole or in part without premium or penalty.


The Term Loans are secured by a first priority security interest in substantially all the assets of the Company and its wholly-owned subsidiaries, Merger Sub, MDRNA Research, Inc. (“Research”) and Atossa HealthCare, Inc. (“Atossa” and, together with Merger Sub and Research, the “Subsidiaries”) pursuant to a Security Agreement (All Assets) by the Company and the Subsidiaries in favor of Cequent dated as of March 31, 2010 (the “Security Agreement”), a Security Agreement (Patents) by the Company in favor of Cequent dated as of March 31, 2010 (the “MDRNA Patent Security Agreement”) and a Security Agreement (Patents) by Research in favor of Cequent dated as of March 31, 2010 (the “Research Patent Security Agreement” and, together with the MDRNA Patent Security Agreement, the “Patent Security Agreements”). The Subsidiaries also entered into a Guaranty Agreement dated as of March 31, 2010 in favor of Cequent (the “Guaranty Agreement”) to guaranty all obligations of the Company and each Subsidiary to Cequent in connection with the Term Loans. The Security Agreement and the Patent Security Agreements collectively provide Cequent with a security interest in substantially all of the assets of the Company and the Subsidiaries, subject to certain permitted encumbrances as set forth in the Loan Agreement. The security interest created in the collateral will be first priority, subject to the permitted encumbrances provided in the Security Agreement and the Patent Security Agreements, and will be perfected to the extent such security interest can be perfected by the filing of a financing statement and filings with the United States Patent and Trademark Office. The security interest created in the collateral will be released at such time as the Term Notes and certain related fees are paid in full.

A copy of each of the form of Term Note, the Loan Agreement, the Security Agreement, the MDRNA Patent Security Agreement, the Research Patent Security Agreement and the Guaranty Agreement are attached hereto as Exhibits 4.1, 10.3, 10.4, 10.5, 10.6 and 10.7, respectively, and are incorporated herein by reference. The foregoing description of the transactions contemplated by the Loan Agreement and the documents and instruments to be executed and/or issued in connection therewith, does not purport to be complete and is qualified in its entirety by reference to the definitive transaction documents, copies of which are attached as exhibits to this Current Report on Form 8-K.

 

Item 3.02. Unregistered Sales of Equity Securities

In connection with the transactions contemplated by the Loan Agreement described in Item 2.03 above, the Company agreed to issue to Cequent on or about the date of each Term Loan a warrant to purchase shares of Common Stock (each, a “Loan Warrant”), with each such Loan Warrant to be exercisable for a number of shares of Common Stock equal to sixty-five percent (65%) of the principal amount of the Term Loan being made on such date divided by the Signing Date Stock Price (as defined in the Merger Agreement). The Loan Warrants are only exercisable upon the occurrence of both of the following: (x) the Merger is not consummated (other than by reason of Cequent’s material breach of the Merger Agreement), and (y) the occurrence of an Acquisition Transaction (as defined in the Loan Warrant). The obligations of the Company and the rights of Cequent under each Loan Warrant will be effective upon the issuance thereof and will survive payment of the Term Loans and the other obligations of the Company to Cequent under the Loan Agreement and the documents related thereto, and the termination of the Loan Agreement.

A copy of the form of Loan Warrant is attached hereto as Exhibit 4.2, and is incorporated herein by reference.

 

Item 3.03. Material Modification to Rights of Security Holders

In connection with the execution of the Merger Agreement described in Item 1.01 above, on March 31, 2010, the Company and American Stock Transfer & Trust Company, LLC (the “Rights Agent”) entered into an amendment (the “Amendment”) to that certain Rights Agreement (the “Rights Agreement”) dated February 22, 2000 between the Company and the Rights Agent. The Amendment provides that (i) no person shall be deemed an “Acquiring Person” (as defined in the Rights Agreement) as a result of the approval, execution or delivery of the Merger Agreement, or the transactions contemplated by the Merger Agreement and (ii) no Distribution Date (as defined in the Rights Agreement) or event described in Section 13 of the Rights Agreement shall be deemed to have occurred by reason of the approval, execution or delivery of the Merger Agreement, the announcement or consummation of the Merger, or the consummation of any other transactions contemplated by the Merger Agreement.

The foregoing summary of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Rights Agreement and to the Amendment, a copy of which is attached hereto as Exhibit 4.3.


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Prior to the execution of the Merger Agreement described in Item 1.01 above, each of J. Michael French, the President and Chief Executive Officer of the Company, Peter S. Garcia, the Chief Financial Officer and Secretary of the Company, and Barry Polisky, Ph.D., the Chief Scientific Officer of the Company, entered into a Waiver Agreement with the Company pursuant to which each such executive officer waived any and all right, title, claim and interest that he may have to receive any payments or accelerated vesting of equity awards under such executive officer’s employment agreement with the Company or under any equity compensation plan of the Company, in each case as a result of the Merger being deemed a Change of Control (as defined in the respective employment agreement or plan). In addition, the Company and each of the aforementioned executive officers agreed that if the executive’s employment is terminated on or before December 31, 2010 for any reason other than termination for cause, then notwithstanding anything to the contrary contained in any employment agreement or in any of the equity compensation plans of the Company, any and all unvested common stock options held by the executive shall immediately vest in full upon the effective date of such termination, and shall remain exercisable for a period of two (2) years thereafter (but in no event after the original expiration date of the award). Moreover, each executive acknowledged that any cash received by the Company as a result of the consummation of the Merger shall not be counted toward the $5 million in unrestricted cash threshold necessary to trigger payment by the Company to the executive of the retention bonuses previously approved by the Board of Directors of the Company.

The foregoing summary of the Waiver Agreements does not purport to be complete and is qualified in its entirety by reference to the full text of each waiver, a copy of each of which is attached hereto as Exhibit 10.8. 10.9 and 10.10, respectively.

 

Item 9.01. Financial Statements and Exhibits

(d) Exhibits:

 

Exhibit

No.

  

Description

  2.1    Agreement and Plan of Merger dated as of March 31, 2010 by and among MDRNA, Inc., Calais Acquisition Corp., Cequent Pharmaceuticals, Inc. and a representative of the stockholders of Cequent Pharmaceuticals, Inc.
  4.1    Form of Term Note
  4.2    Form of Loan Warrant
  4.3    Amendment No. 3, dated March 31, 2010, to the Rights Agreement, dated February 22, 2000, between MDRNA, Inc. and American Stock Transfer & Trust Company, LLC, as Rights Agent.
10.1    Form of Lock-Up Agreement to be signed by the Principal Stockholders of Cequent Pharmaceuticals, Inc.
10.2    Form of Lock-Up Agreement signed by the directors and executive officers of MDRNA, Inc.
10.3    Loan Agreement dated as of March 31, 2010 between MDRNA, Inc. and Cequent Pharmaceuticals, Inc.
10.4    Security Agreement (All Assets) dated as of March 31, 2010 by MDRNA, Inc., Calais Acquisition Corp., MDRNA Research, Inc. ad Atossa HealthCare, Inc. in favor of Cequent Pharmaceuticals, Inc.
10.5   

Security Agreement (Patents) dated as of March 31, 2010 by MDRNA, Inc. in favor of Cequent Pharmaceuticals, Inc.


10.6      Security Agreement (Patents) dated as of March 31, 2010 by MDRNA Research, Inc. in favor of Cequent Pharmaceuticals, Inc.
10.7      Guaranty Agreement dated as of March 31, 2010 by Calais Acquisition Corp., MDRNA Research, Inc. and Atossa HealthCare, Inc. in favor of Cequent Pharmaceuticals, Inc.
10.8      Waiver Agreement dated as of March 31, 2010 by and between MDRNA, Inc. and J. Michael French.
10.9      Waiver Agreement dated as of March 31, 2010 by and between MDRNA, Inc. and Peter S. Garcia.
10.10    Waiver Agreement dated as of March 31, 2010 by and between MDRNA, Inc. and Barry Polisky, Ph.D.

Additional Information about the Merger will be filed with the SEC

This report and the exhibit(s) attached hereto may be deemed to be solicitation material regarding the proposed merger of MDRNA and Cequent. In connection with the proposed merger, MDRNA intends to file relevant materials and documents with the Securities and Exchange Commission (SEC), including a proxy statement, which will be mailed to the stockholders of MDRNA. Investors and the public are urged to read these materials carefully and in their entirety when they become available because they will contain important information about the companies, the proposed merger and the expectations for the combined company. The proxy statement and other relevant materials (when they become available), and any and all documents filed with the SEC, may be obtained free of charge at the SEC’s web site at www.sec.gov. In addition, investors and the public may obtain free copies of the documents filed with the SEC by MDRNA by directing a written request to MDRNA, Inc., 3830 Monte Villa Parkway, Bothell, Washington 98021, Attention: Investor Relations. The directors, executive officers and employees of MDRNA may be deemed to be participants in the solicitation of proxies in connection with the proposed transaction. Information regarding the special interests of these directors, executive officers and employees in the proposed transaction, if any, will be included in the proxy statement referred to above.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    MDRNA, Inc.
April 6, 2010     By:   / S /    J. M ICHAEL F RENCH        
    Name:   J. Michael French
    Title:   President and Chief Executive Officer


EXHIBIT INDEX

 

Exhibit

No.

  

Description

    2.1    Agreement and Plan of Merger dated as of March 31, 2010 by and among MDRNA, Inc., Calais Acquisition Corp., Cequent Pharmaceuticals, Inc. and a representative of the stockholders of Cequent Pharmaceuticals, Inc.
    4.1    Form of Term Note
    4.2    Form of Loan Warrant
    4.3    Amendment No. 3, dated March 31, 2010, to the Rights Agreement, dated February 22, 2000, between MDRNA, Inc. and American Stock Transfer & Trust Company, LLC, as Rights Agent.
  10.1    Form of Lock-Up Agreement to be signed by the Principal Stockholders of Cequent Pharmaceuticals, Inc.
  10.2    Form of Lock-Up Agreement signed by the directors and executive officers of MDRNA, Inc.
  10.3    Loan Agreement dated as of March 31, 2010 between MDRNA, Inc. and Cequent Pharmaceuticals, Inc.
  10.4    Security Agreement (All Assets) dated as of March 31, 2010 by MDRNA, Inc., Calais Acquisition Corp., MDRNA Research, Inc. ad Atossa HealthCare, Inc. in favor of Cequent Pharmaceuticals, Inc.
  10.5    Security Agreement (Patents) dated as of March 31, 2010 by MDRNA, Inc. in favor of Cequent Pharmaceuticals, Inc.
  10.6    Security Agreement (Patents) dated as of March 31, 2010 by MDRNA Research, Inc. in favor of Cequent Pharmaceuticals, Inc.
  10.7    Guaranty Agreement dated as of March 31, 2010 by Calais Acquisition Corp., MDRNA Research, Inc. and Atossa HealthCare, Inc. in favor of Cequent Pharmaceuticals, Inc.
  10.8    Waiver Agreement dated as of March 31, 2010 by and between MDRNA, Inc. and J. Michael French.
  10.9    Waiver Agreement dated as of March 31, 2010 by and between MDRNA, Inc. and Peter S. Garcia.
  10.10    Waiver Agreement dated as of March 31, 2010 by and between MDRNA, Inc. and Barry Polisky, Ph.D.

Exhibit 2.1

AGREEMENT AND PLAN OF MERGER

DATED AS OF MARCH 31, 2010

BY AND AMONG

MDRNA, INC.,

CALAIS ACQUISITION CORP.,

CEQUENT PHARMACEUTICALS, INC.,


TABLE OF CONTENTS

 

     Page
ARTICLE I CERTAIN DEFINITIONS    2
ARTICLE II THE MERGER    12

2.01

   The Merger    12

2.02

   Certificate of Incorporation    12

2.03

   By-Laws    13

2.04

   Directors and Officers    13

2.05

   Effective Time    13

2.06

   Effect of Merger    13

2.07

   Conversion and Exchange of Capital Stock    13

2.08

   Stock Transfer Books    17

2.09

   No Fractional Share Certificates    17

2.10

   Certain Adjustments    17

2.11

   Lost, Stolen or Destroyed Certificates    18

2.12

   Required Deduction or Withholding    18

2.13

   Dissenting Shares    18

2.14

   Additional Actions    18
ARTICLE III CLOSING AND PAYMENT OBLIGATION    19

3.01

   Closing    19

3.02

   Deliveries by Company    19

3.03

   Deliveries by Purchaser and Merger Sub    20
ARTICLE IV ADDITIONAL AGREEMENTS    20

4.01

   Investigation    20

4.02

   Conduct of the Company’s Business Pending the Closing    21

4.03

   Conduct of Purchaser’s Business Pending the Closing    24

4.04

   Proxy Statement; Company Approval    26

4.05

   NASDAQ Global Market Listing    28

4.06

   Appropriate Action; Consents; Filings    28

4.07

   Certain Notices    29

4.08

   No Solicitation of Transactions    29

4.09

   Stock Options and Warrants    30

4.10

   Tax-Free Reorganization    31

4.11

   Tax Matters    31

4.12

   Purchaser Management and Directors Lock-up Agreements; Voting Agreement for Certain Company Stockholders    33
ARTICLE V REPRESENTATIONS AND WARRANTIES OF THE COMPANY    33


TABLE OF CONTENTS

(continued)

 

          Page

5.01

   Organization    33

5.02

   Capital Stock and Related Matters; No Investments    34

5.03

   Authorization    34

5.04

   Valid and Binding    34

5.05

   No Violation    35

5.06

   Consents and Approvals    35

5.07

   Financial Statements    35

5.08

   Interim Operations    36

5.09

   Undisclosed Liabilities    37

5.10

   Taxes    37

5.11

   Condition of Property    39

5.12

   Contracts and Commitments    39

5.13

   Intellectual Property    40

5.14

   Title to the Assets    42

5.15

   Land Use Matters    42

5.16

   Environmental Matters    43

5.17

   Insurance    43

5.18

   Employees and Labor Relations    43

5.19

   Litigation    44

5.20

   Court Orders, Decrees, and Laws    45

5.21

   Employee Benefit Plans; ERISA    45

5.22

   Broker’s Fees    47

5.23

   Related-Party Transactions    47

5.24

   Licenses; Permits    48

5.25

   Accounts Receivable    48

5.26

   Disclosure    48
ARTICLE VI REPRESENTATIONS AND WARRANTIES OF PURCHASER AND MERGER SUB    48

6.01

   Organization    49

6.02

   Capital Stock and Related Matters; No Investments    49

6.03

   Authorization    50

6.04

   Valid and Binding    50

6.05

   No Violation    50

6.06

   Consents and Approvals    50

6.07

   Interim Operations    51

6.08

   Undisclosed Liabilities    52

6.09

   Taxes    52

6.10

   Contracts and Commitments    54

6.11

   Intellectual Property    55

6.12

   Title to the Assets    57

6.13

   Employees and Labor Relations    57

6.14

   Litigation    58

 

-ii-


TABLE OF CONTENTS

(continued)

 

          Page

6.15

   Court Orders, Decrees, and Laws    59

6.16

   Licenses Permits    59

6.17

   Employee Benefit Plans; ERISA    59

6.18

   Broker’s Fees    61

6.19

   Authorization of Purchaser Common Stock    61

6.20

   No Creditor Assignment; No Bankruptcy    62

6.21

   Reports and Financial Statements    62

6.22

   Section 203 of the DGCL Not Applicable    63

6.23

   Rights Agreement    63

6.24

   Interim Operations of Merger Sub    63
ARTICLE VII CONDITIONS OF CLOSING; CERTAIN COVENANTS    63

7.01

   Conditions Precedent to the Obligations of Purchaser and Merger Sub    63

7.02

   Conditions Precedent to the Obligations of the Company    64
ARTICLE VIII    65

8.01

   Survival of Representations and Warranties    65

8.02

   Notice of Damages    65

8.03

   Agreements to Indemnify    65

8.04

   Conditions of Indemnification of Third-Party Claims    66

8.05

   Limitations on Indemnification    67
ARTICLE IX TERMINATION    67

9.01

   Termination of Agreement    67

9.02

   Effect of Termination    68
ARTICLE X MISCELLANEOUS PROVISIONS    69

10.01

   Expenses    69

10.02

   Notices    69

10.03

   Binding; No Assignment    71

10.04

   Severability    71

10.05

   Governing Law; Consent to Jurisdiction and Venue    71

10.06

   Counterparts    72

10.07

   Headings    72

10.08

   Entire Agreement; Amendment; Waiver    72

10.09

   Third Parties    72

10.10

   Publicity    72

10.11

   No Presumption    72

10.12

   Gender; Tense, Etc.    72

10.13

   Reference to Days    73

 

-iii-


SCHEDULES

Company Disclosure Schedule

Purchaser Disclosure Schedule

 

Schedule 1    List of Purchaser Management for purposes of knowledge qualifiers
Schedule 2    List of Company Management for purposes of knowledge qualifiers
Schedule 3    List of Company Stockholders who are signatories to the Lock-up Agreement
Schedule 4    List of Purchaser Management and Directors who are signatories to the Lock-up Agreement
Exhibit A    Form of Certificate of Incorporation
Exhibit B    Form of Delaware Certificate of Merger
Exhibit C-1    Form of Lock-up Agreement for Company Stockholders
Exhibit C-2    Form of Lock-up Agreement for Purchaser Stockholders
Exhibit D    Form of Accredited Investor Questionnaire
Exhibit E    Form of Voting Agreements for certain Company Stockholders
Exhibit F    Form of Stockholders Agreement Relating to Company Director Nominees
Exhibit G    Form of Registration Rights Agreement

 

-iv-


AGREEMENT AND PLAN OF MERGER (this “ Agreement ”) dated as of March 31, 2010, by and among MDRNA, Inc., a Delaware corporation (“ Purchaser ”), Calais Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of Purchaser (“ Merger Sub ”), and Cequent Pharmaceuticals, Inc., a Delaware corporation (the “ Company ”).

WHEREAS, the Company is in the business of the development and commercialization of novel therapeutics to prevent and treat a wide range of human diseases, including, without limitation, inflammatory diseases and cancer, based on the Company’s proprietary technology, TransKingdom RNA interference (the “ Company Business ”); and

WHEREAS, the respective Boards of Directors of Purchaser, Merger Sub and the Company have, subject to the conditions of this Agreement, determined that the Merger (as defined in Section 2.01 below) is advisable and in the best interests of their respective companies and stockholders and approved this Agreement and the transactions contemplated hereby; and

WHEREAS, pursuant to the Merger, Purchaser will acquire all of the outstanding equity securities of Company by way of merger of Company with and into Merger Sub and Purchaser will issue not more than 41,200,000 shares (subject to adjustment in accordance with Section 2.07(j) of the Agreement) of Purchaser Common Stock to the Company (and cash in lieu of fractional shares) in consideration for the Merger, with such shares to include approximately 2,897,629 shares of Purchaser Common Stock subject to stock options and warrants of the Company outstanding on the date of this Agreement;

WHEREAS, within seventy-two (72) hours of the execution and delivery of this Agreement and as a condition and inducement to the parties’ willingness to enter into this Agreement, the stockholders of the Company specified in Section 4.12(b) of this Agreement shall have entered into the Voting Agreement in the form attached hereto as Exhibit E , pursuant to which such stockholders will, among other things, agree to vote in favor of the Merger, and the executive officers and directors of Purchaser specified in Section 4.12(a) shall have entered into the Lock-up Agreement within such 72-hour period in the form attached hereto as Exhibit C-2 ;

WHEREAS, Purchaser, Merger Sub and the Company intend, by approving resolutions authorizing this Agreement, to adopt this Agreement as a plan of reorganization within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended (the “ Code ”), and the regulations thereunder, and to cause the Merger to qualify as a reorganization under the provisions of Section 368(a) of the Code;

WHEREAS, Purchaser, Merger Sub and the Company desire to make certain representations, warranties, covenants and agreements in connection with the Merger;

NOW, THEREFORE, in consideration of the mutual premises recited above and the representations, warranties, covenants and agreements contained in this Agreement, the parties hereto, intending to be legally bound, hereby agree as follows:


ARTICLE I

CERTAIN DEFINITIONS

As used in this Agreement each of the following terms shall have the following meaning:

Acquisition Proposal ” means any proposal or offer from any Person or group of Persons (other than the Company, Purchaser, Merger Sub or their Affiliates) relating to:

(a) any merger, consolidation, amalgamation, share exchange, business combination, issuance of securities, acquisition of securities, reorganization, recapitalization, tender offer, exchange offer or other similar transaction: (i) in which the Company (or any subsidiary thereof) is a constituent corporation; (ii) in which a Person or “group” (as defined in the Exchange Act and the rules promulgated thereunder) of Persons directly or indirectly acquires beneficial or record ownership of securities representing more than 20% of the outstanding securities of any class of voting securities of the Company; or (iii) in which the Company issues securities representing more than 20% of the outstanding securities of any class of voting securities of the Company;

(b) any sale, lease, exchange, transfer, license, acquisition or disposition of any business or businesses or assets that constitute or account for: (i) 20% or more of the consolidated net revenues of the Company, or consolidated book value of the assets of the Company; or (ii) 20% or more of the fair market value of the assets (including intangible assets) of the Company; or

(c) any liquidation or dissolution of the Company; provided , however , that the term “Acquisition Proposal” shall not include the Merger or any of the other transactions contemplated by this Agreement.

Adjudication ” shall have the meaning ascribed to such term in Section 2.07(b).

Affiliate ” shall mean an affiliate of an individual or entity as the term “affiliate” is defined in the rules and regulations promulgated under the Securities Act of 1933, as amended.

Aggregate Merger Consideration Amount ” shall mean $46,000,000 minus the Aggregate Option and Warrant Consideration Amount.

Aggregate Option and Warrant Consideration Amount ” shall mean (A) aggregate number of shares of Company Common Stock for which all Company Stock Options and Warrants that are outstanding immediately prior to Effective Time are exercisable (assuming for such purposes that such Company Stock Options and Warrants are fully vested) (the “ Aggregate Option and Warrant Common Equivalents ”) multiplied by (B) the quotient of (i) $46,000,000, minus the sum of the aggregate Series A-1 Per Share Preference and Series A-1 Accrued Dividends for all shares of Series A-1 Preferred Stock, and plus the Aggregate Option and Warrant Exercise Price Amount and (ii) the sum of the number of outstanding shares of Company Common Stock and Series A-1 Preferred Stock immediately prior to the Effective Time (assuming for purposes of such calculation conversion of the Series A-1 Preferred Stock to Company Common Stock in accordance with the Company Certificate of Incorporation and

 

-2-


assuming no unpaid dividends thereon) plus the Aggregate Option and Warrant Common Equivalents minus (C) the Aggregate Option and Warrant Exercise Amount.

Aggregate Option and Warrant Exercise Amount ” shall mean the aggregate exercise price for the Aggregate Option and Warrant Common Equivalents immediately prior to the Effective Time (assuming for such purposes that such Company Stock Options and Warrants are fully vested).

Agreement ” shall mean this Agreement and Plan of Merger and all schedules and exhibits hereto.

Ancillary Copyrights ” shall mean Intellectual Property constituting unregistered copyrights that either (i) do not embody Proprietary Information or Trade Secrets, or (ii) are not used in the ordinary course of the conduct of the Company Business or Purchaser Business, as applicable.

Audit ” shall mean any audit, any other examination by any Tax Authority, or any judicial, administrative or other proceeding or litigation (including any appeal of any such judicial, administrative or other proceeding or litigation) relating to Taxes and/or Tax Returns.

Charter Amendment ” shall have the meaning ascribed to such term in Section 4.04(a).

Closing ” shall have the meaning ascribed to such term in Section 2.05.

Closing Date ” shall have the meaning ascribed to such term in Section 3.01.

Closing Date Tax Period ” means any Taxable Periods ending on the Closing Date.

Code ” shall have the meaning ascribed to such term in the preamble of this Agreement.

Commonly Controlled Entity ” shall mean any entity which is under common control with the Company within the meaning of Sections 414(b), (c), (m), (o) or (t) of the Code.

Company ” shall have the meaning ascribed to such term in the preamble of this Agreement.

Company Business ” shall have the meaning ascribed to such term in the first WHEREAS clause of this Agreement.

Company Certificates ” shall have the meaning ascribed to such term in Section 2.07(c).

Company Certificate of Incorporation ” shall mean the Amended and Restated Certificate of Incorporation immediately prior to the Effective Time (and immediately prior to being amended and restated in accordance with Section 2.02).

Company Common Stock ” shall mean each outstanding share of common stock, par value $0.001 per share, of the Company.

 

-3-


Company Financial Statements ” shall have the meaning ascribed to such term in Section 5.07.

Company Knowledge ” means the actual knowledge, after reasonable inquiry, of the persons set forth in Schedule 2 .

Company Leases ” shall have the meaning ascribed to such term in Section 5.12(b).

Company Option ” shall have the meaning ascribed to such term in Section 4.09(a).

Company Preferred Stock ” shall mean, collectively, each outstanding share of Series A Preferred Sock and Series A-1 Preferred Stock.

Company Shares ” shall have the meaning ascribed to such term in Section 5.02(a).

Company Stockholder Approval ” shall mean the approval, by the holders of the requisite number of Company Shares, of the Merger and the transactions contemplated by this Agreement.

Company Warrant ” shall have the meaning ascribed to such term in Section 2.07(i).

Contract ” shall mean any contract, agreement, license, commitment, lease, or restriction of any kind to which the Company or Purchaser, as applicable, is a party or by which the Company or Purchaser, as applicable, is bound, including, but not limited to, Third-Party Licenses.

Copyrights ” shall mean the unregistered copyrights, copyright registrations and applications therefor of the Company or Purchaser, as applicable, all of which are set forth on Schedule 5.13(a) or Schedule 6.10(a) .

CSE Exchange Ratio ” shall have the meaning ascribed to such term in Section 2.07(a).

Delaware Certificate of Merger ” shall have the meaning ascribed to such term in Section 2.05.

DGCL ” shall have the meaning ascribed to such term in Section 2.01.

Dissenting Shares ” shall have the meaning ascribed to such term in Section 2.13.

Effective Time ” shall have the meaning ascribed to such term in Section 2.05.

Employee ” and “ Employees ” shall have the meaning ascribed to such term in Section 5.18.

Encumbrance ” shall mean any claim, mortgage, pledge, lien, security or other third party right or interest of any kind whatsoever, conditional sales agreement, option, encumbrance or charge of any kind affecting real or personal property.

 

-4-


Environmental Claims ” shall mean any and all claims, actions, causes of action, or other written notices by any Person or entity alleging potential liability (including, but not limited to, potential liability for investigatory costs, cleanup costs, governmental response costs, natural resources damages, property damages, personal injuries, or civil or criminal penalties) arising out of or resulting from (i) circumstances forming the basis of any violation of any Environmental Laws or (ii) any releases of Hazardous Materials at any real or personal property presently or formerly owned, leased or managed by the Company or at any disposal facility which may have received Hazardous Materials generated by the Company.

Environmental Laws ” shall mean any applicable federal, state, local or foreign law, treaty, judicial decision, regulation, rule, judgment, order, decree, injunction, permit or governmental restriction, each as in effect on or prior to the Closing Date, relating to the environment.

Environmental Permits ” shall mean Permits required by Environmental Laws.

ERISA ” shall mean the Employee Retirement Income Security Act of 1974, as amended.

Escrow Agent ” shall have the meaning ascribed to such term in Section 2.07(b).

Escrow Agreement ” shall have the meaning ascribed to such term in Section 2.07(b).

Escrow Balance ” shall have the meaning ascribed to such term in Section 2.07(b).

Escrow Shares ” shall have the meaning ascribed to such term in Section 2.07(b).

Exchange Act ” shall mean the Securities Exchange Act of 1934, as amended.

Exempt Issuance ” shall mean the issuance by Purchaser of (1) shares of Purchaser Common Stock and options to purchase shares of Purchaser Common Stock to employees, officers or directors of Purchaser in the ordinary course of business and consistent with past practice pursuant to any stock or option plan duly adopted for such purpose by a majority of the non-employee members of the Purchaser Board or a majority of the members of a committee of non-employee directors established for such purpose; (2) shares of Purchaser Common Stock upon the exercise or exchange of or conversion of any securities exercisable or exchangeable for or convertible into shares of Purchaser Common Stock issued and outstanding on the date of this Agreement; (3) securities of Purchaser, including any warrants and other convertible securities, having a fair market value on the date on which definitive agreements are executed of not greater than $5,000,000 in connection with the acquisition by Purchaser of any other entity or the assets of any such entity, or the grant by any other Person to Purchaser of a license to all or a portion of the intellectual property of such Person; or (4) securities of Purchaser, including any warrants and other convertible securities, in a public or private offering of securities to investors having a fair market value on the date on which definitive agreements are executed of not greater than $5,000,000 and at a price of not less than 85% of the fair market value of such securities on the date on which definitive agreements are executed. For purposes of items (3) and (4) of the definition of “Exempt Issuance”, the fair market value of the Purchaser Common Stock shall be

 

-5-


deemed to be the last reported closing price of the Purchaser Common Stock on the Nasdaq Global Market prior to the execution of definitive agreements.

GAAP ” shall mean United States generally accepted accounting principles, consistently applied.

Governmental Authorizations ” shall mean all governmental approvals, authorizations, certifications, consents, variances, permissions, licenses, directives, and permits to or from, or filings, notices, or recordings to or with United States federal, state, and local governmental authorities.

Hazardous Materials ” shall include (a) any element, compound, or chemical that is defined, listed or otherwise classified as a contaminant, pollutant, toxic pollutant, toxic or hazardous substance, extremely hazardous substance or chemical, hazardous waste, biohazardous or infectious waste, special waste, or solid waste under Environmental Laws; (b) petroleum, petroleum-based or petroleum-derived products; (c) polychlorinated biphenyls; (d) any substance exhibiting a hazardous waste characteristic including but not limited to corrosivity, ignitability, toxicity or reactivity as well as any radioactive or explosive materials; and (e) any asbestos-containing materials.

INA ” shall have the meaning ascribed to such term in Section 5.18(h).

ISO’s ” shall have the meaning ascribed to such term in Section 4.09(c).

Intellectual Property ” shall mean any and all of the following: (i) Patents; (ii) Trade Secrets; (iii) Copyrights; and (iv) Trademarks.

Intellectual Property Registrations ” shall mean any and all of the following related to the Intellectual Property: (i) issued Patents and applications for Patents; (ii) Copyright registrations and applications to register Copyrights to the extent eligible for registration; (iii) registered Trademarks, applications to register Trademarks, including intent-to-use applications, or other registrations or applications related to Trademarks; and (iv) any other application, certificate (including supplemental protection certificates), filing, registration or other document issued by, filed with, or recorded by, any governmental entity at any time, which document (when so filed or recorded) creates or conveys legally enforceable rights with respect to any Intellectual Property or proprietary right anywhere in the world.

Investment ” shall mean, as applied to any Person, (i) any direct or indirect purchase or other acquisition by such Person of any notes, obligations, instruments, stock, securities or ownership interest (including without limitation partnership interests and joint venture interests) of any Person and (ii) any capital contribution by such Person to any other Person.

Law ” means any federal, state, foreign, material local or municipal or other law, statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, regulation, ruling or requirement issued enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any governmental entity (or under the authority of the NASDAQ Stock Market, Inc. or the Financial Industry Regulatory Authority).

 

-6-


Leased Tangible Property ” shall mean all machinery, furniture, equipment and other tangible personal property, in each case which is subject to a leasehold interest held by the Company or Purchaser, as applicable.

Licensed Intellectual Property ” shall mean Intellectual Property which the Company or Purchaser, as applicable, has the right to use by agreement (such as a Third-Party License) with a Person (or another Person acting as an authorized representative of such Person) claiming to own (or control the Company’s or Purchaser’s, as applicable, use of) such Intellectual Property.

Licensed Rights ” shall mean the Company’s or Purchaser’s, as applicable, rights to practice or otherwise exploit any intellectual property owned by a third party pursuant to any Contract.

Material Adverse Effect ” shall mean a material adverse effect, either individually or when aggregated with other such effects, on the assets, business, operations, financial condition or results of operations of the Company or Purchaser, as applicable, but excluding changes in the general economy in the United States.

Material Contract ” shall mean the following Contracts:

(a) all Contracts, including, without limitation, broker, distributor, dealer, manufacturer’s representative, franchise, agency, sales promotion, market research, marketing consulting and advertising Contracts to which the Company is a party involving aggregate annual payments by or to the Company of more than $25,000;

(b) all management Contracts (other than employment agreements) and Contracts with other consultants, including any Contracts involving the payment of royalties or other amounts calculated based upon (x) the revenues or income of the Company or (y) the revenues or income of any product of the Company to which the Company is a party, excepting those Contracts that involve aggregate annual consideration payable by the Company of less than $5,000;

(c) all Contracts that limit or purport to limit the ability of the Company or any key executives of the Company (except those between such key executive and the Company) to compete in any line of business or with any Person or in any geographic area or location or during any period of time;

(d) all Contracts obligating the Company to (A) make a future purchase of materials, supplies or equipment that (I) has annual payments by the Company in excess of $25,000, or (II) has a term extending for more than one year from the date of this Agreement, or (B) deliver materials, products or supplies (including sales orders) that (x) has annual payments to the Company in excess of $25,000, or (y) has a term extending for more than one year from the date of this Agreement;

(e) all joint venture Contracts or partnership arrangements involving a sharing of profits, losses, costs or liabilities by the Company;

(f) all contractual obligations to sell or otherwise dispose of any assets;

 

-7-


(g) all Contracts providing for the acquisition by the Company of any Intellectual Property rights from any Person, the grant by any Person to the Company of a license to use any Intellectual Property rights, and the grant by the Company of any Intellectual Property rights to any other Person;

(h) all Contracts between the Company and any other party providing for the acquisition or disposition by the Company (including, without limitation, by merger, consolidation, acquisition or disposition of stock or assets or any other business combination) of any corporation, partnership, other business organization or division thereof or an amount of assets material to the business or to such other party; and

(i) all Contracts under which (i) the Company has any obligation for indebtedness for borrowed money or (ii) the Company has any obligation constituting a guarantee of any indebtedness for borrowed money owing by any other Person.

Merger ” shall have the meaning ascribed to such term in Section 2.01.

Merger Consideration ” shall have the meaning ascribed to such term in Section 2.07(a).

Merger Sub ” shall have the meaning ascribed to such term in the preamble of this Agreement.

Option Holder ” and “ Option Holders ” shall mean those individuals who hold Company Options, all of whom are listed on Schedule 5.02 hereof.

Owned Tangible Property ” shall mean all machinery, furniture, fixtures, equipment and other tangible personal property owned by the Company or Purchaser, as applicable.

Patent Agency ” means any federal, national, multinational, state, provincial or local regulatory agency, department, bureau or other governmental entity with authority to grant legally enforceable protection to inventions or discoveries.

Patents ” shall mean all of the Company’s or Parent’s, as applicable, patents, patent applications, utility models, certificates of invention, patents of addition or substitution, and other governmental grants for the protection of inventions anywhere in the world, including any reissue, renewal, re-examination, or extension thereof, and applications for any of the foregoing, including any international, regional, national, provisional, divisional, continuation, continuation in part, continued prosecution, supplemental protection certificates and petty patent applications, all of which are set forth on Schedule 5.13(a) or Schedule 6.10(a) .

Permit ” shall mean any license, franchise, permit, consent, order, approval, authorization or registration from, of or with a governmental entity.

Person ” shall mean an individual, partnership, corporation, limited liability company, association, joint stock company, trust, joint venture, unincorporated organization or governmental entity or any department, agency or political subdivision thereof.

Plan ” and “ Plans ” shall have the meaning ascribed to such term in Section 5.21.

 

-8-


Post-2006 Period ” shall have the meaning ascribed to such term in Section 5.10(j).

Pre-Closing Straddle Tax Liability ” shall mean any Straddle Period Taxes.

Pre-Closing Tax Periods ” shall mean Taxable Periods ending before the Closing Date.

Principal Stockholder ” and “ Principal Stockholders ” shall mean the stockholders of the Company identified on the signature pages to the Voting Agreement.

Proceeding ” shall mean any notice of investigation or claim or any action, suit, proceeding, hearing, investigation, charge, complaint, claim or demand, pending or threatened, of any nature.

Proprietary Information ” shall mean the technical, commercial, marketing or other information, data and material of the Company or Purchaser, as applicable, as of the Closing Date to the extent that such information, data or material was generally considered by the Company or Purchaser, as applicable, prior to the Effective Date to be confidential or proprietary in nature including any algorithm; procedure; idea; concept; strategic, business and other plan; research; invention or invention disclosure (whether patentable or unpatentable); test, engineering and technical materials, customer lists, know-how, show-how or methodology; trade secret, process, design, formula, software source code and other non-public programming such as applets, assemblers and compilers, and other information or data which has not entered the public domain, and all records or fixations of any of the foregoing, including but not limited to, laboratory notes and software documentation, if any.

Proxy Statement ” shall have the meaning ascribed to such term in Section 4.04(a).

Purchaser ” shall have the meaning ascribed to such term in the preamble of this Agreement.

Purchaser Board ” shall mean the Board of Directors of Purchaser.

Purchaser Business ” shall mean the business of discovery, development and commercialization of pharmaceuticals based on RNA interference.

Purchaser Certificates ” shall have the meaning ascribed to such term in Section 2.07(c).

Purchaser Common Stock ” shall mean the common stock, par value $0.006 per share, of Purchaser.

Purchaser Financial Statements ” shall have the meaning ascribed to such term in Section 6.21(b).

Purchaser Knowledge ” shall mean the actual knowledge, after reasonable inquiry, of the persons set forth in Schedule 1 .

Purchaser Leases ” shall have the meaning ascribed to such term in Section 6.10(b).

 

-9-


Purchaser Material Contract ” shall have the meaning ascribed to such term in Section 6.10(a).

Purchaser Preferred Stock ” shall have the meaning ascribed to such term in Section 6.02(a).

Purchaser Shares ” shall have the meaning ascribed to such term in Section 6.02(a).

Purchaser Stockholder Approval ” shall mean the approval by the stockholders of Purchaser of the Charter Amendment and the Purchaser Stock Issuance at the Purchaser Stockholders’ Meeting.

Purchaser Stockholders’ Meeting ” shall have the meaning ascribed to such term in Section 4.04(a).

Purchaser Stock Issuance ” shall have the meaning ascribed to such term in Section 4.04(a).

Purchaser Subsidiaries ” shall mean, individually or collectively as the context may require, Atossa Healthcare, Inc., a Delaware corporation, MDRNA Research, Inc., a Delaware corporation, and Merger Sub, each of which are wholly-owned Subsidiaries of Purchaser.

Real Property ” means all fee or leasehold interests, easements, real estate licenses, rights to access and other rights with respect to real property.

Related Documents ” shall mean all agreements, instruments, documents and certificates to be executed and delivered pursuant to this Agreement.

Release ” shall mean any spilling, leaking, pumping, emitting, emptying, discharging, injecting, escaping, leaching, migrating, dumping, or disposing of Hazardous Materials (including the abandonment or discarding of barrels, containers or other closed receptacles containing Hazardous Materials) into the environment in violation of any applicable Environmental Law.

Release Date ” shall have the meaning ascribed to such term in Section 2.07(b).

Required Cash Amount ” shall mean, as of the Closing Date, the amount equal to (i) $5,100,000, minus (ii) the amount of the Company’s ordinary course operating expenses from June 2, 2010 through the Closing Date; plus (iii) the difference of $3,000,000 and the aggregate principal amount loaned to the Purchaser by the Company under the Loan Agreement.

SEC ” shall mean the United States Securities and Exchange Commission.

SEC Documents ” shall have the meaning ascribed to such term in Section 6.21.

Securities Act ” shall mean the Securities Act of 1933, as amended.

 

-10-


Series A-1 Per Share Accrued Dividends ” shall have the meaning as ascribed in Section 2.07(a)(ii).

Series A-1 Per Share Preference ” shall mean one dollar ($1.00) per share.

Series A Preferred Stock ” shall mean each shares of Series A convertible preferred stock, par value $0.001 per share, of the Company.

Series A-1 Preferred Stock ” shall mean each share of Series A-1 convertible preferred stock, par value $0.001 per share, of the Company.

Signing Date Stock Price ” shall mean $1.1496.

Stockholders ” shall mean those Persons who hold shares of (i) Company Common Stock and (ii) Company Preferred Stock.

Stockholders’ Representative ” means Ampersand 2006 Limited Partnership.

Straddle Period ” shall mean any tax period which includes, but does not end, on the Closing Date.

Subsidiary ” shall mean with respect to any Person, each entity of which a majority of the voting power or equity interest is owned, directly or indirectly, by such Person.

Subsidiary Business ” shall have the meaning ascribed to such term in Section 4.03.

Surviving Corporation ” shall have the meaning ascribed to such term in Section 2.01.

Tangible Property ” shall mean the Owned Tangible Property and the Leased Tangible Property.

Tax ” shall mean any federal, territorial, state, local, or foreign income, gross receipts, license, payroll, wage, employment, excise, utility, communications, production, occupancy, severance, stamp, occupation, premium, windfall profits, environmental, customs duties, capital stock, capital levy, franchise, profits, withholding, social security (or similar), unemployment, disability, real property, real property gains, recordation, business license, workers’ compensation, Pension Benefit Guaranty Corporation, personal property, sales, use, transfer, registration, value added, ad valorem, alternative or add-on minimum, estimated, or other tax, fee, charge, premium, imposition of any kind whatsoever in the nature of taxes, however denominated, imposed by any Tax Authority, including any obligation to pay any such amount owed by another Person, together with any interest, penalties or other additions to tax and any interest on any such interest, penalties and additions to tax that may become payable in respect thereof.

Tax Authority ” shall mean the Internal Revenue Service (“IRS”) and any other federal, territorial, state, local or foreign government and any agency, authority or political subdivision of any of the foregoing.

 

-11-


Tax Law ” shall mean the Code, any federal, territorial, state, county, local or foreign laws related to Taxes and any regulations or official administrative pronouncements released under any such laws.

Tax Returns ” shall mean all reports, estimates, declarations of estimated tax, information statements and returns relating to, or required to be filed in connection with, any Taxes, including information returns or reports with respect to backup withholding and other payments to third parties.

Taxable Period ” means any taxable year or any other period that is treated as a taxable year with respect to which any Tax may be imposed under any Tax Law.

Third-Party License ” shall mean all licenses, agreements, obligations or other commitments under which a Person has granted the Company or Purchaser, as applicable, a right to use any Licensed Intellectual Property in connection with the Company Business or Purchaser Business, as applicable.

Trademarks ” shall mean the trade names, trade dress, logos, common law trademarks and service marks, trademark and service mark registrations and applications therefor, World Wide Web addresses and domain names and applications and registrations therefor, and all goodwill associated with all of the foregoing throughout the world, in each case of the Company or Purchaser, as applicable, all of which are set forth on Schedule 5.13(a) or Schedule 6.10(a) .

Trade Secrets ” shall mean non-public information, know-how and other Proprietary Information which, as a result of its not being generally known to the public or to a particular industry, confer upon those to whom it has been disclosed a competitive advantage or other valuable benefit in connection with the conduct of the Company Business or Purchaser Business, as applicable, all of which are set forth on, or generally described in, Schedule 5.13(a) or Schedule 6.10(a) .

Treasury Regulations ” shall mean the regulations of the United States Treasury promulgated under the Code.

USPTO ” means the United States Patent and Trademark Office.

ARTICLE II

THE MERGER

2.01 The Merger . Subject to the terms and conditions of this Agreement and in accordance with the Delaware General Corporation Law (the “ DGCL ”), at the Effective Time (as defined in Section 2.05), Merger Sub shall be merged with and into the Company (the “ Merger ”), and the Company shall be the surviving corporation in the Merger (the “ Surviving Corporation ”) and shall continue its corporate existence under the Laws of the State of Delaware with all its rights, privileges, immunities, powers and franchises continuing unaffected by the Merger. At the Effective Time, the separate existence of Merger Sub shall cease.

2.02 Certificate of Incorporation . At the Effective Time, the certificate of incorporation of the Surviving Corporation shall be amended and restated to read as set forth on

 

-12-


Exhibit A hereto, and as so amended shall be the certificate of incorporation of the Surviving Corporation until thereafter amended in accordance with applicable Law.

2.03 By-Laws . At the Effective Time, the by-laws of Merger Sub, as in effect immediately prior to the Effective Time, shall be the by-laws of the Surviving Corporation until thereafter amended or restated as provided therein or by applicable Law.

2.04 Directors and Officers .

(a) At the Effective Time, the directors and officers of Merger Sub immediately prior to the Effective Time shall become the directors and officers of the Surviving Corporation. Each director and officer of the Surviving Corporation shall hold office in accordance with the certificate of incorporation and by-laws of the Surviving Corporation.

(b) Immediately prior to the Effective Time, the Board of Directors of Purchaser shall cause Purchaser’s Board of Directors to consist of no more than seven persons, and with respect to such Board of Directors: (i) to appoint three Company nominees in accordance with the Stockholders Agreement attached as Exhibit F (the “ Company Nominees ”), to the Board of Directors, (ii) to appoint three Purchaser nominees, which may include Purchaser’s directors immediately prior to the Effective Time and (iii) to appoint a nominee selected by both Company and Purchaser, subject in each case to the independence requirements and any other qualification requirements of directors set forth in the applicable Marketplace Rules of the NASDAQ Global Market. In addition, immediately prior to the Effective Time, Purchaser shall take all necessary action so that, following the Effective Time, Peter D. Parker, or another person selected by the directors designated by the Company, shall serve as Chairman of the Purchaser Board, and J. Michael French shall continue to serve as Chief Executive Officer of Purchaser.

2.05 Effective Time . The Merger shall be effected by the filing, at the time of the Closing as provided in Section 3.01 (the “ Closing ”), of a certificate of merger, substantially in the form of Exhibit B hereto (the “ Delaware Certificate of Merger ”), with the Secretary of State of the State of Delaware in accordance with the provisions of Section 251 of the DGCL. The Merger shall become effective at the time of such filing or at such later time as is set forth in the Delaware Certificate of Merger (the “ Effective Time ”).

2.06 Effect of Merger . At and after the Effective Time, the effect of the Merger shall, in all respects, be as provided in this Agreement, the Delaware Certificate of Merger, and the DGCL. Without limiting the generality of the foregoing, and subject thereto, at the Effective Time, all of the property, rights, privileges, powers and franchises of the Company and Merger Sub shall vest in the Surviving Corporation, and all debts, liabilities and duties of the Company and Merger Sub shall become the debts, liabilities and duties of the Surviving Corporation.

2.07 Conversion and Exchange of Capital Stock .

(a) Merger Consideration . At the Effective Time, by virtue of the Merger and automatically without any action on the part of Parent, Company, Merger Sub, or any Stockholder, each share of Series A-1 Preferred Stock and Company Common Stock issued and outstanding immediately prior to the Effective Time, excluding (i) Dissenting Shares and (ii)

 

-13-


shares held in the treasury of the Company and all rights in respect thereof, shall, forthwith cease to exist and be converted into and become exchangeable for the right to receive the number of shares of Purchaser Common Stock (the “ Merger Consideration ”) equal to:

(i) With respect to each outstanding share of Series A-1 Preferred Stock the sum of the following:

(A) the quotient of (1) the sum of the Series A-1 Per Share Preference and the Series A-1 Per Share Accrued Dividends that the holder of such share of Series A-1 Preferred Stock is entitled to receive in accordance with the Company Certificate of Incorporation divided by (2) the Signing Date Stock Price. “ Series A-1 Per Share Accrued Dividends ” is determined on a share-by-share basis based on date of issuance of the share in accordance with the Company Certificate of Incorporation; plus

(B) the product of the number of shares of Common Stock issuable upon the conversion of such share of Series A-1 Preferred Stock immediately prior to the Effective Time pursuant to the Company Certificate of Incorporation in accordance with the Company Certificate of Incorporation (assuming no unpaid dividends thereon) multiplied by the CSE Exchange Ratio;

(ii) With respect to each outstanding share of Company Common Stock, a number equal to the CSE Exchange Ratio. “ CSE Per Share Merger Consideration ” shall equal the quotient of (a) the difference of (i) the Aggregate Merger Consideration Amount minus (ii) the sum of the aggregate Series A-1 Per Share Preference and Series A-1 Accrued Dividends for all shares of Series A-1 Preferred Stock and (b) the number of outstanding shares of Company Common Stock and Series A-1 Preferred Stock immediately prior to the Effective Time (assuming for purposes of such calculation conversion of the Series A-1 Preferred Stock to Company Common Stock in accordance with the Company Certificate of Incorporation and assuming no unpaid dividends thereon). The “ CSE Exchange Ratio ” shall equal the CSE Per Share Merger Consideration divided by the Signing Date Stock Price.

(b) Escrow Arrangement . At the Effective Time, Purchaser shall deduct from the Merger Consideration such number of shares of Purchaser Common Stock as is equal to ten percent (10%) of the aggregate Merger Consideration (such shares, the “ Escrow Shares ”), which Purchaser shall deposit with an internationally recognized escrow agent or bank mutually agreed by the parties (the “ Escrow Agent ”), for the purpose of securing the Company’s indemnification obligations hereunder. The Escrow Shares shall be held by the Escrow Agent in accordance with the terms hereof and of an escrow agreement in a form mutually agreed by the parties (the “ Escrow Agreement ”). On January 1, 2011 (the “ Release Date ”), in accordance with the terms of the Escrow Agreement, the Escrow Agent shall release the Escrow Shares and deliver to the Stockholders all of the Escrow Shares, minus such number of Escrow Shares having a value (based on the Signing Date Stock Price) equal to the amount of any Claim or Claims that have been set forth in a Notice pursuant to Article VIII of this Agreement (whether or not such Claim or Claims have been determined to be valid as of such date) (the remaining Escrow Shares after the Release Date that either have not been released to the Stockholders or have not been released to Purchaser in respect of any Claims being referred to herein as the “ Escrow Balance ”), and the Escrow Balance shall be retained in escrow pending Adjudication of such Claim.

 

-14-


Adjudication ” shall mean, unless otherwise agreed among the parties hereto, a final judgment or order of a court of competent jurisdiction not subject to any further appeals. Upon the Adjudication of a Claim, if the Escrow Balance exceeds the aggregate amount of all remaining unresolved Claims, Purchaser shall instruct the Escrow Agent to release, in accordance with the terms of the Escrow Agreement, to the Stockholders such number of Escrow Shares representing such excess from the Escrow Shares retained by the Escrow Agent, it being understood that if at such time the aggregate number of Escrow Shares being retained by the Escrow Agent have a value that is less than or equal to the aggregate amount of all Claims pending at such time, Purchaser shall not be obligated to release any Escrow Shares to the Stockholders, subject , however to the Adjudication of such Claims. The parties agree that the mechanism set forth in this Section 2.07(b) shall be the sole and exclusive remedy available to Purchaser to satisfy any of its rights to indemnification set forth in Article VIII of this Agreement.

(c) Exchange Procedures . Promptly (but in any event no more than five (5) business days) after the Effective Time, Purchaser shall mail to each holder of record of certificates of Company Common Stock and Company Preferred Stock (collectively, “ Company Certificates ”), whose shares were converted into the right to receive shares of Purchaser Common Stock (and cash in lieu of fractional shares pursuant to Section 2.09): (i) a letter of transmittal in form and substance satisfactory to the Company, such approval not to be unreasonably withheld (which shall specify that delivery shall be effected, and risk of loss and title to the Company Certificates shall pass, only upon receipt of the Company Certificates by Purchaser, and shall be in such form and have such other provisions as Purchaser may reasonably specify); and (ii) instructions for use in effecting the surrender of the Company Certificates in exchange for the applicable Merger Consideration. Upon surrender of a Company Certificate for cancellation to Purchaser or to such agent or agents as may be appointed by Purchaser, together with such letter of transmittal, duly completed and validly executed, and such other documents as may be reasonably required by Purchaser, the holder of such Company Certificate shall be entitled to receive in exchange therefor a certificate of Purchaser Common Stock (“ Purchaser Certificates ”) representing the number of whole shares of Purchaser Common Stock that such holder has the right to receive pursuant to this Article II (together with payment of cash in lieu of fractional shares which such holder has the right to receive pursuant to Section 2.09) and the Company Certificate so surrendered shall forthwith be canceled. Until so surrendered, each outstanding Company Certificate that, prior to the Effective Time, represented shares of Company Common Stock or Company Preferred Stock, as the case may be, will be deemed from and after the Effective Time, for all purposes other than the payment of dividends and distributions, to evidence the ownership of the number of full shares of Purchaser Common Stock into which such shares of Company Common Stock or Company Preferred Stock, as the case may be, shall have been so converted (together with payment of cash in lieu of fractional shares which such holder has the right to receive pursuant to Section 2.09). Notwithstanding any other provision of this Agreement, no interest will be paid or will accrue on any cash payable to holders of Company Certificates pursuant to the provisions of this Article II.

(d) Distributions With Respect to Unexchanged Shares . No dividends or other distributions with respect to Purchaser Common Stock with a record date after the Effective Time will be paid to the holder of any unsurrendered Company Certificate with respect to the shares of Purchaser Common Stock represented thereby until such holder surrenders such Company Certificate. Subject to the effect of applicable escheat or similar Laws, following the

 

-15-


surrender of any such Company Certificate, there shall be paid to the record holder of the Purchaser Certificates issued in exchange therefor, without interest, (i) at the time of such surrender, the amount of any such dividends or other distributions with a record date after the Effective Time theretofore payable (but for the provisions of this Section 2.07(d)) with respect to such shares of Purchaser Common Stock and (ii) at the appropriate payment date the amount of dividends or other distributions with a record date after the Effective Time but prior to such surrender and with a payment date subsequent to such surrender payable with respect to such whole Purchaser Common Stock.

(e) Transfer of Ownership . If any Purchaser Certificate is to be issued in a name, or cash in lieu of fractional shares paid to a person, other than that in which the Company Certificate surrendered in exchange therefor is registered, it will be a condition of the issuance and/or payment thereof that the Company Certificate so surrendered will be properly endorsed and otherwise in proper form for transfer and that the person requesting such exchange will have paid to Purchaser or any agent designated by it any transfer or other Taxes required by reason of the issuance of a Purchaser Certificate for shares of Purchaser Common Stock in any name other than that of the registered holder of the Company Certificate surrendered, or established to the satisfaction of Purchaser or any agent designated by it that such Tax has been paid or is not payable.

(f) Stockholders’ Rights . At and after the Effective Time, the Stockholders shall cease to have any rights as stockholders of the Company, and the Company’s capital stock shall cease to be outstanding and shall be cancelled and retired.

(g) Treasury Stock . Each share of capital stock of the Company held in the Company’s treasury, and each share of capital stock of the Company owned by Purchaser or any wholly-owned subsidiary of Purchaser, in each case immediately prior to the Effective Time shall, by virtue of the Merger and without any action on the part of the Company, be cancelled and retired and cease to exist, without any conversion thereof or any payment of any consideration therefor.

(h) Treatment of Stock Options . All options to purchase Company Common Stock then outstanding under the Company’s 2006 Stock Incentive Plan shall be assumed by Purchaser in accordance with Section 4.09.

(i) Treatment of Warrants . All warrants outstanding at the Effective Time to purchase Company Common Stock (collectively, the “ Company Warrants ”), shall be treated in accordance with Section 4.09.

(j) Adjustment for Additional Cash . If, as of the Closing Date, the Company has available more than the Required Cash Amount, then Purchaser may determine in its sole discretion to accept such additional cash, in exchange for adjusting the CSE Exchange Ratio to reflect such additional value, as may be agreed upon by the parties. If Purchaser does not decide to make such adjustment or the parties cannot agree on the amount of such adjustment, then, notwithstanding anything in Section 4.02, Company shall have the right to distribute (by means of a dividend or otherwise), immediately prior to the Effective Time, such excess Required Cash

 

-16-


Amount to the Company stockholders, in accordance with its certificate of incorporation in effect at such time.

(k) Treatment of Merger Sub Capital Stock . Each share of capital stock of Merger Sub issued and outstanding immediately prior to the Effective Time shall, by virtue of the Merger and without any action on the part of the holder thereof, be converted into one validly issued, fully paid and non-assessable share of common stock of the Surviving Corporation.

(l) Limitations . Notwithstanding anything contained in this Section 2.07, the aggregate number of shares of Purchaser Common Stock issuable under this Section 2.07 (as a result of the conversion of the Company Shares and the exercise of the options and warrants, if any, to purchase Company Common Stock or Company Preferred Stock assumed by Purchaser) shall in no event exceed forty-nine and ninety-nine hundredths percent (49.99%) of the outstanding shares of Purchaser Common Stock immediately after the Effective Time.

2.08 Stock Transfer Books . As of the Effective Time, the stock transfer books of the Company shall each be closed, and there shall be no further registration of transfers of shares of Company Common Stock thereafter on the records of any such stock transfer books. In the event of a transfer of ownership of shares of Company Common Stock that is not registered in the stock transfer records of the Company at the Effective Time, a certificate or certificates representing the number of full shares of Purchaser Common Stock into which such shares of Company Common Stock, as the case may be, shall have been converted, if any, shall be issued to the transferee together with a cash payment in lieu of fractional shares, if any, in accordance with Section 2.09 hereof, and a cash payment in the amount of dividends, if any, in accordance with Section 2.07(d) hereof, if the certificate or certificates representing such shares of Company Common Stock, as the case may be, is or are surrendered as provided in Section 2.07(c) hereof, accompanied by all documents required to evidence and effect such transfer and by evidence of payment of any applicable stock transfer tax.

2.09 No Fractional Share Certificates . No scrip or fractional share Purchaser Certificate shall be issued upon the surrender for exchange of Company Certificates, and an outstanding fractional share interest shall not entitle the owner thereof to vote, to receive dividends or to any rights of a stockholder of Purchaser or of the Surviving Corporation with respect to such fractional share interest. As promptly as practicable following the Effective Time, Purchaser shall pay each holder of Company Common Stock and Company Preferred Stock, as applicable, net of withholding taxes, an amount in cash, rounded to the nearest whole cent, equal to the product obtained by multiplying (i) the fractional share interest to which such holder would otherwise be entitled (after taking into account all shares of Company Common Stock and Company Preferred Stock held at the Effective Time by such holder) by (ii) the Signing Date Stock Price.

2.10 Certain Adjustments . If between the date of this Agreement and the Effective Time, the outstanding shares of Purchaser Common Stock or Company Common Stock shall be changed into a different number of shares by reason of any reclassification, recapitalization, split-up, combination or exchange of shares, or any dividend payable in stock or other securities shall be declared thereon with a record date within such period, then the CSE Exchange Ratio shall be adjusted accordingly to provide to Purchaser and the Company the same economic effect

 

-17-


as contemplated by this Agreement prior to such reclassification, recapitalization, split-up, combination, exchange or dividend.

2.11 Lost, Stolen or Destroyed Certificates . In the event any Company Certificates shall have been lost, stolen or destroyed, Purchaser shall issue in exchange for such lost, stolen or destroyed Company Certificates, upon the making of an affidavit of that fact by the holder thereof, such shares of Purchaser Common Stock (and cash in lieu of fractional shares) as may be required pursuant to Section 2.07(a), provided , however , that Purchaser may, in its discretion and as a condition precedent to the issuance thereof, require the owner of such lost, stolen or destroyed Company Certificates to indemnify Purchaser against any claim that may be made against Purchaser or the Surviving Corporation with respect to the Company Certificates alleged to have been lost, stolen or destroyed.

2.12 Required Deduction or Withholding . Each of Purchaser and the Surviving Corporation shall be entitled to deduct and withhold from the consideration otherwise payable to any holder of Company Common Stock pursuant to this Agreement such amounts as may be required to be deducted or withheld with respect to the making of such payment or any other payment in connection with the transactions contemplated by this Agreement under the Code or any applicable provision of state, local or foreign Tax Law. To the extent that amounts are so deducted or withheld and paid over to the appropriate taxing authority by Purchaser or the Surviving Corporation, such amounts shall be treated for all purposes of this Agreement as having been paid to the person to whom such amounts would otherwise have been paid.

2.13 Dissenting Shares . Notwithstanding anything in this Agreement to the contrary, shares of the Company’s capital stock outstanding immediately prior to the Effective Time and held by a Stockholder who has not voted in favor of the Merger or consented thereto in writing and who has demanded appraisal for such shares in accordance with Section 262 of the DGCL, if such Section 262 provides for appraisal rights for such capital stock in the Merger (“ Dissenting Shares ”), shall not be converted into the right to receive a pro rata portion of the Merger Consideration as provided in Section 2.07, unless and until such holder fails to perfect or withdraws or otherwise loses his or her right to appraisal and payment under the DGCL. If, after the Effective Time, any such holder fails to perfect or withdraws or loses his or her right to appraisal, such Dissenting Shares shall thereupon be treated as if they had been converted as of the Effective Time into the right to receive a pro rata portion of the Merger Consideration, if any, to which such holder is entitled, without interest or dividends thereon. The Company shall give Purchaser prompt notice of any demands received by the Company for appraisal of capital stock and, prior to the Effective Time, Purchaser shall have the right to participate in all negotiations and proceedings with respect to such demands. Prior to the Effective Time, the Company shall not, except with the prior written consent of Purchaser, make any payment with respect to, or settle or offer to settle, any such demands.

2.14 Additional Actions . If, at any time after the Effective Time, the Surviving Corporation shall consider or be advised that any further assignments or assurances in law or any other acts are reasonably necessary or desirable (a) to vest, perfect or confirm, of record or otherwise, in the Surviving Corporation, title to and possession of any property or right of the Company acquired or to be acquired by reason of, or as a result of, the Merger, or (b) otherwise to carry out the purposes of this Agreement, the Company and its proper officers and directors

 

-18-


shall be deemed to have granted to the Surviving Corporation an irrevocable power of attorney to execute and deliver all such proper deeds, assignments and assurances in law and to do all acts necessary or proper to vest, perfect or confirm title to and possession of such property or rights in the Surviving Corporation and otherwise reasonable to carry out the purposes of this Agreement; and the proper officers and directors of the Surviving Corporation are fully authorized in the name of the Company or otherwise to take any and all such action.

ARTICLE III

CLOSING AND PAYMENT OBLIGATION

3.01 Closing . The consummation of the Merger contemplated by this Agreement (the “ Closing ”) shall be held at the offices of Pryor Cashman LLP, 7 Times Square, New York, New York, at 11:00 A.M., local time, no later than the fifth (5th) business day following the satisfaction or waiver (by Purchaser and Merger Sub, in the case of the conditions in Section 7.01 and by the Company in the case of the conditions in Section 7.02) of all of the conditions to Closing set forth in Article VII hereof, or such other time, place and date as may be mutually agreed upon by the parties hereto. The date of the Closing is sometimes herein referred to as the “ Closing Date ”. By mutual agreement of the parties, the Closing may be alternatively accomplished by facsimile transmission to the respective offices of legal counsel for the parties of the requisite documents, duly executed where required, with originals to be delivered by overnight courier service on the next business day following the Closing.

3.02 Deliveries by Company . The Company agrees to deliver (or cause to be delivered) to Purchaser and Merger Sub at the Closing on the Closing Date the following agreements and documents, all reasonably satisfactory in form and substance to Purchaser, Merger Sub and their legal counsel:

(a) a certificate of good standing and/or subsistence, dated as of a recent date prior to the Closing, issued by the Secretary of State of the State of Delaware and of each other jurisdiction in which the Company is required to be qualified to do business;

(b) all corporate minute and stock books, stock ledgers and corporate seals of the Company;

(c) written resignations of all officers and members of the Board of Directors of the Company;

(d) evidence of receipt of all consents set forth on Schedule 5.06 ;

(e) a certificate of an officer of the Company in a form approved in advance by Purchaser, dated the Closing Date, certifying that attached thereto is (A) a true, correct and complete certified copy of the Certificate of Incorporation of the Company, (B) a true, correct and complete copy of the by-laws of the Company, and (C) a true, correct and complete copy of any resolutions adopted by the Board of Directors of the Company or the Stockholders relating to this Agreement or the transactions contemplated hereby, in each case as are then in full force and effect;

 

-19-


(f) a duly executed Lock-Up Agreement signed by each of the Principal Stockholders, in the form of Exhibit C-1 hereto;

(g) Accredited Investor Questionnaires duly signed and completed by all Company Stockholders in the form of Exhibit D hereto;

(h) a duly executed Voting Agreement signed by each of the Principal Stockholders, in the form of Exhibit E hereto;

(i) a duly executed Escrow Agreement signed by the Company, in the form of Exhibit H hereto;

(j) such other documents and instruments as may be reasonably required to effectuate the terms of this Agreement and to comply with the terms hereof.

3.03 Deliveries by Purchaser and Merger Sub . Subject to the terms and conditions of this Agreement, Purchaser and Merger Sub agree to deliver at the Closing to the Company and the Stockholders’ Representative the following:

(a) the Merger Consideration;

(b) a duly executed Escrow Agreement signed by Purchaser, in the form of Exhibit H hereto; and

(c) such other documents and instruments as may be reasonably required to effectuate the terms of this Agreement and to comply with the terms hereof.

ARTICLE IV

ADDITIONAL AGREEMENTS

4.01 Investigation . During the period commencing on the date of this Agreement and ending upon the earlier to occur of the termination of this Agreement and the Effective Time, each party to this Agreement agrees to cooperate fully with the other parties to this Agreement and to give to such other parties, their officers, employees, auditors, legal counsel, representatives and agents reasonable access during normal business hours to all such information, documents, premises and employees as the requesting party reasonably considers necessary or advisable for purposes of its investigation of Purchaser, the Company and the Company Business, as applicable. The parties hereto agree to consult with each other in an effort to establish procedures designed to implement the provisions of this Section 4.01 in order to minimize disruption to Purchaser, the Company and the Company Business, as applicable. Pending the Closing, each party hereto shall preserve the confidentiality of any information provided to such party relating to Purchaser, the Company and the Company Business which is confidential in nature. In the event of termination of this Agreement, the parties hereto agree to maintain the confidentiality of such information except to the extent that such item:

(a) is or becomes publicly known or generally known in the industry through no act of the receiving party;

 

-20-


(b) is required to be disclosed to or by order of a governmental agency or a court of law or otherwise as required by Law; provided that prior to any such disclosure notice of such requirement of disclosure is provided to the disclosing party and the disclosing party is afforded the reasonable opportunity to object to such disclosure; or

(c) is required to be disclosed to the parties’ attorneys, accountants or other agents or employees working on this transaction.

4.02 Conduct of the Company’s Business Pending the Closing . The Company agrees that from the date hereof through the Closing Date, the Company Business will be conducted only in the ordinary course consistent with past practice, and, except as may be permitted by this Agreement, or as otherwise shown on Schedule 4.02 or approved in writing in advance by Purchaser, the Company agrees as follows:

(a) The Company will, so far as it is within its power to do so, carry on the Company Business diligently and substantially in the same manner as heretofore conducted, and the Company shall not institute any new methods of acquisition, production, marketing, distribution, sale, lease, license, management, operation, or engage in any transaction or activity, enter into any agreement or make any commitment, except in the ordinary course of business and consistent with past practice.

(b) The Company shall not institute any new methods of accounting except in accordance with generally accepted accounting principles.

(c) The Company shall use its commercially reasonable efforts to preserve the Company Business intact, to protect and preserve the Company’s assets, and to preserve for Purchaser the Company’s relationships with licensors, suppliers, distributors, customers, contractors and employees.

(d) Except as required pursuant to (i) applicable Law, (ii) any Contract in existence prior to the date hereof binding upon the Company, or (iii) by this Agreement, the Company shall not:

(i)(A) borrow or agree to borrow any funds or (B) incur, or assume or become subject to, whether directly or by way of guarantee or otherwise, any obligation or liability (absolute or contingent), except in the case of clause (B) obligations and liabilities incurred in the ordinary course of business and consistent with past practice;

(ii) permit or allow any of its assets to be subjected to any Encumbrance of any kind or description, other than Encumbrances in existence on the date hereof or mechanics liens or similar Encumbrances for service or work in process;

(iii) sell, assign, transfer, license, dispose of or permit to lapse any rights to the use of any Intellectual Property (and the Company shall take all actions necessary in respect of any infringement of any Intellectual Property of which it has Company Knowledge), or dispose of or disclose to any Person any trade secret, formula, process or know how not theretofore a matter of public knowledge;

 

-21-


(iv) make any single capital expenditure or future commitment in excess of $20,000 for additions to property, plant or equipment or make aggregate capital expenditures or future commitments in excess of $50,000 for additions to property, plant or equipment;

(v) pay, loan or advance any amount to, or sell, transfer or lease any properties or assets to, or enter into any agreement or arrangement with, any Affiliate;

(vi) change any of the Company’s banking or safe deposit arrangements;

(vii) grant or extend any power of attorney or act as guarantor, surety, co-signer, endorser, co maker, indemnitor or otherwise in respect of the obligation of any Person;

(viii) pay any amounts (whether in cash or property) to any employee of the Company other than in the ordinary course of business and consistent with past practice or pursuant to any Contract;

(ix) grant to any officer or employee any increase in compensation or benefits, other than increases in compensation or benefits for employees in the ordinary course of business and consistent with past practice;

(x) pay any pension, retirement allowance or other employee benefit not required by any plan, policy or program identified on Schedule 5.21(a) hereto;

(xi) adopt, agree to adopt, or make any announcement regarding the adoption of (i) any new pension, retirement or other employee benefit plan, policy or program or (ii) any amendments to any existing plan, policy or program identified on Schedule 5.21(a) unless required by applicable Law;

(xii)(A) declare, set aside or pay any dividend or distribution that is payable in cash, stock, or other property with respect to the Company; (B) redeem, purchase or otherwise acquire, directly or indirectly, any shares of the Company, or any other securities thereof or any rights, warrants, or options to acquire any such shares or other securities; (C) other than as set forth at the end of this Section 4.02, authorize for issuance, issue, sell, pledge, deliver or agree to commit to issue, sell or pledge (whether through the issuance or granting of any options, warrants, calls, subscriptions, equity appreciation rights or other rights or other agreements) any equity or debt securities of the Company, or any other securities that are convertible into or exchangeable for shares of any class of the company; or (D) split, combine or reclassify the outstanding shares of the Company, or authorize the issuance of any other securities in respect of, in lieu of or in substitution for shares of any equity securities of the Company;

(xiii) adjust, settle or compromise any claim, obligation, debt, demand, suit or judgment against or on behalf of the Company, except for claims, obligations, debts, demands, suits or judgments that do not involve an Affiliate of the Company and do not exceed more than $20,000 in any single instance or more than $50,000 in the aggregate; or

 

-22-


(xiv) agree, whether in writing or otherwise, to do any of the foregoing.

(e) No contract or commitment will be entered into, and no purchase of supplies and no sale, lease, license, assignment, transfer or disposition of any of the Company’s assets will be made, by or on behalf of the Company, except (i) normal contracts or commitments for the purchase of, and normal purchases of, supplies or inventory or for the sale of inventory, in each case made in the ordinary course of business and consistent with past practice, and (ii) other contracts, commitments, purchases or sales in the ordinary course of business, consistent with past practice and involving assets having a value not in excess of $20,000.

(f) The Company shall maintain the same insurance coverage (to the extent commercially reasonable) set forth on Schedule 5.17 hereto and all property insured thereby shall be used, operated, maintained and repaired in the ordinary course of business and consistent with past practice.

(g) The Company shall not do any act or omit to do any act, or permit any act or omission to act, which will cause a breach of any Material Contract or commitment of the Company or which would cause the breach by the Company of any representation, warranty, covenant or agreement made hereunder.

(h) The Company shall duly comply in all material respects with all Laws applicable to it and its properties, operations, business and employees.

(i) The Company shall file all Federal, state, local and foreign Tax Returns and amendments thereto required to be filed by them and shall pay all Taxes shown as due and payable thereon. All returns and reports in respect of employee withholdings, FICA, unemployment and other similar items and other applicable Taxes shall be timely made as shall all deposits and payments due in respect of such Taxes and obligations.

(j) The Company has provided the Purchaser with an operating budget for the expected period from the date hereof through the Closing Date, as set forth in Schedule 4.02(j) , and agrees it will operate its business according to such operating budget in all material respects.

Notwithstanding anything to the contrary in this Section 4.02, this Section 4.02 shall not prohibit the Company from doing any of the following between the date hereof through the Closing Date:

(1) authorize, issue, and sell additional shares of Company capital stock, or debt or warrants convertible into capital stock of the Company, to new and existing investors in the Company, including but not limited through the sale of up to $7,520,000 of Series A-1 Preferred Convertible Stock of the Company;

(2) accelerating the vesting of outstanding Company Stock Options as described in Schedule 5.21(e) ; and

(3) loan money to the Purchaser as contemplated under that certain Loan Agreement being entered into concurrently with this Agreement between Purchaser and

 

-23-


the Company (the “ Loan Agreement ”) pursuant to the terms of the Loan Documents (as defined in such Loan Agreement).

4.03 Conduct of Purchaser’s Business Pending the Closing . Purchaser agrees that from the date hereof through the Closing Date, the Purchaser Business and the respective businesses of each Purchaser Subsidiary (each, a “ Subsidiary Business ”) will be conducted only in the ordinary course consistent with past practice, and, except as may be permitted by this Agreement, or as otherwise shown on Schedule 4.03 or approved in writing in advance by the Company, Purchaser agrees as follows:

(a) Purchaser will, so far as it is within its power to do so, carry on the Purchaser Business (and will cause each Purchaser Subsidiary to carry on its respective Subsidiary Business) diligently and substantially in the same manner as heretofore conducted, and Purchaser shall not (and shall not permit any Purchaser Subsidiary to) institute any new methods of acquisition, production, marketing, distribution, sale, lease, license, management, operation, or engage in any transaction or activity, enter into any agreement or make any commitment, except in the ordinary course of business and consistent with past practice.

(b) Purchaser shall not (and shall not permit any Purchaser Subsidiary to) institute any new methods of accounting except in accordance with generally accepted accounting principles.

(c) Purchaser shall use (and shall cause each Purchaser Subsidiary to use) its commercially reasonable efforts to preserve the Purchaser Business and each Subsidiary business intact, to protect and preserve Purchaser’s and each Purchaser Subsidiary’s assets, and to preserve for the Company Purchaser’s and each Purchaser Subsidiary’s relationships with licensors, suppliers, distributors, customers, contractors and employees.

(d) Except as required pursuant to (i) applicable Law (ii) any Contract in existence prior to the date hereof binding upon Purchaser, or (iii) this Agreement, Purchaser shall not (and shall not permit any Purchaser Subsidiary to):

(i) (A) borrow or agree to borrow any funds or (B) incur, or assume or become subject to, whether directly or by way of guarantee or otherwise, any obligation or liability (absolute or contingent), except in the case of clause (B) obligations and liabilities incurred in the ordinary course of business and consistent with past practice;

(ii) permit or allow any of its assets to be subjected to any Encumbrance of any kind or description, other than Encumbrances in existence on the date hereof or contemplated hereby, or mechanics liens or similar Encumbrances for service or work in process, and other than in connection with the transactions contemplated by this Agreement;

(iii) sell, assign, transfer, license, dispose of or permit to lapse any rights to the use of any Intellectual Property (and Purchaser shall take (and shall cause each Purchaser Subsidiary to take) all actions necessary in respect of any infringement of any Intellectual Property of which it has Purchaser Knowledge), or dispose of or disclose to any Person any trade secret, formula, process or know how not theretofore a matter of public knowledge, other than (x) any sale, assignment, transfer, license or other disposition of any of

 

-24-


Purchaser’s legacy intranasal assets, and (y) licenses by Purchaser of any of its Intellectual Property in the ordinary course of Purchaser’s Business consistent with past practice (other than licenses solely to Purchaser’s Di-Alkylated Amino Acid delivery technology); provided , however , that nothing in item (y) above shall prohibit Purchaser from licensing any of its Intellectual Property, including its Di-Alkylated Amino Acid delivery technology, in connection with any multi-year target-based or therapeutic-based collaboration between Purchaser and a pharmaceutical company substantially similar to those collaborations previously discussed with the Company;

(iv) make any single capital expenditure or future commitment in excess of $100,000 for additions to property, plant or equipment, make aggregate capital expenditures or future commitments in excess of $200,000 with respect to Purchaser and the Purchaser Subsidiaries as a whole for additions to property, plant or equipment, or make any expenditure with respect to the acquisition of the intellectual property of a third party in excess of $250,000 with respect to Purchaser and the Purchaser Subsidiaries as a whole (but not including future commitments with respect thereto);

(v) pay, loan or advance any amount to, or sell, transfer or lease any properties or assets to, or enter into any agreement or arrangement with, any Affiliate or with any Subsidiary other than a Purchaser Subsidiary;

(vi) change any of Purchaser’s or such Purchaser Subsidiary’s banking or safe deposit arrangements;

(vii) grant or extend any power of attorney or act as guarantor, surety, co-signer, endorser, co maker, indemnitor or otherwise in respect of the obligation of any Person;

(viii) pay any amounts (whether in cash or property) to any employee of Purchaser or any Purchaser Subsidiary other than in the ordinary course of business and consistent with past practice or pursuant to any Contract;

(ix) grant to any officer or employee any increase in compensation or benefits, other than increases in compensation or benefits for employees in the ordinary course of business and consistent with past practice;

(x) pay any pension, retirement allowance or other employee benefit not required by any plan, policy or program identified on Schedule 6.17(a) hereto;

(xi) adopt, agree to adopt, or make any announcement regarding the adoption of (i) any new pension, retirement or other employee benefit plan, policy or program or (ii) any amendments to any existing plan, policy or program identified on Schedule 6.17(a) unless required by applicable Law;

(xii)(A) declare, set aside or pay any dividend or distribution that is payable in cash, stock, or other property with respect to Purchaser (provided that nothing herein shall prohibit the payments of dividends or distributions by any Purchaser Subsidiary to Purchaser); (B) redeem, purchase or otherwise acquire, directly or indirectly, any shares of Purchaser or any Purchaser Subsidiary, or any other securities thereof or any rights, warrants, or

 

-25-


options to acquire any such shares or other securities; (C) except for any pledge of equity securities of each Purchaser Subsidiary to the Company, authorize for issuance, issue, sell, pledge, deliver or agree to commit to issue, sell or pledge (whether through the issuance or granting of any options, warrants, calls, subscriptions, equity appreciation rights or other rights or other agreements) any equity or debt securities of Purchaser or any Purchaser Subsidiary, or any other securities that are convertible into or exchangeable for shares of any class of Purchaser or any Purchaser Subsidiary, other than an Exempt Issuance; or (D) split, combine or reclassify the outstanding shares of Purchaser or any Purchaser Subsidiary, or authorize the issuance of any other securities in respect of, in lieu of or in substitution for shares of any equity securities of Purchaser or any Purchaser Subsidiary;

(xiii) adjust, settle or compromise any claim, obligation, debt, demand, suit or judgment against or on behalf of Purchaser or any Purchaser Subsidiary, except for claims, obligations, debts, demands, suits or judgments that do not involve an Affiliate of Purchaser and do not exceed more than $50,000 in any single instance or more than $100,000 in the aggregate with respect to Purchaser and the Purchaser Subsidiaries as a whole; or

(xiv) agree, whether in writing or otherwise, to do any of the foregoing.

(e) Purchaser shall maintain (and shall cause each Purchaser Subsidiary to maintain) the same insurance coverage (to the extent commercially reasonable) as on the date of this Agreement and all property insured thereby shall be used, operated, maintained and repaired in the ordinary course of business and consistent with past practice.

(f) Purchaser shall not do any act or omit to do any act, or permit any act or omission to act (or permit any Purchaser Subsidiary to so do, or omit to do, or to so permit any act or omission), which will cause a breach of any Purchaser Material Contract or commitment of Purchaser or any Purchaser Subsidiary or which would cause the breach by Purchaser or any Purchaser Subsidiary of any representation, warranty, covenant or agreement made hereunder.

(g) Purchaser shall duly comply (and shall cause each Purchaser Subsidiary to duly comply) in all material respects with all Laws applicable to it and its properties, operations, business and employees.

(h) Purchaser shall file (and shall cause each Purchaser Subsidiary to file) all Federal, state, local and foreign Tax Returns and amendments thereto required to be filed by them and shall pay (and shall cause each Purchaser Subsidiary to pay) all Taxes shown as due and payable thereon. All returns and reports in respect of employee withholdings, FICA, unemployment and other similar items and other applicable Taxes shall be timely made as shall all deposits and payments due in respect of such Taxes and obligations.

4.04 Proxy Statement; Company Approval .

(a) As promptly as practicable after the execution of this Agreement, (but in any event within 30 days after the date hereof) Purchaser shall prepare and shall file with the SEC a document or documents that will constitute the proxy statement with respect to the Merger (together with any amendments thereto, the “ Proxy Statement ”) relating to the special meeting of the stockholders of Purchaser (such meeting, the “ Purchaser Stockholders’ Meeting ”)

 

-26-


to be held to consider approval of an amendment to the Certificate of Incorporation of Purchaser to increase the number of authorized shares of Purchaser Common Stock to 180,000,000 (the “ Charter Amendment ”) and the issuance of Purchaser Common Stock to the Stockholders pursuant to this Agreement and the Merger (the “ Purchaser Stock Issuance ”). Purchaser shall use commercially reasonable efforts to cause the Proxy Statement to be cleared by the SEC as promptly as practicable after the date hereof, and, prior to such date, Purchaser shall take all action required under any applicable Laws in connection with the Purchaser Stock Issuance. The Company shall furnish all information concerning the Company as Purchaser may reasonably request in connection with such actions and the preparation of the Proxy Statement. Purchaser shall notify the Company of the receipt of any comments from the SEC on the Proxy Statement and of any requests by the SEC for any amendments or supplements thereto or for additional information and shall provide to the Company promptly copies of all correspondence between Purchaser or any of its representatives and advisors and the SEC. Purchaser shall mail, or cause to be mailed, to the stockholders of Purchaser, and shall duly call the Purchaser Stockholders’ Meeting, as promptly as reasonably practicable in accordance with applicable Law following the date on which the SEC clears the Proxy Statement.

(b) None of the information supplied by the Company for inclusion or incorporation by reference in the Proxy Statement shall, (a) at the time filed with the SEC or other regulatory agency, (b) at the date it or any amendments or supplements thereto are first mailed to stockholders of Purchaser, (c) at the time of the Purchaser Stockholders’ Meeting and (d) at the Effective Time, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading. If at any time prior to the Effective Time any event or circumstance relating to the Company, or any of its officers or directors, should be discovered by the Company that should be set forth in an amendment or a supplement to the Proxy Statement, the Company shall promptly inform Purchaser. All documents that the Company is responsible for filing with the SEC in connection with the Merger, if any, will comply as to form in all material respects with the applicable requirements of the rules and regulations of the Securities Act and the Exchange Act.

(c) Purchaser shall promptly notify the Company of the receipt of all comments of the SEC staff with respect to the Proxy Statement and of any request by the SEC staff for any amendment or supplement thereto or for additional information and shall promptly provide the Company copies of all correspondence between Purchaser and/or any of its representatives, on the one hand, and the SEC staff, on the other hand, with respect to the Proxy Statement.

(d) Subject to applicable Laws, notwithstanding anything to the contrary stated above, prior to filing or mailing the Proxy Statement or filing any other required filings (or, in each case, any amendment or supplement thereto) or responding to any comments of the SEC staff with respect thereto, Purchaser shall promptly provide the Company with an opportunity to review and comment on such document or response and shall in good faith consider for inclusion in such document or response comments reasonably and timely proposed by the Company.

 

-27-


(e) As promptly as practicable following the execution of this Agreement, and in no event more than seventy-two (72) hours following the execution of this Agreement, the Company shall take, or cause to be taken, all appropriate action, and do, or cause to be done, all things necessary, proper or advisable to obtain the Company Stockholder Approval.

4.05 NASDAQ Global Market Listing . Purchaser shall promptly prepare and submit to The NASDAQ Stock Market, Inc. a listing application covering the shares of Purchaser Common Stock to be issued in the transactions contemplated by this Agreement, such listing to be effective at or prior to the Effective Time and shall use commercially reasonable efforts to cause such shares to be approved for listing on The NASDAQ Global Market. The Company shall furnish such information concerning it, any of its Affiliates and the holders of the Company’s capital stock as Purchaser may reasonably request in connection with such actions and the preparation of the listing application.

4.06 Appropriate Action; Consents; Filings .

(a) Purchaser and the Company shall use their commercially reasonable efforts to (A) take, or cause to be taken, all appropriate action, and do, or cause to be done, all things necessary, proper or advisable under applicable Law or otherwise to consummate and make effective the transactions contemplated by this Agreement as promptly as practicable, (B) obtain from any governmental entity any consents, licenses, permits, waivers, approvals, authorizations or orders required to be obtained or made by Purchaser or the Company or any of their respective Subsidiaries, or to avoid any action or proceeding by any governmental entity, in connection with the authorization, execution and delivery of this Agreement and the consummation of the transactions contemplated hereby, including, without limitation, the Merger, and (C) make all necessary filings, and thereafter make any other required submissions, with respect to this Agreement and the transactions contemplated hereby, including the Merger, required under (x) the Securities Act and the Exchange Act, and any other applicable federal or state securities Laws, and (y) any other applicable Law.

(b) Notwithstanding anything to the contrary contained in this Agreement, but subject to any agreement between Purchaser and the Company contained in any document evidencing or relating to the term loan to be made by the Company to Purchaser on or about the date of this Agreement, no party shall have any obligation under this Agreement: (i) to dispose of or transfer or cause any of its Subsidiaries to dispose of or transfer any assets; (ii) to discontinue, or cause any its Subsidiaries to discontinue, offering any product or service; (iii) to license or otherwise make available, or cause any its Subsidiaries to license or otherwise make available, to any person any Intellectual Property; (iv) to hold, or cause any of its Subsidiaries to hold, separate any assets or operations (either before or after the Effective Time); (v) to make, or cause any of its Subsidiaries to make, any commitment (to any governmental entity or otherwise) regarding its future operations or to contest any Legal Proceeding or any order, writ, injunction or decree relating to the transactions contemplated hereby if such party determines in good faith that contesting such Legal Proceeding or order, writ, injunction or decree could materially adversely affect such party.

(c) Purchaser and the Company shall give (or shall cause any of their respective Subsidiaries to give) any notices to third parties, and use all commercially reasonable

 

-28-


best efforts to obtain any third party consents necessary, proper or advisable to consummate the transactions contemplated in this Agreement.

4.07 Certain Notices .

(a) Purchaser shall give prompt notice to the Company, and the Company shall give prompt notice to Purchaser, of (i) the occurrence, or non-occurrence, of any event the occurrence or non-occurrence of which would be reasonably likely to cause any representation or warranty contained in this Agreement to be materially untrue or inaccurate, and (ii) any failure of Purchaser, any Purchaser Subsidiary or the Company, as the case may be, materially to comply with or satisfy any covenant, condition or agreement to be complied with or satisfied by it hereunder; provided, however, that the delivery of any notice pursuant to this Section 4.07 shall not limit or otherwise affect the remedies available hereunder to the party receiving such notice; and provided, further, that failure to give such notice shall not be treated as a breach of covenant for the purposes of Sections 7.01(c) and 7.02(c) unless the failure to give such notice results in a Material Adverse Effect on the other party.

(b) Each of Purchaser and the Company shall give prompt notice to the other of: (i) any material notice or other communication from any person alleging that the consent of such person is or may be required in connection with the Merger or other transactions contemplated by this Agreement; (ii) any material notice or other communication from any governmental entity in connection with the Merger or other transactions contemplated by this Agreement; (iii) any Legal Proceeding relating to or involving or otherwise affecting Purchaser, any Purchaser Subsidiary, Merger Sub or the Company that relates to the Merger or other transactions contemplated by this Agreement; (iv) the occurrence of a default or event that, with notice or lapse of time or both, is reasonably likely to become a default under a Material Contract; and (v) any change that would be considered reasonably likely to result in a Material Adverse Effect, or is likely to impair in any material respect the ability of either Purchaser or the Company to consummate the transactions contemplated by this Agreement; provided, that failure to give such notice shall not be treated as a breach of covenant for the purposes of Sections 7.01(c) and 7.02(c) unless the failure to give such notice results in a Material Adverse Effect on the other party.

4.08 No Solicitation of Transactions .

(a) At all times during the period commencing with the execution and delivery of this Agreement and continuing until the earlier to occur of the termination of this Agreement pursuant to Article VIII hereof and the Effective Time, the Company shall not, nor shall it authorize any officer, trustee, director, employee, investment banker, financial advisor, attorney, broker, finder or other agent, representative or affiliate of the Company to: (i) initiate, solicit, knowingly encourage or knowingly facilitate (including by way of furnishing nonpublic information or access to properties or assets) any Acquisition Proposal; (ii) furnish any nonpublic information regarding the Company to any Person in connection with or in response to an Acquisition Proposal or an inquiry or indication of interest that would reasonably be expected to lead to an Acquisition Proposal (which shall include any Acquisition Proposal received prior to the date hereof); (iii) enter into discussions or negotiate with any Person in furtherance of an Acquisition Proposal; (iv) approve, endorse or recommend any Acquisition Proposal; or (v) enter

 

-29-


into any letter of intent, memorandum of understanding, agreement in principle, merger agreement, acquisition agreement or other similar agreement or any other contract relating to any Acquisition Proposal, with respect to an Acquisition Proposal. Notwithstanding the foregoing or any other provision of this Agreement to the contrary, if the Company should receive an Acquisition Proposal at any time prior to the Effective Time, the Company shall promptly (and in all cases within one (1) business day) advise Purchaser in writing of such Acquisition Proposal, the terms and conditions of any such Acquisition Proposal and the identity of the Person making any such Acquisition Proposal.

(b) The Company shall, and shall cause its representatives to, cease immediately and cause to be terminated any and all existing soliciting activities, discussions or negotiations and non-public information access, if any, with or to any Person conducted prior to the date hereof with respect to any Acquisition Proposal. The Company shall promptly request that each Person, if any, in possession of the confidential information about the Company that was furnished by or on behalf of the Company in connection with its consideration of any potential Acquisition Proposal to return or destroy all confidential information heretofore furnished to such Person.

4.09 Stock Options and Warrants .

(a) At the Effective Time, the Company’s obligations with respect to each outstanding option to purchase shares of Company Common Stock (each, a “ Company Option ” and collectively, the “ Company Options ”) under the Company Plans, whether vested or unvested, and the Company’s obligations with respect to each warrant to purchase shares of Company Common Stock (each, a “ Warrant ” and collectively, the “ Warrants ”) will be assumed by Purchaser. Each Company Option so assumed by Purchaser under this Agreement shall be subject to substantially the same terms and conditions set forth in the Company Plans (which plans shall be adopted upon substantially the same terms and conditions by Purchaser) or agreement pursuant to which such Company Option was issued as in effect immediately prior to the Effective Time, and each Warrant so assumed by Purchaser under this Agreement shall be subject to substantially the same terms and conditions set forth in such applicable Warrant agreement, except as follows (i) such Company Option or Warrant will be exercisable for that number of shares of Purchaser Common Stock equal to the product of the number of shares of Company Common Stock that were purchasable under such Company Option or Warrant immediately prior to the Effective Time multiplied by the CSE Exchange Ratio, rounded down to the nearest whole number of shares of Purchaser Common Stock, and (ii) the per share exercise price for the shares of Purchaser Common Stock issuable upon exercise of such assumed Company Option or Warrant will be equal to the quotient determined by dividing the exercise price per share of Company Common Stock at which such Company Option or Warrant was exercisable immediately prior to the Effective Time by the CSE Exchange Ratio, and rounding the resulting exercise price up to the nearest whole cent. Following the Effective Time, Purchaser will send to the holders of the assumed Company Options and Warrants a written notice setting forth (i) the number of shares of Purchaser Common Stock that are subject to such assumed Company Option, and (ii) the exercise price per share of Purchaser Common Stock issuable upon exercise of such assumed Company Option. In addition, Purchaser shall file with the SEC, no later than ninety (90) days after the Effective Time, a registration statement on Form S-8 registering the exercise of any Company Options issued under the Company Stock

 

-30-


Plans assumed by Purchaser pursuant to this Section 4.09 (to the extent the exercise of such options is eligible to be registered using a Form S-8 registration statement).

(b) Purchaser and Company shall take all action that may be reasonably necessary to effectuate the provisions of this Section 4.09. The Company Options and Warrants assumed by Purchaser shall retain their existing vesting schedules following the Effective Time.

(c) It is the intention of the parties that Company Options assumed by Purchaser qualify following the Effective Time as incentive stock options as defined in the Code (“ ISO’s ”) to the extent such Company Options qualified as ISO’s prior to the Effective Time.

(d) Purchaser will reserve sufficient shares of Purchaser Common Stock for issuance under this Section 4.09.

4.10 Tax-Free Reorganization . Notwithstanding anything herein to the contrary, each of Merger Sub, Purchaser and Company shall use reasonable best efforts to cause the Merger to qualify, and will not take any actions, or fail to take any action, which could reasonably be expected to prevent the Merger from qualifying as a reorganization under the provisions of Section 368(a) of the Code. Merger Sub shall, and shall cause the Surviving Corporation and Purchaser to, report, to the extent required by the Code or the regulations thereunder, the Merger for United States federal income tax purposes as a reorganization within the meaning of Section of 368(a) of the Code. Purchaser and Company will each make available to the other party and their respective legal counsel copies of all returns requested by the other party

4.11 Tax Matters .

(a) Tax Returns . The Company and Stockholders’ Representative shall duly prepare, or cause to be prepared, and file, or cause to be filed, on a timely basis, all Tax Returns with respect to the Company for Taxable Periods ending before the Closing Date (“ Pre-Closing Tax Periods ”) and for any Taxable Periods ending on the Closing Date (“ Closing Date Tax Period ”). Such Tax Returns shall be filed on a timely basis consistent with the Company’s past practice in filing its Tax Returns and shall not be filed without the approval of the Stockholders’ Representative. Purchaser shall duly prepare, or cause to be prepared, and file, or cause to be filed, on a timely basis all Tax Returns with respect to the Company for any taxable period which includes but does not end on the Closing Date (“ Straddle Period ”) and for any taxable periods beginning after the Closing Date (the “ Post-Closing Tax Periods ”). Purchaser shall permit the Stockholders’ Representative to review and comment on each Tax Return with respect to the Company for any Straddle Period and shall make such revisions as the Stockholders’ Representative shall reasonably request. Tax Returns for a Straddle Period shall be prepared consistent with the Company’s past practice. Unless the prior written consent of the Stockholders’ Representative is first obtained, Purchaser shall not take any action (including without limitation, file any amended Tax Returns or claim any Tax refunds) which would in any way alter the balance of Taxes owing or Tax refunds or credits with respect any Pre-Closing Tax Period or any Closing Date Tax Period. For purposes of this Agreement, in the case of any Straddle Period, Taxes of the Company (“ Pre-Closing Straddle Tax Liability ”) for the portion of any Straddle Period ending on and including the Closing Date (a “ Pre-Closing Straddle Period ”) shall, where possible, be computed as if such taxable period ended as of the close of business on

 

-31-


the Closing Date. For purposes of the foregoing, any items attributable to a Straddle Period which cannot be taken into account in the manner so provided (i.e. Taxes not based upon income or receipts) shall be allocated to the Pre-Closing Straddle Period for purposes of determining the Pre-Closing Straddle Tax Liability, pro rata, based upon the number of days in the Pre-Closing Straddle Period, as compared to the total number of days in the Straddle Period, provided that if any Straddle Period Tax is based on income or revenue, then such allocation shall be based upon the actual activities of the Company as determined from the books and records of the Company for such Pre-Closing Straddle Period. Unless otherwise indicated, a Pre-Closing Straddle Period shall be treated as a “ Pre-Closing Tax Period ” for purposes of this Agreement.

(b) Cooperation on Tax Matters . Purchaser and the Stockholders’ Representative shall cooperate fully, as and to the extent reasonably requested by the other party, in connection with the filing of Tax Returns pursuant to this Section 4.11 (including amended Tax Returns for Pre-Closing Tax Periods and the Closing Date Tax Period (or portions thereof) that the Stockholders’ Representative may reasonably request Purchaser to file) and any Audit. Such cooperation shall include the retention and (upon the other party’s request) the provision of records and information which are reasonably relevant to such Tax Returns or Audit and making employees available on a mutually convenient basis to provide additional information and explanations of materials provided hereunder. Purchaser shall not dispose of any records relating to Taxes paid or payable by the Company and which are attributable to Pre-Closing Tax Periods and the Closing Date Tax Period prior to the later of six months after the expiration of the applicable limitations period on assessment with respect to any such Taxes, or the final resolution of all Audits or litigation initiated prior to the expiration of the applicable limitations period.

(c) Pre-Closing Tax Period Audits . Purchaser will promptly notify Stockholders’ Representative if it receives written notice of any Audits relating to Pre-Closing Tax Periods (a “Pre-Closing Audit”) and/or the Closing Date Tax Period (a “ Closing Date Audit ”). With respect to such Audits the Stockholders (at their expense) through the Stockholders’ Representative may elect (in its sole discretion) to control all proceedings and may make all decisions taken in connection therewith at the Stockholders’ Representative sole discretion, provided that any such proceeding and any such decision taken in connection therewith does not increase the Tax liability for any portion of a Straddle Period beginning after the Closing Date (the “ Post Closing Straddle Period ”) or any Post-Closing Tax Period. In the event a decision with respect to a Pre-Closing Audit or Closing Date Audit would increase a tax liability for a Post-Closing Straddle Period or a Post-Closing Tax Period, no such decision shall be implemented or effectuated without the prior written consent of Purchaser (which consent shall not be unreasonably withheld or delayed). The Stockholders’ Representative shall exercise reasonable efforts to keep Purchaser fully apprised of any such Pre-Closing Audit or Closing Date Audit. With respect to any such Pre-Closing Audit or Closing Date Audit, Purchaser shall furnish the Stockholders’ Representative with the usual form of power of attorney (Form 2848) and provide to the Stockholders’ Representative such records and information as may be necessary for the Stockholders’ Representative to control such Pre-Closing Audit or Closing Date Audit proceeding. If the Stockholders’ Representative has failed to take reasonable steps necessary to control a Pre-Closing Audit or Closing Date Audit, as the case may be, or to timely respond to any requests, demands or proceedings in connection therewith, then Purchaser shall have the right to assume control of such Pre-Closing Audit or Closing Date Audit (at the

 

-32-


Stockholders’ expense), as the case may be, and make all decisions taken in connection therewith at Purchaser’s sole discretion, provided that any such proceeding and any such decision taken in connection therewith does not increase the Tax liability for any Pre-Closing Tax Period or the Closing Date Tax Period. Otherwise, no such decision shall be implemented or effectuated without the prior written consent of the Stockholders’ Representative (which consent shall not be unreasonably withheld or delayed). Purchaser shall exercise reasonable efforts to keep the Stockholders’ Representative apprised of all aspects of any such Pre-Closing Audit or Closing Date Audit.

(d) Purchaser and the Surviving Corporation shall not amend any Tax Return of the Company for Pre-Closing Tax Periods, or file a claim for refund of Taxes attributable to a Pre-Closing Tax Period, without the Stockholders’ Representative’s consent.

4.12 Purchaser Management and Directors Lock-up Agreements; Voting Agreement for Certain Company Stockholders .

(a) As promptly as practicable following the execution of this Agreement, and in no event more than seventy-two (72) hours following the execution of this Agreement, the executive officers and directors of Purchaser set forth in Schedule 4 shall have each executed and delivered the Lock-up Agreement set forth as Exhibit C-2 .

(b) As promptly as practicable following the execution of this Agreement, and in no event more than seventy-two (72) hours following the execution of this Agreement, the Company Stockholders set forth in Schedule 3 shall have each executed and delivered the Voting Agreement set forth as Exhibit E .

ARTICLE V

REPRESENTATIONS AND WARRANTIES

OF THE COMPANY

The Company hereby represents and warrants to Purchaser and Merger Sub that the statements contained in this Article 5 are complete and accurate as of the date hereof, except as set forth in the written disclosure schedule delivered by the Company to the Purchaser. Such Company disclosure schedule shall be arranged in sections corresponding to the numbered and lettered sections and subsections contained in this Article 5, and the disclosures in any section or subsection of the Company’s disclosure schedule shall qualify only the corresponding section or subsection of this Article 5, unless the disclosures in one section or subsection reasonably appear to apply to another section or subsection of the Company’s disclosure schedule.

5.01 Organization . The Company is a corporation duly organized, validly existing and in good standing under the Laws of the State of Delaware. The Company has all requisite corporate power and authority to enable it to own, lease or otherwise hold its properties and assets and to carry on its business as presently conducted. The Company is duly qualified to do business and in good standing in each jurisdiction in which the nature of its business or the ownership, leasing or holding of its properties makes such qualification necessary. A list of the jurisdictions in which the Company is so qualified is set forth on Schedule 5.01 . The Company does not have any Subsidiaries.

 

-33-


5.02 Capital Stock and Related Matters; No Investments .

(a) The authorized capital stock of the Company consists of 172,434,420 authorized shares consisting of: (i) 130,000,000 shares of Company Common Stock, (ii) 14,850,000 shares of Series A Preferred Stock, (iii) 27,584,420 shares of Series A-1 Preferred Stock and (iv) 0 shares of undesignated stock, all par value $0.001, of which as of the date hereof 5,824,710 shares of Company Common Stock are issued and outstanding, 0 shares of the Series A Preferred Stock are issued and outstanding and 15,176,263 shares of the Series A-1 Preferred Stock are issued and outstanding (collectively, the “ Company Shares ”). The Company Shares constitute all of the issued and outstanding shares of capital stock of the Company and are held by the Stockholders in the amounts set forth on Schedule 5.02 hereto.

(b) Except as set forth on Schedule 5.02 hereto, the Company has no outstanding stock or securities convertible into or exchangeable for any shares for its capital stock or containing any profit participation features, nor does it have outstanding any rights or options to subscribe for or purchase its capital stock or any stock or securities convertible into or exchangeable for any shares for its capital stock or any stock appreciation rights or phantom stock plans. The Company is not subject to any obligation (contingent or otherwise) to repurchase or otherwise acquire or retire any shares of its capital stock or any warrants, options or other rights to acquire its capital stock. All of the outstanding shares of the Company’s capital stock have been validly issued and are fully paid and nonassessable.

(c) Except as set forth on Schedule 5.02 there are no statutory or contractual shareholders’ preemptive rights or rights of refusal with respect to the Merger. The Company has not violated any applicable federal or state securities Laws in connection with the offer or sale of the Shares.

(d) The Company does not own or hold any Investment in any Person.

5.03 Authorization . Subject to approvals as are required by Law, the Company has all requisite power and authority (or legal capacity, as the case may be) to enter into this Agreement and the Related Documents to be executed and delivered by the Company pursuant hereto or in connection with the transactions contemplated hereby or thereby, and to consummate the transactions contemplated hereby and thereby. Subject only to Company Stockholder Approval, all acts and other proceedings required to be taken by the Company to authorize the execution, delivery and performance of this Agreement and the Related Documents to which it is a party, and the consummation of the transactions contemplated hereby and thereby have been (or by the Closing will have been) duly and properly taken.

5.04 Valid and Binding . This Agreement constitutes (and, when executed and delivered at Closing, each Related Document, to the extent that the Company is a party thereto, will constitute) a valid and binding obligation of the Company, enforceable against the signatory in accordance with its terms, except that (i) such enforcement may be limited by or subject to any bankruptcy, insolvency, reorganization, moratorium or similar Laws now or hereafter in effect relating to or limiting creditors’ rights generally and (ii) the remedy of specific performance and injunctive and other forms of equitable relief are subject to certain equitable defenses and to the discretion of the court before which any proceeding therefor may be brought.

 

-34-


5.05 No Violation . The execution and delivery of this Agreement and each Related Document by the Company, and the consummation of the transactions contemplated hereby and thereby and compliance with the terms hereof and thereof does not and will not (subject only to obtaining any required consents, approvals, authorizations, exemptions or waivers set forth on Schedule 5.06 hereto) conflict with, or result in any violation of or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancellation or acceleration of any obligation or to loss of a material benefit under or result in the creation of any Encumbrance of any kind upon any of the Company’s assets under, any provision of (i) the certificate of incorporation or by-laws of the Company, (ii) any note, bond, mortgage, indenture, deed of trust, license, lease, contract, commitment or loan or other agreement to which the Company is a party or by which any of its properties or assets are bound, or (iii) any statute, regulation, rule, injunction, judgment, order, Law, ordinance, decree, ruling, charge or other restriction of any government, governmental agency, or court applicable to the Company or its property or assets, except in the case of clauses (ii) and (iii) for any such violations, breaches, defaults, rights of termination, cancellation or acceleration or requirements which, individually or in the aggregate would not have a Material Adverse Effect or would not adversely affect the ability of the Company to consummate the transactions contemplated by this Agreement.

5.06 Consents and Approvals . Other than the filing of the Delaware Certificate of Merger with the Secretary of State of the State of Delaware, or as otherwise set forth in Schedule 5.06 hereto, no consent, approval or authorization of, or declaration, filing or registration with, any governmental or regulatory authority or any court or other tribunal, and no consent or waiver of any party to any Contract is required to be obtained by the Company in connection with the execution, delivery and performance of this Agreement and the Related Documents or the consummation of the transactions contemplated hereby or thereby.

5.07 Financial Statements . The Company has furnished to Purchaser true, correct and complete copies of (i) audited balance sheets of the Company as of December 31, 2007 and December 31, 2008, a draft audited balance sheet of the Company as of December 31, 2009 and an unaudited consolidated balance sheet of the Company as of February 28, 2010, and (ii) audited consolidated income statements of the Company for the years ended December 31, 2007 and December 31, 2008, a draft audited consolidated income statement of the Company for the year ended December 31, 2009 and an unaudited consolidated income statement of the Company for the two-month period ended February 28, 2010 (collectively, the “ Company Financial Statements ”), copies of which are attached hereto as Schedule 5.07 , with the exception of the draft audited balance sheet of the Company as of December 31, 2009 and the draft audited consolidated income statement of the Company for the year ended December 31, 2009, which have been separately furnished to the Purchaser and shall be provided by the Company to the Purchaser as soon as practicable after they are issued to the Company by the Company’s independent auditors. The Company Financial Statements have been prepared by the Company on the basis of the books and records maintained by the Company in the ordinary course of business in a manner consistently used and applied throughout the periods involved. The Company Financial Statements have been prepared in accordance with GAAP and present fairly the assets, liabilities and the financial condition of the Company as at the respective dates thereof, except that the Company’s unaudited consolidated balance sheet as of February 28, 2010 and income statement for the two-month period then ended do not contain footnotes and information related thereto and are subject to normal year end adjustments in the ordinary course

 

-35-


of business. The books and records of the Company to which such statements relate fairly reflect in all material respects the assets, liabilities and operations of the Company.

5.08 Interim Operations . Except as set forth on Schedule 5.08 , since December 31, 2009:

(a) the Company Business has been conducted by the Company only in the ordinary course consistent with past practices;

(i) with respect to the Company Business, the Company has not:

(ii) suffered any Material Adverse Effect;

(iii) incurred any liabilities or obligations (absolute, accrued, contingent or otherwise), except in the ordinary and usual course of business and consistent with past practice, or increased, or experienced any change in any assumptions underlying or methods of calculating, any bad debt, contingency or other reserves;

(iv) paid, discharged or satisfied any claims, liabilities or obligations (absolute, accrued, contingent or otherwise), other than the payment, discharge or satisfaction in the ordinary and usual course of business and consistent with past practice liabilities and obligations reflected or reserved against in the Company Financial Statements or incurred in the ordinary course of business and consistent with past practice;

(v) permitted or allowed the Company’s assets to be subjected to any Encumbrance (except Encumbrances created by Law);

(vi) canceled any debts owing to the Company or waived any claims or rights, except for amounts each individually under $5,000;

(vii) sold, transferred, or otherwise disposed of, or transferred or granted any rights under any lease, license or agreement with respect to, any of its assets, except in the ordinary course of business and consistent with past practices;

(viii) disposed of, failed to take reasonable steps to protect, or permitted to lapse, any rights for the use of, the Company’s Intellectual Property, or disposed of, failed to take reasonable steps to protect any Proprietary Information;

(ix) made any change in any method of accounting or accounting practice;

(x) made any single capital expenditure or future commitment in excess of $20,000, or made aggregate capital expenditures or future commitments in excess of $50,000;

(xi) made any material change in the manner in which the Company Business is conducted;

 

-36-


(xii) made any material change in policies relating to the Company Business (whether or not in the ordinary and usual course of business);

(xiii) had any labor dispute or received notice of any grievance;

(xiv) borrowed or agreed to borrow any funds;

(xv) paid and/or declared any dividends with respect to its shares of capital stock, whether in shares of capital stock or other property;

(xvi) granted to any officer or employee any increase in compensation or benefits, other than increases in compensation or benefits to employees in the ordinary and usual course of business;

(xvii) paid any pension, retirement allowance or other employee benefit not required by any plan, policy or program identified on Schedule 5.21 hereto or any employment agreement set forth on Schedule 5.21 hereto;

(xviii) adopted, agreed to adopt, or made any announcement regarding the adoption of (i) any new pension, retirement or other employee benefit plan, program or policy, or (ii) any amendments to any existing pension, retirement or other employee benefit plan, policy or program identified on Schedule 5.21 unless otherwise required by applicable Law; or

(xix) suffered or agreed to take any of the actions set forth in this subparagraph (ii).

(b) None of the assets of the Company have been affected in any way as a result of fire, explosion or other casualty (whether or not covered by insurance).

5.09 Undisclosed Liabilities . The Company does not have any liabilities or obligations of any nature (whether accrued, absolute, contingent or otherwise), except for liabilities or obligations (i) disclosed on Schedule 5.09 hereto, (ii) disclosed in the Company Financial Statements, (iii) arising in the ordinary course of business consistent with past practice under any Material Contract, or (iv) incurred in the ordinary course of business consistent with past practices since December 31, 2009.

5.10 Taxes .

(a) Except as set forth on Schedule 5.10(a) , the Company has timely filed all Tax Returns required by applicable Law to be filed by or on behalf of the Company on or prior to the date hereof, and such Tax Returns are true, complete, correct and in conformity with applicable Tax Laws in all material respects. The Company has paid all Taxes (whether or not required to be shown on any Tax Return) required to be paid by the Company on or before the date hereof, or where payment is not yet due, has established or will establish, on or before the Closing Date, in accordance with GAAP, an adequate reserve on its books and financial records for the payment of all Taxes due from the Company, with respect to any Pre-Closing Tax Period (including any Pre-Closing Straddle Tax Liability) and the Closing Date Tax Period. All Taxes that the Company is or was required by Law to withhold, deposit or collect have been duly

 

-37-


withheld, deposited or collected and, to the extent required, have been paid to the relevant Tax Authority. The Company has timely complied with all information and reporting and backup withholding requirements, including maintenance of any required records with respect thereto, in connection with amounts paid or owing to any employee, creditor, independent contractor or other third party.

(b) Except as described in Schedule 5.10(b) , the Tax Returns with respect to the Company have not been subject to an Audit since its incorporation, and there are no ongoing Audits of the Company. The Company has not received written notice by any Tax Authority of an Audit nor to Knowledge is any such Audit contemplated, threatened or pending.

(c) to the Company’s Knowledge, there are no claims, investigations, actions or proceedings pending or threatened, against the Company by any Tax Authority for any past due Taxes with respect to which the Company would be liable. There has been no waiver by the Company of any applicable statute of limitations nor any consent for the extension of the time for the assessment of any Tax against the Company.

(d) The Company is not delinquent in the payment of any amount of Taxes and there are no Tax liens upon any property or assets of the Company, except liens for Taxes not yet due and payable.

(e) The Company has not agreed, nor is it required, to make any adjustment under Section 481(a) of the Code by reason of a change in accounting method or otherwise.

(f) The Company is not liable for the Taxes of any Person other than the Company, including, without limitation, (i) under U.S. Treasury Regulations Section 1.1502-6 (or comparable provision of state, local or foreign Law), (ii) as a transferee or successor, or (iii) by contract, indemnity or otherwise. Except as set forth on Schedule 5.10(f) , the Company has not ever been a member of a consolidated, combined or unitary group for federal, state, local or foreign Tax purposes or have ever been included as part of a consolidated, combined or unitary Tax Return.

(g) The Company is not, nor has it ever been, a party to any Tax sharing agreement, Tax indemnity agreement or other similar Tax sharing arrangement.

(h) Except as set forth in Schedule 5.10(h) , since January 1, 2004 no claim has been asserted in writing by a Tax Authority in a jurisdiction where the Company has not filed Tax Returns that the Company is or may be subject to taxation by that jurisdiction. To Knowledge no such claim was asserted prior to 2004.

(i) Schedule 5.10(i) sets forth each of the states for which the Company is currently filing income or franchise Tax Returns (or similar type of Tax Returns) or is required to file for the current Taxable Period.

(j) The Company has provided Purchaser with copies of: (i) all Tax Returns filed by, or on behalf of, the Company for periods beginning on or after January 1, 2006 (the “Post-2006 Period”); (ii) all notices, protests or other correspondence relating to any Post-2006 Period Taxes or Tax Returns; (iii) any letter rulings, determination letters or similar documents

 

-38-


issued by any Tax Authority with respect to the Company; (iv) any closing agreement entered into by the Company with any Tax Authority; and (vi any Tax Return workpapers relating to the Tax Returns referred to in clause (i). The Company has not entered into an exchange under Code Section 1031 with a “related person” (within the meaning of Code Section 1031(f)(3)) which could result in the Company being required to recognize gain under Code Section 1031(f)(1). The Company is not taking into account any gain under the installment method of Code Section 453.

(k) The Company is not, and has never been, a United States real property holding corporation within the meaning of Section 897(c)(2) of the Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code and Purchaser is not required to withhold tax on the purchase of the stock of the Company by reason of Section 1445 of the Code. Except as set forth in Schedule 5.10(k) , the Company has not entered into any compensatory agreements with respect to the performance of services which payment thereunder would result in a nondeductible expense pursuant to Section 162(m) or 280G of the Code or an excise tax to the recipient of such payment pursuant to Section 4999 of the Code. The Company has not participated in an international boycott as defined in Section 999 of the Code.

(l) The Company has not participated in any transaction that is a reportable transaction within the meaning of Treasury Regulation Section 1.6011-4 or Section 6707A of the Code.

(m) Neither the Company nor, to the Company’s Knowledge, any of the Company’s affiliates has taken or agreed to take any action that would prevent the Merger from qualifying as a reorganization within the meaning of Section 368(a) of the Code. The Company is not aware of any agreement, plan or other circumstance that would prevent the Merger from qualifying as a reorganization within the meaning of Section 368(a) of the Code.

5.11 Condition of Property . Except as set forth on Schedule 5.11 , all Tangible Property of the Company is in good operating condition and repair, reasonable wear and tear excepted, and all such Tangible Property is adequate for the uses to which it is being put. None of such Tangible Property is in need of maintenance or repairs except for ordinary, routine maintenance and repairs which are not material in nature or cost.

5.12 Contracts and Commitments .

(a) Schedule 5.12(a) lists all Material Contracts (copies of which have heretofore been made available to Purchaser) and describes all currently effective oral agreements and commitments, if any, to which the Company is a party. Except as set forth on Schedule 5.12(a) hereto, (i) all Material Contracts constitute valid and binding agreements of the Company, and, to the Company’s Knowledge, each other party thereto, enforceable in accordance with their terms except that (A) such enforcement may be limited by or subject to any bankruptcy, insolvency, reorganization, moratorium or similar Laws now or hereafter in effect relating to or limiting creditors’ rights generally and (B) the remedy of specific performance and injunctive and other forms of equitable relief are subject to certain equitable defenses and to the discretion of the court before which any proceeding therefor may be brought, (ii) with respect to the Material Contracts there are no existing material defaults by the Company,

 

-39-


or, to the Company’s Knowledge, by any other party thereto and there is no event which (whether with or without notice, lapse of time or the happening or occurrence of any other event) would constitute a material default under the Material Contracts by the Company, or, to the Company’s Knowledge, by any other party thereto, (iii) the Company is not restricted by agreement from carrying on the Company Business in any geographical location, and (iv) there are no negotiations pending or in progress to revise any Material Contract.

(b) The Company does not own any Real Property. The only leases for Real Property to which the Company is a party is set forth on Schedule 5.12(b) (collectively, and together with all addenda, the “ Company Leases ”). With respect to the Company Leases, (i) each such Company Lease is in full force and effect and is binding and enforceable against the Company, and to the Company’s Knowledge, the lessor, in accordance with its terms except that (A) such enforcement may be limited by or subject to any bankruptcy, insolvency, reorganization, moratorium or similar Laws now or hereafter in effect relating to or limiting creditors’ rights generally and (B) the remedy of specific performance and injunctive and other forms of equitable relief are subject to certain equitable defenses and to the discretion of the court before which any proceeding therefor may be brought; (ii) all rental and other charges payable pursuant to the terms and conditions of each such Company Lease have been paid and no rent has been paid in advance more than 30 days; (iii) there are no charges, offsets or defenses against the enforcement by the respective lessors thereunder of any agreement, covenant or condition on the part of the Company to be performed or observed pursuant to the terms of each Company Lease; (iv) there are no defaults by the Company of any agreement, covenant or condition on the part of the Company to be performed or observed pursuant to the terms of each Company Lease; (v) there are no actions or proceedings pending or, to the Company’s Knowledge, threatened, by the lessor under each such Company Lease; (vi) except for security deposits required by the Company Leases and identified on Schedule 5.12(b) , the respective lessor does not hold any deposits for the Company’s accounts under each such Company Lease; (vii) the Merger and the transactions contemplated hereby will not constitute a prohibited transfer under any Company Lease; and (viii) to the Company’s Knowledge, there are no defaults by respective lessors of any agreement, covenant or condition on the part of such lessor to be performed or observed pursuant to the terms of any such Company Lease. The current expiration date and remaining options to extend each Company Lease are as set forth on Schedule 5.12(b) hereto.

5.13 Intellectual Property .

(a) General . Schedule 5.13(a) contains a complete and accurate list of all Intellectual Property Registrations, including all Patents. Except as disclosed on Schedule 5.13(a) , the Company is not aware of any actions which, if not taken by Purchaser within ninety (90) days of the Closing Date, would limit or preclude Purchaser from obtaining, perfecting, preserving, renewing or maintaining any Intellectual Property Registrations, including the payment of any registration, maintenance or renewal fees or the filing of any responses to Patent Agency office actions, documents, applications or certificates.

(b) Valid Assignment . In each case in which the Company has acquired ownership of (rather than licenses or other rights to) any Intellectual Property from any Person, the Company has obtained a valid and enforceable assignment sufficient to irrevocably transfer

 

-40-


to Purchaser all rights in such Intellectual Property (including the Company’s right to seek past and future damages for infringement with respect thereto to the extent permitted by applicable Law). To the extent required by, and in accordance with, applicable Laws and regulations, the Company has recorded each assignment to it of any Intellectual Property Registrations with the USPTO or equivalent Patent Agencies outside the United States.

(c) No Infringement . To the Company’s Knowledge, no Person is infringing or misappropriating any Intellectual Property or Licensed Rights as of the Effective Date. The Company has not received written notice of a claim from any Person claiming that any Intellectual Property or Licensed Rights infringes or misappropriates any rights of such Person or constitutes unfair competition or trade practices under the Laws of any jurisdiction. With respect to the Patents, although the validity of claims regarding novelty, non-obviousness and enablement have not been established, the Company’s claims and representations made to the USPTO and other Patent Agencies in its applications for Patents regarding novelty, non-obviousness and enablement were made in good faith, and the Company has no Company Knowledge of any facts which the Company reasonably believes would cause such claims or representations to be untrue or misleading. To the Company’s Knowledge, there is no unexpired Patent of any third party that includes claims that would be infringed by the Company Business as currently conducted.

(d) Confidentiality . The Company has taken all actions reasonably necessary to maintain and protect its rights in the Intellectual Property, including in Trade Secrets and other Proprietary Information. Without limiting the foregoing, the Company has and enforces a policy requiring each employee, consultant, contractor and other third parties with access to the Trade Secrets to execute proprietary information and confidentiality agreements, and all such current and former employees, consultants, contractors and third parties have executed such an agreement. To the Company’s Knowledge, there has been no violation or unauthorized disclosure or use of any Intellectual Property.

(e) No Transfer of Rights . Except as disclosed on Schedule 5.13(e), the Company is the exclusive owner of all the Intellectual Property owned by the Company and no other person owns or has any rights to any of the Intellectual Property and no Person has ownership rights or license rights to improvements made by the Company in any Patents. The Company has not transferred to any other Person any interest in, granted to any other Person any license, sublicense or other right to use, authorized the retention by any Person of any rights to use or joint ownership of, or entered into a covenant, in favor of any other Person, not to sue for infringement of, any Intellectual Property, except as disclosed on Schedule 5.13(e) .

(f) Exclusive Rights . All of the Intellectual Property, excluding any Licensed Rights, was created solely by either (A) Employees of the Company acting within the scope of their employment or (B) employees of third parties or consultants or contractors of the Company who have validly and irrevocably assigned all of their rights, including rights to all Intellectual Property therein, to the Company.

(g) No Adverse Proceedings . To the Company’s Knowledge, there are no interference action or other Proceedings pending, or any written communication that threatens an

 

-41-


interference action or other Proceeding, before any Patent Agency or other governmental entity in any jurisdiction in regard to any Intellectual Property.

(h) No Undisclosed Inventions . To the Company’s Knowledge, the Company has not received any notice under any Contract that constitutes a research or other collaborative agreement regarding the Intellectual Property that the other party to such Contract has developed an invention under such Contract for which the Company would have ownership or license rights under such Contract.

(i) Payment of Intellectual Property Costs . Except as described on Schedule 5.13(i) , the Company has paid in full any and all costs whatsoever, including attorney’s fees, associated with the preparation, filing, prosecution and maintenance of the Patents and covering the period ending on the Closing Date, including any maintenance fees which become due for the Patents on or prior to the Closing Date.

5.14 Title to the Assets .

(a) Except as described on Schedule 5.14 or in the Company Financial Statements, the Company has good and marketable title to, or have a valid leasehold interest or valid license or other contractual rights in, the properties and assets used by it in the Business, located on their premises or shown on the most recent Company Financial Statement or acquired thereafter, free and clear of all Encumbrances, except for (i) properties and assets disposed of in the ordinary course of business since December 31, 2009, (ii) Encumbrances for Taxes not yet due and payable or Encumbrances for Taxes which are being contested in good faith, and (iii) Encumbrances which are not material to the value of the properties or assets encumbered and which do not impair in any material respect the current use or operation of such properties and assets. The Company owns, or has a valid leasehold or other interest in, all assets (including all Intellectual Property) necessary for the conduct of the Company Business as currently conducted by the Company, and immediately after the Closing the Company will continue to own, or have a valid leasehold or other interest in all such assets so as to be able to conduct the Company Business in all respects after the Closing in substantially the same manner as the Company Business has been conducted prior to the Closing.

(b) The assets and properties owned by the Company together with the rights enjoyed by the Company, on the date hereof, constitute all of the assets, properties and rights which were used to achieve the financial results set forth on the Company Financial Statements, excepting only those assets and properties disposed of or otherwise transferred by the Company in the ordinary course of business.

5.15 Land Use Matters . There are no pending or, to the Company’s Knowledge, threatened, legal actions or proceedings in the nature of condemnation proceedings that might prohibit, restrict or impair the use and occupancy of the property covered by any Company Leases, or result in the suspension, revocation, impairment, forfeiture or non-renewal of any required licenses, permits, certificates and approvals for the use and occupancy and operation of the property covered by any Company Leases, other than such prohibitions, restrictions, suspensions, revocations, impairments, forfeitures and non-renewals that individually or in the aggregate would not result in a Material Adverse Effect.

 

-42-


5.16 Environmental Matters .

(a) Compliance . (i) The Company is in compliance in all material respects with all applicable Environmental Laws; (ii) the Company has not received any written communication from any Person or governmental entity that alleges that the Company is not in compliance with applicable Environmental Laws; and (iii) there have not been any Releases of Hazardous Materials by the Company, or, by any other party, at any property currently or formerly owned or operated by the Company that occurred during the period of the Company’s ownership or operation of such property.

(b) Environmental Permits . The Company has all Environmental Permits necessary for the conduct and operation of the Company Business. All such permits are in good standing or, where applicable, a renewal application has been timely filed and is pending agency approval. The Company is in compliance with all terms and conditions of all such Environmental Permits and are not required to make any expenditure in order to obtain or renew any Environmental Permits, except where the failure to obtain or be in such compliance and the requirement to make such expenditure do not or will not have a Material Adverse Effect on the Company Business.

(c) Environmental Claims . There are no Environmental Claims pending or, to the Company’s Knowledge, threatened, against the Company or against any real or personal property or operation that the Company owns, leases or manages.

5.17 Insurance . Schedule 5.17 (i) lists the insurance policies currently maintained with respect to the Company and its assets and properties (summaries of which have been provided or made available to Purchaser), and (ii) specifically describes all claims made by the Company during the past three years under any such insurance policies maintained by the Company. All such policies listed on Schedule 5.17 are in full force and effect, all premiums due and payable thereon have been paid and no written or oral notice of cancellation or termination has been received with respect to any such policy which was not replaced on substantially similar terms prior to the date of such cancellation. All such policies will remain in full force and effect at least until the Closing Date.

5.18 Employees and Labor Relations .

(a) Schedule 5.18(a) contains the names of all persons employed by the Company as of the date hereof (each, an “ Employee ” and collectively, the “ Employees ”), lists which Employees are leased, part-time or temporary employees, the salary, commission, bonus opportunity and current vacation accrual for each Employee, and indicates which Employees are currently on short-term or long-term disability, the date of commencement of employment and title. Except for the persons listed on Schedule 5.18(a) , the Company does not have any employment, compensation, noncompetition, nonsolicitation or other similar arrangements with any individuals who perform services for the Company.

(b) Except as set forth on Schedule 5.18(b) , all employees of the Company are “at will” employees, each of whom can be terminated at any time (subject to all applicable Laws) without penalty or premium and whose employment terms are solely governed by the current

 

-43-


policy manual of the Company, a true and complete copy of which has been provided to Purchaser.

(c) Except as set forth on Schedule 5.18(c) , (i) there is no current labor strike or work stoppage or lockout against or materially affecting the Company; during the past five (5) years there has not been any such action against the Company; and to the Company’s Knowledge, there has not been, and is not now, any such action threatened against or materially affecting the Company; (ii) none of the Employees of the Company are represented by a union or subject to a collective bargaining agreement and to the Company’s Knowledge, no union organizational campaign is in progress with respect to the Employees and no question concerning representation exists respecting such Employees; (iii) the Company is in compliance in all material respects with all applicable Laws respecting employment and employment practices, terms and conditions of employment and wages and hours and is not engaged in any unfair labor practice; and (iv) other than with Stockholders, Option Holders and Warrant holders (solely in their capacity as such) there are no agreements or arrangements between (x) the Company and (y) an individual consultant, former consultant, employee or former employee obligating the Company to make any payment to any such individual as a result of the transactions contemplated by this Agreement.

(d) Except as set forth on Schedule 5.18(d) , there are no loans outstanding from the Company to any of the Employees.

(e) The Company is not in breach of any material terms of employment of any of the Employees nor to the Company’s Knowledge is any Employee in breach of any material term of his or her employment relationship.

(f) As of the date hereof, none of the Employees has given or received notice of termination of his or her employment.

(g) None of the Employees is the subject of any material disciplinary action nor is any Employee engaged in any grievance procedure and to the Company’s Knowledge, there is no matter or fact in existence which can be reasonably foreseen as likely to give rise to the same.

(h) The Company has complied in all material respects with the employment eligibility verification form requirements under the Immigration and Naturalization Act, as amended (“ INA ”), in recruiting, hiring, reviewing and documenting prospective employees for employment eligibility verification purposes and the Company has complied in all material respects with the paperwork provisions and anti-discrimination provisions of the INA. The Company has obtained and maintained the employee records and I-9 forms in proper order as required by United States Law. To the Company’s Knowledge the Company does not employ any workers unauthorized to work in the United States.

5.19 Litigation . Except as set forth on Schedule 5.19 , as of the date hereof, there is no pending or, to the Company’s Knowledge, threatened action, proceeding or investigation by or before any court, governmental agency or arbitrator or other tribunal, which is or may be brought against or which involves the Company or the Company Business:

 

-44-


(a) which questions or challenges the validity of, or seeks damages or equitable relief on the basis of, this Agreement or any action taken or to be taken by the Company or the Principal Stockholders pursuant to this Agreement or in connection with the transactions contemplated hereby; or

(b) which might affect the right of Purchaser after the Closing Date to own the Company or to conduct the Company Business as presently conducted;

(c) nor to the Company’s Knowledge is there any valid basis for any such action, proceeding or investigation.

5.20 Court Orders, Decrees, and Laws . Except as described in Schedule 5.20 , there is no outstanding, or to the Company’s Knowledge threatened, order, writ, injunction, or decree of any court, governmental agency, or arbitration tribunal against the Company. The Company is in compliance in all material respects with all applicable federal, state or local Laws, rules, regulations, ordinances, zoning requirements, governmental restrictions, orders, judgments and decrees affecting, involving or relating to the Company Business, and the Company has not received any notices alleging any such violation. The foregoing shall be deemed to include Laws, rules and regulations relating to the federal patent, copyright, and trademark Laws, state trade secret and unfair competition Laws, and to all other applicable Laws, rules and regulations including, but not limited to, equal opportunity, wage and hour, and other employment matters, and antitrust and trade regulations, safety (including OSHA), building, zoning or health Laws, ordinances and regulations.

5.21 Employee Benefit Plans; ERISA .

(a) Schedule 5.21(a) contains a list of each of the Company’s employee benefit plan, arrangement, policy or commitment within the meaning of Section 3(3) of ERISA and any employment, consulting or deferred compensation agreement, incentive compensation, bonus, executive compensation, severance, termination or post-employment pay, disability, hospitalization or other medical, dental, vision, life or other insurance, stock purchase, stock option, stock appreciation, stock award, pension, profit sharing, savings or retirement plan, program or arrangement, or any holiday or vacation practice, whether written or oral, tax-qualified under the Code or non-qualified, whether covered by ERISA or not, maintained or contributed to by the Company covering its employees, former employees, retirees or sales personnel or with respect to which the Company or any Commonly Controlled Entity, respectively, has or in the future could have any direct or indirect, actual or contingent liability (each, a “ Plan ” and collectively, the “ Plans ”). Except as set forth on Schedule 5.21(a) , the Company will not incur any liability in connection with any Plan solely as a result of the consummation of the transactions contemplated by this Agreement. Except as set forth on Schedule 5.21(a) , neither the Company nor any Commonly Controlled Entity has any legally binding oral or written plan or other commitment, whether covered by ERISA or not, to create or participate in any additional plan, agreement or arrangement or to modify or change any existing Plan in any manner. The Company has made available to Purchaser true and complete copies of the Plans, the trust agreements and other contracts (including any amendments to any of the foregoing) relating to the Plans and all other relevant documents governing or relating to the Plans (including, but not limited to, the latest summary plan descriptions, all other material

 

-45-


employee communications, the latest annual report (and all schedules and attachments) filed with the IRS with respect to each of the Plans, as applicable, all material communication with any governmental entity or agency (including, without limitation, the Department of Labor and the IRS) for the last three fiscal years, and, if the Plan is intended to qualify under Section 401(a) of the Code, the most recent determination letter received from the IRS).

(b) Any Plan, including, but not limited to, any Plan that was an “employee pension benefit plan” as defined in Section 3(2) of ERISA, that the Company or any Commonly Controlled Entity has ever sponsored or maintained, or in or to which the Company or any Commonly Controlled Entity has ever participated or contributed, on behalf of its respective employees, former employees, retirees or sales personnel which was subsequently terminated, was terminated in compliance with the requirements of the Code and ERISA and neither the Company nor any Commonly Controlled Entity has incurred any liability with respect to such Plan or the termination of such Plan that is due and owing and has not yet been satisfied under the terms of the Plan, the Code, ERISA or any other Law or regulation pursuant to which Purchaser may incur liability or have liability attributed to it under any federal, state or local Law as a result of the consummation of the transactions contemplated by this Agreement. Neither the Company nor any Commonly Controlled Entity maintains or contributes to, nor, within the past five years has the Company or any Commonly Controlled Entity maintained or contributed to, (i) a “multiemployer plan,” as that term is defined in Section 414(f) of the Code or Sections 3(37) or 4001(a)(31) of ERISA or (ii) an “employee benefit pension plan,” as defined in Section 3(2) of ERISA, that is subject to Section 412 of the Code, Section 302 of ERISA or Title IV of ERISA. No Plan is a multiple employer plan within the meaning of Section 413(c) of the Code or Sections 4063, 4064 or 4066 of ERISA. The Company has not terminated any employee benefit plan as described in Section 3(3) of ERISA.

(c) Full payment has been made as of the Closing Date of all contributions or amounts (other than current outstanding routine claims for benefits) which the Company is required to contribute or pay under the terms of any Plan, and all contributions to any Plan which are required or recommended with respect to any period of time prior to the Closing have been made or such amounts have been accrued in accordance with GAAP. There are no funded benefit obligations for which contributions have not been made or properly accrued and there are no unfunded benefit obligations that have not been accounted for by reserves, or otherwise properly footnoted in accordance with GAAP on the Company Financial Statements.

Each of the Plans is and has been operated and administered in all material respects in accordance with applicable Laws, including but not limited to, ERISA and the Code, and all required material governmental filings and material participant disclosures have been made on a timely basis. With respect to each Plan, no event has occurred, and there exists no condition or set of circumstances in connection with which the Company could, directly or indirectly (through a Commonly Controlled Entity or otherwise), be subject to any liability under ERISA, the Code or any other applicable Law, except liability for benefit claims and funding obligations payable in the ordinary course. No prohibited transaction within the meaning of Section 406 of ERISA or 4975 of the Code, or breach of fiduciary duty under Title I of ERISA, has occurred with respect to any Plan or with respect to the Company or any Commonly Controlled Entity that could reasonably be expected to result in liability to the Company. Each Plan that is intended to qualify under Section 401(a) of the Code has received a currently effective favorable

 

-46-


determination letter from the IRS, and such Plan and its related trust are exempt from taxation under Section 501(a) of the Code.

There are no pending, or, to the Company’s Knowledge, threatened or anticipated claims, litigation, administrative actions or proceedings against or otherwise involving any of the Plans or related trusts, or any fiduciary thereof, by any governmental agency, or by any employee, former employee, leased employee, former leased employee, retiree or sales personnel or by any participant or beneficiary covered under any of the Plans, or otherwise involving the Plans (other than routine claims for benefits). There is no judgment, decree, injunction, rule or order of any court, governmental body, commission, agency or arbitrator outstanding against or in favor of any Plan or, to the Company’s Knowledge, any fiduciary thereof in that capacity. No assets of the Company are allocated to or held in a “rabbi trust” or similar funding vehicle or subject to any lien under ERISA.

(d) Each Plan that is a “group health plan” (as defined in Section 607(1) of ERISA) has been operated in compliance in all material respects with the provisions of COBRA (Section 4980B of the Code), the Health Insurance Portability and Accountability Act of 1996 and, to the extent required, any applicable similar state Law. Each Plan that is an “employee welfare benefit plan” within the meaning of Section 3(1) of ERISA (i) is a fully insured plan, (ii) may be terminated after the Closing Date in accordance with the terms of any underlying contract without liability to the Company, other than liabilities relating to claims incurred prior to the effective date of the termination of such Plan, (iii) is not a multiple employer welfare arrangement within the meaning of Section 3(40) of ERISA and (iv) has no reserves, assets, surpluses or prepaid premiums. Except as set forth on Schedule 5.21(d) , the Company does not currently provide or have a current obligation to provide for any material post-retirement or post-employment health and welfare benefits, including but not limited to, severance, salary continuation, termination, disability, death, or retiree health or medical benefits except as required by applicable Law.

(e) Except as set forth on Schedule 5.21(e) , the consummation of the transactions contemplated by this Agreement will not, of itself, entitle any current or former employee or leased employee of the Company to severance pay, unemployment compensation or any similar payment or accelerate the time of payment or vesting, or increase the amount of compensation due to, or in respect of, any current or former employee or leased employee, nor will it result in the breach of any agreement with any such employee.

(f) None of the assets of the Company is subject to any lien under Section 302(f) of ERISA or Section 412(n) of the Code.

5.22 Broker’s Fees . Neither the Company nor any of its representatives or Persons acting or its behalf have made any commitment or done any other act which would create any liability for any brokerage, finder’s or similar fee or commission in connection with the transactions contemplated by this Agreement.

5.23 Related-Party Transactions . Except as set forth on Schedule 5.23 , the Company is not to the Company’s Knowledge, a party to any contract, agreement, license, lease, or arrangement with, or any other commitment to, directly or indirectly, (i) any Stockholder or any

 

-47-


Affiliate of any Stockholder of the Company; (ii) any officer or employee of the Company; (iii) any corporation, trust, or other entity in which any Stockholder or any such officer or employee has a material equity or participating interest; (iv) any partnership in which any Stockholder or any such officer or employee has a partnership or participating interest, or (v) any such officer or employee, in each case, relating to or involving the Company Business, except, in each instance, for existing compensation arrangements listed in Schedule 5.21(a) . Each contract, agreement, license, lease, arrangement, and commitment listed in Schedule 5.23 was entered into by the Company in the ordinary course of business.

5.24 Licenses; Permits . Schedule 5.24 sets forth, with respect to the Company, all Governmental Authorizations and Permits. Such Governmental Authorizations and Permits constitute all approvals, authorizations, certifications, consents, variances, permissions, licenses, or permits to or from, or filings, notices, or recordings to or with, federal, state, or local governmental authorities that are required for the ownership and use of the assets of the Company and the conduct of the Company Business under federal, state, and local Law, regulation, ordinance, zoning requirement, governmental restriction, order, judgment, or decree, except where the failure to obtain such Governmental Authorizations and/or Permits does not or will not, individually or in the aggregate, have a Material Adverse Effect. The Company is in compliance in all material respects with all terms and conditions of such Governmental Authorizations and Permits. All of such Governmental Authorizations and Permits are in full force and effect, and to Knowledge, no suspension or cancellation of any of them is being threatened, nor will any of such Governmental Authorizations and/or Permits be affected by the consummation of the transactions described in this Agreement. The Company is in compliance in all material respects with all other applicable limitations, restrictions, conditions, standards, prohibitions, requirements, obligations, schedules, and timetables contained in any Law governing the Company Business.

5.25 Accounts Receivable . All Accounts Receivable of the Company have arisen in the ordinary course of business in arms length transactions for goods actually sold and services actually performed or to be performed. The Company has available in its records copies of invoices or electronic records of services performed and all existing Contracts with respect to all such Accounts Receivable.

5.26 Disclosure . The representations and warranties of the Company in this Agreement and each document (including, but not limited to, financial statements, exhibits and schedules), certificate, or other writing furnished or to be furnished by the Company pursuant to the provisions hereof or in connection with the transactions contemplated hereby, when considered as a whole, do not contain any untrue statement of material fact and do not omit to state any material fact necessary in order to make the statements contained herein or therein not misleading.

ARTICLE VI

REPRESENTATIONS AND WARRANTIES OF PURCHASER AND MERGER SUB

Purchaser and Merger Sub hereby represent and warrant to the Company and the Stockholders’ Representative on behalf of the Stockholders that the statements contained in this Article 6 are complete and accurate as of the date hereof, except as set forth in the SEC

 

-48-


Documents (as defined in Section 6.21 below), or in the written disclosure schedule delivered by Purchaser to the Company. Such Purchaser disclosure schedule shall be arranged in sections corresponding to the numbered and lettered sections and subsections contained in this Article 6, and the disclosures in any section or subsection of the Purchaser’s disclosure schedule shall qualify only the corresponding section or subsection of this Article 6, unless the disclosures in one section or subsection reasonably appear to apply to another section or subsection of the Purchaser’s disclosure schedule.

6.01 Organization . Each of Purchaser and Merger Sub is a corporation duly organized, validly existing and in good standing under the Laws of the State of Delaware. Each of Purchaser and Merger Sub has all requisite corporate power and authority to enable it to own, lease or otherwise hold its properties and assets and to carry on its business as presently conducted. Each of Purchaser and Merger Sub is duly qualified to do business and in good standing in each jurisdiction in which the nature of its business or the ownership, leasing or holding of its properties makes such qualification necessary. A list of the jurisdictions in which each of Purchaser and Merger Sub is so qualified is set forth on Schedule 6.01 . A list of all of the Subsidiaries of Purchaser is set forth on Schedule 6.01 . Merger Sub does not have any Subsidiaries.

6.02 Capital Stock and Related Matters; No Investments .

(a) The authorized capital stock of Purchaser consists of 90,100,000 authorized shares consisting of: (i) 90,000,00 shares of Purchaser Common Stock, and (ii) 100,000 shares of preferred stock, par value $0.01 (“ Purchaser Preferred Stock ”), of which 90,000 shares have been designated as Series A Junior Participating Preferred Stock. As of the date hereof 48,881,483 shares of Purchaser Common Stock are issued and outstanding, and no shares of Purchaser Preferred Stock are issued and outstanding (collectively, the “ Purchaser Shares ”). The Purchaser Shares constitute all of the issued and outstanding shares of capital stock of Purchaser and are held by Purchaser’s stockholders. The authorized capital stock of Merger Sub consists of 1,000 shares of common stock, $0.001 par value per share, 100 of which are issued and outstanding and held by Purchaser.

(b) Except as set forth on Schedule 6.02 hereto, neither Purchaser nor Merger Sub has any outstanding stock or securities convertible into or exchangeable for any shares of its capital stock or containing any profit participation features, nor does it have outstanding any rights or options to subscribe for or purchase its capital stock or any stock or securities convertible into or exchangeable for any shares of its capital stock or any stock appreciation rights or phantom stock plans. Neither Purchaser nor Merger Sub is subject to any obligation (contingent or otherwise) to repurchase or otherwise acquire or retire any shares of its capital stock or any warrants, options or other rights to acquire its capital stock. All of the outstanding shares of Purchaser’s and Merger Sub’s capital stock have been validly issued and are fully paid and nonassessable.

(c) Except as set forth on Schedule 6.02 , there are no statutory or contractual shareholders’ preemptive rights or rights of refusal with respect to the Merger. Neither Purchaser nor Merger Sub has violated any applicable federal or state securities Laws in connection with the offer or sale of the Shares.

 

-49-


(d) Except for the Subsidiaries of Purchaser set forth on Schedule 6.01 , neither Purchaser nor Merger Sub owns or holds any Investment in any Person.

6.03 Authorization . Subject to approvals as are required by Law, each of Purchaser and Merger Sub has all requisite power and authority (or legal capacity, as the case may be) to enter into this Agreement and the Related Documents to be executed and delivered by Purchaser and Merger Sub pursuant hereto or in connection with the transactions contemplated hereby or thereby, and to consummate the transactions contemplated hereby and thereby. Subject only to Purchaser Stockholder Approval, all acts and other proceedings required to be taken by Purchaser to authorize the execution, delivery and performance of this Agreement and the Related Documents to which it is a party, and the consummation of the transactions contemplated hereby and thereby have been (or by the Closing will have been) duly and properly taken.

6.04 Valid and Binding . This Agreement constitutes (and, when executed and delivered at Closing, each Related Document, to the extent that Purchaser or Merger Sub is a party thereto, will constitute) a valid and binding obligation of Purchaser or Merger Sub, enforceable against the signatory in accordance with its terms, except that (i) such enforcement may be limited by or subject to any bankruptcy, insolvency, reorganization, moratorium or similar Laws now or hereafter in effect relating to or limiting creditors’ rights generally and (ii) the remedy of specific performance and injunctive and other forms of equitable relief are subject to certain equitable defenses and to the discretion of the court before which any proceeding therefor may be brought.

6.05 No Violation . The execution and delivery of this Agreement and each Related Document by Purchaser and Merger Sub, and the consummation of the transactions contemplated hereby and thereby and compliance with the terms hereof and thereof does not and will not (subject only to obtaining any required consents, approvals, authorizations, exemptions or waivers set forth on Schedule 6.05 hereto) conflict with, or result in any violation of or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancellation or acceleration of any obligation or to loss of a material benefit under or result in the creation of any Encumbrance of any kind upon any of Purchaser’s assets under, any provision of (i) the certificate of incorporation or by-laws of Purchaser, (ii) any note, bond, mortgage, indenture, deed of trust, license, lease, contract, commitment or loan or other agreement to which Purchaser is a party or by which any of its properties or assets are bound, or (iii) any statute, regulation, rule, injunction, judgment, order, Law, ordinance, decree, ruling, charge or other restriction of any government, governmental agency, or court applicable to Purchaser or its property or assets, except in the case of clauses (ii) and (iii) for any such violations, breaches, defaults, rights of termination, cancellation or acceleration or requirements which, individually or in the aggregate would not have a Material Adverse Effect or would not adversely affect the ability of Purchaser to consummate the transactions contemplated by this Agreement.

6.06 Consents and Approvals . Other than the filing of the Delaware Certificate of Merger with the Secretary of State of the State of Delaware, or as otherwise set forth in Schedule 6.06 hereto, no consent, approval or authorization of, or declaration, filing or registration with, any governmental or regulatory authority or any court or other tribunal, and no consent or waiver of any party to any Contract is required to be obtained by Purchaser or Merger Sub in connection

 

-50-


with the execution, delivery and performance of this Agreement and the Related Documents or the consummation of the transactions contemplated hereby or thereby.

6.07 Interim Operations . Except as set forth on Schedule 6.07 , during the period from December 31, 2009 until the date of this Agreement:

(a) the Purchaser Business has been conducted by Purchaser only in the ordinary course consistent with past practices;

(i) with respect to the Purchaser Business, Purchaser has not (except as otherwise permitted by this Agreement):

(ii) suffered any Material Adverse Effect;

(iii) incurred any liabilities or obligations (absolute, accrued, contingent or otherwise), except in the ordinary and usual course of business and consistent with past practice, or increased, or experienced any change in any assumptions underlying or methods of calculating, any bad debt, contingency or other reserves;

(iv) paid, discharged or satisfied any claims, liabilities or obligations (absolute, accrued, contingent or otherwise), other than the payment, discharge or satisfaction in the ordinary and usual course of business and consistent with past practice liabilities and obligations reflected or reserved against in the Purchaser Financial Statements or incurred in the ordinary course of business and consistent with past practice;

(v) permitted or allowed Purchaser’s assets to be subjected to any Encumbrance (except Encumbrances created by Law);

(vi) canceled any debts owing to Purchaser or waived any claims or rights, except for amounts each individually under $5,000;

(vii) sold, transferred, or otherwise disposed of, or transferred or granted any rights under any lease, license or agreement with respect to, any of its assets, except in the ordinary course of business and consistent with past practices;

(viii) disposed of, failed to take reasonable steps to protect, or permitted to lapse, any rights for the use of, the Purchaser’s Intellectual Property, or disposed of, failed to take reasonable steps to protect any Proprietary Information;

(ix) made any change in any method of accounting or accounting practice;

(x) made any single capital expenditure or future commitment in excess of $20,000, or made aggregate capital expenditures or future commitments in excess of $50,000;

(xi) made any material change in the manner in which the Purchaser Business is conducted;

 

-51-


(xii) made any material change in policies relating to the Purchaser Business (whether or not in the ordinary and usual course of business);

(xiii) had any labor dispute or received notice of any grievance;

(xiv) borrowed or agreed to borrow any funds;

(xv) paid and/or declared any dividends with respect to its shares of capital stock, whether in shares of capital stock or other property;

(xvi) granted to any officer or employee any increase in compensation or benefits, other than increases in compensation or benefits to employees in the ordinary and usual course of business;

(xvii) paid any pension, retirement allowance or other employee benefit not required by any plan, policy or program identified on Schedule 6.07 hereto or any employment agreement set forth on Schedule 6.07 hereto;

(xviii) adopted, agreed to adopt, or made any announcement regarding the adoption of (i) any new pension, retirement or other employee benefit plan, program or policy, or (ii) any amendments to any existing pension, retirement or other employee benefit plan, policy or program identified on Schedule 6.07 unless otherwise required by applicable Law; or

(xix) suffered or agreed to take any of the actions set forth in this subparagraph (ii).

(b) None of the assets of Purchaser have been affected in any way as a result of fire, explosion or other casualty (whether or not covered by insurance).

6.08 Undisclosed Liabilities . The Purchaser does not have any liabilities or obligations of any nature (whether accrued, absolute, contingent or otherwise), except for liabilities or obligations (i) disclosed on Schedule 6.08 hereto, (ii) disclosed in the Purchaser Financial Statements, (iii) arising in the ordinary course of business consistent with past practice under any Material Contract, or (iv) incurred in the ordinary course of business consistent with past practices since December 31, 2009.

6.09 Taxes .

(a) Except as set forth on Schedule 6.09(a) , Purchaser has timely filed all Tax Returns required by applicable Law to be filed by or on behalf of Purchaser on or prior to the date hereof, and such Tax Returns are true, complete, correct and in conformity with applicable Tax Laws in all material respects. Purchaser has paid all Taxes (whether or not required to be shown on any Tax Return) required to be paid by Purchaser on or before the date hereof, or where payment is not yet due, has established or will establish, on or before the Closing Date, in accordance with GAAP, an adequate reserve on its books and financial records for the payment of all Taxes due from the Company, with respect to any Pre-Closing Tax Period (including any Pre-Closing Straddle Tax Liability) and the Closing Date Tax Period. All Taxes that Purchaser is or was required by Law to withhold, deposit or collect have been duly withheld, deposited or

 

-52-


collected and, to the extent required, have been paid to the relevant Tax Authority. Purchaser has timely complied with all information and reporting and backup withholding requirements, including maintenance of any required records with respect thereto, in connection with amounts paid or owing to any employee, creditor, independent contractor or other third party.

(b) Except as described in Schedule 6.09(b) , the Tax Returns with respect to Purchaser have not been subject to an Audit since its incorporation, and there are no ongoing Audits of Purchaser. Purchaser has not received written notice by any Tax Authority of an Audit nor to Purchaser’s Knowledge is any such Audit contemplated, threatened or pending.

(c) To Purchaser’s Knowledge, there are no claims, investigations, actions or proceedings pending or, to Purchaser’s Knowledge, threatened, against Purchaser by any Tax Authority for any past due Taxes with respect to which Purchaser would be liable. There has been no waiver by Purchaser of any applicable statute of limitations nor any consent for the extension of the time for the assessment of any Tax against Purchaser.

(d) Purchaser is not delinquent in the payment of any amount of Taxes and there are no Tax liens upon any property or assets of Purchaser, except liens for Taxes not yet due and payable.

(e) Purchaser has not agreed, nor is it required, to make any adjustment under Section 481(a) of the Code by reason of a change in accounting method or otherwise.

(f) Purchaser is not liable for the Taxes of any Person other than Purchaser including, without limitation, (i) under U.S. Treasury Regulations Section 1.1502-6 (or comparable provision of state, local or foreign Law), (ii) as a transferee or successor, or (iii) by contract, indemnity or otherwise. Except as set forth on Schedule 6.09(f) , Purchaser has not ever been a member of a consolidated, combined or unitary group for federal, state, local or foreign Tax purposes or have ever been included as part of a consolidated, combined or unitary Tax Return.

(g) Purchaser is not, nor has it ever been, a party to any Tax sharing agreement, Tax indemnity agreement or other similar Tax sharing arrangement.

(h) Except as set forth in Schedule 6.09(h) , since January 1, 2004 no claim has been asserted in writing by a Tax Authority in a jurisdiction where Purchaser has not filed Tax Returns that Purchaser is or may be subject to taxation by that jurisdiction. To Purchaser’s Knowledge no such claim was asserted prior to 2004.

(i) Schedule 6.09(i) sets forth each of the states for which Purchaser is currently filing income or franchise Tax Returns (or similar type of Tax Returns) or is required to file for the current Taxable Period.

(j) Purchaser has provided the Company with copies of: (i) all Tax Returns filed by, or on behalf of, Purchaser for the Post-2006 Period; (ii) all notices, protests or other correspondence relating to any Post-2006 Period Taxes or Tax Returns; (iii) any letter rulings, determination letters or similar documents issued by any Tax Authority with respect to Purchaser; (iv) any closing agreement entered into by Purchaser with any Tax Authority; and (vi)

 

-53-


any Tax Return workpapers relating to the Tax Returns referred to in clause (i). Purchaser has not entered into an exchange under Code Section 1031 with a “related person” (within the meaning of Code Section 1031(f)(3)) which could result in Purchaser being required to recognize gain under Code Section 1031(f)(1). Purchaser is not taking into account any gain under the installment method of Code Section 453.

(k) Purchaser is not, and has never been, a United States real property holding corporation within the meaning of Section 897(c)(2) of the Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code and the Company is not required to withhold tax on the purchase of the stock of Purchaser by reason of Section 1445 of the Code. Except as set forth in Schedule 6.10(l) , Purchaser has not entered into any compensatory agreements with respect to the performance of services which payment thereunder would result in a nondeductible expense pursuant to Section 162(m) or 280G of the Code or an excise tax to the recipient of such payment pursuant to Section 4999 of the Code. Purchaser has not participated in an international boycott as defined in Section 999 of the Code.

(l) Purchaser has not participated in any transaction that is a reportable transaction within the meaning of Treasury Regulation Section 1.6011-4 or Section 6707A of the Code.

(m) Neither Purchaser nor, to the knowledge of Purchaser, any of Purchaser’s affiliates has taken or agreed to take any action that would prevent the Merger from qualifying as a reorganization within the meaning of Section 368(a) of the Code. Purchaser is not aware of any agreement, plan or other circumstance that would prevent the Merger from qualifying as a reorganization within the meaning of Section 368(a) of the Code.

6.10 Contracts and Commitments .

(a) Schedule 6.10(a) lists any Contract to which Purchaser or any Subsidiary of Purchaser is a party and (i) that is a “material contract” as defined in Section 601(b)(10) of Regulation S-K promulgated by the SEC, (ii) that involves payment or receipt by Purchaser or any Subsidiary of Purchaser under any such Contract of $100,000 or more in the aggregate or obligations after the date of this Agreement in excess of $100,000 in the aggregate or (iii) that is material to the Purchaser Business. Each contract of the type described in this Section 6.10(a), whether or not set forth on Schedule 6.10(a), is referred to herein as a “ Purchaser Material Contract .” Except as set forth on Schedule 6.10(a) hereto, (i) all Purchaser Material Contracts constitute valid and binding agreements of Purchaser or any Subsidiary of Purchaser, and, to Purchaser’s Knowledge, each other party thereto, enforceable in accordance with their terms except that (A) such enforcement may be limited by or subject to any bankruptcy, insolvency, reorganization, moratorium or similar Laws now or hereafter in effect relating to or limiting creditors’ rights generally and (B) the remedy of specific performance and injunctive and other forms of equitable relief are subject to certain equitable defenses and to the discretion of the court before which any proceeding therefor may be brought, (ii) with respect to the Purchaser Material Contracts there are no existing material defaults by Purchaser or any Subsidiary of Purchaser, or, to Purchaser’s Knowledge, by any other party thereto and there is no event which (whether with or without notice, lapse of time or the happening or occurrence of any other event) would constitute a material default under the Purchaser Material Contracts by Purchaser or any

 

-54-


Subsidiary of Purchaser or, to Purchaser’s Knowledge, by any other party thereto, (iii) neither Purchaser nor any Subsidiary of Purchaser is restricted by agreement from carrying on the Purchaser Business in any geographical location, and (iv) there are no negotiations pending or in progress to revise any Purchaser Material Contract.

(b) Purchaser does not own any Real Property. The only leases for Real Property to which Purchaser is a party are set forth on Schedule 6.10(b) (collectively, and together with all addenda, the “ Purchaser Leases ”). With respect to the Purchaser Leases, (i) each such Purchaser Lease is in full force and effect and is binding and enforceable against Purchaser, and to Purchaser’s Knowledge, the lessor, in accordance with its terms except that (A) such enforcement may be limited by or subject to any bankruptcy, insolvency, reorganization, moratorium or similar Laws now or hereafter in effect relating to or limiting creditors’ rights generally and (B) the remedy of specific performance and injunctive and other forms of equitable relief are subject to certain equitable defenses and to the discretion of the court before which any proceeding therefor may be brought; (ii) all rental and other charges payable pursuant to the terms and conditions of each such Purchaser Lease have been paid and no rent has been paid in advance more than 30 days; (iii) there are no charges, offsets or defenses against the enforcement by the respective lessors thereunder of any agreement, covenant or condition on the part of Purchaser to be performed or observed pursuant to the terms of each Purchaser Lease; (iv) there are no defaults by Purchaser of any agreement, covenant or condition on the part of Purchaser to be performed or observed pursuant to the terms of each Purchaser Lease; (v) there are no actions or proceedings pending or, to Purchaser’s Knowledge, threatened, by the lessor under each such Purchaser Lease; (vi) except for security deposits required by the Purchaser Leases and identified on Schedule 6.10(b) , the respective lessor does not hold any deposits for Purchaser’s accounts under each such Purchaser Lease; (vii) the Merger and the transactions contemplated hereby will not constitute a prohibited transfer under any Purchaser Lease; and (viii) to Purchaser’s Knowledge, there are no defaults by respective lessors of any agreement, covenant or condition on the part of such lessor to be performed or observed pursuant to the terms of any such Purchaser Lease. The current expiration date and remaining options to extend each Purchaser Lease are as set forth on Schedule 6.10(b) hereto.

6.11 Intellectual Property .

(a) General . Schedule 6.11(a) contains a complete and accurate list of all Intellectual Property Registrations, including all Patents.

(b) Valid Assignment . In each case in which Purchaser has acquired ownership of (rather than licenses or other rights to) any Intellectual Property from any Person, Purchaser has obtained rights in the interest and title of the Intellectual Property. To the extent required by, and in accordance with, applicable Laws and regulations, Purchaser has recorded each assignment to it of any Intellectual Property Registrations with the USPTO or equivalent Patent Agencies outside the United States.

(c) No Infringement . To Purchaser’s Knowledge, no Person is infringing or misappropriating any Intellectual Property or Licensed Rights as of the Effective Date. Purchaser has not received written notice of a claim from any Person claiming that any Intellectual Property or Licensed Rights infringes or misappropriates any rights of such Person or

 

-55-


constitutes unfair competition or trade practices under the Laws of any jurisdiction. With respect to the Patents, although the validity of claims regarding novelty, non-obviousness and enablement have not been established, Purchaser’s claims and representations made to the USPTO and other Patent Agencies in its applications for Patents regarding novelty, non-obviousness and enablement were made in good faith, and Purchaser has no Purchaser Knowledge of any facts which Purchaser reasonably believes would cause such claims or representations to be untrue or misleading. To Purchaser’s Knowledge, there is no unexpired Patent of any third party that includes claims that would be infringed by or that would or do limit the scope of the Purchaser Business as currently conducted.

(d) Confidentiality . Purchaser has taken all actions reasonably necessary to maintain and protect its rights in the Intellectual Property, including in Trade Secrets and other Proprietary Information. Without limiting the foregoing, Purchaser has and enforces a policy requiring each employee, consultant, contractor and other third parties with access to the Trade Secrets to execute proprietary information and confidentiality agreements, and all such current and former employees, consultants, contractors and third parties have executed such an agreement. To Purchaser’s Knowledge, there has been no violation or unauthorized disclosure or use of any Intellectual Property.

(e) No Transfer of Rights . Except as disclosed on Schedule 6.11(e), Purchaser is the exclusive owner of all the Intellectual Property owned by Purchaser and no other person owns or has any rights to any of the Intellectual Property and no Person has ownership rights or license rights to improvements made by Purchaser in any Patents. Purchaser has not transferred to any other Person any interest in, granted to any other Person any license, sublicense or other right to use, authorized the retention by any Person of any rights to use or joint ownership of, or entered into a covenant, in favor of any other Person, not to sue for infringement of, any Intellectual Property, except as disclosed on Schedule 6.11(e) .

(f) Exclusive Rights . All of the Intellectual Property, excluding any Licensed Rights, was created solely by either (A) Employees of Purchaser acting within the scope of their employment or (B) employees of third parties or consultants or contractors of Purchaser who have validly and irrevocably assigned all of their rights, including rights to all Intellectual Property therein, to Purchaser.

(g) No Adverse Proceedings . To Purchaser’s Knowledge, there are no interference actions or other Proceedings pending, or any written communication that threatens an interference action or other Proceeding, before any Patent Agency or other governmental entity in any jurisdiction in regard to any Intellectual Property.

(h) No Undisclosed Inventions . To Purchaser’s Knowledge, Purchaser has not received any notice under any Contract that constitutes a research or other collaborative agreement regarding the Intellectual Property that the other party to such Contract has developed an invention under such Contract for which Purchaser would have ownership or license rights under such Contract.

(i) Payment of Intellectual Property Costs . Except as described on Schedule 6.11(i) , Purchaser has paid in full any and all costs whatsoever, including attorney’s fees,

 

-56-


associated with the preparation, filing, prosecution and maintenance of the Patents and covering the period ending on the Closing Date, including any maintenance fees which become due for the Patents on or prior to the Closing Date.

6.12 Title to the Assets .

(a) Except as described on Schedule 6.12 or in the SEC Documents or in the Purchaser Financial Statements, Purchaser has good and marketable title to, or has a valid leasehold interest or valid license or other contractual rights in, the properties and assets used by it in the Purchaser Business, located on their premises or shown on the most recent Purchaser Financial Statement or acquired thereafter, free and clear of all Encumbrances, except for (i) properties and assets disposed of in the ordinary course of business since December 31, 2009, (ii) Encumbrances for Taxes not yet due and payable or Encumbrances for Taxes which are being contested in good faith, and (iii) Encumbrances which are not material to the value of the properties or assets encumbered and which do not impair in any material respect the current use or operation of such properties and assets. Purchaser owns, or has a valid leasehold or other interest in, all assets (including all Intellectual Property) necessary for the conduct of the Purchaser Business as currently conducted by Purchaser, and immediately after the Closing Purchaser will continue to own, or have a valid leasehold or other interest in all such assets so as to be able to conduct the Purchaser Business in all respects after the Closing in substantially the same manner as the Purchaser Business has been conducted prior to the Closing.

(b) The assets and properties owned by Purchaser, together with the rights enjoyed by Purchaser, on the date hereof, constitute all of the assets, properties and rights which were used to achieve the financial results set forth on the Purchaser Financial Statements, excepting only those assets and properties disposed of or otherwise transferred by Purchaser in the ordinary course of business.

6.13 Employees and Labor Relations .

(a) The SEC Documents contain the names of all the executive officers employed by Purchaser as of the date hereof, and list the salary and compensation arrangements for each named executive officer (as such term is defined in Item 402 of Regulation S-K).

(b) Except as set forth on Schedule 6.13(b) , all employees of Purchaser are “at will” employees, each of whom can be terminated at any time (subject to all applicable Laws) without penalty or premium and whose employment terms are solely governed by the current policy manual of the Company, a true and complete copy of which has been provided to Purchaser.

(c) Except as set forth on Schedule 6.13(c) , (i) there is no current labor strike or work stoppage or lockout against or materially affecting Purchaser; during the past five (5) years there has not been any such action against Purchaser; and to Purchaser’s Knowledge, there has not been, and is not now, any such action threatened against or materially affecting Purchaser; (ii) none of the employees of Purchaser are represented by a union or subject to a collective bargaining agreement and to Purchaser’s Knowledge, no union organizational campaign is in progress with respect to such employees and no question concerning

 

-57-


representation exists respecting such employees; (iii) Purchaser is in compliance in all material respects with all applicable Laws respecting employment and employment practices, terms and conditions of employment and wages and hours and is not engaged in any unfair labor practice; and (iv) other than with Purchaser’s stockholders, option holders and warrant holders (solely in their capacity as such) there are no agreements or arrangements between (x) Purchaser and (y) an individual consultant, former consultant, employee or former employee obligating Purchaser to make any payment to any such individual as a result of the transactions contemplated by this Agreement.

(d) Except as set forth on Schedule 6.13(d) , there are no loans outstanding from Purchaser to any of its employees.

(e) Purchaser is not in breach of any material terms of employment of any of its employees nor to Purchaser’s Knowledge is any employee in breach of any material term of his or her employment relationship.

(f) As of the date hereof, none of Purchaser’s employees has given or received notice of termination of his or her employment.

(g) None of Purchaser’s employees is the subject of any material disciplinary action nor is any employee engaged in any grievance procedure and to Purchaser’s Knowledge, there is no matter or fact in existence which can be reasonably foreseen as likely to give rise to the same.

(h) Purchaser has complied in all material respects with the employment eligibility verification form requirements under the INA, in recruiting, hiring, reviewing and documenting prospective employees for employment eligibility verification purposes and Purchaser has complied in all material respects with the paperwork provisions and anti-discrimination provisions of the INA. Purchaser has obtained and maintained the employee records and I-9 forms in proper order as required by United States Law. To Purchaser’s Knowledge Purchaser does not employ any workers unauthorized to work in the United States.

6.14 Litigation . Except as set forth in the SEC Documents and on Schedule 6.14 , as of the date hereof, there is no pending or, to Purchaser’s Knowledge, threatened action, proceeding or investigation by or before any court, governmental agency or arbitrator or other tribunal, which is or may be brought against or which involves Purchaser or the Purchaser’s Business:

(a) which questions or challenges the validity of, or seeks damages or equitable relief on the basis of, this Agreement or any action taken or to be taken by Purchaser or Merger Sub pursuant to this Agreement or in connection with the transactions contemplated hereby; or

(b) which might affect the right of Purchaser to conduct the Purchaser’s Business as presently conducted;

(c) nor to Purchaser’s Knowledge is there any valid basis for any such action, proceeding or investigation.

 

-58-


6.15 Court Orders, Decrees, and Laws . Except as described in Schedule 6.15 , there is no outstanding, or to the Purchaser’s Knowledge threatened, order, writ, injunction, or decree of any court, governmental agency, or arbitration tribunal against the Purchaser. The Purchaser is in compliance in all material respects with all applicable federal, state or local Laws, rules, regulations, ordinances, zoning requirements, governmental restrictions, orders, judgments and decrees affecting, involving or relating to the Purchaser’s Business, and the Purchaser has not received any notices alleging any such violation. The foregoing shall be deemed to include Laws, rules and regulations relating to the federal patent, copyright, and trademark Laws, state trade secret and unfair competition Laws, and to all other applicable Laws, rules and regulations including, but not limited to, equal opportunity, wage and hour, and other employment matters, and antitrust and trade regulations, safety (including OSHA), building, zoning or health Laws, ordinances and regulations.

6.16 Licenses Permits . Schedule 6.16 sets forth, with respect to the Purchaser, all Governmental Authorizations and Permits. Such Governmental Authorizations and Permits constitute all approvals, authorizations, certifications, consents, variances, permissions, licenses, or permits to or from, or filings, notices, or recordings to or with, federal, state, or local governmental authorities that are required for the ownership and use of the assets of the Purchaser and the conduct of the Purchaser’s Business under federal, state, and local Law, regulation, ordinance, zoning requirement, governmental restriction, order, judgment, or decree, except where the failure to obtain such Governmental Authorizations and/or Permits does not or will not, individually or in the aggregate, have a Material Adverse Effect. The Purchaser is in compliance in all material respects with all terms and conditions of such Governmental Authorizations and Permits. All of such Governmental Authorizations and Permits are in full force and effect, and to the Purchaser’s Knowledge, no suspension or cancellation of any of them is being threatened, nor will any of such Governmental Authorizations and/or Permits be affected by the consummation of the transactions described in this Agreement. The Purchaser is in compliance in all material respects with all other applicable limitations, restrictions, conditions, standards, prohibitions, requirements, obligations, schedules, and timetables contained in any Law governing the Purchaser’s Business.

6.17 Employee Benefit Plans; ERISA .

(a) Schedule 6.17(a) contains a list of each Plan maintained or contributed to by Purchaser covering its employees, former employees, retirees or sales personnel or with respect to which Purchaser or any Commonly Controlled Entity, respectively, has or in the future could have any direct or indirect, actual or contingent liability. Except as set forth on Schedule 6.17(a) , Purchaser will not incur any liability in connection with any Plan solely as a result of the consummation of the transactions contemplated by this Agreement. Except as set forth on Schedule 6.17 , neither Purchaser nor any Commonly Controlled Entity has any legally binding oral or written plan or other commitment, whether covered by ERISA or not, to create or participate in any additional plan, agreement or arrangement or to modify or change any existing Plan in any manner. Purchaser has made available to Company true and complete copies of the Plans, the trust agreements and other contracts (including any amendments to any of the foregoing) relating to the Plans and all other relevant documents governing or relating to the Plans (including, but not limited to, the latest summary plan descriptions, all other material employee communications, the latest annual report (and all schedules and attachments) filed with

 

-59-


the IRS with respect to each of the Plans, as applicable, all material communication with any governmental entity or agency (including, without limitation, the Department of Labor and the IRS) for the last three fiscal years, and, if the Plan is intended to qualify under Section 401(a) of the Code, the most recent determination letter received from the IRS).

(b) Any Plan, including, but not limited to, any Plan that was an “employee pension benefit plan” as defined in Section 3(2) of ERISA, that Purchaser or any Commonly Controlled Entity has ever sponsored or maintained, or in or to which Purchaser or any Commonly Controlled Entity has ever participated or contributed, on behalf of its respective employees, former employees, retirees or sales personnel which was subsequently terminated, was terminated in compliance with the requirements of the Code and ERISA and neither Purchaser nor any Commonly Controlled Entity has incurred any liability with respect to such Plan or the termination of such Plan that is due and owing and has not yet been satisfied under the terms of the Plan, the Code, ERISA or any other Law or regulation pursuant to which Purchaser may incur liability or have liability attributed to it under any federal, state or local Law as a result of the consummation of the transactions contemplated by this Agreement. Neither Purchaser nor any Commonly Controlled Entity maintains or contributes to, nor, within the past five years has Purchaser or any Commonly Controlled Entity maintained or contributed to, (i) a “multiemployer plan,” as that term is defined in Section 414(f) of the Code or Sections 3(37) or 4001(a)(31) of ERISA or (ii) an “employee benefit pension plan,” as defined in Section 3(2) of ERISA, that is subject to Section 412 of the Code, Section 302 of ERISA or Title IV of ERISA. No Plan is a multiple employer plan within the meaning of Section 413(c) of the Code or Sections 4063, 4064 or 4066 of ERISA. Purchaser has not terminated any employee benefit plan as described in Section 3(3) of ERISA.

(c) Full payment has been made as of the Closing Date of all contributions or amounts (other than current outstanding routine claims for benefits) which Purchaser is required to contribute or pay under the terms of any Plan, and all contributions to any Plan which are required or recommended with respect to any period of time prior to the Closing have been made or such amounts have been accrued in accordance with GAAP. There are no funded benefit obligations for which contributions have not been made or properly accrued and there are no unfunded benefit obligations that have not been accounted for by reserves, or otherwise properly footnoted in accordance with GAAP on the Purchaser Financial Statements.

Each of the Purchaser’s Plans is and has been operated and administered in all material respects in accordance with applicable Laws, including but not limited to, ERISA and the Code, and all required material governmental filings and material participant disclosures have been made on a timely basis. With respect to each Plan, no event has occurred, and there exists no condition or set of circumstances in connection with which Purchaser could, directly or indirectly (through a Commonly Controlled Entity or otherwise), be subject to any liability under ERISA, the Code or any other applicable Law, except liability for benefit claims and funding obligations payable in the ordinary course. No prohibited transaction within the meaning of Section 406 of ERISA or 4975 of the Code, or breach of fiduciary duty under Title I of ERISA, has occurred with respect to any Plan or with respect to Purchaser or any Commonly Controlled Entity that could reasonably be expected to result in liability to Purchaser. Each Plan that is intended to qualify under Section 401(a) of the Code has received a currently effective favorable determination letter

 

-60-


from the IRS, and such Plan and its related trust are exempt from taxation under Section 501(a) of the Code.

There are no pending, or, to Purchaser’s Knowledge, threatened or anticipated claims, litigation, administrative actions or proceedings against or otherwise involving any of the Plans or related trusts, or any fiduciary thereof, by any governmental agency, or by any employee, former employee, leased employee, former leased employee, retiree or sales personnel or by any participant or beneficiary covered under any of the Plans, or otherwise involving the Plans (other than routine claims for benefits). There is no judgment, decree, injunction, rule or order of any court, governmental body, commission, agency or arbitrator outstanding against or in favor of any Plan or, to Purchaser’s Knowledge, any fiduciary thereof in that capacity. No assets of Purchaser are allocated to or held in a “rabbi trust” or similar funding vehicle or subject to any lien under ERISA.

(d) Each Purchaser Plan that is a “group health plan” (as defined in Section 607(1) of ERISA) has been operated in compliance in all material respects with the provisions of COBRA (Section 4980B of the Code), the Health Insurance Portability and Accountability Act of 1996 and, to the extent required, any applicable similar state Law. Each Purchaser Plan that is an “employee welfare benefit plan” within the meaning of Section 3(1) of ERISA (i) is a fully insured plan, (ii) is not a multiple employer welfare arrangement within the meaning of Section 3(40) of ERISA and (iii) has no reserves, assets, surpluses or prepaid premiums. Except as set forth on Schedule 6.17(d) , Purchaser does not currently provide or have a current obligation to provide for any material post-retirement or post-employment health and welfare benefits, including but not limited to, severance, salary continuation, termination, disability, death, or retiree health or medical benefits except as required by applicable Law.

(e) Except as set forth on Schedule 6.17(e) , the consummation of the transactions contemplated by this Agreement will not, of itself, entitle any current or former employee or leased employee of Purchaser to severance pay, unemployment compensation or any similar payment or accelerate the time of payment or vesting, or increase the amount of compensation due to, or in respect of, any current or former employee or leased employee, nor will it result in the breach of any agreement with any such employee.

(f) None of the assets of Purchaser is subject to any lien under Section 302(f) of ERISA or Section 412(n) of the Code.

6.18 Broker’s Fees . Except as set forth on Schedule 6.18 , neither Purchaser, Merger Sub nor anyone acting on its behalf has made any commitment or done any other act which would create any liability for any brokerage, finder’s or similar fees or commissions in connection with the transactions contemplated by this Agreement.

6.19 Authorization of Purchaser Common Stock . The shares of Purchaser Common Stock to be issued at the Closing have been duly authorized and, when issued by Purchaser, will be fully paid and non-assessable, free and clear of any Encumbrance of any third party of any nature whatsoever.

 

-61-


6.20 No Creditor Assignment; No Bankruptcy . Neither Purchaser nor Merger Sub has made a general assignment for the benefit of creditors, filed any voluntary petition in bankruptcy or suffered the filing of any involuntary petition by its creditors, suffered the appointment of a receiver to take possession of all, or substantially all, of its assets, suffered the attachment or seizure of all, or substantially all, of its assets, admitted in writing its inability to pay its debts as they come due or made an offer of settlement, extension or composition to its creditors generally.

6.21 Reports and Financial Statements .

(a) Purchaser has filed all forms, reports and documents required to be filed with the SEC since January 1, 2007 and all such required forms, reports and documents are referred to herein as the “ SEC Documents .” As of their respective dates, the SEC Documents (i) were prepared in accordance with the requirements of the Securities Act or the Exchange Act, as the case may be, and the rules and regulations of the SEC thereunder applicable to such SEC Documents, and (ii) did not at the time they were filed (or if amended or superseded by a filing prior to the date of this Agreement, then on the date of such filing) contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The certifications and statements required by (A) Rule 13a-14 under the Exchange Act and (B) 18 U.S.C. §1350 (Section 906 of the Sarbanes-Oxley Act) relating to the SEC Documents are accurate and complete and comply as to form and content with all applicable legal requirements.

(b) The audited financial statements (including any related notes thereto) contained in the SEC Documents or delivered to the Company representing the balance sheet of Purchaser at December 31, 2009 and the statements of operations, stockholders’ equity and cash flows for the three-year period then ended (the “ Purchaser Financial Statements ”), (x) complied with the published rules and regulations of the SEC with respect thereto, (y) were prepared in accordance with GAAP applied on a consistent basis throughout the periods involved (except as may be indicated in the notes thereto) and (z) fairly presented the results of its operations and cash flows for the periods indicated. The balance sheet of Purchaser as of December 31, 2009 is hereinafter referred to as the “ Purchaser Balance Sheet .”

(c) Purchaser maintains adequate disclosure controls and procedures designed to ensure that material information relating to Purchaser, is made known to the Chief Executive Officer and the Principal Accounting Officer of Purchaser by others within that entity. To Purchaser’s knowledge, there are no (i) significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect in any material respect Purchaser’s ability to record, process, summarize and report financial information and (ii) fraud, or allegation of fraud, whether or not material, that involves management or other employees who have a significant role in Purchaser’s internal controls over financial reporting.

(d) Purchaser maintains a system of internal accounting controls designed to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP principles and to maintain

 

-62-


asset accountability; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.

6.22 Section 203 of the DGCL Not Applicable . Purchaser’s Board has taken all actions so that the restrictions contained in Section 203 of the DGCL applicable to a “business combination” (as defined in Section 203 of the DGCL) shall not apply to the execution, delivery or performance of this Agreement, the Voting Agreements or the consummation of the Merger or the other transactions contemplated by this Agreement or the Voting Agreements.

6.23 Rights Agreement . Purchaser has duly entered into an amendment to the Purchaser Rights Plan, a signed copy of which has been delivered to the Company (the “ Purchaser’s Rights Agreement Amendment ”) and taken all other action necessary or appropriate so that the entering into of this Agreement or the Voting Agreements do not and will not result in the ability of any person to exercise any of Purchaser’s rights under the Purchaser Rights Plan (the “ Purchaser Rights ”) or enable or require Purchaser Rights issued thereunder to separate from the shares of Purchaser Common Stock to which they are attached or to be triggered or become exercisable or cease to be redeemable.

6.24 Interim Operations of Merger Sub . Merger Sub was formed solely for the purpose of engaging in the transactions contemplated by this Agreement, has engaged in no other business activities and has conducted no operations except in connection with the transactions contemplated hereby.

ARTICLE VII

CONDITIONS OF CLOSING; CERTAIN COVENANTS

7.01 Conditions Precedent to the Obligations of Purchaser and Merger Sub . All obligations of Purchaser and Merger Sub hereunder with respect to the Merger are subject to the fulfillment to the satisfaction of Purchaser and its legal counsel, prior to or at the Closing, of each of the following conditions, except to the extent that Purchaser may waive any one or more thereof:

(a) The Purchaser Stockholder Approval and the Company Stockholder Approval shall have been obtained.

(b) The representations and warranties contained in Article V hereof shall be true, complete and accurate in all material respects as of the date when made and at and as of the Closing Date as though such representations and warranties were made at and as of such date (except to the extent such representations are made as of a date specific).

(c) The Company shall have performed and complied in all material respects with all agreements, obligations and conditions required by this Agreement to be performed or complied with by it or him on or prior to the Closing.

(d) No suit, action, investigation, inquiry or other proceeding by any governmental body or other Person or legal or administrative proceeding shall have been

 

-63-


instituted or, to Knowledge, threatened, which seeks to restrain, enjoin, prevent the consummation or otherwise affect the transactions contemplated by this Agreement or which questions the validity or legality of the transactions contemplated hereby.

(e) From December 31, 2009 to the Closing Date, the Company Business shall not have suffered any Material Adverse Effect.

(f) The Company shall have received in writing any and all consents, approvals, authorizations, exemptions or waivers set forth on Schedule 5.06 hereto.

(g) The Company shall have delivered to Purchaser, or cause to be delivered to Purchaser, the other items required to be delivered to Purchaser in accordance with Section 3.02 hereof.

(h) The Company shall have available the Required Cash Amount.

(i) The Company shall have furnished Purchaser with such certificates to evidence compliance with the conditions set forth in this Section 7.01 as may reasonably be requested by Purchaser or its legal counsel.

7.02 Conditions Precedent to the Obligations of the Company . All obligations of the Company hereunder with respect to the Merger and the other agreements hereunder are subject to the fulfillment to the satisfaction of the Company and its legal counsel, prior to or at the Closing, of each of the following conditions, except to the extent that the Company may waive any one or more thereof:

(a) The Purchaser Stockholder Approval and the Company Stockholder Approval shall have been obtained.

(b) The representations and warranties contained in Article VI hereof shall be true, complete and accurate in all material respects as of the date when made and at and as of the Closing Date as though such representations and warranties were made at and as of such date (except to the extent such representations are made as of a date specific).

(c) Purchaser and Merger Sub shall have performed and complied in all material respects with all agreements, obligations and conditions required by this Agreement to be performed or complied with by Purchaser or Merger Sub on or prior to the Closing.

(d) No suit, action, investigation, inquiry or other proceeding by any governmental body or other Person or legal or administrative proceeding shall have been instituted or threatened which seeks to restrain, enjoin, prevent the consummation of or otherwise affect the transactions contemplated by this Agreement or which questions the validity or legality of the transactions contemplated hereby.

(e) From December 31, 2009 to the Closing Date, the Purchaser Business shall not have suffered any Material Adverse Effect.

 

-64-


(f) The shares of Purchaser Common Stock issuable to the Stockholders in the Merger shall have been approved for listing on the NASDAQ Global Market, subject to official notice of issuance.

(g) Purchaser shall have delivered to the Company, or cause to be delivered to the Company, the other items required to be delivered to the Company in accordance with Section 3.03 hereof.

(h) Purchaser and Merger Sub shall have furnished the Company with such certificates of Purchaser and Merger Sub to evidence compliance with the conditions set forth in this Section 7.02 as may be requested by the Company or its legal counsel and all consents, approvals, authorizations, exemptions or waivers set forth on Schedule 6.06 .

(i) Purchaser shall have executed the Registration Rights Agreement in the form of Exhibit G hereto, providing certain registration rights to the Company’s stockholders.

(j) Purchaser shall have executed the Stockholders Agreement in the form of Exhibit F hereto.

ARTICLE VIII

SURVIVAL OF REPRESENTATIONS

AND WARRANTIES; INDEMNIFICATION

8.01 Survival of Representations and Warranties . All representations and warranties made by the Company in this Agreement or in each of the Related Documents delivered pursuant hereto, shall survive the Closing hereunder and any investigation heretofore made by or on behalf of Purchaser through December 31, 2010. All representations and warranties made by Purchaser in this Agreement shall terminate at the earlier of the Effective Time or upon the termination of this Agreement pursuant to Section 9.01. No investigation by Purchaser or the Company, as the case may be, shall relieve the Purchaser or the Company, as the case may be from any liability for any misrepresentation made in this Agreement.

8.02 Notice of Damages . A party seeking indemnity hereunder (the “ Indemnified Party ”) will give the party from whom indemnity is sought hereunder (such party, the “ Indemnitor ”), prompt notice (hereinafter, the “ Indemnification Notice ”) of any demands, claims, actions or causes of action (collectively, “ Claims ”) asserted against the Indemnified Party. Failure to give such notice shall not relieve the Indemnitor of any obligations which the Indemnitor may have to the Indemnified Party under this Article VII, except to the extent that such failure has prejudiced the Indemnitor under the provisions for indemnification contained in this Agreement. For purposes of this Article VIII, notice to the Stockholders’ Representative shall constitute notice to the Stockholders.

8.03 Agreements to Indemnify . (a) Subject to the terms and conditions of this Article VIII, the Stockholders (acting through the Stockholders’ Representative) shall be responsible, severally and not jointly, to the limited extent described below, to indemnify, defend and hold harmless Purchaser and its Affiliates (including any officer, director, shareholder, partner, member, employee, agent or

 

-65-


representative of any thereof) (a “ Purchaser Affiliate ”) from and against all assessments, losses, damages, liabilities, costs and expenses, including, but not limited to, interest, penalties and reasonable fees and expenses of legal counsel (collectively, “ Damages ”) imposed upon or incurred by Purchaser, the Surviving Corporation, or any of its Subsidiaries arising out of, in connection with or resulting from: (i) any breach of any representation or warranty of the Company contained in or made pursuant to this Agreement or any Related Document, or any certificate or other instrument furnished or to be furnished to Purchaser or Merger Sub hereunder; or (ii) any nonfulfillment of any covenant or agreement of the Company contained in or made pursuant to this Agreement or any Related Document, or any certificate or other instrument furnished or to be furnished to Purchaser or Merger Sub hereunder.

(b) The Indemnitor shall reimburse an Indemnified Party promptly after delivery of an Indemnification Notice certifying that the Indemnified Party has incurred Damages after compliance with the terms of this Article VIII; provided , however , that the Indemnitor shall have the right to contest any such Damages or its obligations to indemnify therefor in accordance with the terms of this Agreement.

(c) The right of Purchaser to indemnification pursuant to this Section 8.03 shall be the sole and exclusive right and remedy exercisable against the Company and the Stockholders in connection with the transactions contemplated by this Agreement, regardless of the legal theory advanced in support of such claims, excepting only the case of fraud; provided , that this provision shall not waive or limit any party’s right to injunctive relief or other equitable relief for the limited purpose of avoiding immediate and irreparable harm

8.04 Conditions of Indemnification of Third-Party Claims . The obligations and liabilities of the Stockholders and the Company under Section 8.03 hereof with respect to Damages resulting from Claims by persons not party to this Agreement shall be subject to the following terms and conditions:

(a) Promptly after delivery of an Indemnification Notice to the Stockholders’ Representative in respect of a Claim and subject to paragraph (c) of this Section 8.04, the Stockholders’ Representative may elect, by written notice to the Indemnified Party, to undertake the defense and/or settlement thereof with counsel reasonably satisfactory to the Indemnified Party, at the sole cost and expense of the Indemnitor. If the Stockholders’ Representative chooses to defend any claim, the Indemnified Party shall cooperate with all reasonable requests of the Stockholders’ Representative and shall make available to the Stockholders’ Representative any books, records or other documents within its control that are necessary or appropriate for such defense.

(b) In the event that the Stockholders’ Representative, acting on behalf of the Indemnitor, within a reasonable time after receipt of an Indemnification Notice, does not so elect to defend such Claim, the Indemnified Party will have the right (upon further notice to the Stockholders’ Representative) to undertake the defense, compromise or settlement of such Claim for the account of the Indemnitor, subject to the right of the Stockholders’ Representative, acting on behalf of the Indemnitor, to assume the defense of such Claim pursuant to the terms of paragraph (a) of this Section 8.04 at any time prior to settlement, compromise or final determination thereof, provided, that the Indemnitor reimburses in full all costs of the

 

-66-


Indemnified Party (including reasonable attorney’s fees and expenses) incurred by it in connection with such defense prior to such assumption.

(c) Anything in this Section 8.04 to the contrary notwithstanding, (i) if the Stockholders’ Representative, acting on behalf of the Indemnitor, assumes the defense of any Claim, any Indemnified Party shall be entitled to participate in the defense, compromise or settlement of such Claim with counsel of its own choice at its own expense, provided , however , if representation by counsel selected by the Stockholders’ Representative would present a conflict of interest, then such Indemnified Party shall be entitled to participate in the defense, compromise or settlement of such Claim with counsel of its own choice at the expense of the Indemnitor, (ii) no person who has undertaken to defend a Claim under Section 8.04(a) hereof shall, without written consent of all Indemnified Parties, settle or compromise any Claim or consent to entry of any judgment which (A) does not include as an unconditional term thereof the release by the claimant or the plaintiff of all Indemnified Parties from all liability arising from events which allegedly give rise to such Claim or (B) imposes any restrictions of any kind on the continuing operations of the Business.

8.05 Limitations on Indemnification .

(a) Notwithstanding anything to the contrary provided elsewhere in this Agreement, the obligations of the Stockholders under this Agreement to indemnify any Indemnified Party with respect to any Claim pursuant to Section 8.03 and Section 8.04 shall be of no force and forever barred unless the Indemnified Party has given the Stockholders’ Representative notice of such claim on or prior to December 31, 2010. In any event, the parties shall fully cooperate with each other and their respective counsel in accordance with Section 8.03 and Section 8.04 in connection with any such litigation, defense, settlement or other attempted resolution.

(b) The aggregate amount of Damages for which the Stockholders may be obligated to indemnify any Indemnified Party with respect to all Claims pursuant to Section 8.03 and 8.04 shall not exceed ten percent (10%) of the total value of the aggregate Merger Consideration (the “ Cap ”); provided , however , that the Cap shall not apply in the event of fraud or willful misrepresentation by the Company. The parties agree that any liability that the Stockholders may incur for Damages pursuant to this Article VIII shall be satisfied solely and exclusively by the release by the Escrow Agent to Purchaser for cancellation of that number of Escrow Shares having a value equal to the amount of Damages, as set forth in Section 2.07(b).

ARTICLE IX

TERMINATION

9.01 Termination of Agreement . The parties may terminate this Agreement prior to the Closing as follows:

(a) Purchaser and the Company may terminate this Agreement by mutual written consent;

(b) Purchaser may terminate this Agreement by giving written notice to the Company if the Closing shall fail to occur by reason of the failure of any condition precedent

 

-67-


under Section 7.01 hereof (unless the failure results from a breach by Purchaser of any representation, warranty or covenant contained in this Agreement);

(c) Purchaser may terminate this Agreement by giving written notice to the Company if Stockholders holding more than 10% of the Shares exercise their appraisal rights in accordance with Section 262 of the DGCL;

(d) Purchaser may terminate this Agreement by giving written notice to the Company if the closing price of the Purchaser Common Stock on The NASDAQ Global Market is in excess of 125% of the Signing Date Stock Price for any ten (10) consecutive trading days following the date hereof;

(e) the Company may terminate this Agreement by giving written notice to Purchaser if the Closing shall not have occurred by reason of the failure of any condition precedent under Section 7.02 hereof (unless the failure results primarily from a breach by the Company of any representation, warranty or covenant contained in this Agreement);

(f) the Company may terminate this Agreement by giving written notice to Purchaser if (i) the closing price of the Purchaser Common Stock on The NASDAQ Global Market is below 75% of the Signing Date Stock Price for any ten (10) consecutive trading days following the date hereof or (ii) the Purchase Common Stock is no longer listed on The NASDAQ Global Market or The NASDAQ Capital Market;

(g) either Purchaser, on the one hand, or the Company, on the other hand, may terminate this Agreement on ten (10) days’ prior written notice if the other party is in material breach of this Agreement and such breach is not cured within such ten (10) day period;

(h) either Purchaser, on the one hand, or the Company, on the other hand, may terminate this Agreement upon written notice if the Closing shall not have occurred on or prior to August 31, 2010;

(i) by Purchaser, if there shall have occurred any Material Adverse Effect with respect to Company since the date of this Agreement;

(j) by the Company, if there shall have occurred any Material Adverse Effect with respect to Purchaser since the date of this Agreement; or

(k) by either Purchaser, on the one hand, or Company, on the other hand, if the required approval of the stockholders of Purchaser or Company contemplated by this Agreement shall not have been obtained by reason of the failure to obtain the requisite vote upon a vote taken at a meeting of stockholders convened therefor or at any adjournment thereof; provided , that the right to terminate this Agreement under this Section 8.01(k) shall not be available to any party where the failure to obtain stockholder approval of such party shall have been caused by the action or failure to act of such party in breach of this Agreement.

9.02 Effect of Termination . If either Purchaser and Merger Sub, on the one hand, or the Company on the other hand, terminate this Agreement pursuant to Section 9.01:

 

-68-


(a) each of Purchaser, Merger Sub and the Company will redeliver to the party furnishing the same or destroy all documents, work papers and other material of any other party relating to the transactions contemplated hereby, whether so obtained before or after the execution hereof;

(b) neither the Company, nor Purchaser, nor Merger Sub shall make or issue, or cause to be made or issued, any announcement or written statement concerning termination of this Agreement or the transactions contemplated hereby for dissemination to the general public without the prior written consent of the other parties except as required by Law or legal process;

(c) this Agreement shall become wholly void and of no force or effect, without any liability or further obligation on the part of the Company, Purchaser or Merger Sub or any director, officer, or principal thereof, except for liabilities of one party hereto to another arising from a breach of this Agreement prior to termination in accordance with Section 9.01 (including without limitation the breach of a representation or a covenant that results in the failure of the Closing to occur) and except that the provisions set forth in this Section 9.02 shall survive such termination; and

(d) if the Company shall terminate this Agreement pursuant to Section 9.01(k) due to the fact that the required approval of the stockholders of Purchaser contemplated by this Agreement shall not have been obtained by reason of the failure to obtain the requisite vote upon a vote taken at a meeting of stockholders of Purchaser convened therefor or at any adjournment thereof, Purchaser shall pay to the Company, on or prior to December 31, 2010, an amount equal to the lesser of (i) $500,000 and (ii) the Company’s reasonable and actual out-of-pocket expenses (including, without limitation, all fees and expenses of counsel, accountants, investment bankers, experts and consultants to the Company) incurred by the Company in connection with or related to the authorization, preparation, negotiation, execution and performance of this Agreement and the transactions contemplated hereby. For the avoidance of doubt, in no event shall Purchaser be required to pay the amounts set forth in this Section 9.02(d) if, immediately prior to the termination of this Agreement, the Company was in material breach of its obligations under this Agreement.

ARTICLE X

MISCELLANEOUS PROVISIONS

10.01 Expenses . Except as otherwise provided herein, each of the parties hereto will pay its own expenses incurred by or on its behalf in connection with this Agreement or any transaction contemplated by this Agreement, whether or not such transaction shall be consummated, including without limitation all fees of its respective legal counsel and accountants

10.02 Notices . (a) All notices, requests, demands, consents or waivers and other communications required or permitted hereunder shall be in writing and shall be deemed to have been duly given if delivered by hand or by telecopy (with immediate confirmation), one business day after being sent if by nationally recognized overnight courier or if mailed, then four days after being sent by certified or registered mail, return receipt requested with postage prepaid:

 

-69-


If to the Company:

(Prior to Closing)

Cequent Pharmaceuticals, Inc.

One Kendall Square, Bldg. 700

Cambridge, MA 02139

Attention: Peter D. Parker, President and CEO

Telecopy: 617-995-7941

(After Closing)

Ampersand 2006 Limited Partnership

c/o Ampersand Ventures

55 William Street, Suite 240

Wellesley, MA 02481

Attention: Herbert H. Hooper, Stockholders’ Representative

Telecopy: 781-239-0824

With a copy to:

Edwards Angel Palmer & Dodge LLP

111 Huntington Avenue

Boston, MA 02199-7613

Attention: James T. Barrett, Esq.

                 Matthew J. Gardella, Esq.

Telecopy: 617-227-4420

If to Purchaser or Merger Sub, to:

MDRNA, Inc.

3830 Monte Villa Parkway

Bothell, WA 98021

Attention: J. Michael French, President and CEO

Telecopy: 425-908-3650

With a copy to:

Pryor Cashman LLP

7 Times Square

New York, NY 10036

Attention: Lawrence Remmel, Esq.

Telecopy: (212) 798-6365

or, in each case, to such other person or address as any party shall furnish to the other parties in writing.

 

-70-


10.03 Binding; No Assignment . This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns, but neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the parties hereto without the prior written consent of the other parties, except by operation of Law and except that Purchaser may assign all or part of this Agreement and its rights hereunder (a) to an Affiliate of Purchaser or (b) from and after the Closing to a person, not a party to this Agreement, who acquires substantially all of the assets of such Purchaser and who assumes all of the obligations of such Purchaser hereunder, provided in each such case that no such assignment shall release Purchaser from its duties and obligations hereunder.

10.04 Severability . If in any jurisdiction, any provision of this Agreement or its application to any party or circumstance is restricted, prohibited or unenforceable, such provision shall, as to such jurisdiction, be ineffective only to the extent of such restriction, prohibition or unenforceability without invalidating the remaining provisions hereof and without affecting the validity or enforceability of such provision in any other jurisdiction or its application to other parties or circumstances. In addition, if any one or more of the provisions contained in this Agreement shall for any reason in any jurisdiction be held to be excessively broad as to time, duration, geographical scope, activity or subject, it shall be construed by limiting and reducing it, so as to be enforceable to the extent compatible with the applicable Law of such jurisdiction as it shall then appear.

10.05 Governing Law; Consent to Jurisdiction and Venue .

(a) The parties acknowledge and agree that this Agreement shall be governed by the Laws of the State of Delaware as to all matters including, but not limited to, matters of validity, construction, effect, performance and liability, without consideration of conflicts of laws provisions contained therein and that the courts of the State of Delaware shall have exclusive jurisdiction of all disputes with respect to this Agreement, including without limitation, any dispute relating to the construction or interpretation of the rights and obligations of any party, which is not resolved through discussion between the parties.

(b) Each of the parties hereto hereby irrevocably and unconditionally submit to the non-exclusive jurisdiction of any Delaware State or Federal court sitting in New Castle County in any action or proceeding arising out of or relating to this Agreement, any Related Document or any transaction contemplated hereby or thereby. The Company, Surviving Corporation, Purchaser and the Stockholders’ Representative hereby irrevocably waive, to the fullest extent they may effectively do so, the defense of an inconvenient forum to the maintenance of such action or proceeding, and also irrevocably and unconditionally consent to the service of any and all process in any such action or proceeding by the mailing of copies of such process by certified mail to their respective addresses specified in Section 10.02. The Company, Surviving Corporation, Purchaser and the Stockholders’ Representative further irrevocably and unconditionally agree that a final judgment in any such action or proceeding (after exhaustion of all appeals or expiration of the time for appeal) shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law.

 

-71-


10.06 Counterparts . This Agreement may be executed simultaneously in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

10.07 Headings . The title of this Agreement and the headings of the Sections and Articles of this Agreement are for reference purposes only and shall not be used in construing or interpreting this Agreement.

10.08 Entire Agreement; Amendment; Waiver . This Agreement and the Related Documents delivered pursuant to the terms hereof, sets forth the entire agreement and understanding of the parties hereto in respect of the subject matter hereof, and supersedes all prior agreements, promises, covenants, arrangements, representations or warranties, whether oral or written, by any party hereto or any officer, director, employee or representative of any party hereto. No modification or waiver of any provision of this Agreement shall be valid unless it is in writing and signed by the party to be charged therewith. The waiver of breach of any term or condition of this Agreement shall not be deemed to constitute a waiver of any other breach of the same or any other term or condition.

10.09 Third Parties . Except as specifically set forth or referred to herein, nothing herein expressed or implied is intended or shall be construed to confer upon or give to any person or corporation other than the parties hereto and their respective successors or assigns any rights or remedies under or by reason of this Agreement.

10.10 Publicity . The press release announcing the execution of this Agreement shall be issued in the form as has been mutually agreed upon by Purchaser and the Company and each of Purchaser and the Company shall consult with the other party before issuing any other press release or otherwise making any public statement with respect to the Merger or this Agreement and shall not issue any such press release or make any such public statement prior to consulting with and obtaining the prior consent of the other party (which shall not be unreasonably withheld or delayed); provided, that Purchaser may, without consulting with or obtaining the prior consent of the other party, issue such press release or make such public statement as may be required by applicable Law or any listing agreement with a national securities exchange or automated quotation system to which it is a party.

10.11 No Presumption . The Company, Purchaser and Merger Sub have each participated in the negotiation and drafting of this Agreement and have each been represented throughout to its satisfaction by legal counsel of its choosing. In the event any ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any of the provisions of this Agreement.

10.12 Gender; Tense, Etc . Where the context or construction requires, all words applied in the plural shall be deemed to have been used in the singular, and vice versa; the masculine shall include the feminine and neuter, and vice versa; and the present tense shall include the past and future tense, and vice versa.

 

-72-


10.13 Reference to Days . All references to days in this Agreement shall be deemed to refer to calendar days, unless otherwise specified.

[ remainder of page intentionally left blank; signature page follows ]

 

-73-


IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and delivered in New York, New York, all on the day and year first above written.

 

PURCHASER:
MDRNA, INC.
By:  

/s/ J. Michael French

Name:   J. Michael French
Title:   President and CEO
MERGER SUB:
CALAIS ACQUISITION CORP.
By:  

/s/ J. Michael French

Name:   J. Michael French
Title:   President
THE COMPANY:
CEQUENT PHARMACEUTICALS, INC.
By:  

/s/ Peter D. Parker

Name:   Peter D. Parker
Title:   President and CEO
STOCKHOLDERS’ REPRESENTATIVE:
AMPERSAND 2006 LIMITED PARTNERSHIP
By:   AMP-06 Management Company Limited Partnership, its General Partner
By:   AMP-06 MC LLC, its General Partner
By:  

/s/ Herbert H. Hooper

Name:   Herbert H. Hooper
Title:   Member

Exhibit 4.1

EXECUTION COPY

PROMISSORY NOTE

 

$3,000,000.00    March 31, 2010

FOR VALUE RECEIVED, the undersigned MDRNA, INC., a Delaware corporation (the “ Borrower ”), hereby promises to pay to the order of CEQUENT PHARMACEUTICALS, INC. (the “ Lender ”) the principal amount of Three Million and 00/100 ($3,000,000.00) Dollars or such portion thereof as may be advanced by the Lender pursuant to §1.2 of that certain loan agreement of even date herewith between the Lender and the Borrower (as the same may be amended, restated or otherwise modified from time to time, the “ Loan Agreement ”) and which remains outstanding from time to time hereunder (“ Principal ”), with interest, at the rate hereinafter set forth, on the daily balance of all unpaid Principal, from the date hereof until payment in full of all Principal and interest hereunder.

Interest on all unpaid Principal shall be due and payable monthly in arrears, on the fifteenth day of each month, commencing on the August 15, 2010 and continuing on the fifteenth day of each month thereafter and on the date of payment of this note in full, at a fixed rate per annum (computed on the basis of a year of three hundred sixty (360) days for the actual number of days elapsed) which shall at all times (except as described in the next sentence) be equal to ten percent (10.0%) per annum (but in no event in excess of the maximum rate permitted by then applicable law). After the occurrence and during the continuance of any Event of Default (as defined in the Loan Agreement) interest will, at the option of the Lender, accrue and be payable under this note at a rate per annum which at all times shall be equal to the sum of (i) four (4%) percent per annum plus (ii) the per annum rate otherwise payable under this note (but in no event in excess of the maximum rate permitted by then applicable law). If the entire amount of any required Principal and/or interest is not paid within fifteen (15) days after the same is due, the Borrower shall pay to the Lender a late fee equal to five percent (5%) of the required payment.

Principal of this note shall be repaid by the Borrower to the Lender as follows: Principal hereof will be repaid in three (3) equal consecutive monthly installments (each in an amount equal to 1/3rd of the aggregate principal amount of the Term Loans (as defined in the Loan Agreement) outstanding at the close of business on August 14, 2010), such installments to commence August 15, 2010 and to continue on September 15, 2010, plus a third and final payment due and payable on October 15, 2010 in an amount equal to all then remaining Principal and all interest accrued but unpaid thereon.

The Borrower may at any time and from time to time upon five (5) days’ prior written notice to Lender prepay all or any portion of the Principal of this note, without premium or penalty. Each Principal prepayment shall be accompanied by payment of all interest on the prepaid amount accrued but unpaid to the date of payment. Any partial prepayment of Principal will be applied against Principal installments in inverse order of normal maturity.

Payments of both Principal and interest shall be made, in lawful money of the United States in immediately available funds, at the office of the Lender located at One Kendall Square,


Building 700, Cambridge, Massachusetts 02139, or at such other address as the Lender may from time to time designate.

The undersigned Borrower irrevocably authorizes the Lender to make or cause to be made, on a schedule attached to this note or on the books of the Lender, at or following the time of making any Term Loan and of receiving any payment of Principal, an appropriate notation reflecting such transaction and the then aggregate unpaid balance of Principal. Failure of the Lender to make any such notation shall not, however, affect any obligation of the Borrower hereunder or under the Loan Agreement. The unpaid Principal amount of this note, as recorded by the Lender from time to time on such schedule or on such books, shall constitute presumptive evidence of the aggregate unpaid principal amount of the Term Loans.

The Borrower hereby (a) waives notice of and consents to any and all advances, settlements, compromises, favors and indulgences (including, without limitation, any extension or postponement of the time for payment), any and all receipts, substitutions, additions, exchanges and releases of collateral, and any and all additions, substitutions and releases of any person primarily or secondarily liable, (b) waives presentment, demand, notice, protest and all other demands and notices generally in connection with the delivery, acceptance, performance, default or enforcement of or under this note, and (c) agrees to pay all costs and expenses, including, without limitation, reasonable attorneys’ fees, incurred or paid by the Lender in enforcing this note and any collateral or security therefor, all whether or not litigation is commenced.

This note is the Term Note referred to in, and is entitled to the benefits of, the Loan Agreement and is also entitled to the benefits of the Security Agreement and the Patent Security Agreements (each as defined in the Loan Agreement). The maturity of this note may be accelerated upon the occurrence of an Event of Default, as provided in the Loan Agreement.

THE BORROWER HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVES THE RIGHT TO A TRIAL BY JURY IN RESPECT OF ANY CLAIM BASED ON THIS NOTE OR ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS NOTE OR ANY RELATED DOCUMENTS OR OUT OF ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENTS (WHETHER ORAL OR WRITTEN) OR ACTIONS OF ANY PERSON. THIS WAIVER CONSTITUTES A MATERIAL INDUCEMENT FOR THE LENDER TO ACCEPT THIS NOTE AND TO MAKE THE TERM LOANS AS CONTEMPLATED IN THE LOAN AGREEMENT.

** The next page is the signature page .**

 

-2-


Executed, as an instrument under seal, as of the day and year first above written.

 

MDRNA, INC.
By:  

/s/ J. Michael French

Name:   J. Michael French
Title:  

President and Chief Executive Officer

Signature Page to Term Note

Exhibit 4.2

NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ SECURITIES ACT ”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

COMMON STOCK PURCHASE WARRANT

MDRNA, INC.

 

Warrant Shares: [ ] 1    Initial Exercise Date: [ ], 2010

THIS COMMON STOCK PURCHASE WARRANT (the “ Warrant ”) certifies that, for value received, Cequent Pharmaceuticals, Inc. (the “ Holder ”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “ Initial Exercise Date ”) and prior to the Termination Date (as defined in Section 1 below) but not thereafter, to subscribe for and purchase from MDRNA, Inc., a Delaware corporation (the “ Company ”), up to [ ] 2 shares (the “ Warrant Shares ”) of common stock, par value $.0006 per share (the “ Common Stock ”), of the Company. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Section 1. Definitions .

a) “ Business Day ” means any day except a Saturday, Sunday, any day which shall be a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

b) “ Exempt Issuance ” shall mean the issuance of (a) shares of Common Stock or options or other Common Stock Equivalents to employees, officers, consultants or directors of the Company pursuant to any equity incentive plan approved by the Company’s stockholders, (b) securities exercisable or exchangeable for or convertible into shares of

 

 

1

65% of the Actual Amount Drawn under the Loan Agreement.

2

65% of the Actual Amount Drawn under the Loan Agreement


Common Stock issued and outstanding on the date hereof, and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided that any such issuance shall only be to a Person which is, itself or through its subsidiaries, an operating company in a business synergistic with, or complementary to, the business of the Company and in which the Company receives benefits in addition to the investment of funds, (excluding any transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities).

c) “ Termination Date ” shall mean on or prior to the earlier to occur of (i) the close of business on the five (5) year anniversary of the Initial Exercise Date, (ii) the termination of the Merger Agreement by the Company due to a breach of the Merger Agreement by the Holder, (iii) the Closing, or (iv) the date that is one year after the date of termination of the Merger Agreement, provided that the Company has not completed an Acquisition Transaction with a Person other than the Holder.

d) “ Trading Day ” shall mean a day on which the Common Stock is traded on a Trading Market.

e) “ Trading Market ” shall mean the OTC Bulletin Board, the US Alternext LLC, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange.

f) “ Triggering Event ” shall mean the occurrence of both of the following: (x) the Merger is not consummated (other than by reason of Holder’s material breach of the Merger Agreement), and (y) the occurrence of any one of the following, each of (1), (2) or (3) below are referred to individually as an “ Acquisition Transaction ”:

(1) a merger or consolidation in which:

 

  (i) the Company is a constituent party, or

 

  (ii) a subsidiary of the Company is a constituent party and either (A) the Company issues shares of its capital stock pursuant to such merger or consolidation representing at least 40% or more of the outstanding capital stock of the Company, or (B) as a result of such merger or consolidation of a subsidiary, the Company’s ownership interest in the surviving entity is reduced by at least 40% or more;

(2) the sale, lease, transfer, exclusive out-license or other disposition, in a single transaction or series of related transactions, by the Company or any subsidiary of the Company of at least 40% or more of the assets or intellectual property of the Company and its subsidiaries taken as a whole, or the sale or disposition (whether by merger or otherwise) of one or more subsidiaries of the Company if at least 40% or more of the assets of the Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except where such sale, lease, transfer, exclusive out-license or other disposition is to a wholly owned subsidiary; or

 

- 2 -


(3) the acquisition by a Person of beneficial ownership (as defined under Rule 13(d) of the Securities Exchange Act of 1934, as amended (“ Rule 13(d) ”)) of equity interests representing at least a 40% or greater voting interest in the Company or tender offer or exchange offer that, if consummated, would result in any Person or group (as defined in Rule 13(d)) beneficially owning equity interests representing at least a 40% or greater economic or voting interest in the Company.

g) “ VWAP ” shall mean, for any date, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the NASDAQ Global Market, as reported by Bloomberg L.P.

Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Agreement and Plan of Merger, dated March [ ], 2010 (the “ Merger Agreement ”), by and among the Company, Calais Acquisition Corp., [ ] as stockholders representative and the Holder.

Section 2. Exercise .

a) Exercise of Warrant . Upon the occurrence of the Triggering Event, Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of such Holder appearing on the books of the Company) of (i) a duly executed facsimile copy of the Notice of Exercise Form annexed hereto; (ii) this Warrant; and (iii) to the Company, except as provided in Section 2(c), payment of the aggregate Exercise Price of the shares thereby purchased by wire transfer or cashier’s check drawn on a United States bank. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. If the Warrant is exercised in part only, the Company shall, upon surrender of the Warrant, execute and deliver, within ten (10) days of the date of exercise, a new Warrant, which new Warrant shall in all other respects be identical to this Warrant, evidencing the rights of the Holder, or such other person as shall be designated in the Notice of Exercise, to purchase the balance of the Warrant Shares purchasable hereunder.

b) Exercise Price . The exercise price per share of the Common Stock under this Warrant shall be $[ ] 3 subject to adjustment hereunder (the “ Exercise Price ”).

c) Cashless Exercise . If at any time after the date of issuance of this Warrant there is no effective registration statement under the Securities Act registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then the Holder, at its option, may elect to exercise this Warrant, in whole or in part, at such time by means of a

 

 

3

Exercise Price shall be equal to the Signing Date Stock Price (as defined in the Merger Agreement).

 

- 3 -


cashless exercise ” in which the Holder shall be entitled to receive a certificate for the number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

(A) = the VWAP on the Trading Day immediately preceding the date of such election;

(B) = the Exercise Price of this Warrant, as adjusted; and

(X) = the number of Warrant Shares for which this Warrant is being exercised in accordance with the terms of this Warrant by means of a cash exercise rather than a cashless exercise (which shall include both the number of Warrant Shares issued to the Holder and the number of Warrant Shares subject to the portion of the Warrants being cancelled in payment of the Exercise Price).

Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be deemed automatically exercised via cashless exercise pursuant to this Section 2(c), provided that the Triggering Event has occurred.

d) Mechanics of Exercise .

i. Authorization of Warrant Shares . The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

ii. Delivery of Certificates Upon Exercise . Certificates for shares purchased hereunder shall be transmitted by the transfer agent of the Company to the Holder by crediting the account of the Holder’s prime broker with the Depository Trust Company through its Deposit Withdrawal Agent Commission (“ DWAC ”) system if the Company is a participant in such system, and otherwise by physical delivery to the address specified by the Holder in the Notice of Exercise within five (5) Business Days from the delivery to the Company of the Notice of Exercise Form, surrender of this Warrant and payment of the aggregate Exercise Price as set forth above (or an exercise pursuant to Section 2(c)) (“ Warrant Share Delivery Date ”). This Warrant shall be deemed to have been exercised on the date the Exercise Price is received (or an exercise pursuant to Section 2(c)) by the Company. The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised by payment to the Company of the Exercise Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant to Section 2(d)(vi) prior to the issuance of such shares, have been paid by the Holder.

iii. Rescission Rights . If the Company fails to cause its transfer agent to transmit to the Holder a certificate or certificates representing the Warrant Shares pursuant to Section 2(d)(ii) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

- 4 -


iv. Compensation for Buy-In on Failure to Timely Deliver Certificates Upon Exercise . In addition to any other rights available to the Holder, if the Company fails to cause its transfer agent to transmit to the Holder a certificate or certificates representing the Warrant Shares in accordance with Section 2(d)(ii) pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “ Buy-In ”), then the Company shall (1) pay in cash to the Holder the amount by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (A) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (B) the price at which the sell order giving rise to such purchase obligation was executed, and (2) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (1) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver certificates representing shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

v. No Fractional Shares or Scrip . No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which Holder would otherwise be entitled to purchase upon such exercise, the Company shall at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

vi. Charges, Taxes and Expenses . Issuance of certificates for Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall be paid by the Company, and such certificates shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that (i) in the event certificates for Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder; and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto and (ii) the Company shall not be required to pay any tax which may be payable in respect to any transfer involved in the registration of any certificates for Warrant Shares or Warrants in a name other than that of the Holder. The Holder shall be responsible for all other tax liability that may arise

 

- 5 -


as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise hereof.

vii. Closing of Books . The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

Section 3. Certain Adjustments .

a) Stock Dividends and Splits . If the Company, at any time prior to the Termination Date: (A) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (B) subdivides outstanding shares of Common Stock into a larger number of shares, (C) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (D) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

b) Subsequent Equity Sales . If the Company, at any time prior to the Termination Date, shall sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or securities convertible into or exerciseable or exchangeable for Common Stock (“ Common Stock Equivalents ”) entitling any Person to acquire shares of Common Stock, at an effective price per share less than the then Exercise Price (such lower price, the “ Base Share Price ” and such issuances collectively, a “ Dilutive Issuance ”) (if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock at an effective price per share which is less than the Exercise Price, such issuance shall be deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance), then the Exercise Price shall be reduced and only reduced to equal the Base Share Price. Such adjustment shall be made whenever such Common Stock or Common Stock Equivalents are issued. Notwithstanding the foregoing, no adjustments shall be made, paid or issued under this Section 3(b) in respect of an Exempt Issuance. The Company shall notify the Holder in writing, no later than the Trading Day following the issuance of any Common Stock or Common Stock Equivalents subject to this Section 3(b), indicating therein the applicable issuance price, or applicable reset price, exchange price, conversion price and other pricing terms (such notice the “ Dilutive Issuance Notice ”). For

 

- 6 -


purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section 3(b), upon the occurrence of any Dilutive Issuance, after the date of such Dilutive Issuance the Holder is entitled to receive a number of Warrant Shares based upon the Base Share Price regardless of whether the Holder accurately refers to the Base Share Price in the Notice of Exercise.

c) Subsequent Rights Offerings . If the Company, at any time prior to the Termination Date, shall issue rights, options or warrants to all holders of Common Stock (and not to the Holder) entitling them to subscribe for or purchase shares of Common Stock at a price per share less than the Exercise Price mentioned below in this Section 3(c), then the Exercise Price shall be multiplied by a fraction, of which the denominator shall be the number of shares of the Common Stock outstanding on the date of issuance of such rights or warrants plus the number of additional shares of Common Stock offered for subscription or purchase, and of which the numerator shall be the number of shares of the Common Stock outstanding on the date of issuance of such rights or warrants plus the number of shares which the aggregate offering price of the total number of shares so offered (assuming receipt by the Company in full of all consideration payable upon exercise of such rights, options or warrants) would purchase at that price per share which is less than the Exercise Price. Such adjustment shall be made whenever such rights or warrants are issued, and shall become effective immediately after the record date for the determination of stockholders entitled to receive such rights, options or warrants.

d) Pro Rata Distributions . If the Company, at any time prior to the Termination Date, shall distribute to all holders of Common Stock (and not to the Holder) evidences of its indebtedness or assets (including cash and cash dividends) or rights or warrants to subscribe for or purchase any security other than the Common Stock (which shall be subject to Section 3(a)), then in each such case provision shall be made so that the Holder shall receive upon exercise hereof, in addition to the number of shares of Common Stock issuable hereunder, the kind and amount of securities of the Company, cash or other property which the Holder would have been entitled to receive had this Warrant been exercised on the date of such event and had the Holder thereafter, during the period from the date of such event to and including the date of exercise of this Warrant, retained any such securities receivable during such period, giving application to all adjustments called for during such period under this Section 3 with respect to the rights of the Holder.

e) Fundamental Transaction . If, at any time prior to the Termination Date, (A) the Company effects any merger or consolidation of the Company with or into another Person, (B) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions, (C) any tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to tender or exchange their shares for other securities, cash or property, or (D) the Company effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (each, a “ Fundamental Transaction ”), then the Holder shall have the right thereafter to receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant without regard to any

 

- 7 -


limitations on exercise contained herein (the “ Alternate Consideration ”). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to the Company or surviving entity in such Fundamental Transaction shall issue to the Holder a new warrant consistent with the foregoing provisions and evidencing the Holder’s right to exercise such warrant into Alternate Consideration. The terms of any agreement pursuant to which a Fundamental Transaction is effected shall include terms requiring any such successor or surviving entity to comply with the provisions of this Section 3(e) and insuring that this Warrant (or any such replacement security) will be similarly adjusted upon any subsequent transaction analogous to a Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction that is (1) an all cash transaction, (2) a “ Rule 13e-3 transaction ” as defined in Rule 13e-3 under the Securities Exchange Act of 1934, as amended, or (3) a Fundamental Transaction involving a Person or entity not traded on a national securities exchange, the Company or any successor entity shall pay at the Holder’s option, exercisable at any time concurrently with or within thirty (30) days after the consummation of the Fundamental Transaction, an amount of cash equal to the value of this Warrant as determined in accordance with the Black-Scholes option pricing formula using an expected volatility equal to the one hundred (100) day historical price volatility obtained from the HVT function on Bloomberg L.P. as of the Trading Day immediately prior to the public announcement of the Fundamental Transaction.

f) Calculations . All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

g) Notice to Holder .

i. Adjustment to Exercise Price . Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.

ii. Notice to Allow Exercise by Holder . If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock; (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock; (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights; (D) the approval of any stockholders of the Company shall be required in connection with any

 

- 8 -


reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or any Fundamental Transaction; (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company; then, in each case, except if such notice and the contents thereof shall be deemed to constitute material non-public information, the Company shall deliver to the Holder a notice describing the material terms and conditions of such transaction at least ten (10) Business Days prior to the applicable record or effective date on which a Person would need to hold Common Stock in order to participate in or vote with respect to such transaction, and the Company will take all steps reasonably necessary in order to insure that the Holder is given the practical opportunity to exercise this Warrant prior to such time so as to participate in or vote with respect to such transaction; provided , however , that the failure to deliver such notice or any defect therein shall not affect the validity of the corporate action required to be described in such notice if the Holder is allowed to determine in its discretion that the Company must deem the Warrant exercised immediately prior to and contingent upon the occurrence of the events described in (A), (B), (C), (D) or (E) above.

Section 4. Transfer of Warrant .

a) Transferability . Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable by the Holder, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Within five (5) Business Days of such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. A Warrant, if properly assigned, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued. This Warrant may not be assigned by the Company except to a successor in the event of a Fundamental Transaction.

b) New Warrants . This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice.

c) Warrant Register . The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “ Warrant Register ”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any

 

- 9 -


distribution to the Holder, and for all other purposes, absent actual notice to the contrary reasonably satisfactory to the Company.

d) Transfer Restrictions . If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws, the Company may require, as a condition of allowing such transfer, that (i) the Holder or transferee of this Warrant, as the case may be, furnish to the Company a written opinion of counsel (which opinion shall be in form, substance and scope customary for opinions of counsel in comparable transactions) to the effect that such transfer may be made without registration under the Securities Act and under applicable state securities or blue sky laws, and (ii) the Holder or transferee execute and deliver to the Company an investment letter in form and substance acceptable to the Company, and (iii) the transferee be an “ accredited investor ” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), or (a)(8) promulgated under the Securities Act or a “ qualified institutional buyer ” as defined in Rule 144A(a) promulgated under the Securities Act.

Section 5. Miscellaneous .

a) No Rights as Stockholder Until Exercise . This Warrant does not entitle the Holder to any voting rights or other rights as a stockholder of the Company prior to the exercise hereof.

b) Loss, Theft, Destruction or Mutilation of Warrant . The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate. Any such new Warrant shall constitute an original contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated or destroyed Warrant shall be at any time enforceable by anyone.

c) Saturdays, Sundays, Holidays, etc . If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

d) Authorized Shares .

The Company covenants that during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant, including as the Warrant is adjusted pursuant to Section 3 above. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of executing stock certificates to execute and issue the necessary

 

- 10 -


certificates for the Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.

Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (a) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (b) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant, and (c) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof as may be necessary to enable the Company to perform its obligations under this Warrant.

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

e) Jurisdiction . All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Merger Agreement.

f) Restrictions . The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have restrictions upon resale imposed by state and federal securities laws.

g) Nonwaiver and Expenses . No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice Holder’s rights, powers or remedies, notwithstanding the fact that all rights hereunder terminate on the Termination Date. If the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to Holder such amounts as shall be sufficient to cover any reasonable costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

h) Notices . All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed email, telex or facsimile if sent during normal business hours of the

 

- 11 -


recipient, if not, then on the next Business Day, (c) five (5) Business Days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) Business Day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. The addresses for such communications are:

 

   If to the Company:     

MDRNA, Inc.

3830 Monte Villa Parkway

Bothell, WA 98021

Attention: J. Michael French, President and CEO

Telecopy: 425-908-3650

   With a copy to:     

Pryor Cashman LLP

7 Times Square

New York, NY 10036

Attention: Lawrence Remmel, Esq.

Telecopy: (212) 798-6365

   If to a Holder:     

Cequent Pharmaceuticals, Inc.

One Kendall Square, Bldg. 700

Cambridge, MA 02139

Attention: Peter D. Parker, President and CEO

Telecopy:

   With a copy to:     

Edwards Angell Palmer & Dodge LLP

111 Huntington Avenue

Boston, MA 02199-7613

Attention: James T. Barrett, Esq.

Matthew J. Gardella, Esq.

Telecopy: 617-227-4420

Each party will provide ten (10) days’ advance written notice to the other parties of any change in its address.

i) Limitation of Liability . No provision hereof, in the absence of any affirmative action by Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of Holder, shall give rise to any liability of Holder for the purchase price of any Common Stock hereunder or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

j) Remedies . Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

- 12 -


k) Successors and Assigns . Subject to applicable securities laws and the restrictions on transfer set forth on the first page hereof, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of all Holders from time to time of this Warrant and shall be enforceable by any such Holder or holder of Warrant Shares. Subject to this Section 5(k), nothing in this Warrant shall be construed to give to any Person other than the Company and the Holder any legal or equitable right, remedy or cause of action under this Warrant.

l) Amendment . This Warrant may be modified or amended or the provisions hereof waived, in each case only with the written consent of the Company and the Holder.

m) Severability . Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

n) Headings . The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

[ Remainder of page left blank intentionally; signature page follows ]

 

- 13 -


IN WITNESS WHEREOF , the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

MDRNA, INC.

 

By:  

 

Name:  
Title:  


NOTICE OF EXERCISE

TO: MDRNA, INC.

(1) The undersigned hereby elects to purchase:

 

  ¨              Warrant Shares of the Company pursuant to the terms of the attached Warrant; or

 

  ¨ If permitted by Section 2(c) of the Warrant, the maximum number of Warrant Shares covered by such Warrant pursuant to the cashless exercise procedure set forth in Section 2(c).

(2) Payment shall take the form of (check applicable box):

 

  ¨ in lawful money of the United States; or

 

  ¨ if permitted by Section 2(c), the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).

(3) Please issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name as is specified below:

                                                      

                                                      

                                                      

The Warrant Shares shall be delivered to the following DWAC Account Number or by physical delivery of a certificate to:

(4) Accredited Investor. The undersigned is an “ accredited investor ” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

 

 

Signature

Name of Investing Entity:

Signature of Authorized Signatory of Investing Entity:

Name of Authorized Signatory:

Title of Authorized Signatory:
Date:


ASSIGNMENT FORM

(To assign the foregoing Warrant, execute

this form and supply required information.

Do not use this form to exercise the Warrant.)

FOR VALUE RECEIVED, [            ] all of or [            ] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

 

  whose address is  

 

   

 

   

 

   

 

                        Dated:  

 

 
Holder’s Signature:  

 

 
Holder’s Address:  

 

 
Signature Guaranteed:  

 

 

NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.

Exhibit 4.3

AMENDMENT NO. 3 TO RIGHTS AGREEMENT

This Amendment No. 3 to Rights Agreement (this “ Amendment ”), which is effective March 31, 2010, is by and between MDRNA, Inc. (f/k/a Nastech Pharmaceutical Company Inc.) (the “ Company ”), and American Stock Transfer & Trust Company, LLC (the “ Rights Agent ”). Capitalized terms used in this Amendment but not otherwise defined herein shall have the meanings ascribed to such terms in the Rights Agreement (as defined in the recitals below).

WHEREAS , the Company and the Rights Agent previously entered into that certain Rights Agreement dated February 22, 2000, as amended as of January 17, 2007 and March 17, 2010 (as so amended, the “ Rights Agreement ”) to provide for, among other things, certain preferred share purchase rights of the Company’s stockholders; and

WHEREAS , pursuant to Section 27 of the Rights Agreement, the Board of Directors of the Company (the “ Board ”) is permitted to amend the Rights Agreement; and

WHEREAS , the Company, Calais Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of the Company (“ Merger Sub ”), and Cequent Pharmaceuticals, Inc., a Delaware corporation (“ Cequent ”), are entering into an Agreement and Plan of Merger, dated as of March 31, 2010 (as it may be amended from time to time, the “ Merger Agreement ”), with respect to the acquisition of Cequent by the Company; and

WHEREAS , the Board has approved and declared advisable the Merger (as defined in the Merger Agreement), the Merger Agreement and the transactions contemplated by the Merger Agreement, and has declared that it is in the best interests of its stockholders that the Company enter into the Merger Agreement and consummate the transactions contemplated by the Merger Agreement on the terms and subject to the conditions set forth in the Merger Agreement; and

WHEREAS , the Board has determined that it is in the best interests of the Company and its stockholders, and is consistent with the objectives of the Board in adopting the Rights Agreement, to amend the Rights Agreement to exempt the Merger, the Merger Agreement and all of the transactions contemplated by the Merger Agreement, from the application of the Rights Agreement; and

WHEREAS , pursuant to a resolution duly adopted, the Board authorized and directed the execution and delivery of this Amendment;

NOW, THEREFORE , in consideration of the rights and obligations contained herein, and for other good and valuable consideration, the adequacy of which is hereby acknowledged, the parties agree as follows:

 

  1. Amendments to Section 1 .

(a) Section 1(a) of the Rights Agreement is hereby amended by adding the following


sentence to the end of Section 1(a):

“Notwithstanding the foregoing, no Person shall be deemed to be an Acquiring Person by reason of: (1) the approval, execution or delivery of the Merger Agreement or the Voting Agreements (as defined in the Merger Agreement); (2) the announcement or consummation of the Merger (as defined in the Merger Agreement); or (3) the consummation of any other transactions specifically contemplated by the Merger Agreement.”

(b) Section 1 of the Rights Agreement is hereby amended by adding the following definition in alphabetical order:

Merger Agreement ” shall mean that certain Agreement and Plan of Merger among the Company, Calais Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of the Company, and Cequent Pharmaceuticals, Inc., a Delaware corporation, dated as of March 31, 2010, as it may be amended from time to time.”

3. Amendment to Section 15 . Section 15 of the Rights Agreement is hereby amended by adding the following sentence at the end thereof:

“Nothing in this Agreement shall be construed to give any holder of Rights or any other Person any legal or equitable right, remedy or claim under this Agreement in connection with any transactions contemplated by the Merger Agreement.”

4. New Section 34 . The Rights Agreement is hereby amended by adding a new Section 34 to the end thereof as follows:

Section 34 . Merger Agreement . Notwithstanding anything in this Agreement that might otherwise be deemed to the contrary, no Distribution Date and no event described in Section 13, shall occur, or be deemed to occur, and no Rights shall be exercisable under this Agreement, by reason of: (1) the approval, execution or delivery of the Merger Agreement or the Voting Agreements (as defined in the Merger Agreement); (2) the announcement or consummation of the Merger; or (3) the consummation of any other transactions specifically contemplated by the Merger Agreement.”

5. Full Force and Effect . Except as expressly amended by this Amendment, the Rights Agreement shall remain in full force and effect, and all references to the Rights Agreement from and after such time shall be deemed to be references to the Rights Agreement as amended hereby. In the event of any conflict, inconsistency or incongruity between any provision of this Amendment and any provision of the Rights Agreement, the provisions of this Amendment shall govern and control for purposes of the subject matter of this Amendment only. This Amendment shall be construed in accordance with and as a part of the Rights Agreement, and all terms, conditions, representations, warranties, covenants and agreements set forth in the Rights Agreement and each other instrument or agreement referred to therein, except as herein amended, are hereby ratified and confirmed.


6. Effectiveness . This Amendment shall be deemed effective as of the date first written above as if executed on such date.

7. Governing Law . This Amendment shall be deemed to be a contract made under the laws of the State of Delaware and for all purposes shall be governed by and construed in accordance with the laws of such state applicable to contracts to be made and performed entirely within such state.

8. Counterparts . This Amendment may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

9. Severability . The parties intend that this Amendment be enforced and interpreted as written. If, however, any term, provision, covenant or restriction of this Amendment is held by a court of competent jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Amendment shall remain in full force and effect and shall in no way be affected, impaired or invalidated.

10. Descriptive Headings . Descriptive headings of the several sections, subsections and provisions of this Amendment are inserted for convenience of reference only and shall not control or affect the meaning, interpretation or construction of any of the terms or provisions hereof.

11. Exhibits to the Rights Agreement . Exhibit B (“Form of Right Certificate”) and Exhibit C (“Summary of Rights to Purchase Preferred Shares”) to the Rights Agreement are hereby deemed to be amended in a manner consistent with this Amendment.

[remainder of page intentionally left blank; signature page follows]


IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their respective officers thereunto duly authorized as of this 31 st day of March, 2010.

 

MDRNA, INC.
By:  

/s/ Peter S. Garcia

Name:   Peter S. Garcia
Title:   Chief Financial Officer

AMERICAN STOCK TRANSFER

& TRUST COMPANY, LLC

By:  

/s/ Paula Caroppoli

Name:   Paula Caroppoli
Title:   Vice President

Exhibit 10.1

Lock-Up Agreement

             , 2010

MDRNA, Inc.

3830 Monte Villa Parkway

Bothell, WA 98021

Ladies and Gentlemen:

The undersigned understands that MDRNA, Inc. (the “ MDRNA ”) has entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) by and among MDRNA, Marseilles Acquisition Corp., a wholly-owned subsidiary of MDRNA (“ Merger Sub ”), and Cequent Pharmaceuticals, Inc. (“ Cequent ”), providing for the merger of Merger Sub with and into Cequent, with Cequent surviving as a wholly-owned subsidiary of MDRNA (the “ Merger ”). In connection with the Merger, MDRNA will issue shares (the “ Consideration Shares ”) of its common stock, par value $0.006 per share (“ Common Stock ”), to the securityholders of Cequent, including the undersigned. For the avoidance of doubt, the term “Consideration Shares” shall also include all of the shares of Common Stock issuable by MDRNA upon exercise of options to purchase Common Stock that MDRNA issues to the holders of Company Options, which Company Options will be assumed by MDRNA in connection with the Merger. Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to such terms in the Merger Agreement.

To induce MDRNA to consummate the Merger and to issue the Consideration Shares, the undersigned hereby agrees that, without the prior written consent of MDRNA, it will not, during the period commencing on the effective date of the Merger and ending on the earlier of (A) one hundred and eighty (180) days thereafter or (B) thirty (30) days following the closing of an equity financing by MDRNA for the issuance of shares of equity or securities convertible into or exchangeable or exercisable for shares of equity of MDRNA (an “Equity Financing” ) which, when added together with all other Equity Financings from and after the date of execution of the Merger Agreement, results in aggregate gross proceeds to MDRNA of at least $10 million (the “ Lock-Up Period ”), (1) offer, pledge, sell, contract to sell, grant, lend, or otherwise transfer or dispose of, directly or indirectly, any Consideration Shares or any securities convertible into or exercisable or exchangeable for Consideration Shares, or (2) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Consideration Shares, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Consideration Shares or such other securities, in cash or otherwise.

Notwithstanding the foregoing, the undersigned may transfer Consideration Shares without the prior consent of MDRNA in connection with (a) transfers of Consideration Shares or any security convertible into Consideration Shares as a bona fide gift, by will or intestacy or to a family member or trust for the benefit of a family member; provided that in the case of any transfer or distribution pursuant to clause (a), (i) each donee or distributee shall sign and deliver a lock-up letter substantially in the form of this letter agreement and (ii) no filing under Section 16(a) of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), reporting a reduction in beneficial ownership by the undersigned of Shares, shall be required or shall be voluntarily made during the Lock-up Period, (b) transfer of Consideration Shares to a charity or educational institution, (c) if the undersigned is a corporation, partnership, limited liability company or other business entity, any transfers of Consideration Shares to any shareholder, partner or member of, or owner of similar equity interests in, the undersigned, as the case may be, if, in any such case, such transfer is not for value or (d) if the undersigned is a corporation, partnership, limited liability company or other business entity, any transfer of Consideration Shares made by the undersigned (i) in connection with the sale or other bona fide transfer in a single transaction of all or substantially all of the undersigned’s capital stock, partnership interests, membership interests or other similar equity interests, as the case may be, or all or substantially all of the undersigned’s assets, in any such case not undertaken for the purpose of avoiding the restrictions imposed by this agreement, (ii) to another corporation, partnership, limited liability company or other business entity so long as the transferee is an affiliate of the undersigned and such transfer is not for value, or (iii) to the beneficial owners thereof so long as such transfer is on a pro rata basis and such transfer is not for value.


In addition, the undersigned agrees and consents to the entry of stop transfer instructions with MDRNA’s transfer agent and registrar against the transfer of the undersigned’s Consideration Shares except in compliance with this agreement.

The undersigned shall not be subject to any of the foregoing restrictions in this agreement unless and until MDRNA has confirmed in writing to the undersigned that all officers and directors of MDRNA have executed similar agreements.

In the event a certain percentage of the securities held by the officers and/or directors of MDRNA are released from the restrictions set forth in agreements similar to this agreement prior to the end of the Lock-Up Period, the same percentage of the securities held by the undersigned shall be immediately and fully released from any remaining restrictions under this agreement concurrently therewith. In the event that the undersigned is released early pursuant to the terms of this paragraph, MDRNA shall notify the undersigned concurrently with notification to such other released party.

The undersigned understands that MDRNA is relying upon this agreement in entering into and consummating the Merger. The undersigned further understands that this agreement is irrevocable and shall be binding upon the undersigned’s heirs, legal representatives, successors and assigns.

 

Very truly yours,  

 

Name:  

 

Address:

 

 

 

 

Exhibit 10.2

Lock-Up Agreement

             , 2010

MDRNA, Inc.

3830 Monte Villa Parkway

Bothell, WA 98021

Ladies and Gentlemen:

The undersigned understands that MDRNA, Inc. (the “ MDRNA ”) proposes to enter into an Agreement and Plan of Merger (the “ Merger Agreement ”) by and among MDRNA, Marseilles Acquisition Corp., a wholly-owned subsidiary of MDRNA (“ Merger Sub ”), and Cequent Pharmaceuticals, Inc. (“ Cequent ”), providing for the merger of Merger Sub with and into Cequent, with Cequent surviving as a wholly-owned subsidiary of MDRNA (the “ Merger ”). In connection with the Merger, MDRNA will issue shares (the “ Shares ”) of its common stock, par value $0.006 per share (“ Common Stock ”), to the securityholders of Cequent. Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to such terms in the Merger Agreement.

To induce MDRNA to enter into the Merger Agreement, to consummate the Merger and to issue the Shares, the undersigned hereby agrees that, without the prior written consent of MDRNA, it will not, during the period commencing on the date hereof and ending on the earlier of (A) one hundred and eighty (180) days after the effective date of the Merger or (B) thirty (30) days following the closing of an equity financing by MDRNA for the issuance of shares of equity or securities convertible into or exchangeable or exercisable for shares of equity of MDRNA (an “Equity Financing” ) which, when added together to all other Equity Financings from and after the date of execution of the Merger Agreement, results in aggregate gross proceeds to MDRNA of at least $10 million (the “ Lock-Up Period ”), (1) offer, pledge, sell, contract to sell, grant, lend, or otherwise transfer or dispose of, directly or indirectly, any Shares or any securities convertible into or exercisable or exchangeable for Shares, or (2) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Shares, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Shares or such other securities, in cash or otherwise. For the avoidance of doubt, the term “Shares” shall also include all of the shares of Common Stock issuable by MDRNA upon exercise of options to purchase Common Stock held by the undersigned as of the date hereof or hereafter acquired.

Notwithstanding the foregoing, the undersigned may transfer Shares without the prior consent of MDRNA in connection with (a) transfers of Shares or any security convertible into Shares as a bona fide gift, by will or intestacy or to a family member or trust for the benefit of a family member; provided that in the case of any transfer or distribution pursuant to clause (a), (i) each donee or distributee shall sign and deliver a lock-up letter substantially in the form of this letter agreement and (ii) no filing under Section 16(a) of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), reporting a reduction in beneficial ownership by the undersigned of Shares, shall be required or shall be voluntarily made during the Lock-up Period, (b) transfer of Shares to a charity or educational institution, (c) if the undersigned is a corporation, partnership, limited liability company or other business entity, any transfers of Shares to any shareholder, partner or member of, or owner of similar equity interests in, the undersigned, as the case may be, if, in any such case, such transfer is not for value or (d) if the undersigned is a corporation, partnership, limited liability company or other business entity, any transfer of Shares made by the undersigned (i) in connection with the sale or other bona fide transfer in a single transaction of all or substantially all of the undersigned’s capital stock, partnership interests, membership interests or other similar equity interests, as the case may be, or all or substantially all of the undersigned’s assets, in any such case not undertaken for the purpose of avoiding the restrictions imposed by this agreement, (ii) to another corporation, partnership, limited liability company or other business entity so long as the transferee is an affiliate of the undersigned and such transfer is not for value, or (iii) to the beneficial owners thereof so long as such transfer is on a pro rata basis and such transfer is not for value.

In addition, the undersigned agrees and consents to the entry of stop transfer instructions with MDRNA’s transfer agent and registrar against the transfer of the undersigned’s Shares except in compliance with this agreement.


The undersigned shall no longer be subject to any of the foregoing restrictions in this agreement if MDRNA has confirmed in writing to the undersigned that all the former stockholders of Cequent required to enter into similar lock-up arrangements at Closing have not executed similar agreements. Additionally, in the event that either (i) the Closing has not taken place by August 31, 2010 or (ii) the Merger Agreement is terminated, then this agreement shall be of no further force or effect.

In the event a certain percentage of the securities held by the former stockholders of Cequent entering into similar lock-up arrangements at Closing are released from the restrictions set forth in agreements similar to this agreement prior to the end of the Lock-Up Period, the same percentage of the securities held by the undersigned shall be immediately and fully released from any remaining restrictions under this agreement concurrently therewith. In the event that the undersigned is released early pursuant to the terms of this paragraph, MDRNA shall notify the undersigned concurrently with notification to such other released party.

The undersigned understands that MDRNA is relying upon this agreement in entering into and consummating the Merger. The undersigned further understands that this agreement is irrevocable and shall be binding upon the undersigned’s heirs, legal representatives, successors and assigns.

 

Very truly yours,

 

Name:  
Address:  

 

 

 

Exhibit 10.3

EXECUTION COPY

LOAN AGREEMENT

MDRNA, INC.

3830 Monte Villa Parkway

Bothell, Washington 98021

March 31, 2010

Cequent Pharmaceuticals, Inc.

One Kendall Square

Building 700

Cambridge, MA 02139

Ladies and Gentlemen:

This loan agreement (this “ Agreement ”) will set forth certain understandings between MDRNA, Inc., a Delaware corporation (the “ Borrower ”), and Cequent Pharmaceuticals, Inc., a Delaware corporation (the “ Lender ”), with respect to Term Loans (hereinafter defined) to be made by the Lender to the Borrower. In consideration of the mutual promises contained herein and in the other documents referred to below, and for other good and valuable consideration, receipt and sufficiency of which are hereby acknowledged, the Borrower and the Lender agree as follows:

I. AMOUNTS AND TERMS

1.1. References to Documents . Reference is made to (i) that certain $3,000,000 face principal amount promissory note (the “ Term Note ”) of even date herewith made by the Borrower and payable to the order of the Lender, (ii) that certain Guaranty Agreement (the “ Guaranty ”) of even date herewith jointly and severally made by the Subsidiary Guarantors (as hereinafter defined) in favor of the Lender, (iii) that certain Security Agreement (All Assets) (the “ Security Agreement ”) of even date herewith from the Borrower and each Subsidiary Guarantor to the Lender, (iv) those certain Security Agreements (Patents), each of even date herewith from the Borrower to the Lender and from MDRNA Research, Inc. to the Lender (each, a “ Patent Security Agreement ” and collectively, the “ Patent Security Agreements ”), and (v) those certain Common Stock Purchase Warrants (each, a “ Warrant ” and collectively, the “ Warrants ”), each issued to the Lender by the Borrower.

1.2. The Borrowing; Term Note . Subject to the terms and conditions hereinafter set forth, the Lender will make one or more loans (the “ Term Loans ”) to the Borrower, as the Borrower may request, on any Business Day prior to the first to occur of (i) the consummation of the transaction contemplated by the Merger Agreement, (ii) the termination of the Merger Agreement by either party thereto, or (iii) the earlier termination of the within-described term loan facility pursuant to §5.2 or §6.5. Each such Term Loan shall be in such amount as may be requested by the Borrower; provided that (i) no Term Loan will be made after the first to occur of


(A) the consummation of the transaction contemplated by the Merger Agreement, or (B) the termination of the Merger Agreement by either party thereto; (ii) the aggregate original principal amounts of all Term Loans will not exceed $3,000,000; (iii) no Term Loan will be in a principal amount of less than $500,000, and (iv) not more than $1,000,000 in aggregate original principal amounts of Term Loans may be requested by the Borrower in any consecutive thirty (30) day period.

To request any Term Loan hereunder, the Borrower shall deliver to the Lender a borrowing notice in form and substance acceptable to Lender via facsimile or electronic mail, which borrowing notice shall set forth (i) the requested date of such Term Loan (which, with respect to the initial Term Loan, shall be a Business Day at least 15 days after the date of the corresponding borrowing notice and which, with respect to any subsequent Term Loan, shall be a Business Day at least 5 days after the date of the corresponding borrowing notice), and (ii) the amount of the Term Loan so requested.

The Term Loans will be evidenced by the Term Note. The Borrower hereby irrevocably authorizes the Lender to make or cause to be made, on a schedule attached to the Term Note or on the books of the Lender, at or following the time of making each Term Loan and of receiving any payment of principal, an appropriate notation reflecting such transaction and the then aggregate unpaid principal balance of the Term Loans. The amount so noted shall constitute presumptive evidence as to the amount owed by the Borrower with respect to principal of the Term Loans. Failure of the Lender to make any such notation shall not, however, affect any obligation of the Borrower or any right of the Lender hereunder or under the Term Note.

1.3. Principal Repayment of Term Loans . The Borrower shall repay principal of the Term Loans in three (3) equal consecutive monthly installments, commencing on August 15, 2010 and continuing on the fifteenth (15 th ) day of each month thereafter through and including October 15, 2010. Each such monthly installment of principal shall be in an amount equal to 1/3 rd of the aggregate principal amount of the Term Loans outstanding at the close of business on August 14, 2010. In any event, the then outstanding aggregate principal balance of the Term Loans and all interest then accrued but unpaid thereon shall be due and payable in full on October 15, 2010. Notwithstanding the foregoing, in the event that the transaction contemplated by the Merger Agreement is consummated prior to August 15, 2010, then on the date of the closing of such transaction, the then outstanding principal balance of the Term Loans and all interest then accrued but unpaid thereon shall be forgiven in full, the Term Note shall be cancelled and each of the Loan Documents shall be terminated. The Borrower may prepay, at any time or from time to time, without premium or penalty, the whole or any portion of any Term Loan; provided that (i) each such principal prepayment shall be accompanied by payment of all interest under the Term Note accrued but unpaid to the date of payment, and (ii) the Borrower gives the Lender at least five (5) days’ prior written notice of its intent to so prepay. Any partial prepayment of principal of the Term Loans will be applied in inverse order of normal maturity. Amounts repaid or prepaid with respect to the Term Loans are not available for reborrowing.

 

- 2 -


1.4. Interest on Term Loans . The Borrower will pay interest on the principal amount of each Term Loan outstanding from time to time, from the date of the advance of such Term Loan until payment of such Term Loan and the Term Note in full and the termination of this Agreement. Interest on the Term Loans will be payable monthly in arrears, commencing on August 15, 2010 and continuing on the fifteenth (15 th ) day of each month thereafter until payment of the Term Loans in full, subject to forgiveness of the Term Loans in full upon the consummation of the transaction contemplated by the Merger Agreement as described in §1.3 above. In any event, subject to forgiveness of the Term Loans in full upon the consummation of the transaction contemplated by the Merger Agreement as described in §1.3 above, interest on the Term Loan shall also be paid on the date of payment of the Term Loan in full. Interest on each Term Loan will be payable at a fixed rate of ten (10%) percent per annum; provided that, notwithstanding the foregoing, after the occurrence and during the continuance of any Event of Default, each Term Loan will, at the option of the Lender, bear interest at a rate per annum (the “ Default Rate ”) which at all times shall be equal to the sum of (i) four (4%) percent per annum plus (ii) the per annum rate otherwise payable with respect thereto hereunder (but in no event in excess of the maximum rate from time to time permitted by then applicable law), compounded monthly and payable on demand. All interest payable under this Agreement and/or under the Term Note will be calculated on the basis of a 360-day year for the actual number of days elapsed. If the entire amount of any required principal and/or interest payment is not paid within fifteen (15) days after the same is due, the Borrower shall pay to the Lender a late fee equal to five percent (5%) of the required payment.

1.5. Advances and Payments . The proceeds of all Term Loans shall be funded by the Lender to a general deposit account maintained by the Borrower at a bank in accordance with written instructions provided by the Borrower to the Lender. The proceeds of each Term Loan will be used by the Borrower solely for working capital and other general corporate purposes of the Borrower permitted by this Agreement. The Borrower hereby authorizes the Lender to deduct from the proceeds of initial Term Loan, and to retain for the Lender’s benefit, the Lender’s reasonable attorneys’ fees, costs and expenses related to the preparation, negotiation, execution and delivery of the Loan Documents.

Whenever any payment to be made to the Lender hereunder or under the Term Note shall be stated to be due on a day which is not a Business Day, such payment may be made on the next succeeding Business Day, and interest payable on each such date shall include the amount thereof which shall accrue during the period of such extension of time. All payments by the Borrower hereunder and/or in respect of the Term Note shall be made net of any impositions or taxes and without deduction, set-off or counterclaim, notwithstanding any claim which the Borrower may now or at any time hereafter have against the Lender. All payments of interest, principal and any other sum payable hereunder and/or under the Term Note shall be made to the Lender, in immediately available funds, at its office at One Kendall Square, Building 700, Cambridge, Massachusetts 02139 or to such other address as the Lender may from time to time direct. All payments received by the Lender after 2:00 p.m. (Boston time) on any day shall be deemed received as of the next succeeding Business Day. All monies received by the Lender shall be applied first to fees, charges, costs and expenses payable to the Lender under this Agreement, the

 

- 3 -


Term Note and/or any of the other Loan Documents, next to interest then accrued on account of any Term Loans and only thereafter to principal of the Term Loans; provided that after the occurrence and during the continuance of an Event of Default, all monies received by the Lender shall be applied in such order as the Lender may determine in its sole discretion. All interest and fees payable hereunder and/or under the Term Note shall be calculated on the basis of a 360-day year for the actual number of days elapsed.

1.6. Conditions to Advance . Prior to the making of the initial Term Loan, the Borrower shall deliver to the Lender duly executed copies of this Agreement, the Security Agreement, the Guaranty, each Patent Security Agreement, the Term Note, a Warrant and the documents and other items listed on the Closing Agenda delivered herewith by the Lender to the Borrower, all of which, as well as all legal matters incident to the transactions contemplated hereby, shall be satisfactory in form and substance to the Lender and its counsel. On the date the initial Term Loan is made, all statements, representations and warranties of the Borrower and each Subsidiary Guarantors made in the Merger Agreement shall be correct in all material respects as of such date, and all covenants and agrees of the Borrower and each Subsidiary Guarantor contained in the Merger Agreement shall have been complied with in all material respects on and as of such date.

Without limiting the foregoing, any Term Loan (including the initial Term Loan) is subject to the further conditions precedent that on the date on which such Term Loan is made (and after giving effect thereto):

(a) All statements, representations and warranties of the Borrower and each Subsidiary Guarantors made in this Agreement, the Guaranty and/or in the Security Agreement shall continue to be correct in all material respects as of the date of such Term Loan.

(b) All covenants and agreements of the Borrower and each Subsidiary Guarantor contained herein, in the Merger Agreement and/or in any of the Loan Documents shall have been complied with in all material respects on and as of the date of such Term Loan.

(c) No event which constitutes, or which with notice or lapse of time or both could reasonably be expected to constitute, an Event of Default shall have occurred and be continuing, which has not been cured or waived in accordance with the terms of this Agreement and the other Loan Documents.

(d) No material adverse change shall have occurred in the financial condition of the Borrower from that disclosed in the financial statements then most recently furnished to the Lender.

Each request by the Borrower for any Term Loan, and each acceptance by the Borrower of the proceeds of any Term Loan, will be deemed a representation and warranty by the Borrower and each Subsidiary Guarantor that at the date of such Term Loan and after giving effect thereto all of the conditions set forth in the foregoing clauses (a) - (d) of this §1.6 will be satisfied.

 

- 4 -


1.7. Termination Fee . If the Borrower is required to pay the termination fee pursuant to the terms of Section 9.02(d) of the Merger Agreement (the “ Termination Fee ”) and Borrower does not pay such Termination Fee when due as set forth in Section 9.02(d) of the Merger Agreement, then such Termination Fee shall added to the outstanding principal amount of the Term Note and deemed principal thereunder, and shall bear interest from the date thereof until the date when paid at a rate per annum equal to 4% per annum plus the per annum rate otherwise payable under the Term Note (but in no event in excess of the maximum rate permitted by then applicable law). The Termination Fee shall be an Obligation of the Borrower and shall be secured by the Security Agreement until all outstanding principal (other than that representing the Termination Fee) and all interest accrued and unpaid under the Term Note (other than that arising on such portion of principal representing the Termination Fee), and the fees, costs and expenses of Borrower due Lender hereunder in connection with the Term Loans, have been indefeasibly paid in full in cash. Upon the indefeasible payment in full in cash of such principal, interest and fees, costs and expenses, such Termination Fee shall become unsecured, and all Liens and security interests on the Collateral securing the same shall be released upon the written request of, and at the cost and expense of, the Borrower.

1.8 Warrant . As consideration for the establishment of the within-described Term Loan facility, the Borrower agrees to issue to the Lender on or about the date of each Term Loan hereunder, a Warrant to purchase shares of the Borrower’s capital stock, each such warrant to be exercisable for a number of shares of Borrower’s common stock equal to sixty-five percent (65%) of the principal amount of the Term Loan being made on such date divided by $1.1496 (subject to equitable adjustment in the event of any stock split, stock dividend, stock combination or the like). The obligations of the Borrower and the rights of the Lender under each Warrant will be effective upon the issuance thereof and will (until performed in full unless the Warrant is terminated or expires in accordance with its terms) survive payment of the Term Loans and the other Obligations and termination of this Agreement. In no event may any Warrant be exercised unless the Merger Agreement has been terminated, without the consummation of the transaction contemplated by the Merger Agreement. Upon the consummation of the transaction contemplated by the Merger Agreement, all rights, including rights of exercise, under the Warrants shall terminate and be null and void.

II. REPRESENTATIONS AND WARRANTIES

2.1. Representations and Warranties . In order to induce the Lender to enter into this Agreement and to make Term Loans hereunder, the Borrower warrants and represents to the Lender as follows:

(a) The Borrower is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware. The Borrower has full corporate power to own its property and conduct its business as now conducted and as proposed to be conducted, to grant the security interests contemplated by the Security Agreement and to enter into and perform this Agreement and the other Loan Documents. The Borrower is duly qualified to do business and in

 

- 5 -


good standing in Washington and in each other jurisdiction in which the Borrower maintains any plant, office, warehouse or other facility and in each other jurisdiction where the failure so to qualify could (singly or in the aggregate with all other such failures) have a material adverse effect on the financial condition or business of the Borrower, all such jurisdictions being listed on item 2.1(a) of the attached Disclosure Schedule. At the date hereof, the Borrower has no Subsidiaries, except as listed on said item 2.1(a) of the attached Disclosure Schedule. The Borrower is not a member of any partnership or joint venture pursuant to any arrangement that would permit any other Person to commit any funds of the Borrower, or to subject any assets of the Borrower to any Indebtedness or liability, without the prior written consent of the Borrower, in each instance.

(b) At the date of this Agreement, the Borrower’s authorized capital stock consists of 90,000,000 shares of common stock, par value $0.006 per share, and 100,000 shares of preferred stock, par value $0.01 per share. At the date of this Agreement, the issued and outstanding shares of common stock and of preferred stock of the Borrower are as set forth on item 2.1(b) of the attached Disclosure Schedule and all outstanding shares are duly and validly issued, fully paid and nonassessable. The Borrower owns 100% of the outstanding capital stock of each Subsidiary.

(c) The execution, delivery and performance by the Borrower of this Agreement and each of the other Loan Documents to which the Borrower is a party have been duly authorized by all necessary corporate and other action and do not and will not:

(i) violate any provision of, or require as a prerequisite to effectiveness any filing (other than filings under the Uniform Commercial Code), registration, consent or approval under, any law, rule, regulation, order, writ, judgment, injunction, decree, determination or award presently in effect having applicability to the Borrower;

(ii) violate any provision of the charter or by-laws of the Borrower, or result in a breach of or constitute a default or require any waiver or consent under any indenture or loan or credit agreement or any other material agreement, lease or instrument to which the Borrower is a party or by which the Borrower or any of its properties may be bound or affected or require any other consent of any Person; or

(iii) result in, or require, the creation or imposition of any lien, security interest or other encumbrance (other than in favor of the Lender), upon or with respect to any of the properties now owned or hereafter acquired by the Borrower.

(d) This Agreement and each of the other Loan Documents delivered herewith to which the Borrower is a party has been duly executed and delivered by the Borrower and each is a legal, valid and binding obligation of the Borrower, enforceable against the Borrower in accordance with its respective terms.

 

- 6 -


(e) Except as described on item 2.1(e) of the attached Disclosure Schedule, there are no actions, suits, proceedings or investigations pending or, to the knowledge of the Borrower, threatened by or against the Borrower or any Subsidiary of the Borrower before any court or Governmental Authority, domestic or foreign, which could hinder or prevent the consummation of the transactions contemplated hereby or call into question the validity of this Agreement or any of the other Loan Documents or any other document or instrument provided for or contemplated by this Agreement or any of the other Loan Documents or any action taken or to be taken in connection with the transactions contemplated hereby or thereby or which in any single case or in the aggregate may result in any material adverse change in the business, condition, affairs or operations of the Borrower or any Subsidiary.

(f) The Borrower is not in violation of any term of its charter or by-laws as now in effect. Neither the Borrower nor any Subsidiary of the Borrower is in material violation of any term of any mortgage, indenture or judgment, decree or order, or any other material instrument, contract or agreement to which it is a party or by which any of its property is bound.

(g) The Borrower has filed (and has caused each of its Subsidiaries to file) all federal, foreign, state and local tax returns, reports and estimates required to be filed by the Borrower and/or by any such Subsidiary. All such filed returns, reports and estimates are proper and accurate and the Borrower or the relevant Subsidiary has paid all taxes, assessments, impositions, fees and other governmental charges required to be paid in respect of the periods covered by such returns, reports or estimates. No deficiencies for any tax, assessment or governmental charge have been asserted or assessed, and the Borrower knows of no material tax liability or basis therefore.

(h) The Borrower is in compliance (and each Subsidiary of the Borrower is in compliance) with all requirements of law, federal, foreign, state and local, and all requirements of all Governmental Authorities having jurisdiction over it, the conduct of its business, the use of its properties and assets, and all premises occupied by it, failure to comply with any of which could (singly or in the aggregate with all other such failures) have a material adverse effect upon the assets, business or financial condition of the Borrower or any such Subsidiary. Without limiting the foregoing, the Borrower has all of the material franchises, licenses, leases, permits, certificates and authorizations needed for the conduct of its business and the use of its properties and all premises occupied by it, as now conducted, owned and used and as proposed to be conducted, owned and used.

(i) The audited financial statements of the Borrower and Subsidiaries as at December 31, 2009 heretofore delivered to the Lender, are complete and accurate and fairly present the financial condition of the Borrower and Subsidiaries as at the date thereof and for the periods covered thereby, and have been prepared in accordance with generally accepted accounting principles consistently applied. Neither the Borrower nor any of the Borrower’s Subsidiaries has any liability, contingent or otherwise, not disclosed in the aforesaid financial statements or in any notes thereto that could reasonably be expected to materially affect the financial condition of the Borrower. Since December 31, 2009: (A) there has been no material adverse change in the

 

- 7 -


business, assets or condition (financial or otherwise) of the Borrower, (B) neither the business, condition or operations of the Borrower nor any of its properties or assets has been materially adversely affected as the result of any legislative or regulatory change, any revocation or change in any franchise, license or right to do business, or any other event or occurrence, whether or not insured against; (C) the Borrower has not experienced any material controversy or problem with its employees or with any labor organization; and (D) except for (i) the Merger Agreement and (ii) as set forth on item 2.1 of the attached Disclosure Schedule, the Borrower has not entered into any material transaction other than in the ordinary course.

(j) The principal place of business and chief executive offices of the Borrower are located at 3830 Monte Villa Parkway, Bothell, Washington 98021. Except as described on item 2.1(j) of the attached Disclosure Schedule, none of the assets of the Borrower are now located at any other address. Item 2.1(j) of the attached Disclosure Schedule sets forth the names and addresses of all record owners of each of such premises.

(k) The conduct of the business of the Borrower and its Subsidiaries as presently conducted and as previously conducted prior to the date hereof does not and did not in any material respect infringe, violate, or misappropriate any Intellectual Property of any Person material to the Borrower or any of its Subsidiaries. Item 2.1(k) of the attached Disclosure Schedule contains a complete and accurate list of all Intellectual Property Registrations owned by the Borrower or any of its Subsidiaries. All Intellectual Property Registrations are owned solely by the Borrower and/or its Subsidiaries and are not subject to any Liens or other encumbrances.

(l) None of the executive officers or key employees of the Borrower is subject to any agreement in favor of anyone other than the Borrower which limits or restricts that person’s right to engage in the type of business activity conducted or proposed to be conducted by the Borrower or which grants to anyone other than the Borrower any rights in any inventions or other ideas susceptible to legal protection developed or conceived by any such officer or key employee.

(m) The Borrower is not a party to any contract or agreement which now has or, as far as can be reasonably foreseen by the Borrower at the date hereof, would be reasonably likely to have a material adverse effect on the financial condition, business or properties of the Borrower.

(n) The Borrower is not engaged in the business of extending credit for the purpose of purchasing or carrying margin stock (within the meaning of Regulation U of the Board of Governors of the Federal Reserve System), and no part of the proceeds of any Term Loan will be used to purchase or carry any margin stock or to extend credit to others for the purpose of purchasing or carrying any margin stock or in any other manner which would involve a violation of any of the regulations of the Board of Governors of the Federal Reserve System. The Borrower is not an “investment company” within the meaning of the Investment Company Act of 1940, as amended.

(o) The Borrower and each of its Subsidiaries has good and clear, record and marketable title to such of its fixed assets as are real property and good and merchantable title to all of its other assets now carried on its books, free of any mortgages, pledges, charges, liens,

 

- 8 -


security interests or other encumbrances, except as shown on the financial statements heretofore provided by the Borrower to the Lender. The Borrower and each such Subsidiary enjoys peaceful and undisturbed possession under all leases under which it is operating, and all said leases are valid and subsisting and in full force and effect.

(p) Neither the Borrower nor any of its Subsidiaries has incurred any accumulated funding deficiency within the meaning of ERISA, nor does the Borrower or any such Subsidiary have any material liability to the PBGC in connection with any employee pension benefit plan (or other class of benefit which the PBGC has elected to insure), and there have been no “reportable events” or “prohibited transactions” with respect to any such plan, as those terms are defined in Section 4043 of ERISA and Section 4975 of the Internal Revenue Code of 1986, as amended, respectively.

(q) The Borrower and each Subsidiary of the Borrower is in compliance in all material respects with all applicable Environmental Laws. Neither the Borrower nor any of its Subsidiaries has been notified of any action, suit, proceeding or investigation which calls into question compliance by the Borrower or any such Subsidiary with any Environmental Laws or which seeks to suspend, revoke or terminate any license, permit or approval necessary for the generation, handling, storage, treatment or disposal of any Hazardous Substances. No Environmental Event has occurred that could reasonably be expected to have a material adverse effect on the financial condition, business or properties of the Borrower or any Subsidiary.

(r) After giving effect to the transactions contemplated hereby, the Borrower (i) will be able to pay its debts as they become due, (ii) will have funds and capital sufficient to carry on its business as now conducted and as intended to be conducted, (iii) owns property having a value both at fair valuation and at present fair salable value greater than the amount required to pay its debts as they become due, and (iv) is not insolvent and will not be rendered insolvent as determined by applicable law.

(s) As of the date hereof, there does not exist any Default or Event of Default hereunder.

(t) Neither this Agreement, nor the financial statements referred to herein, nor any other agreement, document, certificate or written statement, taking such other agreements, documents, certificates or written statements as a whole, furnished to the Lender or to the Lender’s counsel by or on behalf of the Borrower or any Subsidiary of the Borrower in connection with the transactions contemplated by this Agreement contains any untrue statement of a material fact or omits to state a material fact necessary in order to make the statements contained herein or therein not misleading. There is no fact within the actual knowledge, after reasonable inquiry, of any of the officers of the Borrower which has not been disclosed herein or in writing by them to the Lender and which materially adversely affects, or in the future in their opinion may, insofar as they can now reasonably foresee, materially adversely affect the business, properties, assets or condition, financial or otherwise, of the Borrower.

(u) The issuance and delivery of the shares to be issued pursuant to each Warrant (the “ Warrant Shares ”) when sold and paid for in accordance with the terms of each such Warrant,

 

- 9 -


will be duly authorized by all necessary corporate action on the part of the Borrower. The Warrant Shares have been duly and validly reserved and, when sold and paid for in accordance with the terms of each Warrant, will be duly and validly issued, fully paid and nonassessable. When issued, the Warrant Shares will be free from any claims, liens or encumbrances created or imposed by any act or omission on the part of the Company other than in connection with Federal or State securities laws, rules or regulations.

(v) No consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any governmental authority is required on the part of the Borrower in connection with the execution, delivery and performance of any Warrant and the consummation of the transactions contemplated thereby or the offer, issuance, sale and delivery of each Warrant and the Warrant Shares, except (a) such filings as shall have been made prior to and shall be effective on and as of the date of each such Warrant, (b) any notices of sale required to be filed with the Securities and Exchange Commission under Regulation D of the Securities Act or with state securities administrators under applicable state securities laws, which will be filed within the required time period therefor, or (c) such filings, registrations and orders as may be required, if applicable, to effect any registration of securities pursuant any Warrant.

(w) The representations and warranties made by the Borrower contained in Sections 6.01 through 6.20, inclusive, of the Merger Agreement (together with the related definitions contained in the Merger Agreement and the relevant exhibits and schedules thereto) are incorporated herein by this reference as effectively as if set forth at length herein. The Borrower hereby represents that all of such representations and warranties are true and correct as if made on and as of the date of this Agreement.

(x) Atossa is an inactive Subsidiary of the Borrower, is in the process of being dissolved and except in connection with the Loan Documents, has no assets, liabilities, properties or operations.

III. AFFIRMATIVE COVENANTS AND REPORTING REQUIREMENTS

3.1 Covenants Effective Regardless of Status of Merger Agreement . Without limitation of any other covenants and agreements contained herein or elsewhere, the Borrower agrees that so long as the financing arrangements contemplated hereby are in effect or all or any portion of any Term Loan or any of the other Obligations shall be outstanding (other than Obligations arising or owing in respect of the Termination Fee).

(a) Covenants Incorporated by Reference . The Borrower will perform (and will cause each of its Subsidiaries to perform) all affirmative agreements and covenants applicable to it set forth in the Merger Agreement, all of which (together with the related definitions contained in the Merger Agreement) are incorporated herein by this reference as effectively as if set forth at length herein. Said agreements and covenants (and the related definitions) are incorporated herein as they exist in the Merger Agreement at the date hereof and without regard for any future termination or waiver of the Merger Agreement.

 

- 10 -


(b) Further Assurances . The Borrower will execute and deliver, or cause to be executed and delivered, to the Lender from time to time, promptly upon request therefor, any and all other and further instruments (including correction instruments) that may be requested by the Lender to cure any deficiency in the execution and delivery of this Agreement or any other Loan Document in which it is named as a party or more fully to describe or give effect to particular aspects of any of the agreements and undertakings of such Borrower provided in this Agreement or intended to be so provided.

3.2 Covenants Effective Upon Termination of the Merger Agreement . Without limitation of any other covenants and agreements contained herein or elsewhere, the Borrower agrees that so long as the financing arrangements contemplated hereby are in effect or all or any portion of any Term Loan or any of the other Obligations shall be outstanding, and only upon and after the Merger Agreement having been terminated without the transactions contemplated thereby having been consummated:

(a) Legal Existence; Qualification; Compliance . The Borrower will maintain (and will cause each Subsidiary of the Borrower to maintain) its corporate existence and good standing in the jurisdiction of its incorporation. The Borrower will remain qualified to do business and in good standing in Washington. The Borrower qualify to do business and will remain qualified and in good standing (and the Borrower will cause each Subsidiary of the Borrower to qualify and remain qualified and in good standing) in each other jurisdiction where the Borrower or such Subsidiary, as the case may be, maintains any plant, office, warehouse or other facility and in each other jurisdiction where the failure so to qualify could (singly or in the aggregate with all other such failures) have a material adverse effect on the financial condition, or business of the Borrower or any such Subsidiary; provided that the Lender acknowledges that Atossa shall be dissolved by the Borrower. The Borrower will comply (and will cause each Subsidiary of the Borrower to comply) with its charter documents and by-laws (other as due to the dissolution of Atossa). The Borrower will comply with (and will cause each Subsidiary of the Borrower to comply with) all applicable laws, rules and regulations (including, without limitation, ERISA and Environmental Laws) other than (i) laws, rules or regulations the validity or applicability of which the Borrower or such Subsidiary shall be contesting in good faith by proceedings which serve as a matter of law to stay the enforcement thereof and (ii) those laws, rules and regulations the failure to comply with any of which could not (singly or in the aggregate) have a material adverse effect on the financial condition, assets or business of the Borrower or any such Subsidiary. Without limitation of any other provisions of this Agreement, (i) the Borrower will cause the Real Property to comply in all material respects with all relevant Environmental Laws, and (ii) will not suffer or permit to exist any Environmental Event; provided, however, that the mere occurrence of an Environmental Event will not be deemed to constitute an Event of Default so long as the Borrower diligently investigates such occurrence and thereafter diligently and continuously proceeds with remediation to the extent required by any applicable Environmental Law, all in a manner consistent with all applicable Environmental Laws.

 

- 11 -


(b) Maintenance of Property; Insurance . The Borrower will maintain and preserve (and will cause each Subsidiary of the Borrower other than Atossa to maintain and preserve) its properties and fixed assets in good working order and condition, making all necessary repairs thereto and replacements thereof, consistent with its past practice. The Borrower will maintain all such insurance as may be required under the Security Agreement and will also maintain (and will cause each Subsidiary of the Borrower other than Atossa to maintain), with financially sound and reputable insurers, insurance with respect to its property and business against such liabilities, casualties and contingencies and of such types and in such amounts as shall be reasonably satisfactory to the Lender from time to time (provided that the insurance carriers and coverage in effect as of the date hereof and disclosed to the Lender are satisfactory to the Lender) and in any event all such insurance as may from time to time be customary for companies conducting a business similar to that of the Borrower in similar locales.

(c) Payment of Taxes and Charges . The Borrower will pay and discharge (and will cause each Subsidiary of the Borrower to pay and discharge) all taxes, assessments and governmental charges or levies imposed upon it or upon its income or property, including, without limitation, taxes, assessments, charges or levies relating to real and personal property, franchises, income, unemployment, old age benefits, withholding, or sales or use, prior to the date on which penalties would attach thereto, and all lawful claims (whether for any of the foregoing or otherwise) which, if unpaid, might give rise to a lien upon any property of the Borrower or any such Subsidiary, except any of the foregoing which is being contested in good faith and by appropriate proceedings which serve as a matter of law to stay the enforcement thereof and for which the Borrower has established and is maintaining adequate reserves. The Borrower will pay, and will cause each of its Subsidiaries to pay, in a timely manner, all material lease obligations, material trade debt, material purchase money obligations, material equipment lease obligations and all of its other material Indebtedness. The Borrower will perform and fulfill (and will cause each of its Subsidiaries to perform and fulfill) all material covenants and agreements under any material leases of real estate, material agreements relating to purchase money debt, material equipment leases and other material contracts. The Borrower will maintain in full force and effect, and comply with the terms and conditions of, all permits, permissions and licenses necessary or desirable for its business.

(d) Maintenance of Property . The Borrower will maintain and preserve, and will cause each of its Subsidiaries other than Atossa to maintain and preserve, all of its properties necessary or useful, as determined in the commercially reasonable judgment of the Borrower consistent with past practice, in the proper conduct of its business in good working order and condition, making all necessary repairs thereto and replacements thereof. The Borrower will not use any of its properties in violation of any insurance thereon. In the event of damage to or destruction of all or any part of its properties from any cause, the Borrower shall repair, replace, restore and reconstruct such property to the extent reasonably necessary or desirable for the continued operation of the business substantially as operated immediately prior to such damage or destruction, and this obligation shall not be limited by the amount of insurance proceeds available.

 

- 12 -


(e) Conduct of Business . The Borrower will conduct (and will cause each of its Subsidiaries other than Atossa to conduct), in the ordinary course, the business in which they are presently engaged. The Borrower will not, without the prior written consent of the Lender, directly or indirectly (itself or through any Subsidiary) enter into any other lines of business, businesses or ventures not substantially related to those being conducted by the Borrower at the date of this Agreement.

(f) Reporting Requirements . The Borrower will furnish to the Lender (or cause to be furnished to the Lender):

(i) Within 90 days after the end of each fiscal year of the Borrower, a copy of the annual audit report for such fiscal year for the Borrower (or a web-link to the SEC EDGAR filing thereof), including therein consolidated and consolidating balance sheets of the Borrower and Subsidiaries as at the end of such fiscal year and related consolidated and consolidating statements of income, stockholders’ equity and cash flow for the fiscal year then ended. The annual consolidated financial statements shall be audited and certified by independent public accountants selected by the Borrower and reasonably acceptable to the Lender, provided, that KPMG is hereby acknowledged to be acceptable to Lender.

(ii) Within 45 days after the end of each fiscal quarter of the Borrower, consolidated and consolidating balance sheets of the Borrower and Subsidiaries and related consolidated and consolidating statements of income and cash flow (or a web-link to the SEC EDGAR filing thereof), unaudited but complete and accurate and prepared in accordance with generally accepted accounting principles consistently applied fairly presenting the financial condition of the Borrower and Subsidiaries as at the dates thereof and for the periods covered thereby (except that such quarterly statements need not contain footnotes) and certified as accurate (subject to year-end audit adjustments, which shall not be material) by the chief financial officer of the Borrower, such balance sheets to be as at the end of such quarter and such statements of income and cash flow to be for such quarter and for the fiscal year to date, in each case together with a comparison to the results for the corresponding fiscal period of the immediately prior fiscal year.

(iii) At the time of delivery of each annual and quarterly financial statement of the Borrower, a certificate executed by the chief financial officer of the Borrower stating that he or she has reviewed this Agreement and the other Loan Documents and has no actual knowledge, after reasonable inquiry, of any Default or Event of Default hereunder or thereunder or, if he or she has such knowledge, specifying each such Default or Event of Default and the nature thereof.

(iv) Promptly after receipt, a copy of all audits or reports submitted to the Borrower by independent public accountants in connection with any annual, special or interim audits of the books of the Borrower and any “management letter” prepared by such accountants.

 

- 13 -


(v) As soon as possible and in any event within five days after the occurrence of any Default or Event of Default known, after reasonable inquiry, to the Borrower or its officers, the statement of the Borrower setting forth details of each such Default or Event of Default and the action which the Borrower proposes to take with respect thereto.

(vi) Promptly after the commencement thereof, notice of all actions, suits and proceedings before any court or Governmental Authority, domestic or foreign, to which the Borrower or any Subsidiary of the Borrower is a party; provided, however, that the Borrower will not be deemed to be required by this clause (vi) to give notice of any such action, suit or proceeding which seeks monetary damages only and in which the amount sought is less than $50,000.

(vii) Promptly upon filing any registration statement or listing application, a copy of same, or a web-link to the SEC EDGAR filing thereof.

(viii) If the Borrower at any time has a class of securities which is publicly traded, a copy of each periodic or current report of the Borrower filed with the SEC or any successor agency (or if applicable, a web-link to the SEC filing thereof) and each annual report, proxy statement and other communication sent by the Borrower to shareholders or other security holders generally, such copy or, if applicable web-link, to be provided to the Lender promptly upon such filing with the SEC or such communication with shareholders or security holders, as the case may be.

(ix) As soon as possible and in any event within 30 days after the Borrower knows, after reasonable inquiry, that any event which would constitute a reportable event under ERISA with respect to any employee pension or other benefit plan subject to ERISA has occurred, or that the PBGC or the Borrower or any of the Borrower’s Subsidiaries has instituted or will institute proceedings to terminate such plan, a certificate of the chief financial officer of the Borrower setting forth details as to such reportable event and the action which the Borrower proposes to take with respect thereto, together with a copy of any notice of such reportable event which may be required to be filed with the PBGC, or any notice delivered by the PBGC evidencing its intent to institute such proceedings, or any notice to the PBGC that the plan is to be terminated, as the case may be.

(x) As soon as possible and in any event within 5 days after the occurrence of any Environmental Event, the statement of the Borrower setting forth the details of such Environmental Event and the action that the Borrower proposes to take with respect thereto.

(xi) Promptly after the Borrower has knowledge thereof, written notice of:

 

- 14 -


(A) termination or potential termination, or any hearings or proceedings which could lead to termination, of any permit, license or contract material to the conduct of the activities of the Borrower or any of its Subsidiaries;

(B) any material loss, damage or destruction to or of any property or assets of the Borrower or any of its Subsidiaries (regardless of whether the same is covered by insurance);

(C) any material controversy on the part of the Borrower or any of its Subsidiaries with its employees or with any labor organization; and/or

(D) any other material development or circumstance which could reasonably be expected to have a material adverse effect on the Borrower or its business, properties, assets, Subsidiaries (other than Atossa) or condition, financial or otherwise, or the Borrower’s ability to carry out its obligations under this Agreement.

(xii) Promptly upon any change in the Borrower’s independent public accountants, notification thereof and such further information as the Lender may reasonably request concerning the resignation, refusal to stand for reappointment after completion of the current audit or dismissal of such accountants.

(xiii) Promptly upon applying for, or being granted, a federal or state registration for any Intellectual Property or purchasing or licensing any Intellectual Property, written notice to the Lender describing same, together with all such documents as may be required to give the Lender a fully perfected first priority security interest in each such item of Intellectual Property.

(xiv) Promptly upon request, such other information respecting the financial condition, operations or business of the Borrower or any Subsidiary as the Lender may from time to time reasonably request.

(g) Books and Records . The Borrower will maintain (and will cause each of its Subsidiaries to maintain) complete and accurate books, records and accounts which will at all times accurately and fairly reflect all of its transactions in accordance with generally accepted accounting principles consistently applied. The Borrower will, at any reasonable time and from time to time upon reasonable notice and during normal business hours (and at any time and without any necessity for notice following the occurrence of an Event of Default), permit the Lender, and any agents or representatives thereof, to examine and make copies of and take abstracts from the records and books of account of, and visit the properties of the Borrower and any of its Subsidiaries, and to discuss its affairs, finances and accounts with its officers, directors and/or independent accountants, all of whom are hereby authorized and directed to cooperate with the Lender in carrying out the intent of this §3.2(g). Each financial statement of the Borrower hereafter delivered pursuant to this Agreement will be complete and accurate and will fairly present the financial condition of the Borrower as at the date thereof and for the periods

 

- 15 -


covered thereby, and all of same will be prepared in accordance with generally accepted accounting principles consistently applied.

(h) Landlord’s Waiver . Promptly upon the request of the Lender, the Borrower will obtain, and will thereafter maintain in effect at all times, waivers from the owners of all premises in which any Collateral is located, such waivers to be in form and substance satisfactory to the Lender.

(i) NASDAQ Listing . The Borrower shall maintain at all times its listing on the NASDAQ Global Market.

3.3 Estoppel . The Lender acknowledges and agrees that the Lender’s security interest in any Intellectual Property that is licensed by the Borrower or any of its Subsidiaries to a third party in a transaction permitted by this Agreement or by any other Loan Document shall be subject to the rights of any such third party licensee. Upon the reasonable request of the Borrower or any of its Subsidiaries, the Lender shall provide an estoppel in form and substance reasonably acceptable to the Lender to such third party licensee with respect to the foregoing. The Lender acknowledges that no security interest or right is granted by the Borrower or any of its Subsidiaries in property to the extent that rights in such property are not owned by the Borrower or such Subsidiary.

IV. NEGATIVE COVENANTS

4.1 Covenants Effective Regardless of Status of Merger Agreement . Without limitation of any other covenants and agreements contained herein or elsewhere, the Borrower agrees that so long as the financing arrangements contemplated hereby are in effect or all or any portion of any Term Loan or any of the other Obligations shall be outstanding (other than Obligations arising or owing in respect of the Termination Fee).

(a) Indebtedness . The Borrower will not create, incur, assume or suffer to exist any Indebtedness (nor allow any of its Subsidiaries to create, incur, assume or suffer to exist any Indebtedness), except for:

(i) Indebtedness owed to the Lender, including, without limitation, the Indebtedness represented by the Term Note;

(ii) Indebtedness of the Borrower or any Subsidiary for taxes, assessments and governmental charges or levies not yet due and payable;

(iii) unsecured current liabilities of the Borrower or any Subsidiary (other than for money borrowed or for purchase money Indebtedness with respect to fixed assets) incurred upon customary terms in the ordinary course of business;

 

- 16 -


(iv) purchase money Indebtedness (including, without limitation, Indebtedness in respect of capitalized equipment leases) hereafter incurred to equipment vendors and/or lessors for equipment purchased or leased by the Borrower or any Subsidiary or for use in the Borrower or such Subsidiary’s business, provided that the total of Indebtedness permitted under this clause (iv) will not exceed $200,000 in the aggregate outstanding at any one time;

(v) other Indebtedness (not described in any of clauses (i)-(iv) above) existing at the date hereof, but only to the extent set forth on item 4.1(a) of the attached Disclosure Schedule; and

(vi) any guaranties or other contingent liabilities expressly permitted pursuant to §4.1(c).

(b) Liens . The Borrower will not create, incur, assume or suffer to exist (nor allow any of its Subsidiaries to create, incur, assume or suffer to exist) any mortgage, deed of trust, pledge, lien, security interest, or other charge or encumbrance (including the lien or retained security title of a conditional vendor) of any nature (collectively, “ Liens ”), upon or with respect to any of its property or assets, now owned or hereafter acquired, except that the foregoing restrictions shall not apply to:

(i) Liens for taxes, assessments or governmental charges or levies on property of the Borrower or any of its Subsidiaries if the same shall not at the time be delinquent or thereafter can be paid without interest or penalty or are being contested in good faith and by appropriate proceedings which serve as a matter of law to stay the enforcement thereof and as to which adequate reserves have been made and are maintained;

(ii) Liens imposed by law, such as carriers’, warehousemen’s and mechanics’ liens and other similar Liens arising in the ordinary course of business for sums not yet due or which are being contested in good faith and by appropriate proceedings which serve as a matter of law to stay the enforcement thereof and as to which adequate reserves have been made and are maintained;

(iii) pledges or deposits under workmen’s compensation laws, unemployment insurance, social security, retirement benefits or similar legislation;

(iv) Liens in favor of the Lender;

(v) Liens in favor of equipment vendors and/or lessors securing purchase money Indebtedness to the extent permitted by clause (iv) of §4.1(a); provided that no such Lien will extend to any property of the Borrower or any Subsidiary other than the specific items of equipment financed;

 

- 17 -


(vi) Liens arising by reason of good faith deposits in connection with leases of real estate, bids or contracts (other than contracts for the payment of money), deposits to secure public or statutory obligations, or to secure, or in lieu of, surety, stay or appeal bonds, and deposits as security for the payment of taxes or assessments or other similar charges; or

(vii) other Liens existing at the date hereof, but only to the extent and with the relative priorities set forth on item 4.1(b) of the attached Disclosure Schedule.

(c) Guaranties . The Borrower will not, without the prior written consent of the Lender, assume, guarantee, endorse or otherwise become directly or contingently liable (including, without limitation, liable by way of agreement, contingent or otherwise, to purchase, to provide funds for payment, to supply funds to or otherwise invest in any debtor or otherwise to assure any creditor against loss) (and will not permit any of its Subsidiaries so to assume, guaranty or become directly or contingently liable) in connection with any indebtedness of any other Person, except (i) guaranties by endorsement for deposit or collection in the ordinary course of business, and (ii) guaranties existing at the date hereof and described on item 4.1(c) of the attached Disclosure Schedule.

(d) Covenants Incorporated by Reference . The Borrower will not violate or suffer or permit the violation of any of the negative covenants or agreements contained in the Merger Agreement by itself or any of the Borrower’s Subsidiaries, all of which (together with the related definitions contained in the Merger Agreement and the relevant schedules and exhibits to the Merger Agreement) are incorporated herein by this reference as effectively as it set forth at length herein. Said agreements and covenants (and the related definitions, schedules and exhibits) are incorporated herein as they exist in the Merger Agreement at the date hereof and without regard for any future termination or waiver of the Merger Agreement.

(e) No Margin Stock . No proceeds of any Term Loan shall be used directly or indirectly to purchase or carry any margin security within the meaning of Regulation U of the Board of Governors of the Federal Reserve Board.

(f) Additional Requirements . The Borrower shall fail to deliver or to cause to be delivered prior to the making of the initial Term Loan and in any event on or before April 16, 2010: (i) original stock certificates representing 100% of the capital stock of each Subsidiary of the Borrower, (ii) a certificate for Calais Acquisition Corp. evidencing its good standing and legal existence in the State of Delaware, and (iii) a foreign qualification certificate for the Borrower evidencing the Borrower’s legal existence and good standing in the State of Washington.

 

- 18 -


4.2 Covenants Effective Upon Termination of Merger Agreement . Without limitation of any other covenants and agreements contained herein or elsewhere, the Borrower agrees that so long as the financing arrangements contemplated hereby are in effect or all or any portion of any Term Loan or any of the other Obligations shall be outstanding (other than Obligations arising or owing in respect of the Termination Fee), and only upon and after the Merger Agreement having been terminated without the transactions contemplated thereby having been consummated:

(a) Dividends . The Borrower will not, without the prior written consent of the Lender, make any distributions to its shareholders, pay any dividends (other than dividends payable solely in capital stock of the Borrower) or redeem, purchase or otherwise acquire, directly or indirectly any of its capital stock.

(b) Loans and Advances . The Borrower will not make (and will not permit any Subsidiary to make) any loans or advances to any Person, including, without limitation, the Borrower’s directors, officers and employees, except advances to such directors, officers or employees with respect to expenses incurred by them in the ordinary course of their duties, all of which loans and advances will not exceed, in the aggregate, $50,000 outstanding at any one time.

(c) Investments . The Borrower will not, without the Lender’s prior written consent, invest in, hold, purchase or acquire any stock or securities of any Person (nor will the Borrower permit any of its Subsidiaries to invest in, purchase, hold or acquire any such stock or securities) except: (i) readily marketable direct obligations of, or obligations guarantied by, the United States of America or any agency thereof; (ii) other investment grade debt securities; (iii) mutual funds, the assets of which are primarily invested in items of the kind described in the foregoing clauses (i) and (ii) of this §4.2(c); (iv) deposits with or certificates of deposit issued by a bank organized in the United States having capital in excess of $100,000,000 and a long-term debt rating of A or better by Standard & Poor’s (or an equivalent rating by another nationally recognized rating agency); and (vi) investments in any Subsidiary Guarantor.

(d) Subsidiaries; Acquisitions . The Borrower will not (and will not permit any Subsidiary to), without the prior written consent of the Lender, form or acquire any Subsidiary or make any other acquisition of all or substantially all of the stock of any other Person or of all or substantially all of the assets of any other Person. The Borrower will not (and will not permit any Subsidiary to) become a partner in any partnership without the prior written consent of the Lender.

(e) Merger, Etc. Except as contemplated by the Merger Agreement, the Borrower will not (and will not permit any Subsidiary to), without the prior written consent of the Lender, liquidate or dissolve or merge or consolidate with any Person, or sell, lease, transfer or otherwise dispose of any material portion of its assets (whether in one or more transactions), other than sales of inventory in the ordinary course.

 

- 19 -


(f) Affiliate Transactions . The Borrower will not, without prior written consent of the Lender, enter into any transaction, including, without limitation, the purchase, sale or exchange of any property or the rendering of any service, with any affiliate of the Borrower, except in the ordinary course of and pursuant to the reasonable requirements of the Borrower’s business and upon fair and reasonable terms no less favorable to the Borrower than would be obtained in a comparable arms’-length transaction with any Person not an affiliate; provided that nothing in this §4.2(f) shall be deemed to restrict the payment of salary or other similar payments to any officer or director of the Borrower at a level consistent with the salary and other payments being paid at the date of this Agreement and heretofore disclosed in writing to the Lender, nor to prevent the hiring of additional officers at a salary level consistent with industry practice, nor to prevent reasonable periodic increases in salary. For the purposes of this Agreement, “affiliate” means any Person which, directly or indirectly, controls or is controlled by or is under common control with the Borrower; any officer or director or former officer or director of the Borrower; any Person owning of record or beneficially, directly or indirectly, 5% or more of any class of capital stock of the Borrower or 5% or more of any class of capital stock or other equity interest having voting power (under ordinary circumstances) of any of the other Persons described above; and any member of the immediate family of any of the foregoing. “Control” means possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of any Person, whether through ownership of voting equity, by contract or otherwise.

(g) Change of Address, etc. The Borrower will not change its corporate name or legal structure, nor will the Borrower change its jurisdiction of organization or its chief executive offices or principal place of business from the address described in §2.1(j) above, nor will the Borrower remove any books or records from such address, nor will the Borrower keep any Collateral at any location other than as described in §2.1(j) above and/or at the locations described on item 2.1(j) of the Disclosure Schedule, in each instance, without giving the Lender at least 30 days’ prior written notice and providing all such financing statements, certificates and other documentation as the Lender may request in order to maintain the perfection and priority of the security interests granted or intended to be granted pursuant to the Security Agreement. The Borrower will not change its fiscal year or methods of financial reporting unless, in each instance, prior written notice of such change is given to the Lender and prior to such change the Borrower enters into amendments to this Agreement in form and substance reasonably satisfactory to the Lender in order to preserve unimpaired the rights of the Lender and the obligations of the Borrower hereunder.

(h) Hazardous Waste . Except as provided below, the Borrower will not dispose of or suffer or permit to exist any Hazardous Substance on any site or vessel owned, occupied or operated by the Borrower or any Subsidiary of the Borrower, nor shall the Borrower store (or permit any Subsidiary to store) on any site or vessel owned, occupied or operated by the Borrower or any such Subsidiary, or transport or arrange the transport of, any Hazardous Substances, except in compliance will all applicable Environmental Laws. The Borrower shall provide the Lender with written notice of (i) the intended storage or transport of any hazardous material or oil by the Borrower or any Subsidiary of the Borrower, (ii) any potential or known release or threat of release of any Hazardous Substance at or from any site or vessel owned,

 

- 20 -


occupied or operated by the Borrower or any Subsidiary of the Borrower, and (iii) any incurrence of any expense or loss by any Governmental Authority in connection with the assessment, containment or removal of any Hazardous Substance for which expense or loss the Borrower or any Subsidiary of the Borrower may be liable. Notwithstanding the foregoing, the Borrower and its Subsidiaries may use, store and transport, and need not notify the Lender of the use, storage or transportation of, (x) oil in reasonable quantities, as fuel for heating of their respective facilities or for vehicles or machinery used in the ordinary course of their respective businesses and (y) Hazardous Substances that are solvents, cleaning agents or other materials used in the ordinary course of the respective business operations of the Borrower and its Subsidiaries, in reasonable quantities, as long as in any case the Borrower or the Subsidiary concerned (as the case may be) has obtained and maintains in effect any necessary governmental permits, licenses and approvals, complies with all requirements of applicable federal, state and local law relating to such use, storage or transportation, follows the protective and safety procedures that a prudent businessperson conducting a business the same as or similar to that of the Borrower or such Subsidiary (as the case may be) would follow, and disposes of such materials (not consumed in the ordinary course) only through licensed providers of hazardous waste removal services.

V. DEFAULT AND REMEDIES

5.1. Events of Default . The occurrence of any one of the following events shall constitute an “ Event of Default ” hereunder:

(a) The Borrower shall fail to make any payment of principal of or interest on the Term Note on or before the date when due, or shall fail to pay when due any other amount payable under this Agreement within three (3) Business Days of the date of the relevant invoice therefor or other notice thereof; or

(b) Any representation or warranty of the Borrower contained herein shall at any time prove to have been incorrect in any material respect when made or any representation or warranty made by the Borrower in connection with any Term Loan shall at any time prove to have been incorrect in any material respect when made; or

(c) The Borrower shall default in the performance or observance of any agreement or obligation under any of §§3.2(a), 3.2(b), 3.2(c), 3.2(d), 3.2(g), or 3.2(i) or any provision of Article IV; or

(d) The Borrower shall default in the performance of any other term, covenant or agreement contained in this Agreement and such default shall continue unremedied for 10 Business Days after notice thereof shall have been given to the Borrower; or

(e) Any default on the part of the Borrower or any Subsidiary of the Borrower shall exist, and shall remain unwaived or uncured beyond the expiration of any applicable notice and/or grace period, under any other contract, agreement or undertaking now existing or hereafter entered into with or for the benefit of the Lender (or any affiliate of the Lender), including

 

- 21 -


without limitation, the Security Agreement and the Guaranty, or any default on the part of the Borrower or any Subsidiary of the Borrower shall exist, and shall remain unwaived or uncured beyond the expiration of any applicable notice and/or grace period, under the Merger Agreement and the Lender shall have terminated the Merger Agreement; or

(f) Any default shall exist and remain unwaived or uncured with respect to any other Indebtedness in principal amount in excess of $50,000 of the Borrower or any Subsidiary of the Borrower or with respect to any instrument evidencing, guaranteeing, securing or otherwise relating to any such Indebtedness, or any such Indebtedness shall not have been paid when due, whether by acceleration or otherwise, or shall have been declared to be due and payable prior to its stated maturity, or any event or circumstance shall occur which permits, or with the lapse of time or the giving of notice or both would permit, the acceleration of the maturity of any such Indebtedness by the holder or holders thereof; or

(g) The Borrower shall be dissolved, or the Borrower or any Subsidiary of the Borrower shall become insolvent or bankrupt or shall cease paying its debts as they mature or shall make an assignment for the benefit of creditors, or a trustee, receiver or liquidator shall be appointed for the Borrower or any Subsidiary of the Borrower or for a substantial part of the property of the Borrower or any such Subsidiary, or bankruptcy, reorganization, arrangement, insolvency or similar proceedings shall be instituted by or against the Borrower or any such Subsidiary under the laws of any jurisdiction (except for an involuntary proceeding filed against the Borrower or any Subsidiary of the Borrower which is dismissed within 60 days following the institution thereof); or

(h) Any attachment, execution or similar process shall be issued or levied against any property of the Borrower or any Subsidiary and such attachment, execution or similar process shall not be paid, stayed, released, vacated or fully bonded within 10 days after its issue or levy; or

(i) Any final uninsured judgment in excess of $25,000 shall be entered against the Borrower or any Subsidiary of the Borrower by any court of competent jurisdiction; or

(j) The Borrower or any Subsidiary of the Borrower shall fail to meet its minimum funding requirements under ERISA with respect to any employee benefit plan (or other class of benefit which the PBGC has elected to insure) or any such plan shall be the subject of termination proceedings (whether voluntary or involuntary) and there shall result from such termination proceedings a liability of the Borrower or any Subsidiary of the Borrower to the PBGC which, in each case, in the reasonable opinion of the Lender may have a material adverse effect upon the financial condition of the Borrower or any such Subsidiary; or

(k) The Security Agreement or any other Loan Document shall for any reason (other than due to payment in full of all amounts secured or evidenced thereby or due to discharge in writing by the Lender) not remain in full force and effect; or

 

- 22 -


(l) The security interest and liens of the Lender in and on any of the Collateral covered or intended to be covered by the Security Agreement and/or any Patent Security Agreement shall for any reason (other than written release by the Lender) not be fully perfected liens and security interests; or

(m) Except as contemplated by the Merger Agreement, a Change of Control shall occur; or

(n) If this Agreement or any of the other Loan Documents shall prove to be illegal or unenforceable in any material respect; or

(o) An Environmental Event shall have occurred that in the reasonable opinion of the Lender materially adversely affects the financial condition, prospects, business or operations of the Borrower or any of its Subsidiaries or any of their respective premises; or

(p) The Borrower or any of its Subsidiaries shall suffer substantial loss, theft, taking, damage or destruction to or of any of its property which, after taking into account any insurance, would have a material adverse effect upon the business, operations or financial condition of the Borrower or any such Subsidiary; or the Borrower or any of its Subsidiaries shall suffer the loss (or proceedings shall be commenced which could result in the loss) of any permit, license or contract material to the operation of the Borrower or any of its Subsidiaries or any of their respective facilities; or

(q) There shall occur any other material adverse change in the condition (financial or otherwise), operations, properties, assets, or liabilities of the Borrower.

5.2. Rights and Remedies on Default . Upon the occurrence and during the continuance of any Event of Default, in addition to any other rights and remedies available to the Lender hereunder or otherwise, the Lender may exercise any one or more of the following rights and remedies (all of which shall be cumulative):

(a) Declare the entire unpaid principal amount of the Term Note then outstanding, all interest accrued and unpaid thereon and all other amounts payable under this Agreement, and all other Indebtedness of the Borrower to the Lender, to be forthwith due and payable, whereupon the same shall become forthwith due and payable, without presentment, demand, protest or notice of any kind, all of which are hereby expressly waived by the Borrower.

(b) Terminate the arrangements for Term Loans provided for by this Agreement.

(c) Exercise all rights and remedies hereunder, under the Security Agreement, under the Term Note, under the other Loan Documents, and under each and any other agreement with the Lender; and exercise all other rights and remedies which the Lender may have under applicable law.

 

- 23 -


5.3. Set-off . In addition to any rights now or hereafter granted under applicable law and not by way of limitation of any such rights, upon the occurrence of any Event of Default, the Lender is hereby authorized at any time or from time to time, without presentment, demand, protest or other notice of any kind to the Borrower or to any other Person, all of which are hereby expressly waived, to set off and to appropriate and apply any and all Indebtedness at any time held or owing by the Lender or any affiliate thereof to or for the credit or the account of the Borrower against and on account of the obligations and liabilities of the Borrower to the Lender under this Agreement or otherwise, irrespective of whether or not the Lender shall have made any demand hereunder and although said obligations, liabilities or claims, or any of them, may then be contingent or unmatured and without regard for the availability or adequacy of other collateral. As security for the Obligations, the Borrower grants to the Lender a security interest with respect to all its monies, securities or other property in the possession of the Lender or any affiliate of the Lender from time to time, and, upon the occurrence of any Event of Default, the Lender may exercise all rights and remedies of a secured party under the Uniform Commercial Code. ANY AND ALL RIGHTS TO REQUIRE THE LENDER TO EXERCISE ITS RIGHTS OR REMEDIES WITH RESPECT TO ANY OTHER COLLATERAL WHICH SECURES ANY OF THE OBLIGATIONS PRIOR TO THE EXERCISE BY THE LENDER OF ITS RIGHT OF SET-OFF UNDER THIS SECTION ARE HEREBY KNOWINGLY, VOLUNTARILY AND IRREVOCABLY WAIVED.

VI. MISCELLANEOUS

6.1. Costs and Expenses . The Borrower agrees to pay, on demand, all costs and expenses (including, without limitation, reasonable legal fees) of the Lender in connection with the preparation, execution and delivery of this Agreement, the Security Agreement, the Patent Security Agreements, the Guaranty, the Term Note, each Warrant and all other instruments and documents delivered or to be delivered in connection with any Term Loan and any amendments, waivers or modifications of any of the foregoing, as well as the costs and expenses (including, without limitation, the reasonable fees and expenses of legal counsel) incurred by the Lender in connection with preserving, enforcing or exercising, upon default, any rights or remedies under this Agreement, the Security Agreement, the Patent Security Agreements, the Guaranty, the Term Note, the Warrants and all other instruments and documents delivered or to be delivered hereunder or in connection herewith, all whether or not legal action is instituted. In addition, the Borrower shall be obligated to pay any and all stamp and other taxes payable or determined to be payable in connection with the execution and delivery of this Agreement, the Security Agreement, the Patent Security Agreements, the Guaranty, the Term Note, each Warrant and all other instruments and documents to be delivered in connection with any Obligation. The Borrower will indemnify and hold the Lender harmless from any loss, liability, damages, judgments, and costs of any kind relating to or arising directly or indirectly out of (a) this Agreement, any of the other Loan Documents or any document required hereunder, (b) any credit extended or committed by the Lender to the Borrower hereunder, and (c) any litigation or proceeding related to or arising out of this Agreement, any Loan Document, any other such document, or any such credit, other than arising from the gross negligence or willful misconduct of the Lender. This indemnity includes but is not limited to attorneys’ fees. This indemnity

 

- 24 -


extends to the Lender, its Subsidiaries and all of their directors, officers, employees, agents, successors, attorneys, and assigns. This indemnity will survive repayment of the Obligations. All sums due to the Lender hereunder shall be Obligations of the Borrower, due and payable immediately without demand. Any fees, expenses or other charges which the Lender is entitled to receive from the Borrower under this Section shall bear interest from the date that is 10 Business Days following the date of any demand therefor until the date when paid at a rate per annum equal to the per annum rate otherwise payable under the Term Note (but in no event in excess of the maximum rate permitted by then applicable law).

6.2. Other Agreements . The provisions of this Agreement are not in derogation or limitation of any obligations, liabilities or duties of the Borrower under any of the other Loan Documents or any other agreement with or for the benefit of the Lender. No inconsistency in default provisions between this Agreement and any of the other Loan Documents or any such other agreement will be deemed to create any additional grace period or otherwise derogate from the express terms of each such default provision. No covenant, agreement or obligation of the Borrower contained herein, nor any right or remedy of the Lender contained herein, shall in any respect be limited by or be deemed in limitation of any inconsistent or additional provisions contained in any of the other Loan Documents or any such other agreement.

6.3. Governing Law . This Agreement, the Term Note and each of the other Loan Documents shall be governed by, and construed and enforced in accordance with, the laws of The Commonwealth of Massachusetts, without giving effect to conflict of laws principles.

6.4. Addresses for Notices, etc. All notices, requests, demands and other communications provided for hereunder shall be in writing and shall be mailed or delivered (by hand or by recognized overnight delivery service) to the applicable party at the address indicated below:

If to the Borrower:

MDRNA, Inc.

3830 Monte Villa Parkway

Bothell, Washington 98021

Attention: J. Michael French, President and Chief Executive Officer

If to the Lender:

Cequent Pharmaceuticals, Inc.

One Kendall Square

Building 700

Cambridge, MA 02139

Attention: Peter D. Parker, President and Chief Executive Officer

 

- 25 -


or, as to each of the foregoing, at such other address as shall be designated by such Person in a written notice to the other party complying as to delivery with the terms of this Section. All such notices, requests, demands and other communications shall be deemed delivered on the earlier of (i) the date received or (ii) the date of delivery, refusal or non-delivery indicated on the return receipt if deposited in the United States mails, sent postage prepaid, certified or registered mail, return receipt requested, addressed as aforesaid. If any such notice, request, demand or other communication is hand-delivered or delivered by overnight delivery service, same shall be effective upon receipted delivery.

6.5. Binding Effect; Assignment; Termination . This Agreement shall be binding upon the Borrower, its successors and assigns and shall inure to the benefit of the Borrower and the Lender and their respective permitted successors and assigns. The Borrower may not assign this Agreement or any rights hereunder without the express written consent of the Lender. The Lender may, in accordance with applicable law and without notice to or consent of the Borrower, from time to time assign or grant participations in this Agreement, the Term Loans and/or the Term Note. The Borrower may terminate this Agreement and the financing arrangements made herein by giving written notice of such termination to the Lender provided that no such termination will release or waive any of the Lender’s rights or remedies or any of the Borrower’s obligations under this Agreement or any of the other Loan Documents unless and until the Borrower has paid in full the Term Loans and all interest thereon and all fees and charges payable in connection therewith. Notwithstanding any this in this §6.5 to the contrary, each Warrant shall survive termination of this Agreement and payment in full of the Term Loans and the other Obligations in accordance with the express terms thereof.

6.6. Consent to Jurisdiction . The Borrower irrevocably submits to the non-exclusive jurisdiction of any Massachusetts court or any federal court sitting within The Commonwealth of Massachusetts over any suit, action or proceeding arising out of or relating to this Agreement, the Term Note and/or any of the other Loan Documents. The Borrower irrevocably waives, to the fullest extent permitted by law, any objection which it may now or hereafter have to the laying of venue of any such suit, action or proceeding brought in such a court and any claim that any such suit, action or proceeding has been brought in an inconvenient forum. The Borrower agrees that final judgment in any such suit, action or proceeding brought in such a court shall be enforced in any court of proper jurisdiction by a suit upon such judgment, provided that service of process in such action, suit or proceeding shall have been effected upon the Borrower in one of the manners specified in the following paragraph of this §6.6 or as otherwise permitted by law.

The Borrower hereby consents to process being served in any suit, action or proceeding of the nature referred to in the preceding paragraph of this §6.6 either (i) by mailing a copy thereof by registered or certified mail, postage prepaid, return receipt requested, to it at its address set forth in §6.4 (as such address may be changed from time to time pursuant to said §6.4) or (ii) by serving a copy thereof upon it at its address set forth in §6.4 (as such address may be changed from time to time pursuant to said §6.4).

 

- 26 -


6.7. Severability . In the event that any provision of this Agreement or the application thereof to any Person, property or circumstances shall be held to any extent to be invalid or unenforceable, the remainder of this Agreement, and the application of such provision to Persons, properties or circumstances other than those as to which it has been held invalid and unenforceable, shall not be affected thereby, and each provision of this Agreement shall be valid and enforced to the fullest extent permitted by law.

6.8. Replacement Note . Upon receipt of an affidavit of an officer of the Lender as to the loss, theft, destruction or mutilation of the Term Note or of any other Loan Document which is not of public record and, in the case of any such mutilation, upon surrender and cancellation of the Term Note or other Loan Document, the Borrower will issue, in lieu thereof, a replacement Term Note or other Loan Document in the same principal amount (as to the Term Note) and in any event of like tenor.

6.9. Usury . All agreements between the Borrower and the Lender are hereby expressly limited so that in no contingency or event whatsoever, whether by reason of acceleration of maturity of the Term Note or otherwise, shall the amount paid or agreed to be paid to the Lender for the use or the forbearance of the Indebtedness represented by the Term Note exceed the maximum permissible under applicable law. In this regard, it is expressly agreed that it is the intent of the Borrower and the Lender, in the execution, delivery and acceptance of the Term Note, to contract in strict compliance with the laws of The Commonwealth of Massachusetts. If, under any circumstances whatsoever, performance or fulfillment of any provision of the Term Note or the other Loan Documents at the time such provision is to be performed or fulfilled shall involve exceeding the limit of validity prescribed by applicable law, then the obligation so to be performed or fulfilled shall be reduced automatically to the limits of such validity, and if under any circumstances whatsoever the Lender should ever receive as interest an amount which would exceed the highest lawful rate, such amount which would be excessive interest shall be applied to the reduction of the principal balance evidenced by the Term Note and not to the payment of interest. The provisions of this §6.9 shall control every other provision of this Agreement and of the Term Note.

6.10. WAIVER OF JURY TRIAL . THE BORROWER AND THE LENDER HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY MUTUALLY WAIVE THE RIGHT TO A TRIAL BY JURY IN RESPECT OF ANY CLAIM BASED HEREON, ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT, THE TERM NOTE OR ANY OTHER LOAN DOCUMENTS OR OUT OF ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENTS (WHETHER ORAL OR WRITTEN) OR ACTIONS OF ANY PARTY. THIS WAIVER CONSTITUTES A MATERIAL INDUCEMENT FOR THE LENDER TO ENTER INTO THIS AGREEMENT AND TO MAKE THE TERM LOANS AS CONTEMPLATED HEREIN.

6.11. Integration; Amendments . This Agreement, the Term Note and such other Loan Documents as are delivered herewith are intended by the parties as the final, complete and exclusive statement of the transactions evidenced by the Loan Documents. All prior or contemporaneous promises, agreements and understandings as to the facility evidenced by this

 

- 27 -


Agreement, whether oral or written, are deemed to be superseded by this Agreement and the other Loan Documents. This Agreement may not be amended or modified or any provision waived except by a written instrument setting forth such amendment, waiver or modification executed by the Borrower and the Lender.

VII. DEFINED TERMS

7.1. Definitions . In addition to terms defined elsewhere in this Agreement, as used in this Agreement, the following terms have the following respective meanings:

Atossa ” - Atossa HealthCare, Inc., a Delaware corporation.

Business Day ” - Any day which is not a Saturday, nor a Sunday nor a public holiday under the laws of the United States of America or The Commonwealth of Massachusetts.

CERCLA ” - The Comprehensive Environmental Response, Compensation and Liability Act of 1980, 42 U.S.C. Section 9601 et seq ., as amended by the Superfund Amendments and Reauthorization Act of 1986, Pub. L. No. 99-499, 100 Stat. 1613.

Change of Control ” - Any event or series of events by which:

(a) any “person” or “group” (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, but excluding any employee benefit plan of such person or its subsidiaries, and any person or entity acting in its capacity as trustee, agent or other fiduciary or administrator of any such plan) becomes the “beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Securities Exchange Act of 1934, except that a person or group shall be deemed to have “beneficial ownership” of all securities that such person or group has the right to acquire, whether such right is exercisable immediately or only after the passage of time (such right, an “ option right ”)), directly or indirectly, of 40% or more of the equity securities of the Borrower entitled to vote for members of the board of directors of the Borrower on a fully-diluted basis (and taking into account all such securities that such “person” or “group” has the right to acquire pursuant to any option right); or

(b) during any period of 12 consecutive months, a majority of the members of the board of directors of the Borrower cease to be composed of individuals (i) who were members of that board on the first day of such period, (ii) whose election or nomination to that board or equivalent governing body was approved by individuals referred to in clause (i) above constituting at the time of such election or nomination at least a majority of that board or (iii) whose election or nomination to that board was approved by individuals referred to in clauses (i) and (ii) above constituting at the time of such election or nomination at least a majority of that board (excluding, in the case of both clause (ii) and clause (iii), any individual whose initial nomination for, or assumption of office as, a member of that board occurs as a result of an actual or threatened solicitation of proxies or consents for the election or removal of one or more directors by any person

 

- 28 -


or group other than a solicitation for the election of one or more directors by or on behalf of the board of directors); or

(c) any Person or two or more Persons acting in concert shall have acquired by contract or otherwise, or shall have entered into a contract or arrangement that, upon consummation thereof, will result in its or their acquisition of the power to exercise, directly or indirectly, a controlling influence over the management or policies of the Borrower, or control over the equity securities of the Borrower entitled to vote for members of the board of directors of the Borrower on a fully-diluted basis (and taking into account all such securities that such Person or Persons have the right to acquire pursuant to any option right) representing 40% or more of the combined voting power of such securities.

Collateral ” - All property now or hereafter owned by the Borrower or any Subsidiary Guarantor or in which the Borrower or any Subsidiary Guarantor now or hereafter has any interest which is now or hereafter described as “Collateral” in the Security Agreement.

Default ” - Any event or circumstance which, with the passage of time or the giving of notice or both, could become an Event of Default under this Agreement.

Environmental Event ” - Each of: (i) the generation, storage, disposal, removal, transportation or treatment of Hazardous Substances on any of the Real Property (or on any of the real property adjoining or in the vicinity of any of the Real Property, if, through soil or groundwater migration, such Hazardous Substances could have come to be located at any of the Real Property) or on any other property owned, occupied or operated by the Borrower or any Subsidiary of the Borrower resulting in a level of contamination greater than the levels permitted or established by any Governmental Authority having or claiming jurisdiction over the Borrower or any of the Real Property or such other property of the Borrower or any Subsidiary of the Borrower; (ii) the receipt by the Borrower or any Subsidiary of the Borrower of any notice or claim of any violation of any Environmental Law or of any action based upon nuisance, negligence or other tort theory alleging liability on the basis of improper generation, storage, disposal, removal, transportation or treatment of Hazardous Substances on any of the Real Property or any other affected property of the Borrower or any Subsidiary of the Borrower; or (iii) the presence or release of Hazardous Substances at or upon any of the Real Property (or upon any other property owned, occupied or operated by the Borrower or any Subsidiary of the Borrower) that has resulted in contamination or deterioration of any portion of the Real Property or any other affected property resulting in a level of contamination greater than the levels permitted or established by any Governmental Authority having or claiming jurisdiction over the Borrower or any of the Real Property or such other property.

Environmental Laws ” - Any and all federal, state and local statutes, laws, regulations, ordinances, rules, judgments, orders, decrees, permits, concessions, grants, franchises, licenses, agreements or other governmental restrictions relating to the environment or the release of any materials into the environment, including, without limitation, CERCLA and the Resource Conservation and Recovery Act of 1976, 42 U.S.C. §§6901-6987.

 

- 29 -


ERISA ” - The Employee Retirement Income Security Act of 1974, as amended.

Event of Default ” - As defined in § 5.1.

Governmental Authority ” - Any federal, state, local or other governmental or administrative body, instrumentality, department or agency or any court, tribunal, administrative hearing body, arbitration panel, commission or other similar dispute-resolving panel or body.

Hazardous Substances ” - Each of the following: “hazardous substances”, “hazardous waste” and “pollutants”, or similar terms as defined in CERCLA or in any Environmental Laws, as well as other hazardous materials, oil, asbestos and materials containing asbestos.

Indebtedness ” - All obligations of a Person, whether current or long-term, senior or subordinated, which in accordance with generally accepted accounting principles would be included as liabilities upon such Person’s balance sheet at the date as of which Indebtedness, is to be determined, and shall also include guaranties, endorsements (other than for collection in the ordinary course of business) or other arrangements whereby responsibility is assumed for the obligations of others, whether by agreement to purchase or otherwise acquire the obligations of others, including any agreement, contingent or otherwise, to furnish funds through the purchase of goods, supplies or services for the purpose of payment of the obligations of others.

Intellectual Property ” - All U.S. and foreign (i) patents, including continuations, divisionals, continuations-in-part, or reissues of patent applications and patents issuing thereon, (ii) inventions (whether or not patentable), (iii) trademarks, service marks, trade names, service names, brand names, trade dress rights, and logos (in each case regardless whether registered) and goodwill associated with any of the foregoing, (iv) Internet domain name registrations, (v) copyrights (regardless whether registered), (vi) all trade secrets and confidential business information (including, without limitation, ideas, concepts, formulae, know-how, research and development information, drawings, specifications, designs, plans, proposals, technical data, financial, business and marketing plans, and customer and supplier lists and related information), (vii) registrations and applications for registration for the foregoing, and (viii) all other intellectual property rights.

Intellectual Property Registrations ” - Any and all of the following related to the Intellectual Property: (i) issued patents and applications for patents; (ii) copyright registrations and applications to register copyrights to the extent eligible for registration; (iii) registered trademarks, applications to register trademarks, including intent-to-use applications, or other registrations or applications related to trademarks; and (iv) any other application, certificate (including supplemental protection certificates), filing, registration or other document issued by, filed with, or recorded by, any governmental entity at any time, which document (when so filed or recorded) creates or conveys legally enforceable rights with respect to any Intellectual Property or proprietary right anywhere in the world.

Lender Certificate ” - A certificate signed by an officer of the Lender setting forth any additional amount required to be paid by the Borrower to the Lender pursuant to §1.7 of this

 

- 30 -


Agreement, which certificate shall be submitted by the Lender to the Borrower in connection with each demand made at any time by the Lender upon the Borrower with respect to any such additional amount, and each such certificate shall, save for manifest error, constitute presumptive evidence of the additional amount required to be paid by the Borrower to the Lender upon each demand. A claim by the Lender for all or any part of any additional amount required to be paid by the Borrower may be made before and/or after the end of the period to which such claim relates or during which such claim has arisen and before and/or after any payment hereunder to which such claim relates. Each Lender Certificate shall set forth in reasonable detail the basis for and the calculation of the claim to which it relates.

Loan Documents ” - Each of this Agreement, the Term Note, the Security Agreement, the Guaranty, the Patent Security Agreements, each Warrant and each other instrument, document or agreement evidencing, securing, guaranteeing or relating in any way to any of the Term Loans, all whether now existing or hereafter arising or entered into.

Merger Agreement ” - That certain Agreement and Plan of Merger dated as of even date herewith by and between the Borrower, Calais Acquisition Corp. and the Lender, as the same is amended or modified from time to time in accordance with the terms thereof.

Obligations ” - All Indebtedness, covenants, agreements, liabilities and obligations, now existing or hereafter arising, made by the Borrower with or for the benefit of the Lender or owed by the Borrower to the Lender in any capacity.

PBGC ” - The Pension Benefit Guaranty Corporation or any successor thereto.

Person ” - An individual, corporation, partnership, limited liability company, joint venture, trust or unincorporated organization, or a government or any agency or political subdivision thereof.

Real Property ” - The real estate of the Borrower, now owned or leased or hereafter owned or leased.

SEC ” - The Securities and Exchange Commission or any successor thereto.

Subsidiary ” - Any corporation or other entity of which the Borrower and/or any of its Subsidiaries, directly or indirectly, owns, or has the right to control or direct the voting of, fifty (50%) percent or more of the outstanding capital stock or other ownership interest having general voting power (under ordinary circumstances).

Subsidiary Guarantors ” - Atossa, MDRNA Research, Inc., a Delaware corporation, Calais Acquisition Corp., a Delaware corporation, and each other Subsidiary of the Borrower which subsequently becomes a party to the Guaranty.

 

- 31 -


Any defined term used in the plural preceded by the definite article shall be taken to encompass all members of the relevant class. Any defined term used in the singular preceded by “any” shall be taken to indicate any number of the members of the relevant class.

[ The next page is the signature page. ]

 

- 32 -


This Agreement is executed, as an instrument under seal, as of the day and year first above written.

 

Very truly yours,
MDRNA, INC.
By:  

/s/ J. Michael French

Name:   J. Michael French
Title:   President and Chief Executive Officer

Accepted and agreed:

 

CEQUENT PHARMACEUTICALS, INC.
By:  

/s/ Peter D. Parker

Name:   Peter D. Parker
Title:   President and Chief Executive Officer

Signature Page to Loan Agreement


DISCLOSURE SCHEDULE

 

Item 2.1(a)   Jurisdictions in which Borrower is qualified; Subsidiaries
Item 2.1(b)   Issued and Outstanding Stock
Item 2.1(e)   Litigation
Item 2.1(i)   Non-Ordinary Course Transactions
Item 2.1(j)   Collateral locations; record owner of each location
Item 2.1(k)   Intellectual Property
Item 4.1(a)   Existing Indebtedness
Item 4.1(b)   Existing Liens
Item 4.1(c)   Existing Guaranties

Exhibit 10.4

EXECUTION COPY

SECURITY AGREEMENT (ALL ASSETS)

SECURITY AGREEMENT (ALL ASSETS) (as may be amended, restated, supplemented and/or otherwise modified from time to time, this “ Security Agreement ”) dated as of March 31, 2010 from MDRNA, Inc., a Delaware corporation (“ Borrower ”), Atossa HealthCare, Inc., a Delaware corporation (“ Healthcare ”), MDRNA Research, Inc., a Delaware corporation (“ Research ”), Calais Acquisition Corp., a Delaware corporation (“ Merger Sub ”)(Healthcare, Research and Merger Sub being hereinafter referred to, collectively, as “ Guarantors ” and, individually, as a “ Guarantor ”) (Borrower and each Guarantor being hereinafter referred to, collectively, as “ Obligors ” and, individually, as an “ Obligor ”), to Cequent Pharmaceuticals, Inc., a Delaware corporation (“ Secured Party ”).

WITNESSETH:

WHEREAS, Borrower and Secured Party are entering into that certain Loan Agreement dated as of the date hereof (as amended, restated, supplemented and/or otherwise modified from time to time, the “ Loan Agreement ”), pursuant to which Secured Party will establish a facility for a term loan (the “ Loan ”) that may be advanced to the Borrower in installments; and

WHEREAS, the Loan is evidenced by the Borrower’s promissory note (as amended, restated, supplemented and/or otherwise modified from time to time, the “ Note ”) in an aggregate face principal amount of $3,000,000, payable to the order of Secured Party; and

WHEREAS, pursuant to a Guaranty Agreement dated as of the date hereof (the “ Guaranty ”), the Guarantors guarantee all of the obligations of the Borrower under and in respect of the Loan Agreement and the Note, among other things; and

WHEREAS, the Guarantors are wholly-owned subsidiaries of the Borrower and participate in a common business enterprise with the Borrower; and

WHEREAS, the Secured Party’s agreement to enter into the Loan Agreement is and will be beneficial to Borrower and to each other Obligor, as each such Obligor has a significant economic interest in the strength and success of the Borrower;

WHEREAS, a condition to the Secured Party entering into the Loan Agreement, the Secured Party requires that the Obligors grant to the Secured Party a security interest in the Collateral (as defined in Section 1);

NOW, THEREFORE, in consideration of the Secured Party entering into the Loan Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby act and agree as follows:

1. Definitions . As used in this Security Agreement, the following terms have the following meanings:


Collateral ” – All of the following now or hereafter existing or owned by any Obligor or in which any Obligor shall now or hereafter have any interest:

(a) all Equipment;

(b) all Receivables;

(c) all contracts and contract rights; all rights to the payment of money; all obligations owing to any Obligor of every kind and nature; and all tax refunds of every kind and nature, including, without limitation, loss carryback refunds; and all of the foregoing whether now existing or hereafter acquired or arising;

(d) all Inventory;

(e) all Intellectual Property Rights;

(f) all general intangibles, goodwill, customer lists, choses in action, chattel paper, insurance policies, bank deposits, deposit accounts, checking accounts, certificates of deposit, money, cash, securities (whether certificated or uncertificated), securities accounts, security entitlements, commodity contracts, commodity accounts, documents and instruments (whether negotiable or non-negotiable and regardless of attachment to chattel paper), whether arising out of, relating to or evidencing all or any of the foregoing Collateral or otherwise, and all whether now existing and owned by any Obligor or hereafter acquired or arising;

(g) all liens, guaranties, securities, rights, remedies and privileges pertaining to, and all products and proceeds (including, without limitation, insurance proceeds) of and all accessions to, any of the foregoing items of Collateral (all whether now existing and owned by any Obligor or hereafter arising or acquired); and

(h) all information, data, files, writings, correspondence, books and records (including, without limitation, all electronically recorded data) relating to any of the foregoing items of Collateral (all whether now existing and owned by any Obligor or hereafter arising or acquired);

provided , however , that Collateral shall not include the Excluded Property.

Default Rate ” – A rate per annum equal to the highest default rate applicable to the Loan.

Equipment ” – All of each Obligor’s machinery, equipment, tools, furniture, furnishings and fixtures, including, without limitation, all processing and manufacturing equipment, machine tools, data processing and computer equipment, tools, dies, molds, motor vehicles, rolling stock, trailers, airplanes, vessels and other equipment of every kind and description, and all accessions, additions, substitutions or replacements to or for any of the foregoing and all attachments, components, accessories, parts and supplies relating thereto; all whether now owned or existing or hereafter arising or acquired, whether movable or affixed, and wherever located.

 

- 2 -


Event of Default ” – The occurrence of any one or more of the following: (i) any “Event of Default” as defined in any Loan Document; or (ii) any representation or warranty by any Obligor contained in this Security Agreement shall prove to have been inaccurate or incomplete in any material respect on the date when made; or (iii) the failure or default by any Obligor under any of Sections 4(a), 4(c), 4(d), 4(f), 4(h) or 4(i); or (iv) any failure by any Obligor to perform or observe any of its other obligations or agreements under this Security Agreement, which failure remains uncured for ten (10) days after the earlier of (A) the date when notice thereof has been given to the Obligors, or (B) the date when any executive officer of any Obligor first has knowledge (or should reasonably have knowledge) of such failure or of the facts or circumstances giving rise thereto.

Excluded Property ”– Each of the following: (i) any permit or license issued by a Governmental Authority to an Obligor or any agreement, contract or lease to which an Obligor is a party, in each case, only to the extent and for so long as the terms of such permit, license, agreement, contract or lease or any applicable law validly and effectively prohibit the creation by an Obligor of a security interest in such permit, license or agreement in favor of the Secured Party (after giving effect to Sections 9-406(d), 9-407, 9-408 or 9-409 of the UCC (or any successor provision or provisions) or any other applicable law (including the United States Bankruptcy Code) or principles of equity); and (ii) equipment owned by an Obligor on the date hereof or hereafter acquired that is subject to a Lien securing a purchase money obligation or capital lease obligation permitted to be incurred pursuant to the provisions of the Loan Agreement if the contract or other agreement in which such Lien is granted (or the documentation providing for such purchase money obligation or capital lease obligation) validly prohibits the creation of any other Lien on such Equipment;

provided , however , that Excluded Property shall not include any proceeds of any property referred to in clauses (i) or (ii) or any substitutions or replacements of any property referred to in clause (i) or (ii).

Intellectual Property Rights ” – All of each Obligor’s U.S. and foreign (i) patents, including continuations, divisionals, continuations-in-part, or reissues of patent applications and patents issuing thereon, including, without limitation, the registered (or applied for) patents described on Exhibit A hereto, (ii) inventions (whether or not patentable), (iii) trademarks, service marks, trade names, service names, brand names, trade dress rights, and logos (in each case regardless whether registered) and goodwill associated with any of the foregoing, including, without limitation, the registered (or applied for) trademarks (if any) described on Exhibit A hereto, (iv) Internet domain name registrations, (v) copyrights (regardless whether registered), including, without limitation, the registered (or applied for) copyrights (if any) described on Exhibit A hereto, (vi) trade secrets and confidential business information (including, without limitation, ideas, concepts, formulae, know-how, research and development information, drawings, specifications, designs, plans, proposals, technical data, financial, business and marketing plans, and customer and supplier lists and related information), (vii) registrations and applications for registration for the foregoing, and (viii) all other intellectual property rights and the goodwill of the business associated with each of the foregoing, together with all right, title and interest of such Obligor therein, including, without limitation, all common law rights, registrations, renewals of registrations, applications for new uses, the right to sue for past, present and future infringements thereof, and all other intellectual property rights necessary and

 

- 3 -


proper to the continuation of the business associated with and symbolized by any of the foregoing.

Inventory ” – All goods now owned or hereafter acquired by any Obligor and intended for sale, all raw materials, parts, work-in-process, finished goods, and all materials and supplies which are used or which may be used in manufacturing, selling, packing, shipping, advertising or furnishing of goods, whether now owned or hereafter acquired or created and wherever located, as well as all proceeds (including, without limitation, insurance proceeds) of any of the foregoing.

Lien ” – Any lien, charge, encumbrance or security interest, whether voluntary or involuntary.

Loan Documents ” – This Security Agreement, the Loan Agreement, the Note, the Guaranty, the Patent Security Agreement (and any replacement thereof or substitutions therefor) and any other instruments, documents or other agreements made by any one or more of the Obligors with or in favor of the Secured Party, in connection with the Loan, whether now existing or hereafter entered into or delivered.

Obligations ” – Any and all indebtedness, liabilities or obligations of any Obligor, joint or several, direct or indirect, absolute or contingent, due or to become due, now existing or hereafter arising, to or for the benefit of the Secured Party arising out of or provided for in any of the Loan Documents or the Merger Agreement, such term to include obligations to perform acts and refrain from taking action as well as obligations to pay money.

Person ” – As defined in the Loan Agreement.

Premises ” – All locations owned, leased, operated or used by any Obligor, all of which are listed on Exhibit B hereto together with the record owner of each such location.

Receivables ” – All of each Obligor’s accounts (as defined in the UCC), accounts receivable, notes, bills, drafts, acceptances, instruments, documents, chattel paper and all other debts, obligations and liabilities in whatever form owing to any Obligor from any Person for goods (as defined in the UCC) sold by it or for services rendered by it, or however otherwise established or created, all guaranties and security therefor, all right, title and interest of the relevant Obligor in the goods or services that have given rise thereto, including rights to reclamation and stoppage in transit and all rights of an unpaid seller of goods or services; all whether any of the foregoing be now existing or hereafter arising, now or hereafter received by or owing or belonging to any Obligor.

UCC ” – The Uniform Commercial Code as in effect from time to time in Massachusetts (or any other relevant jurisdiction, as the case may be).

Capitalized terms defined in the Loan Agreement and not otherwise defined herein shall have the respective meanings set forth in the Loan Agreement. Any defined term used in the plural preceded by the definite article shall be taken to encompass all members of the relevant class. Any defined term used in the singular preceded by “any” shall be taken to indicate any number of the members of the relevant class.

 

- 4 -


2. Grant of Security Interest . As security for the full and timely satisfaction of the Obligations, each Obligor hereby grants to the Secured Party, a continuing security interest in the Collateral, and in each item thereof, all to the maximum extent that such Obligor has an interest therein or at any time in the future obtains such an interest.

3. Representations and Warranties . Each Obligor represents and warrants to the Secured Party that:

(a) The execution, delivery and performance by each Obligor of this Security Agreement, including the security interests herein granted or intended to be granted, has been duly authorized by all necessary corporate and other action and does not and will not:

(i) require any waiver, consent or approval of such Obligor’s stockholders, any governmental authority or any other Person, other than any such waiver, consent or approval which has been heretofore obtained;

(ii) contravene the charter or by-laws or other organizational documents of such Obligor;

(iii) violate any provision of, or require any filing (other than the filing of financing statements under the UCC with respect to the security interests herein granted), registration, consent or approval under, any law, rule, regulation (including, without limitation, Regulation U), order, writ, judgment, injunction, decree, determination or award presently in effect having applicability to such Obligor;

(iv) result in a breach of or constitute a default or require any waiver or consent under any indenture or loan or credit agreement or any other agreement, lease or instrument to which such Obligor is party or by which it or any of its properties may be bound or affected; or

(v) result in, or require, the creation or imposition of any Lien (other than as created hereunder) upon or with respect to any of the properties now owned or hereafter acquired by such Obligor.

(b) This Security Agreement has been duly executed and delivered on behalf of each Obligor and is a legal, valid and binding obligation of such Obligor, enforceable against such Obligor in accordance with its terms.

(c) No Obligation has been or will hereafter be incurred on account of personal, family or household purposes.

(d) The principal place of business and chief executive offices of each Obligor are currently located at 3830 Monte Villa Parkway, Bothell, Washington 98021 and all of the books and records of each Obligor are kept at that location or at one of the locations described on Exhibit B . All of the tangible Collateral is and will be kept at the Premises. Except as otherwise described on Exhibit B , an Obligor is the record owner of all of the Premises.

 

- 5 -


(e) Except as otherwise described on Exhibit C , no Obligor conducts business under any trade name or style other than its corporate or other entity name and no Obligor has used any other name within the last five years.

(f) Each Obligor owns the Collateral free and clear of all Liens except (i) Liens in favor of the Secured Party, and (ii) Liens that are expressly permitted by Section 4.1(b) of the Loan Agreement.

(g) Except as shown on Exhibit A hereto, none of the Intellectual Property Rights owned by any Obligor is the subject of any state or federal registration or any application therefor.

(h) This Security Agreement, coupled with the filing of appropriate UCC financing statements with the filing offices listed on Exhibit D hereto (these being the only locations in which such filing is required by the UCC in order to perfect the security interests granted herein), creates in favor of the Secured Party a valid and perfected first priority security interest in all of the Collateral (except that no representation is made as to perfection or priority of any security interest in motor vehicles and no representation is made as to priority of any security interest in fixtures), which security interest secures the Obligations.

(i) Exhibit E hereto contains a true and complete list of all of each Obligor’s bank accounts, brokerage accounts and other accounts holding any investment securities and any other securities of any nature held or owned by any Obligor.

4. Covenants . (a)  Payment and Performance . The Obligors jointly and severally agree to pay unconditionally when due or within any applicable grace or cure period (or on demand, if so payable) each Obligation and to perform duly and punctually each Obligation.

(b) Further Assurances . The Obligors will from time to time, at their expense, upon the Secured Party’s request, promptly execute and deliver all such further instruments and documents, and take all such further action, as may be necessary or that the Secured Party may reasonably request in order to perfect and/or protect the security interests granted or intended to be granted hereby or to enable the Secured Party to enforce its rights and remedies hereunder with respect to any Collateral, including, without limitation: executing and delivering written assignments of Receivables (but failure to deliver the same shall not affect or limit the Secured Party’s security interest therein); furnishing copies of invoices relating to Receivables; identifying Equipment; furnishing the originals of all bills of lading, trust receipts and warehousemen’s receipts, with such endorsements as may be required by the Secured Party; stamping chattel paper to reflect the Secured Party’s security interest or delivering same to the Secured Party; and executing and filing financing statements. Each Obligor hereby authorizes the Secured Party to file financing or continuation statements and amendments thereto relating to Collateral without the signature of such Obligor. With respect to such contracts and contract rights as are by their terms non-assignable, each Obligor agrees: (i) to hold same in trust for the benefit of the Secured Party, (ii) at any time or from time to time (if the Secured Party shall so request) to use its reasonable efforts to seek the approval of the other parties to the relevant contracts so that assignment to the Secured Party will be permitted and (iii) at the request of the Secured Party, to assign to the Secured Party all rights in and to said contracts and contract rights

 

- 6 -


to the maximum extent that same may from time to time be assignable. Notwithstanding the foregoing, the Obligors will not be required to re-title motor vehicles or to note the interest of the Secured Party on the certificate of title for any motor vehicle unless an Event of Default has occurred.

(c) Information . Each Obligor shall maintain complete and accurate records of all of its Collateral and its dealings with respect thereto. Upon reasonable notice from time to time during normal business hours (and at any time and without notice after the occurrence and during the continuance of any Event of Default), the Obligors shall permit the Secured Party and its employees, representatives and agents access to the Premises and the Secured Party shall have the right to inspect the Collateral and make copies of such books and records. The Obligors shall from time to time furnish to the Secured Party such information concerning the Collateral as the Secured Party may reasonably request, and will promptly notify the Secured Party if any representation or warranty of any Obligor in Section 3 hereof becomes inaccurate, incomplete or misleading in any material respect. Without limiting the generality of the foregoing, the Obligors will promptly upon the Secured Party’s request provide the Secured Party with a written listing of all Collateral.

(d) Insurance . The Obligors shall at their expense maintain fire and extended coverage insurance policies insuring the Inventory and the Equipment, with responsible and reputable insurance companies or associations, in amounts sufficient to provide for full replacement cost coverage (with agreed amount endorsement) and in any event not less than the amount necessary to avoid co-insurance. All such casualty insurance shall name the Secured Party as secured party and loss payee. All policies of such insurance shall contain a provision forbidding cancellation of such insurance either by the carrier or by the insured without at least 30 days’ prior written notice to the Secured Party. Not less than 30 days prior to the expiration date of any such insurance policy, the Obligors shall deliver to the Secured Party certificates of the renewal or replacement of such insurance (with evidence of premiums having been paid) from the insurer or a reputable insurance broker.

Following any damage to or destruction of any of the Collateral, the parties shall cooperate in order to recover any applicable proceeds of insurance, with the Obligors to have primary responsibility to recover the proceeds. All insurance proceeds shall be paid to the Secured Party. From such proceeds, if any, as are actually received by the Secured Party, the Secured Party shall provide for the payment or reimbursement of its reasonable expenses (if any) of obtaining the recovery as reasonably determined by the Secured Party. The Secured Party shall then give notice to the Obligors of such expenses and of the amount of the remaining proceeds actually held by the Secured Party (the “ Net Proceeds ”). If the Net Proceeds are less than $100,000 and no Default or Event of Default shall have occurred and be then continuing, the Secured Party shall pay the same to Obligors for their use. If the Net Proceeds are more than $100,000, if the Obligors desire to use any or all of the Net Proceeds held by the Secured Party for repair, restoration or replacement of the Collateral, the Obligors shall request same from the Secured Party within 30 days after receipt of the aforesaid notice of the amount of the Net Proceeds. Provided that all of the below-described Readvancement Conditions shall have been satisfied as at the time of each release of all or any portion of the Net Proceeds held by the Secured Party, the Secured Party, subject to the other requirements described below, will permit the use of the Net Proceeds held by the Secured Party, to the extent required, for such repair,

 

- 7 -


restoration and replacement. As used herein, the term “ Readvancement Conditions ” means each of the following: (1) no Event of Default, nor any event or circumstance which with the passage of time or the giving of notice or both could become an Event of Default, shall have occurred and be then continuing, and (2) the Net Proceeds held by the Secured Party, in the reasonable opinion of the Secured Party, shall be sufficient for the purpose of the required repair, restoration and replacement (or, if insufficient, the Obligors shall have deposited with the Secured Party, for application as provided in this Section, additional funds in the amount of such insufficiency). Any disbursement of such Net Proceeds and such additional funds, if any, will be made subject to the reasonable requirements imposed by the Secured Party, including, without limitation, requirements as to certification by an architect or engineer, approval of plans, obtaining waivers of liens, and the receipt of requisitions, affidavits and opinions in form and substance reasonably satisfactory to the Secured Party. If, for any reason, the Collateral is not promptly so repaired, restored and replaced (or if there shall be any of such Net Proceeds or additional funds remaining after such repair, restoration and replacement have been fully completed), the Net Proceeds and additional funds, if any (or the balance thereof so remaining) actually held by the Secured Party shall (A) be applied first against payment of the Obligations to the extent then due (being applied in the order provided for in the Loan Agreement) and (B) after payment of the Obligations then due may, at the option of the Secured Party, be held by the Secured Party as further security for any Obligations which may thereafter come due. If any of the Readvancement Conditions shall not have been satisfied at any time when any Net Proceeds and/or any such additional funds remain in the control of the Secured Party, the Secured Party may, in its sole discretion, either apply the Net Proceeds and additional funds, if any, within its control to the outstanding Obligations (being applied in the order provided for in the Loan Agreement) and/or use any or all of such Net Proceeds and additional funds, if any, for the repair, restoration or replacement of the Collateral. Each Obligor hereby grants to the Secured Party full power and authority, as attorney-in-fact irrevocable of such Obligor, to act after the occurrence of an Event of Default in order to cancel or transfer the insurance described in this Section, to collect and endorse any checks issued in the name of such Obligor and to retain any premium or proceeds and to apply the same to the debt secured hereby. Upon default by any Obligor hereunder and exercise by the Secured Party of any of its rights or remedies hereunder, each such insurance policy, including the right to unearned premiums, shall become property of the Secured Party.

(e) Receivables . Each Obligor shall notify the Secured Party promptly of all material disputes with respect to its Receivables. No Obligor shall, without the prior written consent of the Secured Party, settle or adjust any dispute or claim which (together with all other such settlements or adjustments relating to the Receivables of any Obligor) in any fiscal quarter would exceed $25,000 nor shall any Obligor grant any material discount, credit or allowance except in the ordinary course of such Obligor’s business nor accept any return of merchandise except in the ordinary course of such Obligor’s business without the Secured Party’s consent. Upon the occurrence of any Event of Default and while it is continuing, the Secured Party may settle or adjust disputes or claims directly with customers or account debtors for amounts and upon terms which it considers reasonably advisable; in all such cases, the relevant Obligor will be credited only with amounts actually received by the Secured Party; and where any Obligor receives collateral of any kind by reason of transactions between itself and its customers or account debtors, it will hold the same on the Secured Party’s behalf, subject to the Secured Party’s instructions, and as property forming part of the Collateral. Upon the occurrence of an Event of Default and while it is continuing, the Secured Party or its designee may at any time notify each

 

- 8 -


Obligor’s customers or account debtors of the Secured Party’s security interest in Receivables, collect the same directly and charge the collection costs and expenses to the Obligors; whenever the Secured Party deems it desirable that any legal or other action be instituted in order to collect any Receivable, the Secured Party may at its option reassign any such Receivable to an Obligor (and any such reassignment shall be deemed to be without recourse to the Secured Party in any event) and require the Obligors to proceed with such legal or other action at the Obligors’ sole liability, cost and expense, in which event all amounts collected by any Obligor on such Receivable shall nevertheless be subject to this Security Agreement; and the Obligors jointly and severally agree to pay to the Secured Party a reasonable collection charge on all Receivables collected by the Secured Party under this Security Agreement. If the Secured Party elects that the Obligors continue to collect their Receivables after the occurrence of an Event of Default, each Obligor will collect its Receivables as the Secured Party’s collection agent, hold such collections in trust for the Secured Party without commingling the same with other funds of any Obligor and, if requested, by the Secured Party, will promptly, on the day of receipt thereof, transmit such collections to the Secured Party in the identical form in which they were received by the relevant Obligor, with such endorsements as may be appropriate. Further, and without limitation of the foregoing, after the occurrence and during the continuance of an Event of Default, the Secured Party may, at its option, establish a lockbox arrangement to collect and hold the Receivables and each Obligor will thereupon irrevocably direct its account debtors to make all payments to said lockbox.

(f) Title; Sale or Removal of Collateral . No Obligor shall create or suffer to exist any Lien in or on any of the Collateral, except the Lien of the Secured Party and other Liens that are expressly permitted by Section 4.1(b) of the Loan Agreement. Except for dispositions of assets that are expressly permitted by Section 4.2(e) of the Loan Agreement and Section 4.03(d)(iii) of the Merger Agreement, no Obligor shall, without the Secured Party’s prior written approval, sell, transfer or remove from the Premises or otherwise dispose of any of the Collateral. No Collateral will be located at any premises other than as described in Section 3(d) above. Each Obligor (i) shall maintain books and records relating to Collateral only as described in Section 3(d) above, (ii) will not move its chief executive office from the existing location described in Section 3(d) above, (iii) will not change its name or identity, and (iv) will not make or suffer to be made any change in its corporate or organizational structure or jurisdiction of incorporation or organization until, in each case, after receipt of a certificate from the Secured Party, signed by an officer thereof, stating that the Secured Party has, to its satisfaction, obtained all documentation that it deems necessary or desirable to obtain, maintain, perfect and/or confirm the security interests granted or intended to be granted herein with the priority described herein.

(g) Maintenance and Use of Equipment . The Obligors will maintain their respective Equipment in good order and condition consistent with past practice, reasonable wear and tear excepted, making all necessary repairs thereto. The Obligors will not suffer any waste or destruction of any Inventory or Equipment, nor shall any Obligor use any Equipment in violation of any applicable law or any insurance thereon. The Obligors will promptly restore or replace any Inventory or Equipment damaged or destroyed by fire or other casualty unless Obligors in the exercise of their commercial reasonable business judgment determine such restoration or replacement is not in the best interest of the Obligors’ business, and this obligation will not be limited by the availability or sufficiency of insurance proceeds. The Obligors shall promptly

 

- 9 -


furnish to the Secured Party a statement as to any casualty, loss or damage in excess of $25,000 to any Inventory or Equipment.

(h) Taxes . Each Obligor promptly shall pay, as they become due and payable, all taxes, unemployment contributions and all other charges of any kind or nature levied, assessed or claimed against such Obligor or the Collateral by any Person whose claim could result in a Lien upon any of the Collateral, except to the extent such taxes, contributions or other charges are being contested in good faith and by appropriate proceedings which operate as a matter of law to stay the enforcement of any such Lien and reserves required by generally accepted accounting principles have been established and are maintained by such Obligor.

(i) Intellectual Property Rights . Each Obligor agrees that it will not sell, assign, transfer, license, dispose of, or permit to lapse any of the Collateral consisting of Intellectual Property Rights or any interest therein or grant a security interest in any of such Collateral (other than to the Secured Party) or suffer or permit to exist any other encumbrance thereon, or dispose of or disclose to any Person any trade secret, formula, process or know how not theretofore a matter of public knowledge, without, in each instance, the prior written consent of the Secured Party; provided that the foregoing restrictions shall not apply to (x) any sale, assignment, transfer, license or other disposition of any of the Borrower’s legacy intranasal assets, and (y) licenses by the Borrower of any of its Collateral consisting of Intellectual Property Rights in the ordinary course of the Borrower’s business consistent with past practice (other than licenses solely to the Borrower’s Di-Alkylated Amino Acid delivery technology); provided , however , that nothing in item (y) above shall prohibit the Borrower from licensing any of its Intellectual Property Rights, including its Di-Alkylated Amino Acid delivery technology, in connection with any multi-year target-based or therapeutic-based collaboration between the Borrower and a pharmaceutical company substantially similar to those collaborations previously discussed with the Secured Party. Each Obligor warrants that it has unencumbered title to or a license to use the Intellectual Property Rights now being used by it and full right and authority to grant to the Secured Party the within security interests in the Collateral consisting of Intellectual Property Rights. Each Obligor agrees to defend its title to (or license of) the Collateral consisting of Intellectual Property Rights (other than related to its legacy intranasal business) and to take all steps reasonably necessary to preserve its title to (or license of) the same and ability to use same, including defense of any claims of infringement and action against any infringers. If, during the term of this Security Agreement, any Obligor shall obtain rights to any new or additional United States trademark registrations, trademark applications, patents, patent applications or copyrights, the same shall automatically constitute Intellectual Property Rights subject to this Security Agreement, and the Obligors agree to give the Secured Party prompt written notice thereof, describing and identifying such Intellectual Property Rights in the same manner as on Exhibit A hereto. Upon the occurrence of any Event of Default, the Obligors will assemble and make available to the Secured Party all books, records and data, whether in written form or electronically recorded, representing any of the Intellectual Property Rights.

(j) Condemnation . Notwithstanding any taking by eminent domain or other injury to or decrease in value of the Collateral or any of the rights of any Obligor therein by action of any public or quasi-public authority or corporation, the Obligors shall continue to pay interest on the entire principal sum secured hereby until the award or payment for any such taking, injury or decrease in value shall have been actually received by the Secured Party and applied to the debt

 

- 10 -


secured hereby, and any reduction in the principal sum resulting from the application by the Secured Party of such award or payment as hereinafter set forth shall be deemed to take effect only on the date of such receipt. In the event of any such taking, injury or decrease in value, the parties shall cooperate as in Section 4(d) in order to recover any applicable proceeds. Such proceeds shall be paid to the Secured Party. The Secured Party shall make appropriate deductions from such proceeds, if any, as are actually received by it as in the case of insurance proceeds and shall give notice to the Obligors of such deductions and of the amount of the net proceeds remaining and actually held by the Secured Party (the “ Eminent Domain Net Proceeds ”). Eminent Domain Net Proceeds shall be dealt with in the same manner as Net Proceeds of insurance as described in Section 4(d).

(k) Delivery of Pledged Securities . All securities of each Obligor, whether now owned or hereafter acquired by such Obligor, shall be promptly delivered to the Secured Party by the Obligors (which securities, together with all other securities, security entitlements, securities accounts and shares of stock which may hereafter be delivered to the Secured Party pursuant to the terms hereof, are hereinafter called the “ Pledged Securities ”), shall be in suitable form for transfer by delivery, or shall be accompanied by duly executed instruments of transfer or assignments in blank, and accompanied in each case by any required transfer tax stamps, all in form and substance satisfactory to the Secured Party. Each Obligor shall inform the Secured Party promptly upon the acquisition, after the date hereof, of any securities, security entitlements and/or security accounts and shall, from time to time promptly and in accordance with the foregoing provisions, deliver to the Secured Party any and all Pledged Securities which may hereafter be acquired by such Obligor. Each Obligor will execute and deliver to the Secured Party all such control agreements with respect to Pledged Securities as the Secured Party may from time to time reasonably request, and, if requested by the Secured Party as a security device, will transfer the Pledged Securities into the name of the Secured Party or its nominee. The Secured Party may at any time or from time to time, in its sole discretion, require the Obligors to cause any chattel paper included in any Obligor’s Receivables to be delivered to the Secured Party or any agent or representative designated by it, or to cause a legend referring to the Secured Party’s security interests to be placed on such chattel paper and upon any ledgers or other records concerning any Obligor’s Receivables. Each Obligor shall inform the Secured Party promptly of the establishment of any bank account and will, upon the request of the Secured Party, deliver to the Secured Party control agreements, in form and substance reasonably satisfactory to the Secured Party, from each depository bank. Nothing contained herein will be deemed to permit any Obligor to have or maintain any bank account at a bank other than the Secured Party, except to the extent (if any) expressly authorized by the Loan Agreement.

After the occurrence and during the continuance of an Event of Default, the Secured Party may cause any or all of the Pledged Securities to be transferred of record into the Secured Party’s name. The Obligors will promptly give to the Secured Party copies of any notices or other communications received by any Obligor with respect to Pledged Securities registered in the name of such Obligor.

Unless an Event of Default shall occur and be continuing and the Secured Party shall have given written notice to the Obligors of its election to so vote, the relevant Obligor shall have the right, from time to time, to vote and to give consents, ratifications and waivers with respect to its Pledged Securities and to exercise conversion rights with respect to the convertible

 

- 11 -


securities included therein, and the Secured Party shall, upon receiving a written request from the relevant Obligor accompanied by a certificate signed by its principal financial officer stating that no Event of Default has occurred and is continuing, deliver to such Obligor or as specified in such request such proxies, powers of attorney, consents, ratifications and waivers as the Secured Party shall approve in respect of any Pledged Securities which are registered in the Secured Party’s name, and make such arrangements with respect to the conversion of convertible securities as shall be specified in such Obligor’s request and shall be in form and substance satisfactory to the Secured Party.

If an Event of Default shall occur and be continuing, and provided the Secured Party elects to exercise the rights hereinafter set forth by written notice to the Obligors of such election, the Secured Party shall have the right to the extent permitted by law, and each Obligor shall take all such action as may be necessary or appropriate to give effect to such right, to vote and to give consents, ratifications and waivers and take any other action with respect to all the Pledged Securities with the same force and effect as if the Secured Party were the absolute and sole owner thereof. The curing of any such Event of Default shall not divest Secured Party of its rights hereunder unless and until the Secured Party in writing reinstates the rights of the Obligors that existed prior to the occurrence of the breach.

5. Secured Party Appointed Attorney-in-Fact . (a) Each Obligor hereby irrevocably appoints the Secured Party as such Obligor’s attorney-in-fact, with full authority after the occurrence and during the continuance of an Event of Default in the name, place and stead of such Obligor, from time to time in the Secured Party’s discretion, to take any action and to execute any instrument which the Secured Party may deem necessary or advisable to accomplish the purposes of this Security Agreement, including, without limitation:

(i) to obtain and adjust any insurance required pursuant to this Security Agreement and/or the Loan Agreement;

(ii) to ask, demand, collect, sue for, recover, compromise, receive and give acquittances for monies due and to become due under or in respect of any of the Collateral;

(iii) to receive, endorse and collect any notes, drafts or other instruments, documents and chattel paper;

(iv) to file any claims or take any action or institute any proceedings for the collection of any of the Collateral or otherwise to enforce the rights of the Secured Party with respect to any of the Collateral;

(v) to sign the name of such Obligor on invoices or bills of lading, drafts against customers, notices of assignment, verifications and schedules;

(vi) to defend any suit, action or proceeding brought against such Obligor in respect of any Collateral, to settle, compromise or adjust any such suit, action or proceeding and, in connection therewith, to give such discharges or releases as the Secured Party may deem appropriate;

 

- 12 -


(vii) to notify the U.S. Postal Service authorities to change the address for delivery of mail to an address designated by the Secured Party and to open and dispose of mail addressed to the Obligor; and, generally,

(viii) to do all things necessary to carry out the intent of this Security Agreement.

(b) The power of attorney granted pursuant to this Section 5 is a power coupled with an interest and shall be irrevocable until the Obligations are paid indefeasibly in full.

6. Secured Party May Perform . If the Obligors fail to perform any agreement contained herein, the Secured Party may itself perform, or cause performance of, such agreement, and the expenses of the Secured Party incurred in connection therewith shall be payable by the Obligors, jointly and severally, as provided under Section 9 hereof, with interest at the Default Rate.

7. Secured Party’s Duties . The powers conferred on the Secured Party hereunder are solely to protect its interests in the Collateral and shall not impose any duty upon it to exercise any such powers. Except for the safe custody of any Collateral actually in its possession and the accounting for monies actually received by it hereunder, the Secured Party shall have no duty as to any Collateral. The Secured Party shall not be liable for any acts, omissions, errors of judgment or mistakes of fact or law including, without limitation, acts, omissions, errors or mistakes with respect to the Collateral, except for those arising out of or in connection with the Secured Party’s gross negligence or willful misconduct. The Secured Party shall be deemed to have exercised reasonable care in the custody and preservation of the Collateral in its possession if the Collateral is accorded treatment substantially equal to that which the Secured Party accords its own like property, it being understood that the Secured Party shall be under no obligation to take any necessary steps to collect any Collateral or preserve rights against prior parties or any other rights pertaining to any Collateral, but may do so at its option, and all expenses incurred in connection therewith shall be for the sole account of the Obligors and shall be added to the Obligations.

8. Remedies . If any Event of Default shall have occurred and be continuing:

(a) The Secured Party may exercise in respect of the Collateral, in addition to other rights and remedies provided for herein or otherwise available to it, all the rights and remedies of a secured party under the UCC and also may without limitation:

(i) require the Obligors to, and each Obligor hereby agrees that it will, at its expense and the upon reasonable request of the Secured Party, forthwith assemble all or any part of the Collateral as directed by the Secured Party and make it available to the Secured Party at a place or places to be designated by the Secured Party which is or are reasonably convenient to the respective parties;

(ii) itself or through agents, without notice to any Person and without judicial process of any kind, enter any Obligor’s Premises (or any other premises or location where any Collateral may be) and take physical possession of any Collateral or

 

- 13 -


disassemble, render unusable and/or repossess any of the same, and the Obligors shall peacefully and quietly yield up and surrender the same; and

(iii) without notice except as specified below, sell, lease, assign, grant an option or options to purchase or otherwise dispose of the Collateral or any part thereof in one or more parcels at public or private sale, at any exchange, broker’s board or at the Secured Party’s offices or elsewhere, for cash, on credit or for future delivery, and upon such other terms as are commercially reasonable.

(b) The Secured Party may maintain possession of Collateral at the Premises or remove the same or any part thereof to such places as the Secured Party may elect. Each Obligor waives all rights that it would otherwise have under any applicable law to prohibit entry to any premises or to require notice of any such action, to the maximum extent permitted by applicable law. Each Obligor agrees that, to the extent notice of sale shall be required by law, 10 days’ prior written notice to the Obligors shall constitute reasonable notification. Notice of any public sale shall be sufficient if it describes the Collateral to be sold in general terms, stating the items or amounts thereof and the location and nature thereof, and is published at least once in any newspaper selected by the Secured Party and of general circulation in the locale of such sale, not less than 10 days prior to the sale. The Secured Party shall not be obligated to make any sale of Collateral regardless of notice of sale having been given and may be the purchaser at any such sale, if public, to the extent permitted by applicable law, free from any right of redemption. The Obligors shall be fully liable for any deficiency, jointly and severally. The Secured Party may adjourn any public or private sale from time to time by announcement at the time and place fixed therefor, and such sale may, without further notice, be made at the time and place to which it was so adjourned.

(c) All cash proceeds received by the Secured Party in respect of any sale of, collection from, or other realization upon all or any part of the Collateral, shall (subject to Sections 4(d) and 4(j) with respect to insurance and condemnation proceeds) be applied by the Secured Party in accordance with the Loan Agreement.

9. Expenses and Indemnification . Each Obligor, jointly and severally, agrees to reimburse the Secured Party for and to indemnify and hold harmless the Secured Party, from and against any and all liability, loss, damage, and all costs or expenses (including, without limitation, reasonable fees and disbursements of counsel, experts and agents) imposed on, incurred by or asserted against the Secured Party arising out of or in connection with: preparation of this Security Agreement, the documents relating hereto, or amendments, modifications or waivers hereof; taxes (excluding any corporate excise or income taxes payable by the Secured Party by reason hereof or otherwise) and other governmental charges in connection with this Security Agreement and the Collateral; exercise of the Secured Party’s rights with respect to this Security Agreement and the Collateral; any enforcement, collection or other proceedings resulting therefrom or any negotiations or other measures to preserve the Secured Party’s rights hereunder; the custody or preservation of, or the sale of or other realization upon, any of the Collateral; any failure by any Obligor to perform or observe any of the provisions of this Security Agreement; any investigative, administrative or judicial proceeding (whether or not the Secured Party is designated a party thereto) relating to or arising out of this Security Agreement; or any bankruptcy, insolvency or other similar proceeding

 

- 14 -


relating to any Obligor, unless the party seeking indemnity was at fault with respect to such liability, loss, damage, cost or expense or acted in bad faith with respect thereto. Each Obligor’s obligations under the preceding sentence shall constitute Obligations and shall survive the termination of this Security Agreement.

10. Termination . This Security Agreement shall remain in full force and effect until the date on which no Obligation remains outstanding and all credit facilities now or hereafter provided by the Secured Party for any Obligor have terminated or expired. Upon the satisfaction in full of all of the Obligations and the termination or expiration of all credit facilities now or hereafter provided by the Secured Party for any Obligor, the Secured Party shall, at the Obligors’ expense, execute and deliver to the Obligors all instruments of assignment or otherwise as may be necessary to establish full title of the Obligors to any of the Collateral, subject to any prior sale or other disposition thereof pursuant to Section 8. Until then, this Security Agreement shall itself constitute conclusive evidence of the validity, effectiveness and continuing force hereof, and any Person may rely hereon.

11. Waiver; Rights Cumulative . No failure to exercise and no delay in exercising, on the part of the Secured Party, any right or remedy hereunder or otherwise shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right or remedy. Waiver by the Secured Party of any right or remedy on any one occasion shall not be construed as a bar to or waiver thereof or of any other right or remedy on any future occasion. The Secured Party’s rights and remedies hereunder and under the Loan Documents shall be cumulative, may be exercised singly or concurrently and are not exclusive of any rights or remedies provided by law.

The provisions of this Security Agreement are not in derogation or limitation of any obligations, liabilities or duties of the Obligors under any of the other Loan Documents or any other agreement with or for the benefit of the Secured Party. No inconsistency in default provisions between this Security Agreement, any of the other Loan Documents or any such other agreement will be deemed to create any additional grace period or otherwise derogate from the express terms of each such default provision. No covenant, agreement or obligation of the Obligors contained herein, nor any right or remedy of the Secured Party contained herein, shall in any respect be limited by or be deemed in limitation of any inconsistent or additional provisions contained in any of the other Loan Documents or any such other agreement. No reference in this Security Agreement to any other indebtedness now or hereafter incurred by the Borrower will be deemed a consent or waiver of any provision of the Loan Documents that prohibits or limits such indebtedness.

12. Severability . In the event that any provision of this Security Agreement or the application thereof to any Person, property or circumstance shall be held to any extent to be invalid or unenforceable, the remainder of this Security Agreement and the application of such provision to Persons, properties and circumstances other than those as to which it has been held invalid or unenforceable shall not be affected thereby, and each provision of this Security Agreement shall be valid and enforceable to the fullest extent permitted by law.

13. Binding Effect; Assignment . This Security Agreement shall be binding upon the Obligors and their respective successors and assigns and shall inure to the benefit of the Obligors

 

- 15 -


and the Secured Party and their respective permitted successors and assigns. All representations, warranties, covenants and agreements of the Obligors contained in this Security Agreement shall be deemed to be joint and several representations, warranties, covenants and agreements of the Obligors, whether or not expressly so stated herein.

14. Notices . All notices and other communications under or relating to this Security Agreement shall be given in the manner and to the addresses of the parties provided for in the Loan Agreement (or, in the case of the Guarantors, the Guaranty).

15. Headings . Section headings in this Security Agreement are included herein for convenience of reference only and shall not constitute a part of this Security Agreement for any other purpose.

16. Governing Law . This Security Agreement shall be governed by, and construed and enforced in accordance with, the laws of The Commonwealth of Massachusetts, except to the extent that other laws of another jurisdiction may govern the perfection of security interests granted by any Obligor due to the jurisdiction of incorporation of the relevant Obligor.

17. Jury Waiver . As to any dispute or claim arising hereunder or under any of the other Loan Documents, the parties waive all rights to trial by jury, as further set forth in the Loan Agreement (as to the Borrower) or in the Guaranty (as to the Guarantors).

18. Concerning the Secured Party . (a) The Secured Party may employ agents and attorneys-in-fact in connection herewith and shall not be liable for the negligence or misconduct of any such agents or attorneys-in-fact selected by it in good faith.

(b) The Secured Party shall be entitled to rely upon any written notice, statement, certificate, order or other document or any telephone message believed by it to be genuine and correct and to have been signed, sent or made by the proper person, and, with respect to all matters pertaining to this Security Agreement and its duties hereunder, upon advice of counsel selected by it.

(c) In the event of any conflict between the provisions hereof and the provisions of any other deed of trust, mortgage, security agreement, pledge or instrument of any type in respect of the Collateral, the Secured Party, in its sole discretion, shall select which provision or provisions shall control.

[Signature pages follow.]

 

- 16 -


IN WITNESS WHEREOF, the Obligors and the Secured Party have caused this Security Agreement to be executed, as an instrument under seal, by their respective officers thereunto duly authorized, as of the date first above written.

 

BORROWER :

 

MDRNA, INC.
By:  

/s/ J. Michael French

Name:   J. Michael French
Title:   President and Chief Executive

 

GUARANTORS :

 

ATOSSA HEALTHCARE, INC.
By:  

/s/ J. Michael French

Name:   J. Michael French
Title:   President

 

MDRNA RESEARCH, INC.
By:  

/s/ J. Michael French

Name:   J. Michael French
Title:   President

 

CALAIS ACQUISITION CORP.
By:  

/s/ J. Michael French

Name:   J. Michael French
Title:   President

 

SECURED PARTY :
CEQUENT PHARMACEUTICALS, INC.
By:  

/s/ Peter D. Parker

Name:   Peter D. Parker
Title:   President and Chief Executive Officer

Signature Page to Security Agreement (All Assets)


EXHIBIT LIST

 

EXHIBIT A – Intellectual Property

EXHIBIT B – Locations of Collateral

EXHIBIT C – Tradenames; Corporate and Other Entity Names Used in Last Five Years

EXHIBIT D – Filing Offices

EXHIBIT E – Bank accounts; brokerage accounts, investment accounts and other securities

Exhibit 10.5

EXECUTION COPY

SECURITY AGREEMENT (PATENTS)

WHEREAS, MDRNA, INC., a Delaware corporation, formerly known as Nastech Pharmaceutical Company Inc., with a principal place of business at 3830 Monte Villa Parkway, Bothell, Washington 98021 (the “Company”) and CEQUENT PHARMACEUTICALS, INC., a Delaware corporation, with a place of business at One Kendall Square, Building 700, Cambridge, Massachusetts 02139 (the “Lender”) have entered into a Security Agreement (All Assets) dated March 31, 2010 (as amended, the “Security Agreement”) and are also parties to a related loan agreement (as amended, the “Loan Agreement”) between the Company and the Lender; and

WHEREAS, the Company is the owner of the registered United States Patents (“U.S. Patents”) and United States Patent Applications (“U.S. Applications”) listed on Schedule A hereto; and

WHEREAS, among the security interests granted by the Company to the Lender pursuant to the Security Agreement is a security interest in the U.S. Patents and U.S. Applications listed on Schedule A hereto and in any registered patents which may hereafter issue in respect of such U.S. Applications; and

WHEREAS, the parties to the Security Agreement contemplate and intend that, if an Event of Default (as defined in the Loan Agreement) shall occur and be continuing, the Lender shall have all rights of a foreclosing secured party in and to the U.S. Patents and U.S. Applications and any registered patents which may hereafter issue in respect of such U.S. Applications and any proceeds thereof, including, without limitation, the right, following such foreclosure, to transfer to a purchaser all of the Company’s right, title and interest in and to the U.S. Patents and U.S. Applications and any registered patents which may hereafter issue in respect of such U.S. Applications;

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties reconfirm the terms of the Security Agreement, as if set forth fully herein, and acknowledge that the Lender has a security interest in the U.S. Patents and U.S. Applications listed on Schedule A hereto and in any registered patents which may hereafter issue in respect of such U.S. Applications; as security for the Obligations (as defined in the Security Agreement) the Company hereby collaterally assigns to the Lender, and grants a security interest to the Lender in and to, all of the Company’s right, title and interest in and to said U.S. Patents and U.S. Applications and any registered patents which may hereafter issue in respect of such U.S. Applications; the Company agrees that except as permitted by the Security Agreement, it will not sell or assign any of the U.S. Patents, any of the U.S. Applications or any registered patents which may hereafter issue in respect of such U.S. Applications without the prior written consent of the Lender; and the Company and the Lender request that the Commissioner of Patents and Trademarks record this document with respect to the U.S. Patents and U.S. Applications.

 


The Company hereby appoints the Lender as the Company’s attorney-in-fact (with full power of substitution and resubstitution) with the power and authority, after the occurrence and during the continuance of any Event of Default (as defined in the Loan Agreement), to execute and deliver, in the name and on behalf of the Company, and to cause the recording of all such further assignments and other instruments as the Lender may deem necessary or desirable in order to carry out the intent of the Security Agreement and this Security Agreement (Patents). The Company agrees that all third parties may conclusively rely on any such further assignment or other instrument, so executed, delivered and recorded by the Lender (or the Lender’s designee in accordance with the terms hereof) and on the statements made therein.

 

MDRNA, INC., formerly known as

Nastech Pharmaceutical Company Inc.

    CEQUENT PHARMACEUTICALS, INC.,
By:  

/s/ J. Michael French

    By:  

/s/ Peter D. Parker

Name:   J. Michael French     Name:   Peter D. Parker
Title:   President and Chief Executive Officer     Title:   President and Chief Executive Officer

Signature Page to Security Agreement (Patents)


SCHEDULE A

TO

SECURITY AGREEMENT (PATENTS)

Patents with United States Registration

 

Patent Description

 

Registration No.

 

Issue Date

   

 

United States Patent Applications

   

Description

 

Serial No.

 

Filing Date

               

Exhibit 10.6

EXECUTION COPY

SECURITY AGREEMENT (PATENTS)

WHEREAS, MDRNA RESEARCH, INC., a Delaware corporation, with a principal place of business at 3830 Monte Villa Parkway, Bothell, Washington 98021 (the “Company”) and CEQUENT PHARMACEUTICALS, INC., a Delaware corporation, with a place of business at One Kendall Square, Building 700, Cambridge, Massachusetts 02139 (the “Lender”) have entered into a Security Agreement (All Assets) dated March 31, 2010 (as amended, the “Security Agreement”), which Security Agreement was executed in connection a loan agreement (as amended, the “Loan Agreement”) between MDRNA, Inc., the corporate parent of the Company, and the Lender; and

WHEREAS, the Company is the owner of the registered United States Patents (“U.S. Patents”) and United States Patent Applications (“U.S. Applications”) listed on Schedule A hereto; and

WHEREAS, among the security interests granted by the Company to the Lender pursuant to the Security Agreement is a security interest in the U.S. Patents and U.S. Applications listed on Schedule A hereto and in any registered patents which may hereafter issue in respect of such U.S. Applications; and

WHEREAS, the parties to the Security Agreement contemplate and intend that, if an Event of Default (as defined in the Loan Agreement) shall occur and be continuing, the Lender shall have all rights of a foreclosing secured party in and to the U.S. Patents and U.S. Applications and any registered patents which may hereafter issue in respect of such U.S. Applications and any proceeds thereof, including, without limitation, the right, following such foreclosure, to transfer to a purchaser all of the Company’s right, title and interest in and to the U.S. Patents and U.S. Applications and any registered patents which may hereafter issue in respect of such U.S. Applications;

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties reconfirm the terms of the Security Agreement, as if set forth fully herein, and acknowledge that the Lender has a security interest in the U.S. Patents and U.S. Applications listed on Schedule A hereto and in any registered patents which may hereafter issue in respect of such U.S. Applications; as security for the Obligations (as defined in the Security Agreement) the Company hereby collaterally assigns to the Lender, and grants a security interest to the Lender in and to, all of the Company’s right, title and interest in and to said U.S. Patents and U.S. Applications and any registered patents which may hereafter issue in respect of such U.S. Applications; the Company agrees that except as permitted by the Security Agreement, it will not sell or assign any of the U.S. Patents, any of the U.S. Applications or any registered patents which may hereafter issue in respect of such U.S. Applications without the prior written consent of the Lender; and the Company and the Lender request that the Commissioner of Patents and Trademarks record this document with respect to the U.S. Patents and U.S. Applications.


The Company hereby appoints the Lender as the Company’s attorney-in-fact (with full power of substitution and resubstitution) with the power and authority, after the occurrence and during the continuance of any Event of Default (as defined in the Loan Agreement), to execute and deliver, in the name and on behalf of the Company, and to cause the recording of all such further assignments and other instruments as the Lender may deem necessary or desirable in order to carry out the intent of the Security Agreement and this Security Agreement (Patents). The Company agrees that all third parties may conclusively rely on any such further assignment or other instrument, so executed, delivered and recorded by the Lender (or the Lender’s designee in accordance with the terms hereof) and on the statements made therein.

 

MDRNA RESEARCH, INC.     CEQUENT PHARMACEUTICALS, INC.,
By:  

/s/ J. Michael French

    By:  

/s/ Peter D. Parker

Name:   J. Michael French     Name:   Peter D. Parker
Title:   President     Title:   President and Chief Executive Officer

Signature Page to Security Agreement (Patents)


SCHEDULE A

TO

SECURITY AGREEMENT (PATENTS)

Patents with United States Registration

 

Patent Description

 

Registration No.

 

Issue Date

   

 

United States Patent Applications

   

Description

 

Serial No.

 

Filing Date

Exhibit 10.7

EXECUTION COPY

GUARANTY AGREEMENT

GUARANTY AGREEMENT dated as of March 31, 2010 from Atossa HealthCare, Inc., a Delaware corporation (“ Healthcare ”), MDRNA Research, Inc., a Delaware corporation (“ Research ”), and Calais Acquisition Corp., a Delaware corporation (“ Merger Sub ”) (Healthcare, Research and Merger Sub being hereinafter referred to, collectively, as “ Guarantors ” and, individually, as a “ Guarantor ”), to Cequent Pharmaceuticals, Inc., a Delaware corporation (“ Lender ”).

WITNESSETH:

WHEREAS, MDRNA, Inc., a Delaware corporation (“ Borrower ”), and Lender are entering into that certain Loan Agreement dated as of the date hereof (as amended, restated, supplemented and/or otherwise modified from time to time, the “ Loan Agreement ”), pursuant to which Lender will establish a facility for a term loan (the “ Loan ”) that may be advanced to the Borrower in installments; and

WHEREAS, the Loan is evidenced by the Borrower’s promissory note (as amended, restated, supplemented and/or otherwise modified from time to time, the “ Note ”) in an aggregate face principal amount of $3,000,000, payable to the order of Lender; and

WHEREAS, in order to induce the Lender to enter into the Loan Agreement, the Borrower has agreed to obtain and deliver this Agreement; and

WHEREAS, the Guarantors are wholly-owned subsidiaries of the Borrower and participate in a common business enterprise with the Borrower; and

WHEREAS, the Lender’s agreement to enter into the Loan Agreement is and will be beneficial to each Guarantor, as each Guarantor has a significant economic interest in the strength and success of the Borrower;

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Guarantors hereby jointly and severally agree as follows:

ARTICLE I

CERTAIN DEFINITIONS

Section 1.01. Defined Terms . As used in this Agreement, the following terms shall have the meanings set out respectively after each:

Agreement ” – This Guaranty Agreement, as same may be from time to time amended.

Business Day ” – As defined in the Loan Agreement.


Environmental Event ” – Each of (i) the generation, storage, disposal, removal, transportation or treatment of Hazardous Substances on any property owned, occupied or operated by any Guarantor or any Subsidiary of a Guarantor; (ii) the receipt by any Guarantor or by any Subsidiary of a Guarantor of any notice or claim of any violation of any Environmental Law or of any action based upon nuisance, negligence or other tort theory alleging liability on the basis of improper generation, storage, disposal, removal, transportation or treatment of Hazardous Substances on any affected property; or (iii) the presence or release of Hazardous Substances at or upon any property owned, occupied or operated by any Guarantor or any Subsidiary of a Guarantor that has resulted in contamination or deterioration of any property resulting in a level of contamination greater than the levels permitted or established by any Governmental Authority of competent jurisdiction.

Governmental Authority ” – As defined in the Loan Agreement.

Guaranteed Obligations ” – Any and all indebtedness, liabilities or obligations of the Borrower, joint or several, direct or indirect, absolute or contingent, due or to become due, now existing or hereafter arising, to or for the benefit of the Lender arising out of or provided for in any of the Loan Documents or the Merger Agreement, such term to include obligations to perform acts and refrain from taking action as well as obligations to pay money.

Guarantors’ Agreements ” – Collectively, this Agreement, the Security Agreement and any other instrument, document or other agreement between any one or more of the Guarantors and the Lender or given by any one or more of the Guarantors to the Lender, whether now existing or hereafter arising.

Guaranty ” – The guaranty of the Guarantors set forth in Section 2.01 below.

Hazardous Substances ” – As defined in the Loan Agreement.

Indebtedness ” – As defined in the Loan Agreement.

Loan Documents ” – The Loan Agreement, the Note, the Security Agreement and any other instruments, documents or other agreements made by the Borrower with or in favor of the Lender in connection with the Loan, whether now existing or hereafter entered into or delivered.

Merger Agreement ” – As defined in the Loan Agreement.

Person ” – As defined in the Loan Agreement.

Security Agreement ” – The Security Agreement (All Assets) of even date herewith given by the Borrower and the Guarantors to the Lender.

Capitalized terms defined in the Loan Agreement and not otherwise defined herein shall have the respective meanings set forth in the Loan Agreement.

Section 1.02. Use of Defined Terms . Any defined term used in the plural preceded by the definite article shall be taken to encompass all members of the relevant class. Any defined

 

- 2 -


term used in the singular preceded by “any” shall be taken to indicate any number of the members of the relevant class.

ARTICLE II

THE GUARANTY

Section 2.01. Guaranty . In consideration of the Lender entering into the Loan Agreement, the Guarantors hereby jointly and severally guaranty to the Lender the due and punctual payment of all of the Guaranteed Obligations, as and when the same shall become due and payable, whether on demand or at maturity, by declaration or otherwise, according to the terms thereof, and all losses, costs, expenses and reasonable attorneys’ fees and disbursements incurred by reason of a default under any of said Guaranteed Obligations. In case of any failure by the Borrower punctually to pay any of the Guaranteed Obligations, the Guarantors unconditionally, jointly and severally agree to cause such payment to be made punctually as and when the same shall become due, whether at maturity or by declaration or otherwise, and as if such payment were made by the Borrower. This Guaranty is an absolute, unlimited, unconditional and continuing guaranty of the full and punctual payment by the Borrower of the Guaranteed Obligations and not merely of their collectibility, and is in no way conditioned upon any requirement that the Lender first collect or attempt to collect the Guaranteed Obligations or any portion thereof from the Borrower or from any other guarantor (nor, as to any Guarantor, from any other Guarantor) of any of same or resort to any security or other means of obtaining payment of any of the Guaranteed Obligations that the Lender now has or may acquire after the date hereof, or upon any other contingency whatsoever. Upon the occurrence of any Event of Default (as defined herein) and written notice thereof to the Guarantors, all liabilities and obligations of each Guarantor to the Lender shall, at the option of the Lender, become due and payable to the Lender without further demand or notice of any nature, all of which are expressly waived by the Guarantors. Payments by the Guarantors hereunder may be required by the Lender on any number of occasions.

Section 2.02. Guarantors’ Further Agreements to Pay . The Guarantors further jointly and severally agree, as principal obligors and not as guarantors, to pay to the Lender, on demand, in funds immediately available to the Lender, all costs and expenses (including court costs and reasonable attorneys’ fees and disbursements) incurred or expended by the Lender in connection with the enforcement of this Guaranty, together with interest on any sum now or hereafter payable by the Guarantors under this Agreement, such interest to accrue from the date of demand for any payment to the date of actual payment. Such interest will be payable at the rate set forth in Section 6.04 below.

Section 2.03. Freedom to Deal with Borrower and Other Parties . The Lender shall be at liberty, without giving notice to or obtaining the assent of any Guarantor and without relieving any Guarantor of any liability hereunder, to deal with each other Guarantor, with the Borrower and with each other party who now is or after the date hereof becomes liable in any manner for any of the Guaranteed Obligations in such manner as the Lender in its sole discretion deems fit. The Lender may in its sole discretion (to the extent permitted by the Loan Agreement) do any or all of the following things, none of which shall discharge or affect any Guarantor’s liability

 

- 3 -


hereunder: (i) extend credit, make loans and afford other financial accommodations to the Borrower at such times, in such amounts and on such terms as the Lender may approve; (ii) modify, amend, vary the terms and grant extensions or renewals of any present or future indebtedness or of all or any of the Guaranteed Obligations held by Lender or any instrument relating to or securing same; (iii) grant time, waivers and other indulgences in respect thereto; (iv) vary, exchange, release or discharge, wholly or partially, or delay or abstain from perfecting and enforcing any security or guaranty held by Lender (including, as to any Guarantor, varying, exchanging, releasing, discharging or delaying or abstaining to enforce this Guaranty with respect to any other Guarantor ) or other means of obtaining payment of any of the Guaranteed Obligations that the Lender now has or acquires after the date hereof; (v) take or omit to take any of the actions referred to in the Loan Documents or other instrument evidencing, securing or relating to any of the Guaranteed Obligations or any actions under this Agreement; (vi) fail, omit or delay to enforce, assert or exercise any right, power or remedy conferred on the Lender in this Agreement or in any other Loan Document or other instrument evidencing, securing or relating to any of the Guaranteed Obligations or take or refrain from taking any other action; (vii) accept partial payments from the Borrower or any other party; (viii) as to any Guaranteed Obligations held by Lender, release or discharge, wholly or partially, any other Guarantor, any endorser or any guarantor, or accept additional collateral for the payment of any Guaranteed Obligations held by Lender; (ix) compromise or make any settlement or other arrangement with the Borrower or any other Person as to the Guaranteed Obligations held by Lender; and (x) consent to and participate in the proceeds of any assignment, trust or mortgage for the benefit of creditors as to the Guaranteed Obligations held by Lender.

Section 2.04. Unenforceability of Guaranteed Obligations; Invalidity of Security or Other Guaranties . If for any reason now or hereafter the Borrower has no legal existence or is under no legal obligation to discharge any of the Guaranteed Obligations undertaken or purported to be undertaken by it or on its behalf, or if any of the moneys included in the Guaranteed Obligations have become irrecoverable from the Borrower by operation of law or for any other reason, this Agreement shall nevertheless be binding on the Guarantors jointly and severally to the same extent as if the Guarantors at all times had been the joint and several principal debtors on all of the Guaranteed Obligations (and no invalidity or unenforceability as to one Guarantor shall affect the obligations of any other Guarantor hereunder). This Agreement shall be in addition to any other guaranty or other security for the Guaranteed Obligations, and it shall not be prejudiced or rendered unenforceable by the invalidity of any such other guaranty or security. The liability of each Guarantor under this Agreement shall remain in full force and effect until payment and performance in full of all of the Guaranteed Obligations. This Agreement shall continue to be effective or be reinstated, as the case may be, if at any time any payment of any of the Guaranteed Obligations is rescinded or must otherwise be restored or returned by the Lender upon the insolvency, bankruptcy or reorganization of the Borrower, any Guarantor or otherwise, all as though such payment had not been made.

Section 2.05. Waivers by Guarantors . Each Guarantor waives: notice of acceptance hereof and reliance hereon, notice of any action taken or omitted by the Lender in reliance hereon, any requirement that the Lender be diligent or prompt in making demands hereunder, any requirement as to any presentment, demand, protest, giving notice of any default by the Borrower (except as otherwise specifically required under the Loan Agreement) or asserting any other right

 

- 4 -


of the Lender hereunder and all demands, notices (except as aforesaid) and all suretyship defenses generally. Each Guarantor also irrevocably waives, to the fullest extent permitted by law, all defenses which at any time may be available in respect of such Guarantor’s obligations hereunder by virtue of any statute of limitations, valuation, stay, homestead or moratorium law or other similar law now or hereafter in effect.

Without limiting the generality of the foregoing provisions of this Agreement, the liability of each Guarantor shall not be released, discharged or otherwise affected by:

(i) any extension, renewal, settlement, compromise, waiver or release in respect of any obligation of the Borrower, any other Guarantor or any other guarantor of any of the Guaranteed Obligations;

(ii) any change in the time, manner, amount or place of payment of any Guaranteed Obligation or any modification or amendment of or supplement to any Loan Document or this Agreement;

(iii) any release, non-perfection or invalidity of any direct or indirect security for any obligation of the Borrower, any Guarantor or any other guarantor of any of the Guaranteed Obligations;

(iv) any change in the legal existence, structure, record or beneficial ownership or control of the Borrower, any Guarantor or any other guarantor of any of the Guaranteed Obligations, or any insolvency, bankruptcy, reorganization or other similar proceeding affecting any such Person or its assets;

(v) the existence of any claim, set-off or other rights that any Guarantor may have at any time against the Borrower, the Lender, any Guarantor or any other guarantor of any of the Guaranteed Obligations or any other Person, whether or not arising in connection with this Agreement;

(vi) any invalidity or unenforceability relating to or against the Borrower or any Guarantor for any reason under any Loan Document or under this Agreement; or any provision of applicable law or regulation purporting to prohibit the payment by any Person of the principal of or interest on the Note or any other amount payable under any Loan Document or under this Agreement; or

(vii) any other act or omission to act or delay of any kind by the Borrower, any other Guarantor, the Lender, or any other Person or any other circumstances whatsoever that might, but for the provisions of this paragraph, constitute a legal or equitable discharge of any Guarantor’s obligations hereunder.

Section 2.06. Subrogation . Unless and until all Guaranteed Obligations shall have been indefeasibly paid in full and discharged, each Guarantor hereby irrevocably and unconditionally waives enforcement of any and all rights of subrogation, contribution or similar rights that, but for this Section 2.06, such Guarantor might otherwise have in relation to the Borrower, any other Guarantor or any other guarantor as a result of this Agreement. No right of subrogation,

 

- 5 -


contribution or any similar rights will in any event be deemed to give any Guarantor any cause of action against the Lender or any of its respective officers, employees or agents for any act or omission on the part of the Lender; the Lender may, without liability, release or fail to perfect any security interest and may take or omit to take any action under any of the Loan Documents, even if same would reduce the value of any Guarantor’s subrogation or similar rights.

Section 2.07. No Contest with Lender . No set-off, counterclaim, reduction or diminution of any obligation, or any claim or defense of any kind or nature that any Guarantor has or may have against the Borrower, any other Guarantor, any other guarantor, or the Lender, as the case may be, shall be available hereunder to any Guarantor. No Guarantor will, in any proceedings under the Bankruptcy Code or insolvency proceedings of any nature, prove in competition with the Lender in respect of any payment hereunder or be entitled to have the benefit of any counterclaim or proof of claim or dividend or payment by or on behalf of the Borrower or the benefit of any other security for any Guaranteed Obligation that, now or hereafter, any Guarantor may hold in competition with the Lender.

Section 2.08. Stay of Acceleration . If acceleration of the time for payment of any amount payable by the Borrower under any Loan Document is stayed upon the insolvency, bankruptcy or reorganization of the Borrower, all such amounts otherwise subject to acceleration under the terms of this Agreement shall nonetheless be payable jointly and severally by the Guarantors hereunder forthwith on demand by the Lender.

Section 2.09. Payments . All payments by any Guarantor to the Lender hereunder shall be made, without withholding, deduction or offset of any sort, in lawful currency of the United States in immediately available funds at the offices of the Lender at One Kendall Square, Building 700, Cambridge, MA 02139, or such other place as the Lender may designate. Whenever any payment hereunder shall be due on a day that is not a Business Day, the date for payment thereof shall be extended to the next succeeding Business Day, and any interest payable thereon shall be payable for such extended time at the specified rate. Any payments received after 2:00 p.m. on any day will be deemed received on the next succeeding Business Day.

ARTICLE III

REPRESENTATIONS AND WARRANTIES

Section 3.01. Representations and Warranties . Each Guarantor hereby represents and warrants that:

(a) Each Guarantor (i) is a corporation, duly incorporated, validly existing and in good standing under the laws of the jurisdiction indicated in the introductory sentence of this Agreement, (ii) has the corporate power and authority to own its assets and to transact the business in which it is now engaged and to enter into and perform this Agreement and each of the other Guarantors’ Agreements in which such Guarantor is named as a party, and (iii) is duly qualified as a foreign corporation (or company, as the case may be) and in good standing under the laws of each jurisdiction in which failure to be so qualified could have a material adverse effect on the business, assets or condition of such Guarantor. At the date of this Agreement, no

 

- 6 -


Guarantor has any Subsidiaries, except as shown on item 3.01(a) of the attached Disclosure Schedule.

(b) The owners of all of the equity securities of each Guarantor are set forth on item 3.01(b) of the attached Disclosure Schedule.

(c) The execution, delivery and performance by each Guarantor of this Agreement and each of the other Guarantors’ Agreements in which such Guarantor is named as a party have been duly approved by such Guarantor’s Board of Directors (and, if required, by such Guarantor’s shareholders) and do not and will not:

(i) contravene such Guarantor’s charter documents or by-laws;

(ii) violate any provision of, or require any filing, registration, consent or approval under, any law, rule, regulation, order, writ, judgment, injunction, decree, determination or award presently in effect having applicability to such Guarantor;

(iii) result in a breach of or constitute a default or require any consent (not heretofore obtained) under any indenture or loan or credit agreement or any other agreement, lease or instrument to which such Guarantor is a party or by which such Guarantor or any of its properties may be bound or affected; or

(iv) result in, or require, the creation or imposition of any lien, security interest or other encumbrance upon or with respect to any of the properties now owned or hereafter acquired by such Guarantor.

(d) This Agreement has been duly executed and delivered on behalf of each Guarantor and is the legal, valid and binding joint and several obligation of the Guarantors, enforceable against the Guarantors in accordance with its terms. Each of the other Guarantors’ Agreements in which any Guarantor is named as a party has been duly executed and delivered on behalf of each such Guarantor and is the legal, valid and binding obligation of such Guarantor, enforceable against such Guarantor in accordance with its terms.

(e) Each Guarantor is an affiliate of the Borrower and wishes to enter into this Agreement in furtherance of its corporate purposes. Each Guarantor has a substantial interest in the continued financial strength of the Borrower and, in particular, its financing arrangements with the Lender, and the execution and delivery of this Agreement is a substantial inducement for the Lender to enter into the Loan Agreement. Each Guarantor has determined the execution, delivery and performance of this Agreement to be necessary and convenient to the conduct, promotion and attainment of the businesses of such Guarantor and the Borrower.

(f) Except as described on item 3.01(f) of the attached Disclosure Schedule, there are no actions, suits, proceedings or investigations pending or, to the knowledge of any Guarantor, threatened by or against any Guarantor or any Subsidiary of a Guarantor before any court or governmental department, commission, board, bureau, agency or instrumentality, domestic or foreign, which could hinder or prevent the consummation of the transactions contemplated hereby or call into question the validity of this Agreement or any action taken or to be taken in

 

- 7 -


connection with the transactions contemplated hereby or which in any single case or in the aggregate might result in any material adverse change in the business, condition, affairs or operations of any Guarantor or any such Subsidiaries.

(g) After giving effect to this Agreement and the transactions contemplated hereby, each Guarantor (i) is and will be able to pay its debts as they become due, (ii) has and will have funds and capital sufficient to carry on its business as now conducted or as contemplated to be conducted, (iii) owns property having a value both at fair valuation and at present fair salable value greater than the amount required to pay its debts as they become due, and (iv) is not insolvent and will not be rendered insolvent as determined by applicable law, after taking into account the reasonable likelihood of payments being required hereunder.

ARTICLE IV

COVENANTS

Section 4.01. Guarantors’ Covenants Effective Regardless of Status of Merger Agreement . Without limitation of any other covenants and agreements contained herein or elsewhere, so long as the Loan Agreement is in effect or any of the Guaranteed Obligations remain outstanding:

(a) Covenants Incorporated by Reference . Each Guarantor (i) will perform (and will cause each of its Subsidiaries to perform) all affirmative agreements and covenants applicable to it set forth in the Merger Agreement, and (ii) will not violate or suffer or permit the violation of any of the negative covenants or agreements applicable to it contained in the Merger Agreement by itself or by any of such Guarantor’s Subsidiaries; all of which affirmative and negative covenants and agreements (together with the related definitions contained in the Merger Agreement) are incorporated herein by this reference as effectively as if set forth at length herein. Said agreements and covenants (and the related definitions) are incorporated herein as they exist in the Merger Agreement at the date hereof and without regard for any future termination or waiver of the Merger Agreement.

(b) Further Assurances . Each Guarantor will execute and deliver, or cause to be executed and delivered, to the Lender from time to time, promptly upon request therefor, any and all other and further instruments (including correction instruments and supplemental security documents) that may be reasonably requested by the Lender to cure any deficiency in the execution and delivery of this Agreement or any of the other Guarantors’ Agreements in which such Guarantor is named as a party or more fully to describe or give effect to particular aspects of any of the agreements and undertakings of such Guarantor provided in this Agreement or any of the other Guarantors’ Agreements or intended to be so provided.

Section 4.02 Guarantors’ Covenants Effective Upon Termination of the Merger Agreement . Without limitation of any other covenants and agreements contained herein or elsewhere, so long as the Loan Agreement is in effect or any of the Guaranteed Obligations remain outstanding, the Guarantors will observe and perform each of the covenants and agreements contained in the Loan Agreement and relevant to the Guarantors, all such covenants

 

- 8 -


and agreements of the Loan Agreement (together with the related definitions) being incorporated herein by this reference as effectively as if set forth at length herein.

ARTICLE V

DEFAULT AND REMEDIES

Section 5.01. Events of Default . An Event of Default will be deemed to have occurred under this Agreement upon the occurrence of any one or more of the following:

(i) Any Guarantor shall fail to make any monetary payment hereunder when due; or

(ii) Any representation or warranty of any Guarantor contained herein or made in connection herewith shall at any time prove to have been incorrect in any material respect when made; or

(iii) Any Guarantor shall fail to perform or observe any obligation or agreement under Section 4.01 or Section 4.02 and such failure shall, as to any provision incorporated herein by reference to the Loan Agreement and/or the Merger Agreement, continue beyond the expiration of the notice and/or grace period (if any) provided for the corresponding provision in the Loan Agreement or the Merger Agreement, as applicable; or

(iv) Any Guarantor shall fail to perform or observe any other obligation or agreement contained in this Agreement and such failure shall continue uncured for ten (10) Business Days after written notice of such failure is given to such Guarantor; or

(v) Any default on the part of any Guarantor or any Subsidiary of any Guarantor shall exist, and shall remain unwaived or uncured beyond the expiration of any applicable notice and/or grace period, under any other contract, agreement or undertaking now existing or hereafter entered into with or for the benefit of the Lender (or any affiliate of the Lender); or

(vi) Any default shall exist and remain unwaived or uncured beyond the expiration of any applicable notice and/or grace period with respect to any other Indebtedness of any Guarantor or any Subsidiary of any Guarantor that would constitute an “Event of Default” under and as defined in the Loan Agreement; or

(vii) Any Guarantor, other than Healthcare, shall be dissolved; or any Guarantor or any Subsidiary of any Guarantor shall become insolvent or bankrupt or shall cease paying its debts as they mature or shall make an assignment for the benefit of creditors; or a trustee, receiver or liquidator shall be appointed for any Guarantor or any Subsidiary of any Guarantor or for a substantial part of the property of any of the foregoing; or bankruptcy, reorganization, arrangement, insolvency or similar proceedings shall be instituted by or against any Guarantor or any such Subsidiary under the laws of any jurisdiction (except for an involuntary proceeding filed against any Guarantor or any

 

- 9 -


Subsidiary of any Guarantor that is dismissed within 60 days following the institution thereof); or

(viii) Any final uninsured judgment shall be entered against any Guarantor or any Subsidiary of any Guarantor which would constitute an “Event of Default” under and as defined in the Loan Agreement; or

(ix) Any Guarantor or any Subsidiary of any Guarantor shall fail to meet its minimum funding requirements under ERISA with respect to any employee benefit plan (or other class of benefit which the PBGC has elected to insure) or any such plan shall be the subject of termination proceedings (whether voluntary or involuntary) and there shall result from such termination proceedings a liability of any Guarantor or any Subsidiary of any Guarantor to the PBGC which in the reasonable opinion of the Lender may have a material adverse effect upon the financial condition of any Guarantor and its Subsidiaries, taken as a whole; or

(x) An Environmental Event shall have occurred that in the reasonable opinion of the Lender materially adversely affects the financial condition, prospects, business or operations of any Guarantor or any of its Subsidiaries or any of their respective premises; or

(xi) There shall occur any other material adverse change in the condition (financial or otherwise), operations, properties, assets, liabilities or earnings of any Guarantor and its Subsidiaries, taken as a whole.

Section 5.02. Rights and Remedies Upon Default . Upon the occurrence of any Event of Default and at any time thereafter during the continuance thereof, in addition to any other rights and remedies available to the Lender hereunder or otherwise, the Lender may exercise any one or more of the following rights and remedies (all of which shall be cumulative):

(a) Enforce the provisions of this Agreement by legal proceedings for the specific performance of any covenant or agreement contained herein or for the enforcement of any other appropriate legal or equitable remedy, and the Lender may recover damages caused by any breach by any Guarantor of the provisions of this Agreement, including court costs, reasonable attorneys’ fees and other costs and expenses incurred in the enforcement of the obligations of any Guarantor hereunder.

(b) Exercise all rights and remedies hereunder, under the Guarantors’ Documents, under the Loan Documents, and under any other agreement with the Lender, and exercise all other rights and remedies that the Lender may have under applicable law.

Section 5.03. Set-off . In addition to any rights now or hereafter granted under applicable law and not by way of limitation of any such rights, upon the occurrence of any Event of Default and during the continuance thereof, the Lender is hereby authorized at any time or from time to time, without presentment, demand, protest or other notice of any kind to any Guarantor or to any other Person, all of which are hereby expressly waived, to set off and to appropriate and apply

 

- 10 -


any and all deposits and any other Indebtedness at any time held or owing by the Lender or any affiliate of the Lender to or for the credit or the account of any Guarantor against and on account of the obligations and liabilities of any Guarantor to the Lender, under this Agreement or otherwise, although said obligations, liabilities or claims, or any of them, may then be contingent or unmatured and without regard for the availability or adequacy of other collateral. ANY AND ALL RIGHTS TO REQUIRE THE LENDER TO EXERCISE ITS RIGHTS OR REMEDIES WITH RESPECT TO ANY COLLATERAL WHICH SECURES ANY OF THE OBLIGATIONS PRIOR TO THE EXERCISE BY THE LENDER OF ITS RIGHT OF SET-OFF UNDER THIS SECTION ARE HEREBY KNOWINGLY, VOLUNTARILY AND IRREVOCABLY WAIVED.

Section 5.04. Distribution . All cash actually received by the Lender pursuant to this Agreement or the exercise of its rights hereunder shall be applied by the Lender in the manner set forth in Section 1.5 of the Loan Agreement.

ARTICLE VI

MISCELLANEOUS

Section 6.01. No Waiver; Cumulative Remedies . No failure or delay on the part of any party in exercising any right, power or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right, power or remedy preclude any other or further exercise thereof or the exercise of any other right, power or remedy hereunder. The remedies herein provided are cumulative and not exclusive of any remedies provided by law or otherwise available to the Lender. Such remedies may be exercised without resort or regard to the other source of satisfaction of any liabilities of any Guarantor to the Lender. The provisions of this Agreement are not limited by nor in limitation of any additional or inconsistent provisions contained in the Loan Agreement or elsewhere.

Section 6.02. Amendments, Waivers and Consents . Neither this Agreement nor any provision hereof may be amended, waived discharged or terminated orally. Any such amendment, waiver, discharge or termination must be in writing signed by the party against whom enforcement of the amendment, waiver, discharge or termination is sought. Any waiver or consent may be given subject to satisfaction of conditions stated therein and any waiver or consent shall be effective only in the specific instance and for the specific purpose for which given.

Section 6.03. Addresses for Notices, etc. Except as otherwise expressly provided in this Agreement, all notices, requests, demands and other communications provided for hereunder shall be in writing and shall be mailed or delivered to the applicable party at the address indicated below:

 

- 11 -


If to the Guarantors:

Atossa HealthCare, Inc.

MDRNA Research, Inc.

Calais Acquisition Corp.

c/o MDRNA, Inc.

3830 Monte Villa Parkway

Bothell, Washington 98021

Attention: J. Michael French, President

and Chief Executive Officer

If to the Lender:

Cequent Pharmaceuticals, Inc.

One Kendall Square

Building 700

Cambridge, MA 02139

Attention: Peter D. Parker, President

and Chief Executive Officer

or, as to each of the foregoing, at such other address as shall be designated by such Person in a written notice to the other party complying as to delivery with the terms of this Section. Except as otherwise provided herein, all such notices, requests, demands and other communications shall be deemed delivered on the earlier of (i) the date received or (ii) the date of delivery, refusal or non-delivery indicated on the return receipt if deposited in the United States mails, sent postage prepaid, registered or certified mail, return receipt requested, postage and registration or certification charges prepaid, addressed as aforesaid. If any such notice, request, demand or other communication is hand-delivered or delivered by overnight delivery service, same shall be effective upon receipted delivery.

Section 6.04. Costs, Expenses and Taxes . The Guarantors jointly and severally agree to pay all costs and expenses (including, without limitation, reasonable legal fees) incurred by the Lender in connection with the preparation, execution and delivery of this Agreement and all other instruments and documents to be delivered in connection herewith and any amendments or modifications of any of the foregoing, as well as the costs and expenses incurred by the Lender in connection with the administration, default, collection, waiver or amendment of any terms of this Agreement and/or such other instruments and documents, or in connection with the Lender’s exercise, preservation or enforcement of any of its rights, remedies or options hereunder or thereunder, including, without limitation, fees of outside legal counsel or the allocated costs of in-house legal counsel, accounting, consulting, brokerage or other similar professional fees or expenses, and any fees or expenses associated with travel or other costs relating to any appraisals or examinations conducted in connection with this Agreement or any collateral therefor, all whether or not legal action is instituted. In addition, the Guarantors shall be jointly and severally obligated to pay any and all stamp and other taxes payable or determined to be payable in connection with the execution and delivery of this Agreement and all other instruments and documents to be delivered in connection with any Guaranteed Obligation. Any fees, expenses or

 

- 12 -


other charges that the Lender is entitled to receive from any Guarantor hereunder shall bear interest from the date of any demand for payment until paid at a rate per annum equal to the rate that would be then applicable to the Loan or that would have been then applicable to the Loan, if the Loan is not then outstanding.

Section 6.05. Representations and Warranties . All covenants, agreements, representations and warranties made herein or in any other document delivered by or on behalf of any Guarantor pursuant to or in connection with this Agreement are material and shall be deemed to have been relied upon by the Lender, notwithstanding any investigation heretofore or hereafter made by the Lender and shall survive the issuance of any Guaranteed Obligations, and shall continue in full force and effect so long as the Loan Agreement is in effect or any of the Guaranteed Obligations remain outstanding and unpaid or any facility for the making of loans to the Borrower remains in effect. All statements contained in any certificate or other paper delivered to the Lender at any time by or on behalf of any Guarantor pursuant hereto shall constitute representations and warranties by such Guarantor hereunder. All representations, warranties, covenants, agreements and obligations of the Guarantors contained herein shall be deemed to be joint and several representations, warranties, covenants and agreements of the Guarantors, whether or not expressly so stated herein.

Section 6.06. Binding Effect; Assignment . This Agreement shall be binding upon each Guarantor and its respective successors and assigns and shall inure to the benefit of the Lender and its successors and assigns. No Guarantor may assign this Agreement or any rights hereunder without the express written consent of the Lender.

Section 6.07. Reproduction of Agreement . This Agreement and all other instruments, documents and papers which relate thereto that have been or may be hereafter furnished to the Lender may be reproduced by the Lender by any photographic, photostatic, micro-card, miniature photographic, xerographic or similar process, and the Lender may destroy the original from which any document was so reproduced. Any such reproduction shall be admissible in evidence as the original itself in any judicial or administrative proceeding (whether or not the original is in existence and whether or not such reproduction was made in the regular course of business).

Section 6.08. Replacement Documents . Upon receipt of an affidavit of an officer of the Lender as to the loss, theft, destruction or mutilation of this Agreement or of any other document delivered pursuant hereto that is not of public record and, in the case of any such mutilation, upon surrender and cancellation of this Agreement or such other document, the Guarantors will issue, in lieu thereof, a replacement Guaranty Agreement or other document.

Section 6.09. Consent to Jurisdiction . Each Guarantor irrevocably submits to the non-exclusive jurisdiction of any Massachusetts court or any federal court sitting within The Commonwealth of Massachusetts over any suit, action or proceeding arising out of or relating to this Agreement. Each Guarantor irrevocably waives, to the fullest extent permitted by law, any objection which it may now or hereafter have to the laying of venue of any such suit, action or proceeding brought in such a court and any claim that any such suit, action or proceeding has been brought in an inconvenient forum. Each Guarantor agrees that final judgment in any such suit, action or proceeding brought in such a court shall be enforced in any court of proper

 

- 13 -


jurisdiction by a suit upon such judgment, provided that service of process in such action, suit or proceeding shall have been effected upon such Guarantor in one of the manners specified in the following paragraph of this Section 6.09 or as otherwise permitted by law.

Each Guarantor hereby consents to process being served in any suit, action or proceeding of the nature referred to in the preceding paragraph of this Section 6.09 either (i) by mailing a copy thereof by registered or certified mail, postage prepaid, return receipt requested, to it at its address set forth in Section 6.03 or (ii) by serving a copy thereof upon it at its address set forth in Section 6.03. Each Guarantor irrevocably waives, to the fullest extent permitted by law, all claims of error by reason of any service as contemplated herein and agrees that such service shall (x) be deemed in every respect effective service upon such Guarantor in any such suit, action or proceeding and (y) to the fullest extent permitted by law, be taken and held to be valid personal service upon and personal delivery to such Guarantor.

Section 6.10. Governing Law . This Agreement shall be governed by, and construed in accordance with, the laws of The Commonwealth of Massachusetts (without giving effect to conflict of laws principles).

Section 6.11. Severability . In the event that any provision of this Agreement or the application thereof to any Person, property or circumstances shall be held to any extent to be invalid or unenforceable, the remainder of this Agreement and the application of such provision to Persons, properties or circumstances other than those as to which it has been held invalid or unenforceable shall not be affected thereby, and each provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.

Section 6.12. Usury . It is expressly stipulated and agreed to be the intent of each Guarantor and the Lender at all times to comply with applicable state law or applicable United States federal law (to the extent that it permits the Lender to contract for, charge, take, reserve or receive a greater amount of interest than under state law) and that this Section shall control every other covenant and agreement in this Agreement and the other Loan Documents. If applicable state or federal law should be at any time be judicially interpreted so as to render usurious any amount called for under this Agreement, or any of the other Loan Documents, or contracted for, charged, taken, reserved or received with respect to this Agreement, or if the acceleration of any Guaranteed Obligation, or any prepayment, results in any Guarantor having paid any interest in excess of that permitted by applicable law, then it is the Lender’s express intent that all excess amounts theretofore actually collected by the Lender from such Guarantor and then retained by the Lender shall be credited on the principal balance of the indebtedness guaranteed hereby, and the provisions of this Agreement shall immediately be deemed reformed and the amounts thereafter collectible hereunder and thereunder reduced, without the necessity of the execution of any new documents, so as to comply with the applicable law, but so as to permit the recovery of the fullest amount otherwise called for hereunder or thereunder. All sums paid or agreed to be paid by any Guarantor to the Lender for the use or forbearance of the Guaranteed Obligations shall, to the extent permitted by applicable law, be amortized, prorated, allocated and spread throughout the full stated term of the Guaranteed Obligations until payment in full so that the rate or amount of interest collected under this Agreement does not exceed the maximum lawful rate from time to time in effect and applicable to the obligations payable under this Agreement.

 

- 14 -


Section 6.13. Headings . Article and Section headings in this Agreement are included herein for convenience of reference only and shall not constitute a part of this Agreement for any other purpose.

Section 6.14. WAIVER OF JURY TRIAL . THE GUARANTORS AND THE LENDER WAIVE TRIAL BY JURY IN RESPECT OF ANY DISPUTE OR CLAIM HEREUNDER OR UNDER ANY OF THE OTHER LOAN DOCUMENTS AND ANY ACTION ON SUCH DISPUTE. THIS WAIVER IS KNOWINGLY, WILLINGLY AND VOLUNTARILY MADE BY THE GUARANTORS AND THE LENDER, AND THE GUARANTORS AND THE LENDER HEREBY REPRESENT THAT NO REPRESENTATIONS OF FACT OR OPINION HAVE BEEN MADE BY ANY PERSON OR ENTITY TO INDUCE THIS WAIVER OF TRIAL BY JURY OR TO IN ANY WAY MODIFY OR NULLIFY ITS EFFECT. THIS PROVISION IS A MATERIAL INDUCEMENT FOR THE PARTIES ENTERING INTO THE LOAN DOCUMENTS. THE GUARANTORS AND THE LENDER ARE EACH HEREBY AUTHORIZED TO FILE A COPY OF THIS SECTION IN ANY PROCEEDING AS CONCLUSIVE EVIDENCE OF THIS WAIVER OF JURY TRIAL. EACH GUARANTOR FURTHER REPRESENTS AND WARRANTS THAT IT HAS BEEN REPRESENTED IN THE SIGNING OF THIS AGREEMENT AND IN THE MAKING OF THIS WAIVER BY INDEPENDENT LEGAL COUNSEL, OR HAS HAD THE OPPORTUNITY TO BE REPRESENTED BY INDEPENDENT LEGAL COUNSEL SELECTED OF ITS OWN FREE WILL, AND THAT IT HAS HAD THE OPPORTUNITY TO DISCUSS THIS WAIVER WITH COUNSEL.

Section 6.15. Integration . This Agreement and any other documents delivered herewith are intended by the parties as the final, complete and exclusive statement of the transactions evidenced by this Agreement. All prior or contemporaneous promises, agreements and understandings, whether oral or written, are deemed to be superseded by this Agreement and the other documents delivered herewith.

Section 6.16. Counterparts . This Agreement may be signed in any number of counterparts with the same effect as if the signatures hereto and thereto were upon the same instrument.

[Signature pages follow.]

 

- 15 -


IN WITNESS WHEREOF, the Guarantors have executed this Agreement, as an instrument under seal, as of the day and year first above written.

 

ATOSSA HEALTHCARE, INC.
By:  

/s/ J. Michael French

Name:   J. Michael French
Title:   President
MDRNA RESEARCH, INC.
By:  

/s/ J. Michael French

Name:   J. Michael French
Title:   President
CALAIS ACQUISITION CORP.
By:  

/s/ J. Michael French

Name:   J. Michael French
Title:   President

Signature Page to Guaranty Agreement


Accepted:

 

CEQUENT PHARMACEUTICALS, INC.
By:  

/s/ Peter D. Parker

Name:   Peter D. Parker
Title:   President and Chief Executive Officer

Signature Page to Guaranty Agreement


DISCLOSURE SCHEDULE

 

Item 3.01(a)   - Subsidiaries of Guarantors
Item 3.01(b)   - Ownership of Stock of Guarantors
Item 3.01(f)   - Litigation and Administrative Proceedings


Item 3.01(a)

Subsidiaries of Guarantors

None


Item 3.01(b)

Ownership of Stock of Guarantors

 

Guarantor:

  

Stockholder:

  

Number of Shares/Class:

   Percent
Ownership:
 
Atossa HealthCare, Inc.    MDRNA, Inc.    100 / Common    100
MDRNA Research, Inc.    MDRNA, Inc.    360,000 / Common    100
   MDRNA, Inc.    1,839,080 / Series A Participating Preferred    100
Calais Acquisition Corp.    MDRNA, Inc.    1,000 / Common    100


Item 3.01(f)

Litigation and Administrative Proceedings

None

Exhibit 10.8

MDRNA, INC.

WAIVER AGREEMENT

This Waiver Agreement (this “ Agreement ”), dated as of March 31, 2010, is made by and between MDRNA, Inc. (the “ Company ”) and J. Michael French (“ Executive ”).

RECITALS

WHEREAS, the Company and Executive are parties to that certain Employment Agreement, effective June 23, 2008 (as amended from time to time, the “ Employment Agreement ”);

WHEREAS, the Company maintains the 2008 Stock Incentive Plan, the 2004 Stock Incentive Plan, the 2002 Stock Option Plan and the 2000 Non-Qualified Stock Option Plan (collectively, the “ Plans ”);

WHEREAS, pursuant to Section 21 of the Employment Agreement, in the event of Executive’s separation from the Company under certain conditions within one year of a Change of Control (as such term is defined in the Employment Agreement), Executive is entitled to additional base compensation and incentive compensation and all of Executive’s Outstanding Options (as such term is defined in the Employment Agreement) become fully vested as of the date of any Change in Control;

WHEREAS, Executive is the recipient of awards granted pursuant to one or more of the Plans, plus additional non-plan options that were issued to Executive as an employment inducement grant;

WHEREAS, the Company is a party to that certain Agreement and Plan of Merger by and among MDRNA, Inc., Calais Acquisition Corp. and Cequent Pharmaceuticals, Inc., dated as of March 31, 2010 (the “ Merger Agreement ”), pursuant to which Calais Acquisition Corp. will merge with and into Cequent Pharmaceuticals, Inc. (the “ Merger ”);

WHEREAS, Executive acknowledges that the consummation of the Merger may be deemed a Change of Control, as defined under the Employment Agreement; and

WHEREAS, as a material inducement for Cequent Pharmaceuticals, Inc. to consummate the Merger, Executive and the Company wish to enter into this Agreement pursuant to which Executive will waive any right and entitlement that he or she may have to receive certain compensation and benefits under the Employment Agreement and any equity compensation awards granted to Executive as a result of the Merger being deemed a Change of Control.

NOW, THEREOFRE, in consideration of the covenants and undertakings contained herein, and for other good and valuable consideration, the sufficiency of which is hereby acknowledged, the Company and Executive hereby agree as follows:

1. Waiver .

(a) With respect to the Merger, Executive hereby waives, relinquishes and gives up any and all right, title, claim and interest that Executive may have: (i) to receive any amount

 

1


payable pursuant to Section 21(a)(i) of the Employment Agreement; (ii) to receive any amount payable pursuant to Section 21(a)(ii) of the Employment Agreement; and (iii) to any accelerated vesting of Outstanding Options pursuant to Section 21(a)(iii) of the Employment Agreement, pursuant to any of the Plans and pursuant to the grant agreement for any awards (including any non-plan options), in each case, as a result of the Merger being deemed a Change of Control. For the avoidance of doubt, the waiver contained in this Section 1(a) shall not in any way reduce the rights and payments to which Executive would otherwise be entitled pursuant to Section 12 of the Employment Agreement in connection with a termination of Executive’s employment. In addition, if Executive’s employment is terminated on or before December 31, 2010 for any reason other than termination for Cause, then notwithstanding anything to the contrary contained in any of the Plans, in any grant agreement, or in any other provision of the Employment Agreement, any and all unvested common stock options held by Executive shall immediately vest in full upon the effective date of such termination, and shall remain exercisable for a period of two (2) years thereafter (but in no event after the original expiration date of the award).

(b) Executive also hereby acknowledges that any cash received by the Company as a result of the consummation of the Merger shall not be counted toward the $5 million in unrestricted cash threshold necessary to trigger payment by the Company to Executive of the retention bonuses approved by the Board of Directors of the Company on March 1, 2010.

2. No Good Reason . Executive hereby acknowledges and agrees that nothing contained in this Agreement shall, or shall be construed so as to, constitute Good Reason (as defined in the Employment Agreement) for purposes of the Employment Agreement or any other agreement between Executive and the Company.

3. Applicable Law . This Agreement shall be administered, interpreted and enforced under the internal laws of the State of Washington, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Washington or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Washington.

4. Enforceability . If any provision of this Agreement is determined to be invalid or unenforceable, it shall be adjusted rather than voided, to achieve the intent of the parties to the extent possible, and the remainder of the Agreement shall be enforced to the maximum extent possible.

5. Counterparts . This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which together shall constitute one and the same instrument.

6. Captions . The captions contained in this Agreement are included for convenience only and shall have no bearing on the meaning or interpretation of the provisions contained herein.

[ remainder of page intentionally left blank; signature page follows ]

 

2


IN WITNESS WHEREOF, the Company and Executive have caused this Agreement to be executed as of the date first above written.

 

MDRNA, Inc.
By:  

/s/ Bruce R. Thaw

Name:   Bruce R. Thaw
Title:   Chairman of the Board
EXECUTIVE

/s/ J. Michael French

J. Michael French

[S IGNATURE P AGE TO J.M. F RENCH W AIVER A GREEMENT ]

Exhibit 10.9

MDRNA, INC.

WAIVER AGREEMENT

This Waiver Agreement (this “ Agreement ”), dated as of March 31, 2010, is made by and between MDRNA, Inc. (the “ Company ”) and Peter S. Garcia (“ Executive ”).

RECITALS

WHEREAS, the Company and Executive are parties to that certain Employment Agreement, effective July 13, 2009 (as amended from time to time, the “ Employment Agreement ”);

WHEREAS, the Company maintains the 2008 Stock Incentive Plan, the 2004 Stock Incentive Plan, the 2002 Stock Option Plan and the 2000 Non-Qualified Stock Option Plan (collectively, the “ Plans ”);

WHEREAS, pursuant to Section 20 of the Employment Agreement, in the event of Executive’s separation from the Company under certain conditions within one year of a Change of Control (as such term is defined in the Employment Agreement), Executive is entitled to additional base compensation and incentive compensation and all of Executive’s Outstanding Options (as such term is defined in the Employment Agreement) become fully vested as of the date of any Change in Control;

WHEREAS, Executive is the recipient of awards granted pursuant to one or more of the Plans;

WHEREAS, the Company is a party to that certain Agreement and Plan of Merger by and among MDRNA, Inc., Calais Acquisition Corp. and Cequent Pharmaceuticals, Inc., dated as of March 31, 2010 (the “ Merger Agreement ”), pursuant to which Calais Acquisition Corp. will merge with and into Cequent Pharmaceuticals, Inc. (the “ Merger ”);

WHEREAS, Executive acknowledges that the consummation of the Merger may be deemed a Change of Control, as defined under the Employment Agreement; and

WHEREAS, as a material inducement for Cequent Pharmaceuticals, Inc. to consummate the Merger, Executive and the Company wish to enter into this Agreement pursuant to which Executive will waive any right and entitlement that he or she may have to receive certain compensation and benefits under the Employment Agreement and any equity compensation awards granted to Executive as a result of the Merger being deemed a Change of Control.

NOW, THEREOFRE, in consideration of the covenants and undertakings contained herein, and for other good and valuable consideration, the sufficiency of which is hereby acknowledged, the Company and Executive hereby agree as follows:

1. Waiver .

(a) With respect to the Merger, Executive hereby waives, relinquishes and gives up any and all right, title, claim and interest that Executive may have: (i) to receive any amount

 

1


payable pursuant to Section 20(a)(i) of the Employment Agreement; (ii) to receive any amount payable pursuant to Section 20(a)(ii) of the Employment Agreement; and (iii) to any accelerated vesting of Outstanding Options pursuant to Section 20(a)(iii) of the Employment Agreement, pursuant to any of the Plans and pursuant to the grant agreement for any awards, in each case, as a result of the Merger being deemed a Change of Control. For the avoidance of doubt, the waiver contained in this Section 1(a) shall not in any way reduce the rights and payments to which Executive would otherwise be entitled pursuant to Section 11 of the Employment Agreement in connection with a termination of Executive’s employment. In addition, if Executive’s employment is terminated on or before December 31, 2010 for any reason other than termination for Cause, then notwithstanding anything to the contrary contained in any of the Plans, in any grant agreement, or in any other provision of the Employment Agreement, any and all unvested common stock options held by Executive shall immediately vest in full upon the effective date of such termination, and shall remain exercisable for a period of two (2) years thereafter (but in no event after the original expiration date of the award).

(b) Executive also hereby acknowledges that any cash received by the Company as a result of the consummation of the Merger shall not be counted toward the $5 million in unrestricted cash threshold necessary to trigger payment by the Company to Executive of the retention bonuses approved by the Board of Directors of the Company on March 1, 2010.

2. No Good Reason . Executive hereby acknowledges and agrees that nothing contained in this Agreement shall, or shall be construed so as to, constitute Good Reason (as defined in the Employment Agreement) for purposes of the Employment Agreement or any other agreement between Executive and the Company.

3. Applicable Law . This Agreement shall be administered, interpreted and enforced under the internal laws of the State of Washington, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Washington or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Washington.

4. Enforceability . If any provision of this Agreement is determined to be invalid or unenforceable, it shall be adjusted rather than voided, to achieve the intent of the parties to the extent possible, and the remainder of the Agreement shall be enforced to the maximum extent possible.

5. Counterparts . This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which together shall constitute one and the same instrument.

6. Captions . The captions contained in this Agreement are included for convenience only and shall have no bearing on the meaning or interpretation of the provisions contained herein.

[ remainder of page intentionally left blank; signature page follows ]

 

2


IN WITNESS WHEREOF, the Company and Executive have caused this Agreement to be executed as of the date first above written.

 

MDRNA, Inc.
By:  

/s/ J. Michael French

Name:   J. Michael French
Title:   President and Chief Executive Officer
EXECUTIVE

/s/ Peter S. Garcia

Peter S. Garcia

 

[S IGNATURE P AGE TO P.S. G ARCIA W AIVER A GREEMENT ]

Exhibit 10.10

MDRNA, INC.

WAIVER AGREEMENT

This Waiver Agreement (this “ Agreement ”), dated as of March 31, 2010, is made by and between MDRNA, Inc. (the “ Company ”) and Barry Polisky (“ Executive ”).

RECITALS

WHEREAS, the Company and Executive are parties to that certain Employment Agreement, effective January 2, 2009 (as amended from time to time, the “ Employment Agreement ”);

WHEREAS, the Company maintains the 2008 Stock Incentive Plan, the 2004 Stock Incentive Plan, the 2002 Stock Option Plan and the 2000 Non-Qualified Stock Option Plan (collectively, the “ Plans ”);

WHEREAS, pursuant to Section 20 of the Employment Agreement, in the event of Executive’s separation from the Company under certain conditions within one year of a Change of Control (as such term is defined in the Employment Agreement), Executive is entitled to additional base compensation and incentive compensation and all of Executive’s Outstanding Options (as such term is defined in the Employment Agreement) become fully vested as of the date of any Change in Control;

WHEREAS, Executive is the recipient of awards granted pursuant to one or more of the Plans;

WHEREAS, the Company is a party to that certain Agreement and Plan of Merger by and among MDRNA, Inc., Calais Acquisition Corp. and Cequent Pharmaceuticals, Inc., dated as of March 31, 2010 (the “ Merger Agreement ”), pursuant to which Calais Acquisition Corp. will merge with and into Cequent Pharmaceuticals, Inc. (the “ Merger ”);

WHEREAS, Executive acknowledges that the consummation of the Merger may be deemed a Change of Control, as defined under the Employment Agreement; and

WHEREAS, as a material inducement for Cequent Pharmaceuticals, Inc. to consummate the Merger, Executive and the Company wish to enter into this Agreement pursuant to which Executive will waive any right and entitlement that he or she may have to receive certain compensation and benefits under the Employment Agreement and any equity compensation awards granted to Executive as a result of the Merger being deemed a Change of Control.

NOW, THEREOFRE, in consideration of the covenants and undertakings contained herein, and for other good and valuable consideration, the sufficiency of which is hereby acknowledged, the Company and Executive hereby agree as follows:

1. Waiver .

(a) With respect to the Merger, Executive hereby waives, relinquishes and gives up any and all right, title, claim and interest that Executive may have: (i) to receive any amount

 

1


payable pursuant to Section 20(a)(i) of the Employment Agreement; (ii) to receive any amount payable pursuant to Section 20(a)(ii) of the Employment Agreement; and (iii) to any accelerated vesting of Outstanding Options pursuant to Section 20(a)(iii) of the Employment Agreement, pursuant to any of the Plans and pursuant to the grant agreement for any awards, in each case, as a result of the Merger being deemed a Change of Control. For the avoidance of doubt, the waiver contained in this Section 1(a) shall not in any way reduce the rights and payments to which Executive would otherwise be entitled pursuant to Section 11 of the Employment Agreement in connection with a termination of Executive’s employment. In addition, if Executive’s employment is terminated on or before December 31, 2010 for any reason other than termination for Cause, then notwithstanding anything to the contrary contained in any of the Plans, in any grant agreement, or in any other provision of the Employment Agreement, any and all unvested common stock options held by Executive shall immediately vest in full upon the effective date of such termination, and shall remain exercisable for a period of two (2) years thereafter (but in no event after the original expiration date of the award).

(b) Executive also hereby acknowledges that any cash received by the Company as a result of the consummation of the Merger shall not be counted toward the $5 million in unrestricted cash threshold necessary to trigger payment by the Company to Executive of the retention bonuses approved by the Board of Directors of the Company on March 1, 2010.

2. No Good Reason . Executive hereby acknowledges and agrees that nothing contained in this Agreement shall, or shall be construed so as to, constitute Good Reason (as defined in the Employment Agreement) for purposes of the Employment Agreement or any other agreement between Executive and the Company.

3. Applicable Law . This Agreement shall be administered, interpreted and enforced under the internal laws of the State of Washington, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Washington or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Washington.

4. Enforceability . If any provision of this Agreement is determined to be invalid or unenforceable, it shall be adjusted rather than voided, to achieve the intent of the parties to the extent possible, and the remainder of the Agreement shall be enforced to the maximum extent possible.

5. Counterparts . This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which together shall constitute one and the same instrument.

6. Captions . The captions contained in this Agreement are included for convenience only and shall have no bearing on the meaning or interpretation of the provisions contained herein.

[remainder of page intentionally left blank; signature page follows]

 

2


IN WITNESS WHEREOF, the Company and Executive have caused this Agreement to be executed as of the date first above written.

 

MDRNA, Inc.
By:  

/s/ J. Michael French

Name:   J. Michael French
Title:   President and Chief Executive Officer
EXECUTIVE

/s/ Barry Polisky

Barry Polisky

[S IGNATURE P AGE TO B. P OLISKY W AIVER A GREEMENT ]